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Abstract 
Musculoskeletal pain, and particularly low back pain, has been identified as a considerable burden 
to health and society globally. Psychological factors are known to impact on pain and disability 
and targeting such factors during treatment has been shown to be effective. Optimising 
treatment effectiveness requires the identification of key mediators that can be targeted during 
treatment to lead to an improvement in outcome. However, the study designs and methods of 
mediation analysis most often applied have been found to be flawed, limiting the interpretability 
of current treatment mediation literature. The aim of this thesis was to identify, apply, and 
evaluate the methods and analyses used to carry out treatment mediation analysis in 
psychological intervention studies of musculoskeletal pain populations in order to improve future 
mediation studies. 
 
A systematic review identified 10 studies of psychological interventions of musculoskeletal pain 
populations which had carried out a mediation analysis. Although several treatment mediators 
were identified, the quality of the analyses were poor with few studies using optimal methods. 
Secondary analysis of observational data identified several potential treatment mediators. 
Mediation analysis, performed using recommended methods, subsequently tested factors in two 
trials previously hypothesised by the study authors as being responsible for the study’s success 
(psychological distress and fear avoidance). A final analysis of diary data investigating the value of 
measuring key mediators during treatment found that this provided more information than pre-
post-treatment scores usually included in intervention studies.  
 
This thesis highlights how a few small changes to the RCT design commonly used to test study 
effectiveness can allow the inclusion of mediation analysis aiming to identify how a treatment 
works, leading to more streamlined, focused interventions in the future that more directly target 
factors most likely to lead to disability improvement. 
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Chapter 1: Introduction 
 
This thesis explores the methodological challenges that can be encountered when conducting 
treatment mediation analysis. This first chapter provides the context of this PhD and explains the 
background to the project and how the question around mediating factors emerged. It also sets 
out the definitions of mediation and psychological interventions that will be used throughout this 
thesis and explains why the investigation of psychological interventions is of particular interest. 
This chapter helps to focus the reader on the rationale for this project by setting out why research 
of mediating factors in psychological treatments of back pain and other musculoskeletal (MSK) 
conditions is important and what work needs to be done to address the current gaps in the 
literature. 
 
1.1 Defining the Problem 
The global prevalence of low back pain (LBP) has been estimated to be 9.4% (95% CI 9.0 to 9.8) 
(age standardised point prevalence in 2010), with a mean age-standardised point prevalence of 
15% (95% CI 14.1 to 16.0) in Western European countries (Hoy et al 2014). LBP has been rated as 
the greatest contributor to years lived with disability (Hoy et al 2014). A review of the 
epidemiology of pain conditions identified lifetime prevalence estimates for LBP as being between 
51% and 84% (Henschke et al 2015), although the authors describe problems with the definitions 
used across studies to estimate these prevalence estimates, including variability in the definition 
of an ‘episode’ of back pain. In the UK, LBP has been found to affect between 49%-80% of the 
population at some point in their lifetime, leading to high costs in terms of healthcare, workplace 
absence and impact on the individual (Maniadakis & Gray 2000). In the UK, MSK conditions are 
predominantly managed in primary care, with back pain being the most common reason for 
patients to consult (Jordan et al 2010). A recent UK case-control study comparing people with and  
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without chronic LBP found that healthcare costs for those with chronic LBP, including general 
practitioner (GP) visits, outpatient referrals and prescriptions, were almost double the costs for 
those without chronic LBP (Hong et al 2012). GP consultation costs for MSK consultations were 
third in 2003, behind costs for respiratory and circulatory system diseases (March et al 2014). 
Other, less well described costs include the impact on activities of daily living, work and support 
from family or carers (March et al 2014). 
 
The prognosis of patients with an acute episode of LBP is often good (Pengel et al 2003; Menezes 
Costa et al 2012). Most patients (68%) return to work within a month and 93% are back at work 
after six months (Wynne-Jones et al 2014). Indeed, return to work and normal activities as quickly 
as possible is the recommended course of action for sufferers of acute LBP (Main & Williams 
2002). However, prognosis varies substantially for individual patients (Hayden et al 2010) and 
persisting symptoms have been reported by some patients up to a year after their initial 
consultation (Hayden et al 2010; Menezes Costa et al 2012). Pain duration is only one of many 
factors that are important in defining further chronicity; other factors include the impact on 
function and the intensity of use of healthcare services (Cedraschi et al 1999). Further, the 
definitions of acute and chronic pain, and whether these terms should be used at all, have been 
disputed over the years (Cedraschi et al 1999; Von Korff & Miglioretti 2005; Dunn & Croft 2006). 
The label of “chronic” has negative connotations, both for healthcare practitioners (Cedraschi et 
al 1999; Barker et al 2009) and for patients, often suggesting incurability and inciting fear (Barker 
et al 2009). Both “acute” and “chronic” have been found to be often misinterpreted by patients, a 
fact acknowledged by practitioners (Barker et al 2009). One approach to try and address this has 
been to employ a prognostic approach to defining chronic pain, and incorporate not only pain 
duration but also key prognostic variables such as depression and pain severity, to examine 
whether a person’s condition is likely to improve or worsen (Von Korff & Miglioretti 2005). A risk  
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score for clinical use was developed to support this approach (Von Korff & Miglioretti 2005), with 
results being replicated in a UK primary care sample (Dunn et al 2008). The replication study 
found differences compared to the US sample included in the original study in terms of the 
proportion of patients assigned to each risk category, which the authors suggest could be due to 
differences between the healthcare systems or the healthcare settings of the two studies (Dunn 
et al 2008). Further work on developing this risk score to classify chronic pain found that the risk 
score was much more predictive of future back pain than pain duration only (Von Korff & Dunn 
2008). This prognostic approach also takes into account the uncertainty of risk predictions, by 
defining chronic pain as “possible” or “probable” (Von Korff & Miglioretti 2005; Von Korff & Dunn 
2008). Other studies of long-term trajectories suggest that back pain intensity remains fairly 
stable over time, depending on patients’ baseline pain or short-term trajectory (Dunn et al 
2013a), and that while most LBP cases are mild, there is individual variation in terms of whether 
patients improved or had recurrent pain (Cassidy et al 2005). This again suggests that LBP is not as 
easy to define as the terms “acute” and “chronic” would suggest.  
 
In summary, MSK pain represents a significant burden for the individual and the wider 
community. It is a common condition that is likely to fluctuate over time, with sufferers consulting 
primary care when their pain is most severe. The commonly used terms of “acute” and “chronic” 
pain have been disputed, with a prognostic approach to LBP that captures the risk of a person 
developing long-term pain being considered more informative. Identification of prognostic factors 
that can help to improve the prediction of long-term outcomes of people with MSK pain, or 
identify those most likely to develop long-term disability, has therefore been the focus of research 
in recent years. 
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1.1.1 Keele University Research Institute for Primary Care and Health Sciences  
This PhD was developed as part of the psychological workstream of the Research Institute’s Spinal 
Pain Programme, funded by a National Institute for Health Research (NIHR) Programme Grant for 
Applied Research with the aim of investigating and addressing obstacles to recovery through 
three separate workstreams (physical, psychological and occupational) to incorporate each 
element of the biopsychosocial model (see Section 1.2). The psychological workstream aimed to 
develop better targeting of treatment, so that those who were most in need of psychological 
treatment would receive appropriate care. Much of the evidence for this work was generated 
from prognostic studies, including previous Research Institute work, which found that 
psychological factors were important in predicting LBP outcomes in primary care, including illness 
perceptions (Foster et al 2008; Foster et al 2010; Campbell et al 2013a), fear-avoidance beliefs 
(Verkerk et al 2012; Wertli et al 2014a) and catastrophising thoughts (Wertli et al 2014b). Work 
conducted in the Research Institute also showed that a stratified care approach, where patients 
consulting in primary care with LBP were assessed for their risk of a poor outcome and treated 
accordingly (the STarT Back trial), was successful at reducing disability and was also more cost-
effective than usual care (Hill et al 2011). The STarT Back trial aimed to not only identify particular 
groups of patients that needed more specialist care, but also to improve the quality of care by 
tackling modifiable predictors most likely to lead to an improvement in patient outcomes. The 
most complex patients, with high scores on measures of physical and psychological factors, 
received specialised physiotherapy treatment to address these factors. However, the inclusion of 
psychological factors as targets for treatment was based on their prognostic value, irrespective of 
the extent to which they were potentially modifiable and therefore appropriate treatment 
targets. Preliminary analysis of a wide range of psychological factors indicated that illness 
perceptions in particular appeared to be stable over time, suggesting that they may be difficult to 
influence and were perhaps not modifiable. This highlighted the difference between predictors  
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and mediators: a predictor is a factor that is associated with outcome regardless of treatment 
received, while (treatment effect) mediators are factors which change as a result of treatment 
and therefore contribute to the explanation of outcome. Psychological factors are not only strong 
predictors but were considered potentially modifiable and were therefore selected as the primary 
vehicle for the investigation of mediators of treatment outcome. The PhD offered an opportunity 
to investigate the methodological challenges in explaining outcomes of treatment and help 
improve the design of interventions designed specifically to identify and target treatment 
mediators in future studies. 
 
 
1.2 Biopsychosocial Model of Pain 
Individual experiences of pain differ depending on not only physiology but also on previous 
experience of pain, the context within which it is experienced (Cederaschi & Allaz 2005; Linton & 
Shaw 2011) and what the person believes the pain to mean (Main & Watson 1999; Turk & Okifuji 
2002). The amount of physical damage often does not correlate strongly with the amount of pain 
or disability reported (Sharp 2001) and it is therefore necessary to move beyond a purely 
biomedical model of pain to a more evidence-based biopsychosocial model (Vlaeyen & Morley 
2005; Gatchel & Turk 2008) which acknowledges the influence of people’s response to pain 
(whether gauged in pain, behaviours, thought processes or emotional responses) and the 
influence of the person’s social environment (Waddell 1987). In the context of LBP, Brunner et al 
(2013) describe both pain and disability as being multidimensional and part of a biopsychosocial 
model. It follows that any treatment of pain and disability should encompass not only physical 
aspects of the complaint but also psychosocial aspects. The biopsychosocial model is therefore 
important not only for understanding how the condition of LBP develops but also how it is treated 
(Main & Williams 2002). 
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It is important to recognise that psychological reactions to pain are normal and expected (Main & 
Watson 1999; Eccleston et al 2013) and should not to be confused with mental illness (Main & 
George 2011). The experience of pain is hard to ignore (Linton & Shaw 2011) and we are 
programmed to respond to it (Williams 2002). Certain behaviours, like rest and avoidance of 
activities, may be adaptive after an acute injury (Turk & Okifuji 2002), but persistence of pain may 
lead to these strategies becoming maladaptive (Turk & Okifuji 2002; Linton & Shaw 2011). 
Similarly, attention to pain is adaptive initially as it helps to motivate us to do something about it 
(Linton & Shaw 2011), but hypervigilance to pain, especially when little can be done to reduce its 
intensity, may cause additional anxiety and fear (Turk & Okifuji 2002) and lead to further disability 
(Crombez et al 2012). Psychological factors or experiences related to pain are therefore not 
pathological, but do sometimes need modification in order for the patient to regain function and 
the ability to do most of his or her everyday activities. 
 
However, the need to accept the biopsychosocial model is not just limited to clinicians and 
researchers – patients also need to accept that psychosocial factors play an important role in their 
pain experience. In a qualitative study of patients with persistent pain (n=10), Snelgrove et al 
(2013) found that most of their participants viewed their pain in a biomedical context, and were 
wary of ‘alternative’ treatments that focused on psychosocial aspects of their pain experience. 
The authors suggested that this focus on physical pain and trying to ‘fix’ it maintained their pain 
experiences over time. Pincus et al (2013) also assert that the biopsychosocial model is currently 
not being well applied in practice, especially in a primary care context, with only one or two of the 
components being integrated into treatment. It could be that those working in primary care are 
not always sufficiently skilled to identify psychological factors contributing to the persistence or 
development of pain-related disability. This could help explain why current primary care 
psychological treatments do not show large effects. Nonetheless, there is evidence to support 
psychologically orientated pain management in secondary and tertiary care (Eccleston et al 2009).  
Chapter 1 Introduction Page 7 
 
1.3 Evidence for the Importance of Psychological Factors in Predicting LBP 
Outcomes 
The majority of evidence for the importance of psychological factors comes from prognostic 
studies, where psychological factors have been found to predict patient outcome regardless of 
what treatment a patient received (Hill & Fritz 2011). A number of reviews exist that have 
investigated the relationships between psychological factors and functional limitations. Factors 
investigated have included fear-avoidance behaviours and beliefs (Linton 2000; Pincus et al 2002; 
Geisser et al 2003; Pincus et al 2006; Lakke et al 2009; Ramond et al 2011; Verkerk et al 2012; Zale 
et al 2013; Wertli et al 2014a), catastrophising thoughts (Geisser et al 2003; Wertli et al 2014b), 
self-efficacy (Geisser et al 2003; Jackson et al 2014), depression (Linton 2000; Geisser et al 2003; 
Mallen et al 2007; Ramond et al 2011), psychological distress (Hayden et al 2009), negative 
cognitions (Hayden et al 2009), recovery expectations (Laisné et al 2012), somatisation (Mallen et 
al 2007; Laisné et al 2012), passive or maladaptive coping (Linton 2000; Chou & Shekelle 2010; 
Ramond et al 2011; Laisné et al 2012) and anxiety (Mallen et al 2007). Almost all of these reviews 
report evidence for the importance of psychological factors, with strong associations with 
functional limitations both cross-sectionally and over time. However, several reviews also 
highlight the poor quality of the included studies, stating that the evidence is conflicting and that 
the heterogeneity across the studies makes it difficult to draw strong conclusions. One study that 
looked to create new prognostic models for the outcomes of pain, activity limitation and 
participation restriction (Kent & Keating 2008) found that the conflicting evidence made this task 
impossible, and concluded that future prognostic studies with better designs and stronger 
methodology were needed. For fear-avoidance in particular, the evidence is somewhat mixed 
with some reviews concluding that this factor is important (Linton 2000; Geisser et al 2003; 
Ramond et al 2011), others reporting a lack of or little evidence for the importance of fear-
avoidance (Pincus et al 2002; Pincus et al 2006; Lakke et al 2009), and others still reporting 
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inconclusive findings for this factor (Verkerk et al 2012; Wertli et al 2014). In primary care studies 
specifically, there is inconsistent (and insufficient) evidence for fear-avoidance beliefs (Verkerk et 
al 2012; Wertli et al 2014a) and catastrophising thoughts (Wertli et al 2014b) as predictors of LBP 
outcomes.  
 
Overall, this body of research highlights the importance of psychological factors as predictors of 
LBP outcomes and evidence for their potential importance in influencing treatment. Guidelines on 
the management of LBP also recommend screening for and management of psychological factors 
(Koes et al 2010; Mayer et al 2010) although actual formal treatment of psychological factors 
seems to remain within the remit of secondary care according to some guidelines (Mayer et al 
2010). Psychological treatments such as cognitive-behavioural therapy (CBT) for chronic LBP is 
also recommended (Eccleston et al 2009; NICE Low back pain guideline 2009 (CG88)), although it 
is noted that to treat a complex chronic pain condition a range of interventions may be required 
(Airaksinen et al 2006).  
 
However, it is still unclear how psychological factors can best be utilised to improve patient 
outcomes (Linton & Shaw 2011). Some studies have carried out process analyses, which have 
investigated whether change in psychological variables is related to change in outcome. These 
studies move on a step from prediction studies by looking at how variables relate to each other 
over time and within a specific treatment. For example, Vowles et al (2007) found that changes in 
measures of catastrophising thoughts and acceptance contributed to changes in the outcomes of 
depression and physical performance in patients with chronic pain who had completed CBT 
treatment. This finding was supported by Baranoff et al (2013) who found statistically significant 
correlations between pre-post treatment change in catastrophising and acceptance as predictors 
of pre-treatment to three-month follow-up change in disability, a finding which was still present 
at six-month follow-up (Baranoff et al 2014). Other studies have gone further by including 
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assessments made during treatment, or at multiple time points, in their analysis. Burns et al 
(2003) investigated whether catastrophising thoughts and helplessness were associated with 
outcomes of CBT in 90 patients with chronic pain. Assessments were made at pre-, mid- and post-
treatment. They found that early (pre- to mid-treatment) changes in both catastrophising 
thoughts and helplessness were associated with later (mid- and post-treatment) changes in pain 
interference after controlling for depression. Bergbom et al (2012) explored changes in 
depression, catastrophising thoughts, worry, fear and avoidance beliefs on disability in 64 patients 
with a MSK problem (mostly LBP). Measurements were taken weekly from two weeks before to 
two weeks after psychological treatment which aimed to address worry, catastrophising thoughts 
and depression, and early change (pre-treatment to third week of treatment) in all variables 
except for catastrophising thoughts were associated with outcome. Overall, this evidence 
suggests that psychological factors are modifiable when targeted within treatments and that 
change in those factors is related to change in outcome. However, more work is needed in order 
to investigate how psychological factors can best be utilised in interventions to help improve 
outcomes in primary care LBP populations.  
 
1.3.1 Psychological interventions in LBP 
Interventions designed to influence psychological factors in order to improve functional outcomes 
in LBP have given mixed results, with some reporting positive findings (Lemstra & Olszynski 2005; 
Lamb et al 2010) and others not being particularly successful (Jellema et al 2005; Hay et al 2005). 
The reasons behind this have been explored, with one review identifying key issues which could 
explain the small treatment effects seen: the heterogeneity of patient populations, treatment 
content and delivery; issues around suboptimal assessment of back pain; and not enough 
assessment points being included in trials to show the course of back pain and how this changes 
over time (van der Windt et al 2008). A recent systematic review of psychological interventions 
for acute and subacute LBP found that the included studies had either no or inconsistent impact 
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on outcomes such as pain and functioning (Ramond-Roquin et al 2014). However, the review 
authors used a very wide definition of “psychosocial interventions” that mostly included an 
information intervention (reassurance, advice, encouraging patient to stay active). It could be 
argued that information giving is not a formal “psychological” intervention and that this term 
should be reserved for interventions that explicitly focus on psychological factors and attempt to 
change them, such as CBT. It is acknowledged that even within CBT interventions can vary 
enormously, from specialist care by a clinical psychologist in cases where pain results in a severe 
psychological impact, to psychologically informed physiotherapy delivered by non-psychologists 
trained to manage psychological obstacles to recovery (Main & George 2011). In this thesis, 
“psychological interventions” are defined as those which specifically target psychological factors 
for change, regardless of the setting, delivery or ‘strength’ of the intervention.  
 
 
1.4 The Use of Mediation Analysis to Extend Investigation into the 
Importance of Psychological Factors in LBP Outcomes 
1.4.1 Definition of mediation 
In order to improve the effectiveness of future interventions, variables that lead to change must 
be identified (Smeets et al 2006). Such information can help to tailor treatment in order to most 
effectively target the key factors that will improve patient outcome (Keefe et al 2004). These 
factors are known as mediators, and from a psychological treatment perspective are defined as 
factors which help explain how a treatment works by measuring the change that happens during 
treatment as well as its subsequent association with outcome (Vlaeyen & Morley 2005). A simple 
mediation model (involving only one potential mediator) is shown in Figure 1.1 below. Mediation 
analysis is important not only in terms of showing how a treatment may work, but also in terms of 
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showing which variables included in an intervention were key to changing the outcomes and 
suggesting how future interventions can be improved (MacKinnon et al 2007). 
 
Figure 1.1 Example of a simple mediation model 
 
 
 
 
 
 
Figure 1.1 presents a causal pathway between the intervention, mediator and outcome. The 
letters a, b and c denote the direct effects of each variable on the other. The c path is the direct 
effect of treatment on outcome, before taking into account the effects of specific mediating 
variables. The mediating effect is defined in different ways (see Chapter 3) but the method used 
in this thesis defines mediation as the product of paths a and b (a x b, or ab). The ć path denotes 
the total effect of the whole model (ab+c).  
 
In order for a variable to be considered a potential mediator, it must be potentially modifiable, be 
correlated with change in the outcome measure (Kazdin 2007) and the intervention should also 
be associated with change in the mediator (Kazdin 2007). Kraemer et al (2002) also specify that to 
be a mediator the variable must change during treatment. It has been acknowledged that just 
because a factor is prognostic (has been found to be related to outcome) does not mean it is 
necessarily causally related to outcome (van der Windt et al 2008). Causality is a key issue in 
mediation analysis and is explored in depth in Chapter 3. 
 
  
Mediator 
b a 
c 
Outcome Intervention 
ć 
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1.4.2 Related terms and common misinterpretations 
Analysis and ideas around mediation have been developed in different fields, leading to different 
terms being used to describe the same concept. “Intermediate variable” and “intervening 
variable” are commonly used terms for mediating factors (Kraemer et al 2001). The word 
mechanism is also often associated with mediation analysis and the two words are often used 
interchangeably. However, identifying mediators is only a first stage in establishing mechanisms; 
many mediators may not actually be the key factor responsible for the treatment’s effect despite 
being causally associated with both treatment and outcome (Laurenceau et al 2007). Another 
term that is often confused with mediation is moderation, which concerns factors predicting 
(rather than explaining) the effect of treatment. Vlaeyen & Morley (2005) define moderation as a 
factor that affects how strong a relationship is between an indicator and the outcome and 
specifies when and at what point an effect occurs (i.e. what works for which patient(s)). They 
define mediation as a factor that helps explain how an effect occurs (Vlaeyen & Morley 2005). In 
the context of treatment, moderators can be used to help identify which individuals or groups of 
patients are most likely to respond well to a specific treatment, and mediators can be used to 
understand why a specific treatment is effective, aiming to optimise treatment effects. The terms 
mediation and moderation are often described together in the literature and it is easy to see that 
investigation of both of these elements of an intervention would be important and potentially 
linked, which may be the reason behind the terms being used interchangeably in early literature. 
Mediation is also often confused with confounding, which occurs when a variable not specified in 
the causal pathway partly explains the relationship between two variables (MacKinnon et al 
2000). 
 
“Indirect effect”, a term from the epidemiological and statistical literature, is also used to describe 
mediating effects. It has been suggested that a distinction can be made between mediating and 
indirect effects, as an indirect effect occurs when there is no direct effect of the treatment on 
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outcome but there may still be an association along a causal pathway, while a mediating effect 
occurs when there is an effect of the intervention on outcome (Hayes 2009). These terms are 
often used interchangeably but this suggests that they are not synonymous. Further, Kline (2015) 
suggests that “mediation” should only be used in a design with time precedence or other aspects 
that provide support for a causal link, while “indirect effect” can be used in cross-sectional 
designs. The term ‘mediating’ effect should therefore perhaps only be used when examining 
mediators in the context of a specific treatment, where an intervention is used in the study and 
the effect of this intervention is positive, and that the term ‘indirect effect’ could possibly be used 
for mediation analysis in observational designs or for intervention studies in a non-randomised 
context. In this thesis, the words “mediation” and “indirect effect” are both used depending on 
the analysis being applied and the evidence being described (i.e. if an author has used the term 
mediation rather than indirect effect then this term was used when summarising the findings). 
However, when relating to the empirical work generated as part of the thesis, the term 
“mediation” will be used to reflect the treatment-specific context of this work. 
 
1.4.3 Action theory and conceptual theory 
Chen (1990; 2015) discussed how mediation models of intervention studies can be evaluated by 
being split into two parts; the action theory (a path) and the conceptual theory (b path). Action 
theory is described as the intervention’s power to detect the potential mediator while conceptual 
theory is described as the potential mediator’s power to detect the outcome (Chen 2015). It has 
been suggested that these two elements form the theoretical basis between the two paths 
(Stanton et al 2013). If the association between the intervention and the potential mediator is 
weak, this suggests that the action theory has failed – that the intervention is not doing enough to 
affect the mediator (Chen 2015). If the association between the potential mediator and the 
outcome is weak, then the conceptual theory has failed – the intervention is targeting the wrong 
factors for change (Chen 2015), meaning that the underlying theory is wrong. It is not always clear 
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whether the point of this is to test the theory underlying the intervention or the intervention itself 
(Coryn et al 2011), but from a clinical perspective, conceptualising a mediation analysis in this way 
may help to see which path needs strengthening to help improve future studies. 
 
 
1.5 Psychological Models 
Theoretical models can be said to have three main purposes (McCracken & Morley 2014): they 
can help us integrate our research findings into key principles; they can include specific goals and 
assumptions; and they can help promote progress through testing and revision. In the field of 
psychology, and specifically pain psychology, many models have been developed to try and 
explain the reasons why people may develop persistent pain or other poor outcomes from a pain 
experience. Painter et al (2008) highlight the importance of theoretical models in explaining how 
behaviour affects outcome, but their systematic review of the use of theoretical models in health 
behaviour research showed that only around a third of articles acknowledged a specific 
theoretical basis. The authors also noted that non-intervention studies were more likely than 
intervention studies to attempt to apply or test theoretical models. Interventions that are 
explicitly based on a theory rather than just using it to inform their intervention allow the testing 
of causal pathways that may underlie the treatment (Michie et al 2008), allowing assumptions 
about how the theory works to be tested, and also help to generate hypotheses of how we might 
go about changing those factors or determinants during treatment. Interventions that target 
these determinants are more likely to be effective (Michie et al 2008). However, few theoretical 
models have a clear explanation of how they may be operationalised (Michie et al 2008), which 
leads to theory being used to explain behaviour but not necessarily to suggest how to alter it. 
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However, not all studies have found the inclusion of theory to lead to more effective 
interventions. Prestwich et al (2014), in a review of interventions to improve physical activity and 
diet, found that tailoring an intervention or referring to a specific theory (the Trans-Theoretical 
Model and Social Cognitive Theory) did not lead to larger intervention effects, although 
interventions based on a single theory were found to be more effective than those based on 
multiple theories. The authors did note a number of limitations in their review, including the 
restrictive inclusion criteria (topic and theory) and problems with treatment fidelity, meaning that 
interventions may not have been delivered in the optimum way. They suggest that further 
investigation into specific causal pathways between theory components would be useful. 
 
In the context of mediation, a theoretical basis to the analysis has been suggested to be important 
in a number of ways. It helps to generate hypotheses about which variables to test as potential 
mediators, and how they might relate to each other (Kazdin & Nock 2003; Maric et al 2012), 
leading to stronger models and a stronger justification for any mediating effects found (Mathieu 
et al 2008). It also allows decisions to be made about when change in the mediator and outcome 
variables is likely to occur, so that assessments can be made at these points in order to capture 
this change (Kazdin 2007). Basing mediation analysis on a specific theory has therefore been 
recommended as an important pre-requisite in mediation analysis in a number of fields (Kazdin & 
Nock 2003; Johansson & Høglend 2007; Kazdin 2007; Maric et al 2012). 
 
Psychological models of pain imply a person-centred approach, and posit that each individual 
needs to be treated according to their own personal situation (Linton & Shaw 2011). While the 
summaries below are not an exhaustive account of the models that have been proposed in the 
psychological literature, these have been reviewed by Linton & Shaw (2011) who stated them to 
be the current key models of pain and disability; some of which being specific models of chronic 
pain (fear-avoidance model (FAM), acceptance and commitment model, misdirected problem 
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solving model) and others being more generic models of health and pain (self-efficacy model, 
diathesis-stress model). The FAM is the most researched of the models summarised, especially in 
the context of mediation, therefore more attention is given to this model. 
 
1.5.1 Fear-avoidance model (FAM) 
The term “fear-avoidance” encompasses how both cognitive and behavioural factors play an 
important role in pain and disability (Boersma et al 2004) by linking pain avoidance as an aspect of 
pain behaviour (Fordyce 1976; Main et al 2015) with beliefs about pain. The FAM can therefore be 
described as a specific application of cognitive-behavioural theory (CBT) (Skinner et al 2012). 
Several FAMs have been proposed, including Lethem et al’s (1983) model of pain perception in 
relation to fear-avoidance and a cognitive model of avoidance proposed by Philips (1987). 
However, within the pain literature the FAM proposed by Vlaeyen et al (1995a) has received the 
most attention and it is this version that will be focused on in this thesis. This model states that 
when an individual experiences pain, a number of thought processes and behaviours then impact 
on outcome. Negative thought processes such as pain catastrophising (an exaggerated negative 
perception of a pain experience (Turk & Wilson 2010)) lead to fear and avoidance of behaviours 
that the patient feel may cause damage or further pain, and may be enhanced further by 
hypervigilance to perceived threat-related stimuli, which in turn lead to disuse, further disability 
and depression (Vlaeyen & Linton 2000). This becomes a cycle in which further experiences of 
pain lead to further catastrophising thoughts and fear-avoidance behaviour, exacerbating the 
problem (Vlaeyen & Linton 2000). In contrast, individuals who do not catastrophise and/or do not 
avoid certain behaviours or tasks in an attempt to avoid pain are more likely to recover. 
Adaptations to Vlaeyen et al’s model have been proposed (e.g. Norton & Asmundson’s (2003) 
extension to include an explanation of how physiological processes might be involved in fear-
avoidance behaviour).  
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The evidence for the main components of the FAM (fear-avoidance beliefs and behaviour, 
catastrophising thoughts, hypervigilance and depression) indicates that each of these components 
are important in predicting pain and disability outcomes. Reviews of evidence for specific 
components of the FAM have concluded that there is a positive relationship between the model 
components and disability (Turk & Okifuji 2002; Leeuw et al 2007a; den Hollander et al 2010), and 
that fear-avoidance beliefs and behaviour can lead to poor physical function (Vlaeyen & Linton 
2000; Wertli et al 2014a).  
 
However, not all of the evidence for the predictive value of the FAM components is supportive. 
While there is strong cross-sectional evidence that supports the FAM, the evidence in prospective 
studies is mixed (Pincus et al 2010). Also, work using structural equation modelling (SEM), a 
technique which builds on regression analysis and allows for paths between variables to be 
investigated, has found that pain-related fear is not necessarily associated with pain intensity in 
patients with pain, thereby casting doubt on the cyclical hypothesis of the FAM (Gheldof et al 
2010), and suggesting a more direct link between catastrophising thoughts and depression than 
the model hypothesises (Cook et al 2006). The evidence includes intervention studies where fear-
avoidance was not necessarily targeted for change, and the authors of these reviews are cautious 
about stating whether reducing fear-avoidance and catastrophising thoughts directly leads to 
improved outcome (Vlaeyen & Linton 2000; Wertli et al 2014a). Finally, partial support has been 
found for catastrophising thoughts as a mediator between fear-avoidance beliefs and both pain 
and disability (George et al 2011) but this was a cross-sectional study so the hypothesised order of 
the FAM variables cannot be tested. A process analysis study (Wideman et al 2009) which 
hypothesised that early changes in catastrophising thoughts would be associated with late 
changes in fear-avoidance behaviour and depression, which would then predict return to work 
outcome, failed to show a positive relationship between these variables despite each being  
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individually associated with the outcome. The authors suggested that the lack of evidence for a 
temporal link between catastrophising thoughts and fear-avoidance behaviour could be because 
the variables were not measured at optimal time points, as the FAM gives no guidance on when 
these variables are likely to change.  
 
In addition, intervention studies that have been designed to target fear-avoidance behaviour have 
not shown large improvements in outcome (Pincus et al 2010). This may be due to the construct 
of fear-avoidance behaviour, and also the patients most at risk of being fear-avoidant, being 
poorly identified in interventions (Pincus et al 2010). Fear-avoidance can be related to either 
behaviour or beliefs in different contexts, such as damage caused by movement, particular 
activities, or both and current measures of fear-avoidance do not distinguish these different types 
clearly (Pincus et al 2010). Indeed, the evidence summarised above often did not specify whether 
the study was investigating beliefs or behaviour, but the common measures of fear-avoidance 
relate to beliefs. Previous reviews also noted that many studies did not clearly differentiate 
between various psychological constructs, leading to terms being used interchangeably (e.g. 
distress and depressive mood) (Pincus et al 2002; Turk & Wilson 2010).  
 
Limitations with the model itself have also been described in the literature. The FAM does not 
take into account that the course of back pain, in terms of the number of episodes experienced, 
pain duration, fluctuation and the impact on the individual, will vary substantially between 
patients (Leeuw et al 2007a). The model may only account for a particular sub-group of patients 
with persistent LBP rather than being applicable to all LBP populations (Leeuw et al 2007a). Most 
recently, Wideman et al (2013) have urged a ‘rethink’ of the FAM due to the proposed causal links 
between each of the variables not being empirically supported, and that other factors not 
currently included in the model, such as resilience, may potentially explain why not all patients 
follow the FAM’s proposed pathways. Leeuw et al (2007a) also pointed out that just because 
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there is evidence of associations between each of the constructs in the FAM does not mean that 
these links are causal, and that further evidence is needed to test this.  
 
Overall, while the FAM components may individually be predictive of LBP outcomes, the model as 
it currently stands may not be able to fully explain how people transition towards more persistent 
or recurrent trajectories of back pain. Vlaeyen et al (2009) point out that the FAM as they 
described it was never meant to be a finished article, and that amendments and improvements 
were welcomed. It is clear that, from an explanatory point of view, further work is needed to truly 
test the hypothesised framework of the FAM and whether the components work together in the 
sequence described. 
 
1.5.2 Acceptance and Commitment Theory (ACT) 
Acceptance and Commitment Therapy (ACT) is described as a type of “third wave” CBT (de Boer et 
al 2014), following the first wave of early behavioural approaches and second wave of cognitive-
behavioural approaches. While CBT is focused on changing thoughts and behaviours (Forman et al 
2012), ACT additionally focuses on living with and accepting thoughts and on the values of the 
patient (Gauntlett-Gilbert et al 2013). ACT has its theoretical basis in Relational Frame Theory 
(RFT), which assumes that cognition and language are specific learned behaviours (Hayes et al 
2006). ACT has six core principles (Hayes et al 2013): Cognitive defusion, where people are taught 
to notice their negative or unhelpful thoughts rather than taking thoughts literally; Acceptance, 
which is trying to accept unwanted cognitions rather than changing them; Being present, which 
involves people focusing on themselves as they are now, not as they were in the past or could be 
in the future (Twohig 2012); Values, where the patient’s goals and values are clarified as a way of 
keeping them motivated to change (Twohig 2012); Self as observer, which is “what we believe 
ourselves to be” (Twohig 2012, p. 503) and Committed action, which combines the other  
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processes and helps people to continue to practice them and achieve their value-linked goals 
(Twohig 2012). The end goal of ACT, through each of the principles, is to achieve psychological 
flexibility (Hayes et al 2013), which is the process of behaving in a way consistent with the persons 
values and goals (McCracken & Velleman 2010). Treatment involves building processes of 
acceptance and mindfulness using metaphors to help patients relate to therapy in a way which is 
more generalisable to the world outside of treatment (Hayes et al 2013). ACT is still evolving, and 
recently the six processes described earlier were paired up into three response styles (Vowles et 
al 2014): Open (defusion/acceptance); Centered (being present/self as observer); and Engaged 
(values/committed action), but the usefulness of these distinctions has not yet been tested. 
 
Evidence for the key processes of ACT as mediators of outcomes is emerging, with some support 
for acceptance, flexibility and values (Vowles et al 2013), and avoidance and cognitive fusion 
(Wicksell et al 2010) being mediators of disability outcome. Acceptance has also been found to 
mediate outcome when not directly targeted for change (Åkerblom et al 2015), suggesting further 
research is needed to explore how ACT components are associated with treatment outcome. 
 
1.5.3 Misdirected problem solving model 
Eccleston & Crombez (1999; 2007) describe the misdirected problem solving model as being the 
result of pain demanding attention, and that in persistent pain this means that attention is 
constantly interrupted resulting in a vicious cycle of worry, vigilance and problem solving through 
repeated unsuccessful attempts to reduce pain. As was mentioned earlier, some worry and 
attention to pain in the short-term is adaptive (Eccleston & Crombez 2007; Flink et al 2012), but 
constant worry about how to stop pain may lead to hypervigilance and depression (Aldrich et al 
2000; Linton & Shaw 2011). Pain is still often viewed by sufferers as a biomedical problem, leading 
to problem-solving behaviour around reducing the pain from a medicalised perspective (Eccleston  
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& Crombez 2007). If pain reduction is achieved then worry reduces, but if pain persists a 
“perseverance loop” is created by which the failure to reduce pain leads to further worry and 
further problem-solving attempts, which may again be futile. To the author’s knowledge little 
work has been done to assess this model from a mediation perspective. One study by Flink et al 
(2012) examined whether framing the pain problem as a biomedical one mediated the 
relationship between catastrophising thoughts and biomedical-focused problem-solving 
behaviour in 173 patients with back, neck or shoulder pain. However, the analysis did not support 
this model, suggesting that the hypothesised model pathways need further examination. 
 
1.5.4 Self-efficacy model 
In the context of this thesis, self-efficacy suggests that in order to improve their outcome, patients 
need to take responsibility for their pain problem by trying to understand it and developing self-
management strategies (Linton & Shaw 2011). People who have low self-efficacy may be less 
likely to develop coping mechanisms or give up more easily if there is no change in their condition 
(Turk & Okifuji 2002), leading to further pain and disability. Self-efficacy has been found to predict 
pain and disability outcomes (see Section 1.3). 
 
Jackson et al (2014) conducted a meta-analysis to examine how self-efficacy impacts on outcomes 
such as impairment and pain in chronic pain populations (including, but not limited to, MSK pain) 
and to identify potential moderators of that relationship. Of the 83 studies they included in their 
review (23 of chronic LBP), older age was found to be a moderator of the self-efficacy – 
impairment relationship and interestingly so was the content of the measure of self-efficacy used, 
with studies using a measure that assessed the capacity to function despite pain having larger 
effect sizes than measures which evaluated pain or symptom management. The authors found 
that the included studies used 40 different measures of self-efficacy to correspond with the  
Chapter 1 Introduction Page 22 
 
specific context of pain they were studying. It has been suggested that the reason self-efficacy is 
so highly correlated with measures of pain and disability is due to the similarity between the 
commonly-used self-report measures of these factors (Keefe et al 2004; CJ Main, personal 
communication). Simply put, one would expect a high correlation between a report on what one 
had found difficult to do (high self-reported disability) and where one feels a lack of confidence 
(low self-efficacy). Several studies of observational data have shown self-efficacy to be a mediator 
of the relationship between pain and disability (Arnstein et al 1999; Denison et al 2004; Söderlund 
& Åsenlöf 2010; Costa et al 2011), and of the relationship between pain-related fear and disability 
(Woby et al 2007). Studies investigating self-efficacy as a mediator of the outcome of a specific 
treatment are scarce in the MSK pain field (see Chapter 4), although reviews exist in the fields of 
physical activity promotion (Baranowski et al 1998; Lubans et al 2008; Rhodes & Pfaeffli 2010), 
dietary behaviour change (Cerin et al 2009) and psychosocial interventions for patients with 
cancer (Stanton et al 2013) which all provide support for self-efficacy as a mediator of treatment 
outcome. 
 
Self-efficacy is a central tenet of Social Cognitive Theory (SCT) (Bandura 1989), one of the few 
theoretical frameworks that actually gives information on how to influence self-efficacy using a 
range of techniques (Michie et al 2008). Many treatment programmes for people with persistent 
MSK pain focus on trying to change maladaptive behaviours that have been learned over time 
(Linton & Shaw 2011). Linton & Shaw (2011) also state that learning involves the individual’s 
wider social environment, and manifested pain behaviours may partly be the result of this 
environment. SCT, which takes into account the context of behaviour, therefore may be 
important in helping to understand how these behaviours are learned and how they can be 
unlearned. 
 
 
Chapter 1 Introduction Page 23 
 
1.5.5 Diathesis-stress model 
The diathesis-stress model suggests that individuals may be more likely to experience pain 
because of predisposing characteristics that interact with the personal experience of stressful 
events (Flor et al 1985). In other words, if a person is already under stress due to other factors, 
then pain might add to this pressure (Linton & Shaw 2011), or their genetics or personal history 
may make coping with pain more difficult for them than for others with different characteristics 
(Gatchel & Turk 2008). This model may help us understand the individual differences in patients 
with pain (Gatchel & Turk 2008). Evidence supporting this model comes from an experimental 
study of 51 patients who had either persistent LBP, general pain or no pain (Flor et al 1985). All 
patients were exposed to experimentally induced pain in four different conditions (two personally 
relevant stressors where the patient had to describe a pain or stressful experience, a general 
stressor which involved a timed mathematical task, and a neutral task which involved reciting the 
alphabet). Participants with persistent LBP who also experienced worry and depression 
experienced more muscle reactivity in the personally relevant stress conditions than those in the 
general or no pain groups, although the difference between the groups was small. Further 
evidence comes from a more recent study by Martin et al (2010) which used SEM to examine the 
relationships between pain and disability. They found relationships between anxiety sensitivity 
and fear of pain and catastrophising thoughts, fear of pain and avoidance behaviour, and 
avoidance behaviour and disability. The authors suggested that these results provided support for 
the diathesis-stress model, but their results still cannot establish the temporal order of the 
variables in the model (i.e. whether the variables are affected in the sequence hypothesised by 
the model).  
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1.5.6 Self-regulation model (SRM) 
A final model, not described in Linton & Shaw’s paper but of interest in this thesis, is the self-
regulation model (SRM) (also known as the Common Sense Model). This model assumes that 
people develop personal ideas and perceptions about their illness, based on previous experience, 
which impact on how they react to it (Leventhal et al 2003). The model has five dimensions which 
cover how people identify their illness, what they see as the cause of it, what might happen as a 
result (consequences), how long it will last (timeline), and how or if they can control it and 
whether it can be cured. Our perceptions affect how we choose to cope with illness, for example 
whether or not we seek treatment (McAndrew et al 2008). The SRM has been described as a CBT 
model of physical illness rather than mental illness (Hobro et al 2004), making it potentially more 
relevant to pain populations where reactions are likely to be ‘normal’ rather than pathological. 
This is supported by a study which found illness perceptions to be related more strongly to 
physical health than mental health in a primary care population seeking treatment for a health 
problem (Frostholm et al 2007). 
 
Evidence exists for illness perceptions as predictors of health outcomes (Frostholm et al 2007; 
Foster et al 2008; Foster et al 2010). While Frostholm et al’s study examined patients with a range 
of health conditions, Foster et al’s studies were specific to LBP. Three illness perceptions in 
particular (identity, control and acute-chronic timeline) were found by Foster et al to be 
independently predictive of disability outcome, along with self-efficacy. Patients who experienced 
a good outcome at six-month follow-up experienced positive changes in illness perceptions over 
that time period (Foster et al 2008), while those with negative changes were more likely to have a 
poor outcome. The authors suggested that a person’s illness perceptions could explain why they 
respond or do not respond to a particular treatment and that changing these could potentially be 
important. Another study investigated the differences between people with longer- and shorter- 
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term LBP (van Wilgen et al 2013). They found that illness perceptions differed between the two 
groups, with those with persistent LBP more likely to think that the cause was physical and 
needed biomedical intervention and that keeping active was important. 
 
There is also some evidence for illness perceptions being modifiable, with one randomised 
controlled trial (RCT) of 156 patients with persistent LBP evaluating an intervention that 
specifically targeted illness perceptions finding a between-group difference in illness perceptions 
between those who received the intervention and the waiting list control (Siemonsma et al 2011). 
However, this study did not find a between-group difference in their outcome of back pain-
related disability, suggesting that while illness perceptions can potentially be changed if 
specifically targeted by an intervention, this may not necessarily lead to a change in outcome. This 
suggests that illness perceptions are not mediators of treatment outcome, but to my knowledge 
there have not been studies to formally investigate this in a MSK pain population.  
 
1.5.7 Comparison of psychological models 
While these models have been described separately, there is a degree of overlap between the 
constructs included in each. For example, the earliest description of the FAM (Lethem et al 1983) 
also talks about factors that could affect how a person reacts psychologically to pain, describing 
how stressful life events, previous pain experience and personal coping strategies that may have 
been used previously to cope with pain as key factors in whether a person avoids or confronts 
pain. This has some similarities with the Diathesis-stress model and Misdirected problem solving 
model. Also, Turk & Okifuji (2002) suggest that self-efficacy may be linked to fear-avoidance 
behaviour in that by having the confidence to expose themselves to a feared activity, patients 
may be able to reduce their fear of performing that activity. This highlights how patients may 
experience different ‘pathways’ to persistent pain or poor outcomes that may include similar  
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constructs. Overall, each model provides some evidence for the significance of each of the 
variables included in the model and the strength of their relationships with one another. 
However, few models have been tested in a way that allows the hypothesised pathways between 
the variables in the models to be investigated. In the case of the FAM, the evidence suggests that 
the model is in fact not working in the way it is hypothesised to with studies finding little support 
for the causal links between the variables. This highlights where mediation analysis could perhaps 
be useful in helping to examine these links. 
 
 
1.6 Rationale for Thesis 
To summarise, LBP globally is a costly problem in terms of time off work, healthcare utilisation, 
and loss of quality of life. In the UK, primary care is often the first point of call for patients 
experiencing LBP and this is therefore a crucial point at which patients can be identified to try and 
prevent further problems. Psychological factors have been found to play an important role in 
predicting which patients are likely to have poor outcomes and develop persistent LBP, and 
psychological treatments have been found to be successful in improving LBP outcomes, but it is 
not clear exactly how these treatments work and many only show small treatment effects. The 
evidence summarised above suggests that future psychological interventions for LBP need to 
establish what components of treatment are most effective and for which patients (Ehde et al 
2014), and highlights that while several theoretical frameworks have been proposed to explain 
how LBP develops these models have rarely been tested using data in intervention studies. 
Identifying mediators of treatment effect will be important to help explain why treatments do or 
don’t work (Kraemer et al 2002) and to identify the true mechanisms of treatment which will help 
to streamline psychological treatments, so that only elements that are likely to lead to positive 
change are included (Kazdin & Knock 2003). Day & Thorn (2014) state that there is now a  
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consensus that moving past efficacy to understanding treatment processes will help to maximise 
the value of the intervention. It is also thought that identifying mediators may help identify 
similarities across psychological treatments; that is, whether different treatments work through 
the same mechanisms (Thorn & Burns 2011; Day & Thorn 2014). Macfarlane et al (2006) state 
that work is needed to specifically identify which psychological factors are most important in 
terms of the onset and maintenance of LBP so studies can be designed to target them. 
 
One of the reasons behind the lack of strong treatment effects of psychological treatments in 
previous trials may be that the most important factors for causing change in functional outcomes 
were not targeted during treatment. Several authors have emphasised the need for testing which 
psychological variables are most important, and also that different sub-groups of patients may 
require different factors to be targeted (e.g. Keefe et al 2004; Jellema et al 2006; Koes et al 2006; 
Kamper et al 2010).  
 
Little work has been carried out in the field of MSK research related to mediation analysis, 
especially in terms of treatment mediation. The applied work that does exist often shows 
limitations in terms of design and analysis techniques, potentially leading to invalid conclusions 
being drawn about particular mediating factors. The importance of this thesis lies in moving 
forward and improving analysis and study design so that future intervention studies can include 
robust mediation analysis as part of a future RCT or programme of research. The next chapter will 
set out the overall aim and specific objectives of this thesis.  
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Chapter 2: Aims and Objectives 
 
The introduction chapter defined the clinical problem and the need to improve treatment 
outcomes for musculoskeletal (MSK) pain (and specifically low back pain (LBP)). The concept of 
mediation analysis was introduced, the literature on the potential of psychological factors as 
treatment targets reviewed and the rationale of the thesis explained. This chapter describes the 
overall aim and specific objectives of the thesis, and provides an outline of the thesis. 
 
2.1 Aim of Thesis 
The overall aim of this thesis was to identify and evaluate methods and analyses used in 
treatment mediation analysis in MSK pain intervention studies. The relevance of this work lies in 
its potential to assist and improve the design, delivery and outcome of clinical trials of 
psychological interventions for MSK pain. The thesis will therefore begin by providing an overview 
of the methods of mediation analysis, explaining the different statistical approaches, assumptions 
often made in mediation analysis and providing recommendations regarding optimal methods for 
conducting mediation analysis (Chapter 3), which will be adopted where possible in the thesis. 
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2.2 Objectives of Thesis 
Following the review of mediation analysis methods, this thesis has been split into three sections, 
each with its own specific objective. Each of these objectives is addressed across one or more of 
the thesis chapters.  
 
2.2.1 Objective 1: What is the current evidence that psychological factors mediate 
disability outcome in MSK pain populations? 
A systematic review was undertaken to identify previous psychological interventions in MSK 
populations where a mediation analysis was performed, in order to assess methods of mediation 
analysis and types of intervention design previously employed to investigate psychological 
mediators of treatment effect in MSK intervention studies (Chapter 4). Critical appraisal of study 
design and particularly methodology was carried out to assess whether identified mediation 
studies met current best practice as set out in the literature (see Chapter 3). 
 
2.2.2 Objective 2: How can we best investigate psychological mediators of treatment 
effect on disability outcomes? 
Observational and randomised controlled trial (RCT) data was analysed to test different elements 
of the framework for identifying mediators described in Chapter 3. Mediation analysis was 
performed across different study designs to investigate the use of different statistical approaches 
and identify opportunities and obstacles to using different approaches in the field of MSK pain, 
enabling specific recommendations for future mediation research to be made. 
 
Observational data can be important in generating hypotheses regarding factors being potential 
treatment mediators, therefore observational study data was analysed to identify which of a 
number of psychological factors were potentially modifiable and related to change in functional 
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outcome in patients with back pain (Chapter 5). This did not involve conducting mediation 
analysis, but instead provided testable hypotheses for use with RCT data. 
 
Data from RCTs which attempted to address psychological factors measured over at least two 
time points with the aim of reducing disability was then used to carry out mediation analysis. The 
RCTs were chosen based on their suitability for mediation analysis, as described in Chapter 3. This 
gave the opportunity to explore different statistical approaches to mediation analysis, including 
structural equation modelling (SEM) (Chapter 6) and latent growth modelling (LGM) (Chapter 7), 
and also allowed the testing of factors identified in Chapter 5 as potential mediators of treatment 
effect. Chapter 6 describes testing of some of these potential mediators using data from the 
STarTBack study, a large primary care-based RCT that included a psychologically informed 
physiotherapy intervention aimed to reduce psychological distress in patients at high risk of 
persistent low back pain. In Chapter 7 a more novel form of mediation analysis was carried out in 
another large primary care-based RCT which focused on reducing fear-avoidance beliefs in 
patients with low back pain (Back In Action study). 
 
2.2.3 Objective 3: How might treatment processes be investigated using repeated 
assessments of key mediators and disability outcomes over time? 
This final question addressed a specific aspect of study design that is seen as key to the 
identification of treatment mediators: the measurement of the potential mediator and outcome 
of interest over time. Secondary analysis was conducted on diary data obtained from secondary 
care patients who underwent a psychological intervention as part of their treatment for 
persistent MSK pain. Data on potential mediators and outcome was available both at baseline and 
follow-up and also during the treatment period, as patients were asked to fill in a short diary each 
week to help monitor their progress during treatment. This study, presented in Chapter 8, 
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provided the opportunity to examine when particular factors of interest change and whether this 
provided better, more useful information than data collected only at pre- and post-treatment. 
 
The final chapter of the thesis (Chapter 9) gives the overall discussion of the thesis, synthesising 
each of the empirical chapters to bring together what has been learned. It discusses the strengths 
and limitations of the work contained in the thesis and provides an outline of how future 
treatment mediation can best be conducted, highlighting the clinical and research implications of 
the work presented. 
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Chapter 3: Methodological and Design Issues of Mediation Analysis 
 
 
This chapter contains an overview of the different design and methodology issues that have been 
outlined in relation to mediation analyses, in both observational and experimental studies. Not all 
of these designs confirm mediators of specific treatment effects, but each have a role in 
identifying potential mediating factors. Building on the definition of mediation outlined in Chapter 
1, the purpose of this chapter is to describe the different design options for mediation analysis, 
summarise the current debate over the statistical options, and finally to derive recommendations 
for optimal methods of conducting mediation analysis to be employed in the thesis where 
possible. An overview of the sections of this chapter is given in Figure 3.1.  
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Figure 3.1 Overview of Chapter 3: Methodological and design issues of mediation analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1 Design 
Mediation analysis has been performed using a number of different study designs. Maric et al 
(2012) outlined a “scientific ladder of mediation evidence” in which they proposed that while 
there are many types of study design that can help build evidence for mediating factors, including 
observational and experimental studies, some studies provide stronger evidence than others. This 
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section will therefore outline some of the different types of study design that have been used to 
carry out mediation analysis, and the problems associated with each. 
 
Studies of mediation analysis have mostly been conducted using cross-sectional or cohort study 
designs. Observational studies such as these generally have the advantage of including a more 
representative study sample and larger sample size than experimental studies and they allow 
associations between variables to be established. However, confirming that a factor is a mediator 
of a specific treatment effect is problematic with observational data because of problems with 
causal inference and bias. Mediation analysis carried out on data from randomised controlled 
trials (RCTs) offers several benefits over observational study designs in terms of improving aspects 
of causality and reducing bias (Mathieu & Taylor 2006; Kazdin 2007; Nock 2007; Maric et al 2012). 
For example, mediation analysis in RCTs can strengthen the evidence for the mediating effect 
being causal because in this type of design the intervention period is clearly defined, making it 
easier to attribute any change in the mediator and outcome variables as being the result of a 
specific treatment (Mackinnon et al 2004). The inclusion of a control group as a comparison is 
crucial in that this gives a condition against which to compare changes in variables in the 
treatment group (Judd & Kenny 1981; Hill & Fritz 2011), which provides evidence for the 
effectiveness of the treatment above the control condition, and manipulation of a potential 
mediating variable within an RCT design offers a stronger basis for causal inference. However, as 
discussed below, there remain some problems with causality, bias and confounding. 
 
3.1.1 Causality 
In mediation analysis, it is assumed that the mediator is on a causal pathway between the 
independent variable (IV) e.g. treatment allocation and the dependent variable (DV) i.e. outcome. 
A number of authors point out the problem of establishing different aspects of causality (Maxwell 
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& Cole 200; Hoyt et al 2008; Gelfand et al 2009) which impact on different study designs in slightly 
different ways, as set out below.  
 
An important criterion for causality is temporality, which is the timeline associated with the 
variables in the analysis. In order for one variable (A) to be potentially causing another (B), A must 
precede B in time (Rothman & Greenland 1998). In cross-sectional studies, an assessment is only 
provided at a single time point and therefore no start point for the first measured variable in the 
model can be established (Maxwell & Cole 2007), making it impossible to ascertain a causal link. A 
number of authors have suggested that longitudinal designs are better placed to assess change 
over time (e.g. Liu et al 2009; Kline 2015) and suggest that three or more waves of data may be 
useful for assessing temporality (Collins et al 1998; Lockhart et al 2011; Maric et al 2012; Kline 
2015) despite the increase in complexity of the analysis and modelling procedures (Lockhart et al 
2011). More accurate estimates of the mediating effect can be made when a number of time 
points are available for analysis (Maxwell & Cole 2007), but if there are not enough assessments 
of all potential mediator and outcome variables in cohort studies there might not be enough 
information to assess which variable occurred first (see Chapter 5). Hence, even in longitudinal 
study designs temporality cannot always be established. 
 
It is important to consider not just the number of time points but also when assessments should 
be made. Including a large number of time points will still not help solve the issue of temporality if 
they miss the point at which the potential mediator and outcome change. The decisions around 
the timing of the assessments are very important and need to be based on the hypothesised 
mediation process (Collins et al 1998). Change may occur very early on or much later depending 
on, for example, the patient or the treatment given. In order for any mediating effects to be 
captured, assessments must be taken at key, clearly defined points (Laurenceau et al 2007), 
ideally informed by previous observational study data on the natural history and clinical course of 
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the condition and possibly prior research into how treatment may impact on this. An important 
issue highlighted here is the fact that both observational studies and RCT designs rarely include 
enough assessments at key time points to establish exactly when change from a specific 
treatment occurred (Kazdin 2007; Laurenceau et al 2007), making it difficult to determine 
whether change in the mediator has occurred before the change in the outcome and not vice-
versa. 
 
Plausibility (whether an association makes rational sense) is often based on what people believe 
to make sense rather than what is known empirically, especially if there is not much existing 
evidence (Rothman & Greenland 1998). Also, strong associations can be non-causal, such as the 
link between Down Syndrome and birth rank which was found to be confounded by the age of the 
mother (Rothman & Greenland 1998). A theoretical or pre-existing empirical basis for the 
relationship, discussed in Section 3.3.1, is therefore important in terms of justifying a proposed 
link. 
 
Consistency of observations and dose-response are two important aspects of causality in the 
context of mediation analyses (MacKinnon 2008). Consistency suggests that repeated similar 
findings in different studies provide evidence of a causal link (Rothman & Greenland 1998), and 
dose-response is described as any effect on outcome increasing or decreasing depending on the 
level of the mediator (MacKinnon 2008).  
 
3.1.2 Bias 
Bias occurs as the result of error in the design of a study or measurement of the outcome variable 
(Sim & Wright 2000). Bias can take many forms and can also affect different study designs in 
different ways. The most important sources of bias in the context of mediation are selection bias 
and information bias. 
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Selection bias occurs when the probability of participants being enrolled in the study is related to 
the outcome of the study (Rothman & Greenland 1998). A common example is that participants 
are often self-selected, and there may be differences in the probability of the outcome between 
those who choose to take part in research and those who do not. This is true of all study designs, 
although in RCT designs participants are randomised once they enter the study preventing bias 
due to selective participation. However, there may still be participants with particular 
characteristics, or participants who were allocated to a particular treatment, who are more likely 
to drop out of the trial over time. Selection bias occurs when selective participation or drop-out is 
associated with outcome. 
 
Information bias refers to errors in the collection of data that could affect the study findings 
(Rothman & Greenland 1998). In all study designs assessing psychological factors this can be an 
issue because the measurement of psychological factors needs to be via questionnaires, 
interviews and observations which all rely on subjective interpretation by the patient and/or 
observer. This precludes the provision of a ‘gold standard’ which measures of the factor can be 
compared against. Information bias is therefore hard to assess and avoid. 
 
3.1.3 Confounding 
Any association between two variables could be the result of other variables that are not 
measured or adjusted for in the analysis, meaning that any observed changes in the outcome 
cannot confidently be attributed to the variable of interest (Sim & Wright 2000). Confounding 
variables are those which offer an alternative explanation of a relationship between two variables 
(Greenland & Rothman 1998), but unlike mediating variables, confounders are not on the causal 
pathway under investigation. In observational designs in particular, the issue of confounding can 
be a significant problem.  
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When an RCT design is utilised, randomisation helps ensure that participants in the different 
treatment or exposure groups have similar characteristics at baseline and so any findings are less 
likely to be a result of a different distribution of confounding variables (Bullock et al 2010; 
Lockhart et al 2011). Randomisation therefore strengthens the argument for the treatment having 
a causal effect as it helps to control for confounding. A control or comparison group is also 
beneficial in detecting mediating effects, in that any effect of treatment given to one group, and 
not to other randomised (and therefore similar) groups, is more likely to be due to the treatment 
being given than to other factors such as the natural history of the condition (Murphy et al 2009). 
This can help researchers to determine whether any mediating effects would have occurred in 
spite of treatment or whether they are due to the treatment being given and are therefore on a 
causal pathway (Murphy et al 2009). 
 
However, it has also been argued that conducting mediation analysis in the context of an RCT 
design does not necessarily control for all unmeasured variables that could impact on outcome 
(Judd & Kenny 1981), and that the problems with confounding associated with conducting 
mediation analysis in observational studies may therefore also apply to an extent in RCTs (Imai et 
al 2013). More recently this assumption has been referred to as ‘sequential ignorability’ (e.g. 
Lynch et al 2008; Imai et al 2010a; Imai et al 2010b; Ten Have & Joffe 2010) which describes how 
in experimental study designs it is firstly assumed that there are no pre-treatment confounders, 
and secondly that there are no confounders that could affect the relationship between the 
mediator and outcome variables. Imai et al (2010a) state that whilst the first part of this 
assumption does usually hold in randomised studies, the second part does not because although 
participants may be randomised to the intervention itself, the mediator(s) and outcome(s) are 
outcomes of randomisation (Lynch et al 2008; Emsley et al 2010; Lockhart et al 2011) and 
therefore other variables may still provide alternative explanations for any observed mediating 
effects. Even if an intervention sets out to directly change a mediator, the analysis cannot 
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determine whether any mediating effects are due to that particular factor and not to other, 
unmeasured variables (Bullock et al 2010). These issues can potentially be resolved by 
randomising at the level of the mediator variable during the intervention (MacKinnon & Dwyer 
1993; MacKinnon et al 2007; Imai et al 2013). However, it is acknowledged that randomising the 
mediator may be a challenge, especially if there is no clear evidence for a single mediating factor 
(MacKinnon & Dwyer 1993) and that it can be difficult to manipulate psychological mediators 
(Imai et al 2013). These issues are discussed in more detail in Section 3.3.5. 
 
While the arguments for testing mediators only in RCT designs appear strong, several key authors 
have opposed this conclusion. They state that randomisation and manipulation of particular 
mediator variables may not always be ethical (Kenny 2008) and, as noted above, RCTs are not 
always perfectly implemented and there may still be problems with randomisation and missing 
data that preclude valid conclusions being drawn (Kenny 2008; Mathieu et al 2008). 
 
3.1.4 Summary 
In terms of designing studies to best investigate mediating factors, the literature suggests that 
RCTs offer the highest level of evidence as they are able to better address potential problematic 
issues around causality and bias as discussed above. However, even RCT designs are not able to 
fully account for all of these issues, and more innovative designs (e.g. with potential mediators 
being stratified or randomised) are required to address this. As noted in the introduction to this 
chapter, observational and other types of intervention study design may also be useful in terms of 
exploring which variables are most likely to change over time and which are related to change in 
outcome, which can start to address issues of causality particularly when strengthened by 
plausible mechanisms based on previous evidence and consistent findings from preceding studies. 
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Section 3.2 provides an outline of mediation analysis itself. Although design and analysis are 
closely related, mediation analysis involves some very technical analysis challenges which are 
therefore discussed separately. 
 
 
3.2 Mediation Analysis 
Several different approaches to mediation analysis have been proposed, and the most 
appropriate method to use is currently subject to debate. A review by MacKinnon et al (2002) 
identified 14 different tests for mediation, which they ranked in terms of power and Type I error 
rates. This review discussed different approaches to mediation analysis and described several 
tests of the mediated effect, which are detailed below. 
 
3.2.1 Statistical approaches to mediation analysis: Causal steps approach 
A number of statistical methods for analysing mediators are available (Cheung & Lau 2008). The 
causal steps approach, proposed by Baron & Kenny (1986), is the most widely used method of 
mediation analysis. In this approach a series of regression analyses examine the separate effects 
of the independent variable (IV) or treatment and mediator on the dependent variable (DV) or 
outcome, and also the effect of the IV on the DV after controlling for the effect of the potential 
mediator. Three steps are proposed, outlined in Figure 3.2, which would show the presence of 
mediation: 
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Figure 3.2. Example of a simple mediation model in the Causal Steps approach 
 
 
 
 
 
 
1. Demonstrate that the IV (e.g. treatment) has an effect on the outcome, DV (c) 
2. Demonstrate that the IV (e.g. treatment) has an effect on the proposed mediator (a) and that the 
mediator has an effect on the outcome, DV (b) 
3. Demonstrate that the effect of the IV on the DV is reduced, or becomes non-significant, after 
controlling for the effect of the proposed mediator on the DV (ć) 
 
However, this is also one of the most heavily criticised methods of mediation analysis (MacKinnon 
et al 2002; Emsley et al 2010). Several authors have questioned the need for the first step to be 
statistically significant (e.g. MacKinnon & Fairchild 2009; Emsley et al 2010), as indirect effects can 
exist even if there is no overall effect of treatment on outcome (Rucker et al 2011). This means 
that effects could potentially be missed if this step is rigidly adhered to, and also discourages 
researchers from using this type of analysis to explore why the findings from a trial were negative 
(Emsley et al 2010; Collins et al 1998). This approach also does not impose the demonstration of a 
temporal order, something which was corrected in Kraemer et al’s MacArthur approach (Kraemer 
et al 2001; 2002; 2008) which sought to more clearly define mediation.  
 
The requirement for statistically significant relationships at each of the three steps in the Baron & 
Kenny approach may also reduce the power of this method to detect an effect of mediation  
Mediator 
e.g. fear-avoidance 
beliefs 
a 
b 
IV 
e.g. treatment 
DV 
e.g. disability 
ć 
c 
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(MacKinnon et al 2002). Fritz & MacKinnon (2007) conducted a simulation study to test the 
sample size required to detect a mediating effect, and found that the causal steps approach 
proposed by Baron & Kenny required the largest sample size of a range of different methods 
tested. Others have pointed out that the third step (i.e. demonstrating that the effect of the IV on 
the DV is reduced after controlling for the effect of the proposed mediator on the DV) does not 
take into account the potentially confounding effects of unobserved variables, thus leading to 
inaccurate estimates (Emsley et al 2010). 
 
Baron & Kenny (1986) distinguish between “full” or “partial” mediation, in that if the ć path 
becomes non-significant or is reduced when the mediator variable is included, this is indicative of 
full mediation; if the ć path is reduced but is still statistically significant, this suggests partial 
mediation. Again, a number of authors have suggested problems with these concepts. If 
researchers see full mediation as showing that a single variable accounts for a given relationship 
between two variables and that no other mediating pathways are present, this may impact on 
theory development (Rucker et al 2011). The expectation of full mediation may also be an 
unrealistic concept as this would require perfect measurement of all possible mediator variables 
(Rucker et al 2011). As psychological factors are by their nature latent and not directly 
measurable, this limitation is particularly relevant in studies involving examination of 
psychological factors. It is also very unlikely that any intervention would work entirely through 
change in a single factor for every patient. 
 
A final problem of the Baron & Kenny approach is that it does not actually provide a test of the 
mediating effect; instead the effect is inferred from the results of the regression analyses (Hayes 
2009) and relies on the statistical significance of the regression equations, something known to be 
problematic as this can be affected by sample size. The MacArthur approach also recognises this 
and recommends calculating an effect size (Kraemer et al 2008), which gives more information on 
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the magnitude of an effect in the population being examined and is therefore more clinically 
useful. Alternative approaches to mediation analyses outlined below (Section 3.2.2) are able to 
provide an estimate of the mediating effect itself. 
 
However, there is some support for the Baron & Kenny approach. The method is said to perform 
as well as the other proposed approaches once the first step is removed (Hoyt et al 2008), and the 
analysis is easier to perform and interpret (Hoyt et al 2008). It has also been suggested that 
whether or not the first step in the model is included should depend on the temporal distance 
between the intervention and outcome variable (Frazier et al 2004). This is based on work by 
Shrout & Bolger (2002) who suggested that mediating effects are less likely to be detected if there 
is a long span of time between the intervention occurring and the outcome being measured, so 
the first step in Baron & Kenny’s model would be unnecessary. In such cases the focus should be 
on the theoretical argument for a variable being a mediator (Shrout & Bolger 2002) rather than 
being based on statistical considerations. Others (e.g. Imai et al 2010b) have suggested that this 
approach can be interpreted as an average causal mediation effect so long as certain assumptions 
are satisfied (see Section 3.2.5). On weighing up the evidence and expert opinions overall 
however, it can be concluded that the Baron & Kenny approach is now somewhat outdated. 
Indeed, one of the original authors of the paper has also reflected that the steps outlined in the 
paper may have been too prescriptive, leading researchers to ignore some of the key assumptions 
and problems in conducting mediation analysis (Kenny 2008). 
 
3.2.2 Statistical approaches to mediation analysis: Structural equation modelling (SEM) 
Correlation and multiple regression analyses have historically been used to perform mediation 
analysis, with multiple regression being the method most often used to perform the causal steps 
approach (see Chapters 4 and 5 for summaries of the literature). The problems associated with 
the various steps of the causal steps approach are described above, but there are also problems 
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with the use of regression models in general to analyse mediators because they cannot account 
for measurement error, and therefore assume perfect measurement of the potential mediator 
variables (Brown 1997; Cheung & Lau 2008). This assumption is problematic, especially when 
dealing with psychological factors and self-report measures. Measurement error is a potential 
problem for all regression models, but especially when trying to establish whether a particular 
factor is responsible for the change in outcome seen, as in mediation analysis. Accurate 
measurement of change requires highly reliable measurement (Streiner & Norman 2008). 
Measurement error is magnified when looking at change, especially if a raw change score 
(difference between pre- and post-test) is used as there will be error in both measurements 
(Streiner & Norman 2008). Regression procedures also assume a causal order to the variables 
included in the model, which is not necessarily established (Streiner & Norman 2008). 
 
Structural equation modelling (SEM) is a confirmatory (theory based) approach that enables the 
mapping out of paths or relationships between variables, taking into account error variance 
(Byrne 2010). SEM combines linear regression and factor analysis (Tabachnick & Fidell 2007) and 
models can be made up of observed and unobserved variables. The unobserved factors are latent 
constructs that are thought to underlie the observed (measured) variables (Holbert & Stephenson 
2002). The models comprise two parts; a measurement model, examining how the observed 
variables relate to the unobserved (latent) factors, and a structural model, examining the 
relationships between the latent factors and other observed or unobserved factors. It has been 
recommended (Anderson & Gerbing 1988; McDonald & Ho 2002; O’Boyle & Williams 2011) that 
the measurement model be constructed and examined before the structural model is evaluated. 
This is to ensure there are no problems with the measurement model that could affect the 
interpretability of the structural model (O’Boyle & Williams 2011). 
 
Chapter 3 Methodology Review Page 45 
 
SEM has a number of benefits over traditional regression techniques. Firstly, measurement error 
can be taken into account in the model (Brown 1997; Ullman 2007). Two properties of 
measurement that are particularly important in mediation analysis are convergent validity 
(whether the items seem to represent the same construct) and discriminant validity (how 
distinguishable the constructs are from each other) (Mathieu & Taylor 2006). Both of these can be 
tested with confirmatory factor analysis (CFA) carried out within SEM, which ensures the 
measurement properties of the observed and latent variables in the model are examined before 
the structural model (examining the relationships between the latent variables) is tested. SEM 
also allows alternative models to be compared more easily (Mathieu & Taylor 2006). Most SEM 
packages also include tests of goodness-of-fit for the model, although some authors argue that 
the indices provided are subjective and there are no guidelines about which indices to report 
(McDonald & Ho 2002). This issue is discussed in more detail in Chapter 6. These benefits of SEM 
are evidenced in a simulation study by Iacobucci et al (2007) comparing SEM with traditional 
regression for mediation analysis. They found that SEM outperformed regression in terms of 
smaller standard errors and greater reliability of measurement with the ability to use more 
measures per construct.  
 
However, SEM is not without its problems. This method generally requires a larger sample size 
than traditional regression analysis methods in order to obtain precise values for the specified 
pathways, which limits the number of studies to which this type of analysis can be applied 
(Quintana & Maxwell 1999). There is also no real consensus on the minimum sample size which 
should be used for SEM, with numbers of between 150 (Holbert & Stephenson 2002) and 200 
(Tomarken & Waller 2005) being suggested. SEM also only accounts for the paths specified in the 
model, when in reality there could be many alternative models that are not included (Frazier et al 
2004). This could lead to the goodness-of-fit indices suggesting the model is a poor fit to the data 
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(Quintana & Maxwell 1999). SEM also still does not test the temporal order of the variables in the 
model. 
 
3.2.3 Statistical approaches to mediation analysis: Latent Growth Modelling (LGM) 
In the context of mediation analysis it has been argued that the temporality of the relationship 
between two variables, regardless of study design, is often only an illusion as the analysis is based 
on between-subject rather than within-subject correlations (Collins et al 1998; Roe 2012), and 
that the use of two-dimensional, time-lagged models might help rectify this issue. One method 
that shows promise is latent growth modelling (LGM). LGM can be conducted using SEM, but 
differs in that the latent variables included in the LGM models represent participants’ start point 
or baseline and their change over time, while in SEM the latent variables represent underlying 
constructs. LGM involves repeated measurements of observed variables to account for change 
over time (MacCallum & Austin 2000). LGM is becoming a more popular method of analysing 
longitudinal data, and could be useful in conducting mediation analysis (Lockhart et al 2011). The 
main strength of this approach is its ability to include variations in time (Tomarken & Waller 
2005).  
 
3.2.4 Tests of statistical significance in mediation analysis 
Several methods exist to estimate the statistical significance of the indirect (mediating) effect 
(Mackinnon et al 2004). The most well-known of these tests is the Sobel test (Sobel 1982). This 
approach allows the determination of whether the potential mediator has a statistically 
significant effect on outcome by dividing the estimate of the effect of the mediator by its standard 
error and comparing this to a normal distribution (MacKinnon et al 2002). This test was 
recommended by Baron & Kenny (1986) to be used in conjunction with their causal steps 
approach as a test of statistical significance, although it has been argued that the preceding  
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regression analyses they propose are not necessary for this test to be performed (Hayes 2009). 
However, the Sobel test assumes normal distribution of the mediating effect which is frequently 
not the case (MacKinnon et al 2004; Hayes 2009). This is because the test is the product of two 
parameter estimates (a and b) (Zhao et al 2010) which may be measured on different scales and 
have different mean values, and also because tests of mediation are often carried out with small 
sample sizes (Gelfand et al 2009).  
 
Differences in coefficients tests are used to compare the effect of treatment on outcome before 
and after accounting for the potential mediator (MacKinnon et al 2002; MacKinnon et al 2004). In 
their review, MacKinnon et al (2002) state that such tests have higher power compared to the 
causal steps approach but result in an increase in Type I errors compared to the other methods, 
meaning that a positive result may be found when in fact one is not present (Sim & Wright 2000). 
They also state that these tests are more useful for “simple” mediation models containing only a 
single potential mediator (Hayes 2009) and are more difficult to interpret in complex, multiple 
mediation models.  
 
Product of coefficients approaches involve multiplying the coefficients of paths a and b together 
(MacKinnon et al 2004). Such tests have traditionally been more popular in sociological research, 
but are now frequently adopted in the psychological literature. These tests were found in 
MacKinnon’s review (Mackinnon et al 2002) to be more conservative than the causal steps 
approach with lower Type I error rates, meaning that they are less likely to give a positive result if 
one does not exist. They are also more easily applied to models containing more than one 
mediator (Fritz et al 2012).  
 
Again, these tests are not without their assumptions. It is acknowledged that the tests assume 
there is no measurement error in the variables being tested and that there are no omitted 
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variables (MacKinnon et al 2004). However, as long as these assumptions are met (see Section 
3.2.5), these methods can provide accurate estimates of the mediating effect (Imai et al 2010a). 
 
Several authors (Shrout & Bolger 2002; MacKinnon et al 2004; Gelfand et al 2009; Hayes 2009; 
Lockhart et al 2011) recommend that a bias-corrected bootstrap procedure should be used when 
assessing the magnitude of the mediating effect, as this does not assume that the effect is 
normally distributed. This procedure allows for nonparametric confidence intervals (CIs) to be 
generated, allowing estimation of the precision of the effect and of statistical significance 
(MacKinnon et al 2004; MacKinnon & Fairchild 2009). Bootstrapping is a process of re-sampling 
the data to create numerous subsamples from a single dataset (Hayes 2009; Byrne 2010). This 
then creates a number of parameter distributions to create a new sampling distribution (Byrne 
2010). The bootstrapped estimate is the average of all of the newly created parameters 
(MacKinnon 2008). A bias-corrected bootstrap is particularly recommended when testing 
mediating effects as simulation studies have found that this method provided the lowest Type I 
error rate and the most power compared with other bootstrap methods (MacKinnon et al 2004; 
MacKinnon 2008; Williams & MacKinnon 2008). This method can be applied to complex as well as 
simple mediation models (Hayes 2009). The use of bootstrapping can mean it is difficult to 
replicate study results as the bootstrapped samples differ on each occasion, but this is not 
problematic if large numbers of bootstrapped samples are used (MacKinnon et al 2004; Cheung & 
Lau 2008).  
 
3.2.5 Assumptions made in mediation analysis 
The approaches to mediation analysis, the statistical methods available for testing mediation and 
the tests for the statistical significance of the mediating effect all make a number of assumptions 
about the data being analysed, which can be problematic if they are not adequately considered. 
These assumptions are also closely related to the design issues in Section 3.1. The assumptions 
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outlined below have been highlighted as particularly important as they may lead to biased or 
misleading findings.  
 
Some mediation analysis methods, such as linear regression, do not allow for the inclusion of an 
estimate of measurement error in their models and therefore assume perfect measurement 
(Emsley et al 2010). This is not always appropriate, especially when dealing with psychological, 
self-report measures (Cole & Maxwell 2003; Frazier et al 2004; Kazdin 2007; Gelfand et al 2009). 
Other authors (e.g. Hoyle & Robinson 2004) advocate only using measures which have an internal 
consistency of >0.90 or using models which contain latent variables, although other authors have 
cautioned against spuriously high correlations as they could suggest a lack of distinctiveness 
between variables (e.g. Mathieu & Taylor 2006). SEM allows the inclusion of multiple indicators to 
provide a more accurate measure of a construct (Anderson & Gerbing 1988) and both SEM and 
LGM allow for the inclusion of an estimate of error in the model, although in practice few studies 
currently include more than one measure of a construct.  
 
The problem of unmeasured or ‘omitted’ variables could also impact on the hypothesised 
mediation model (Judd & Kenny 1981; Frazier et al 2004; Gelfand et al 2009; Coffman 2011; 
Lockhart et al 2011) as these could provide alternative explanations for the mediating effect seen, 
or could include potential confounding factors. It is almost impossible to include measures of all 
possible confounding or omitted variables in a single analysis (Bullock et al 2010) and instead it 
has been suggested that a statement should be made that refers to this limitation in all mediation 
analysis studies (Gelfand et al 2009). 
 
Any single regression or SEM/LGM analysis will only show the potential mediating pathway(s) 
identified by the researchers, when in fact many other models may exist. This issue is closely 
linked to the assumption of no unmeasured variables. The potential for alternative models to 
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those proposed in the study is not always acknowledged by applied researchers (Kazdin 2007; 
Fiedler et al 2011). SEM does have an advantage here in that models can be modified to show 
alternative models quite easily, although any modifications should be based on theoretical rather 
than statistical grounds as this will be useful in compiling evidence for a causal effect (McDonald 
& Ho 2002; Tomarken & Waller 2003). Alternative models may also fit the data equally as well as 
the hypothesised model according to the model fit statistics, so it is difficult to judge which model 
represents the data best (Tomarken & Waller 2003; Stone-Romero & Rosopa 2011).  
 
A final issue with SEM/LGM analyses specifically is that while they allow multiple mediators to be 
included in a single analysis, they then assume independence between these different mediators 
which may in fact not be the case (Keele 2015). Careful consideration of each tested mediator is 
required to ensure they are each testing a different concept. 
 
It is impossible to determine for certain what the direction of the relationship is when 
implementing correlational methods, even in the context of an experimental study. The temporal 
order of the variables is assumed to be correct in current proposed mediator models, when of 
course change in the outcome variable will still be related to change in the potential mediator 
whether it occurred first or second (MacKinnon 2011). The language of the approaches and 
methods of testing mediation however does imply causality, particularly when drawing SEM/LGM 
models which contain unidirectional arrows to indicate a hypothesised relationship. This has led 
to some applied researchers stating that their results indicate a causal relationship when in fact 
this assumption is not met (Quintana & Maxwell 1999).  
 
3.2.6 Summary 
This section has provided an outline of the available approaches to mediation and how they can 
be tested statistically. The literature suggests that the product of coefficients approach, carried 
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out using SEM and incorporating bias-corrected bootstrapped CIs for the indirect effect, is 
currently the most effective method in terms of addressing the assumptions made when 
conducting mediation analysis, with LGM being a promising new statistical approach to mediation 
analysis. Combining these recommendations with those suggested in Section 3.1 should help 
ensure that future mediation analysis studies provide better evidence for mediating effects. 
However, it is clear that even the best available methods are not without their problems and 
assumptions. Section 3.3 is focussed on recommendations for improvements to current best 
practice and outlines ways to further account for the assumptions made in mediation analysis. 
 
 
3.3 Recommendations for Research 
Overall, while observational studies are useful for generating hypotheses and can give 
information about which variables have the potential to mediate outcomes, there seems to be a 
move towards conducting treatment mediation analysis within the context of experimental study 
designs, particularly RCT designs. A number of authors from different fields have suggested ways 
to incorporate mediation analysis into future RCTs by making small changes to the current trial 
design, such as including assessments of key mediators during the intervention period. The 
literature concerning methods of analysis suggests that the product of coefficients approach, 
when conducted using SEM and including bias-corrected bootstrapped CIs, is currently considered 
the most robust way of performing mediation analysis.  
 
MacKinnon (1994) and more recently Kazdin (2007) have set out guidelines concerning issues of 
study design and recommendations for future research. Although MacKinnon’s monograph was 
written 13 years before Kazdin’s recommendations, some of the proposed changes are very 
similar. Other authors (Tomarken and Waller 2003; Frazier et al 2004) have also made  
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recommendations as to how the mediation analysis itself should be conducted and/or reported. 
There is obviously overlap between some of the recommendations, and for this reason this 
section combines the key recommendations these authors made for improvements that apply to 
aspects of both design and analysis of mediation studies. My own reflections, which combine the 
most important recommendations given here and throughout this chapter, are given in Figure 3.3. 
 
3.3.1 The importance of theory in mediation study design and analysis 
It is important to choose mediator variables on a theoretical basis (MacKinnon 1994; Kraemer et 
al 2002, Frazier et al 2004; Kazdin 2007; Mathieu et al 2008) or based on previous empirical 
studies. Observational studies may play an important role in testing aspects of a model before 
particular variables are included in an RCT. The decision to conduct treatment mediation analysis 
should be made before the study begins, to ensure all variables to be tested as mediators can be 
included and measured at the right time (Kraemer et al 2002). There may be many variables in a 
process that help explain the effect of treatment on outcome but it is often impractical to 
measure all of these within a single study (MacKinnon 1994). Selecting mediators based on theory 
can therefore help researchers choose the key factors to focus on, which also means that clear 
hypotheses regarding how a treatment might work are created before the study begins (Murphy 
et al 2009, MacKinnon et al 2011). A theoretical basis will also help with the issue of temporality 
described above as this provides a framework for showing how variables might occur in a 
particular order (Mathieu & Taylor 2006). In addition to using an underlying theoretical 
framework, several authors have emphasised the importance of previous research evidence for 
choosing potential mediator variables to analyse (Lockhart et al 2011; MacKinnon & Fairchild 
2009; Maric et al 2012). Repeating studies using different designs will add to the evidence for 
specific mediators and allow analysis of consistencies to add to the causal argument (Kazdin 
2007).  
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3.3.2 Establishing temporality 
Several authors (Murphy et al 2009; Kazdin 2007; Laurenceau et al 2007; Maric et al 2012; Grice 
et al 2015) have highlighted the importance of the timing of assessments in terms of establishing 
temporal precedence of the mediator before the outcome, something that is not currently 
routinely acknowledged in mediation research despite this being part of the definition of a 
mediating factor (see Chapter 1). Both the mediator and outcome should be assessed frequently 
over the period of time that change is expected to occur (e.g. Kazdin 2007; Laurenceau et al 
2007). This again shows the importance of deciding to investigate mediation a priori, as having a 
clear hypothesis regarding when a mediator is likely to change will help researchers to plan when 
the optimal measurement points might be (Tomarken & Waller 2003). While studies that include 
assessments before and after treatment may still provide some useful information on what 
factors are related to outcome (Maric et al 2012), there is still a significant problem with only 
assessing mediator and outcome variables at pre- and post-treatment, as this does not provide 
evidence regarding which variable changed first (Kazdin 2007). Mediation may sometimes occur 
early on in treatment, meaning that mediating effects might be missed if measurements are only 
taken at pre- and post-treatment (Kraemer et al 2002). An intervention may also work differently 
for different people and the effects could occur at different times (Kazdin 2007; Laurenceau et al 
2007). Multiple assessments allow exploration of this variability.  
 
3.3.3 Psychometric properties of measures 
The use of unreliable measures can increase the rate of Type II errors (the failure to detect an 
effect when one exists) and reduce power (MacKinnon 1994; Maric et al 2012; Frazier et al 2004; 
Kazdin 2007). Future studies of mediation need to take the psychometric properties of measures 
into account in both the design and analysis stages. A number of different psychometric 
properties, some of which are outlined below, are important to consider when evaluating a 
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measurement tool (Terwee et al 2007). All of these, where possible, should be established a 
priori.  
 
Construct validity refers to how well a tool is measuring what it purports to measure (Terwee et al 
2007). Prior to the study being undertaken, suitable validated measures should be selected. 
Related to this is the concept of interpretability, or how well items are understood (Terwee et al 
2007). As many of the constructs to be assessed as potential mediators can only be accessed via 
self-report from participants it is essential that the measures make sense to those who are using 
them. Mathieu et al (2008) highlight this as a real issue not often considered by researchers and 
that construct validity should not be readily assumed. 
 
Internal consistency relates to whether or not all the items in a tool are correlated (Terwee et al 
2007). It is important that all items of a measure refer to the same underlying construct, and does 
not include items relating to other constructs (Streiner 2003) which would reduce its internal 
consistency. However, a measure with very high internal consistency may only be capturing a 
specific aspect of a construct, which would then impact on content validity (Streiner & Norman 
2008).  
 
Reproducibility refers to whether similar results can be obtained over time in the same 
participants given stability of the concept to be measured. This is important in studies of 
mediation where participants are likely to be followed over several time points, meaning any 
measurement error is magnified (Streiner & Norman 2008). Measurement error can hinder our 
ability to make causal inferences (Imai & Yamamoto 2010). SEM and LGM can take measurement 
error into account, but study designs do not always include multiple measures of variables and 
SEM/LGM is therefore often not used to its full potential. Any measure to be used in mediation 
analysis should be shown to be consistent over time. 
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Responsiveness is key to establishing mediating effects, as it relates to whether or not a measure 
can detect change over time and separate this from measurement error (Terwee et al 2007). The 
use of unresponsive measures in studies of mediation analysis could result in Type II errors. Floor 
and ceiling effects can also affect the responsiveness of a measure (Terwee et al 2007). Again, the 
presence of these effects should be explored in a measure prior to its inclusion in a mediation 
study. 
 
3.3.4 Assessing more than one mediator 
The inclusion of more than one potential mediator in studies of mediation is highly recommended 
(Kazdin 2007). An intervention is unlikely to work through a single mediating factor, and including 
several mediators makes more economical sense as it allows several tests of mediation from a 
single study. It is also difficult to focus on one variable in particular, especially in psychological 
research where the potential mediators are often subjective and closely linked to other factors 
(Bullock et al 2010; Campbell et al 2013b). The mediator under investigation is not necessarily also 
the mechanism, or the variable causally responsible for of the change seen (Fiedler et al 2011). 
Many variables may act as mediators, but only a few will actually represent causal mechanisms 
(Kazdin 2007; Mathieu et al 2008). However, it can also be argued that by not targeting a single 
mediator in particular it will not be clear which factors need to be targeted in future interventions 
(Bullock et al 2010). The decision of whether to include single or multiple mediators will depend 
on the theory being tested, the measures available and the design of the intervention. 
 
3.3.5 Aspects of design and analysis that can facilitate mediation research 
One design put forward by MacKinnon et al (2007) among others to prevent confounding as a 
result of unbalanced mediating variables across intervention groups in a trial involves randomising 
participants at the level of the mediator variable. Such a design would need to involve  
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randomisation of factors measured at baseline that were being manipulated, or could potentially 
be manipulated, during the study. This change in design is endorsed by others (e.g. Spencer et al 
2005; Bullock et al 2010; Stone-Romero & Rosopa 2011; Keele 2015), who also suggest that 
participants should perhaps be exposed to different levels of the mediator variable to help 
establish mediating effects. This would be useful in establishing causality, as if a more intense 
condition of the mediator resulted in greater changes in the outcome, this change could be more 
readily attributed to the mediator than to another (perhaps unmeasured) variable. This is also 
known as the biologic gradient, or dose-response curve (Rothman & Greenland 1998). Two other 
experimental methods that may be useful in testing for mediation include blockage designs, 
which include a condition where the mediator is blocked in some way (MacKinnon & Fairchild 
2009); and enhancement designs, which include a condition where the mediator is increased 
(MacKinnon & Fairchild 2009; Keele 2015). Keele (2015) gives the example of those randomised to 
the treatment arm of an intervention being randomly split again into two groups, where in one 
group the mediator is randomly encouraged. However, Keele (2015) points out that this design 
then requires additional assumptions, such as that the outcome is then only affected via the 
mediator of interest and not via other variables. Also, while these designs have been proposed as 
possible solutions there do not appear to be any examples of such designs actually being 
implemented. “Fixing” the mediator at particular levels may be impossible, especially if they 
relate to behaviour, meaning that while such design ideas in theory appear to be the way forward 
they may be difficult to apply in practice (Lynch et al 2008). It is also often difficult to manipulate 
psychological factors in experimental situations (Spencer et al 2005; Stone-Romero & Rosopa 
2011). This issue is acknowledged as potentially the most difficult aspect of designing mediation 
studies (MacKinnon et al 2007).  
 
A number of statistical methods that may strengthen the investigation of causality have been 
suggested, such as propensity score and instrumental variable methodology to adjust for 
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confounding (Coffman 2011; Rassen et al 2009; Emsley et al 2010), but these are often complex 
and there is some disagreement over their usefulness in the analysis of mediating factors. The 
assessment of mediation using the causal inference approach has recently gained attention, 
which involves the use of the potential outcomes framework (Imai et al 2011; Dunn et al 2013b). 
While these techniques are beyond the scope and focus of this PhD, future work investigating 
their utility is warranted. They are discussed in more detail in Chapter 9. 
 
However, most recently even the most advanced methods of analysis have been called into 
question for only providing aggregate estimates, which may not be true for all individuals in the 
study, let alone the population to which the authors may wish to generalise the results (Grice et al 
2015). Data should be observed at a very basic, individual level to pick up these differences (Grice 
et al 2015). 
 
3.3.6 Back to basics? 
Finally, a workshop facilitated by Mansell, Hill, Kamper and Kent at the Odense International 
Forum XII in October 2012 provided some insight into the opinions of MSK pain researchers 
regarding the future of mediation research. The general consensus at this workshop was that, 
aside from the points mentioned above, there was a need to return to exploratory and qualitative 
analyses in order to pinpoint the concepts that are most important in terms of a treatment 
changing outcome (i.e. the mechanisms of action). The importance of qualitative research in 
helping to identify key factors to test as mediators has also been advocated by other authors 
(Kazdin 2007), and can be especially useful in areas where no theories are available. It can be used 
to explore therapeutic processes and how these impact on the therapist and patient, and also 
why factors do or do not change and the reasons behind this (Kazdin 2007). There might be 
multiple outcomes of a single mediating factor, or multiple mediating factors accounting for a  
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single outcome, and exploratory work might be key in helping to unpick this (Kazdin 2007). 
Identifying key mediators is a long process, and replication of findings to give support for certain 
mediators being key mechanisms of outcome is an essential part of that process (MacKinnon 
1994). It has been suggested that a programme of research, incorporating several different types 
of study designs, is needed (MacKinnon 1994; Bullock et al 2010). 
 
3.3.7 Summary 
This section has highlighted a number of recommendations from different fields on how to 
improve design and analysis aspects of mediation studies. There is considerable overlap between 
design and analysis and the recommendations can often be applied to both aspects. The key 
design aspects appear to involve: (1) a priori, theory-based decision-making around which 
variables could be mediating outcome; (2) assessing the proposed mediator(s) and outcome(s) 
frequently, during and after treatment; and (3) using well-validated measures in order to provide 
stronger evidence for a causal pathway. In terms of the analysis, similar recommendations are 
made but these also include more specific guidance including (1) the need for a power calculation 
for testing mediating effects and (2) testing for or acknowledging the possible presence of 
alternative models. However, it is important to acknowledge that many of the new ideas 
proposed for future research are far more complex than the design and analysis techniques 
currently employed and careful thought will be required in order to incorporate these new ideas 
into future studies. 
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3.4 Overall Summary 
3.4.1 Design 
Section 3.1 gave an overview of the designs used historically to carry out treatment mediation 
analysis, and outlined the problems with each type of design. Observational studies suffer from 
problems related to causality and bias. The general consensus from the current literature is that 
experimental designs in the form of RCTs provide the most robust evidence for mediating effects, 
and while issues with causality and bias are not totally solved, several authors suggest that 
making a few changes to how we conduct RCTs can support the design of studies that are more 
able to detect mediating effects. Suggestions for the future also indicate that the current research 
on mediation within the field of MSK pain may need to be brought back a few stages; several 
authors suggest the use of qualitative and other exploratory work to identify key factors to test as 
potential mediators in experimental studies. 
 
3.4.2 Analysis 
Section 3.2 highlighted the complexities in carrying out mediation analysis and the problems 
associated with the methods currently available. The product of coefficients approach, carried out 
using SEM and including bias-corrected bootstrapped CIs for the indirect (mediating) effect, is 
currently seen as the most appropriate method of conducting mediation analysis to examine 
change in potential treatment mediators. However, a number of assumptions are made by the 
analysis methods traditionally used which are often not met or recognised by the researchers 
using them, leading to potentially ‘untrustworthy’ mediation analysis being published in the past. 
The current best method described above can relax some of the assumptions and allow us to 
make stronger claims regarding causality, but problems with the application of SEM remain and 
some authors have suggested that even this method of conducting mediation analysis may still 
not actually provide true tests of mediating effects. More modern approaches that have been 
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suggested recently, such as LGM, may help to solve some of the issues highlighted in this section 
but they substantially increase the complexity of the analysis. 
 
3.4.3 Key recommendations 
Perhaps the most important suggestion arising from this overview is that mediation analysis 
should be part of a programme of work that is based on sound theory to guide decision making. It 
is interesting to note that many of the current issues and problems with design in mediation 
studies, such as the timing of assessments, the inclusion of potential confounding variables and 
the issue of causality, can be at least partially addressed by using a strong theoretical basis. The 
replication of work and the use of different designs to build up evidence for particular mediating 
factors is also important to note, as this will help to support or refute existing theoretical models 
or help to build new ones. Including multiple assessments of the mediator and outcome variables 
during and after the intervention is also seen as key in addressing issues around causality and 
bias. Finally, the use of measures with sound psychometric properties or the use of analysis 
methods which account for measurement error are required. 
 
This PhD thesis explored how psychological treatment mediators could be better investigated in 
RCTs which aimed to reduce disability in MSK pain populations. The work built on that reviewed 
above, focusing specifically on MSK pain, to provide further evidence for best practice in the 
design, conduct and analysis of studies of mediation. The current evidence for mediation studies 
in the MSK pain literature was firstly reviewed, followed by a series of analyses of existing 
datasets which tested some of the recommendations made in this chapter in order to improve 
and add to the current recommendations.
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Figure 3.3 Current best practice, problems and recommendations regarding the design and analysis of mediators 
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Chapter 4: What is the current evidence that psychological factors mediate 
disability outcome in musculoskeletal pain populations? 
 
4.1 Introduction 
The literature review presented in Chapter 3 gave an overview of the different methods available 
for conducting mediation analysis and outlined the debate around the most appropriate method 
to use. It also highlighted the current best practice for mediation analysis and areas for 
improvement. An overview of the current evidence of mediation analysis in relation to 
musculoskeletal (MSK) pain populations is currently lacking and would be useful in terms of 
identifying what is already known about psychological mediators in this area, comparing different 
existing methodologies, and recommending areas for future research improvements. This chapter 
details a systematic review which has been carried out to address this gap in the research 
literature. An earlier version of this review was published as part of an article in Best Practice and 
Research Clinical Rheumatology (Mansell et al 2013). 
 
Mediation analysis is not a new topic and has been used widely in other areas of health 
psychology. Systematic reviews in other fields exist, highlighting many of the issues discussed in 
Chapter 3. For example, Lubans et al (2008) conducted a review of mediators of physical activity 
in behavioural interventions for children and found seven articles that met their inclusion criteria. 
The numerous differences between the studies in terms of design, interventions, potential 
mediators, and outcomes meant that the authors struggled to come to a conclusion about specific 
mediators, but they did state that self-efficacy would be a good target for future interventions 
based on the available evidence. Another review by Cerin et al (2009) aimed to identify mediators 
of dietary behaviour change in adolescents and again only found seven relevant papers. The 
authors stated that the variety of different interventions and tested mediators made the task of 
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synthesising the evidence difficult, but found some evidence for self-efficacy, habit, and outcome 
expectations being related to outcomes. However, the authors did not feel the evidence was 
strong enough for these variables to be seen as treatment mediators. Finally, a recent review by 
Stanton et al (2013) of mediators of psychosocial interventions for patients with cancer located 16 
studies which varied in terms of the type of cancer being studied and the content of the 
intervention. The authors identified several “classes” of mediators, including cognitive 
expectancies, illness representations and self-efficacy, but again highlighted several flaws with the 
included studies such as not basing interventions on a specific theory, using a sub-optimal method 
of mediation analysis and not attempting to establish the temporal relationship between the 
variables. These papers highlight some of the difficulties in reviewing this topic, but also the 
importance in bringing these problems to light so that future studies can improve the way 
mediation analysis is conducted.  
 
This review identified studies of MSK pain populations where mediation analysis had been carried 
out on a psychological intervention (defined in Section 4.4.1). There was a need not only to 
provide information on constructs that have already been formally tested as treatment 
mediators, but also to identify which methods have been used to conduct this research. Chapter 3 
identified a number of areas where mediation analysis may be flawed, potentially limiting the 
usefulness of previous research into mediators of treatment effect. Therefore, while the 
identification of variables tested previously as mediators was required, how each factor was 
identified was also very important to review.  
 
Although the overall aim of this thesis was to identify mediators of low back pain interventions, 
there appeared to be a lack of studies that have conducted mediation analysis in this area 
specifically. The scope of this review was therefore widened to include any psychological 
intervention study in MSK pain populations that had conducted mediation analysis. It was thought 
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that this may also help identify additional treatment mediators that can be applied to the field of 
low back pain (LBP). 
 
 
4.2 Aim 
To systematically review the current evidence for psychological factors that have been tested as 
psychological treatment mediators in studies involving patients with MSK pain. 
 
 
4.3 Objectives 
1. To identify psychological constructs tested as mediators of treatment effect in intervention 
studies for MSK pain; 
2. To assess the evidence for these constructs mediating treatment effect; 
3. To identify which methods have been used to conduct mediation analysis and explore whether 
the choice of method may have had an impact on the study findings. 
 
 
4.4 Methodology 
Cochrane Review guidelines were followed to structure the review and define all its 
methodological processes (Higgins & Green 2011). This provides a systematic, transparent way of 
reporting and conducting the review so that it may be replicated. 
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4.4.1 Inclusion and exclusion criteria 
Criteria for inclusion and exclusion were applied to each paper so that it was clear which papers 
should be included in the review. Details of the criteria that were applied to each paper being 
assessed for inclusion are given below, and summarised in Box 4.1 (page 67). 
 
The population of interest in this review included any adult (aged 18 years or above) with non-
traumatic, non-inflammatory MSK pain, such as non-specific low back pain, chronic pain or 
osteoarthritis. Inflammatory conditions such as rheumatoid arthritis (RA) or conditions with a 
known structural pathology (e.g. spinal cord injury) were excluded. Only studies that included 
participants with a single relevant MSK condition were included in the review, unless the paper 
presented analyses and results for the relevant subgroups separately. For example, if a study had 
included a group of patients with back pain and a group with RA, the study would be included if 
the groups were analysed separately so that the results for the back pain group only were given.  
 
In this review, a psychological intervention was defined as any intervention provided by any 
health professional that specifically set out to change psychological factors. A control or 
comparator group was required so that the results from the intervention group could be 
compared to those of the non-intervention group. 
 
The evidence summarised in Chapter 3 suggested that mediation analysis that provides a test of 
the indirect (mediating) effect conducted using structural equation modelling (SEM) or latent 
growth modelling (LGM) and includes bootstrapped confidence intervals (CIs) is currently seen as 
being able to provide the best evidence for mediation. However, as the aim of this review is to 
explore all the evidence of mediation analysis conducted in the field of MSK pain research, no 
specific type of mediation analysis was specified for inclusion. This will help address Objective 3 
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which involves identifying the methods used to conduct mediation analysis in MSK pain 
intervention studies. 
 
In order to be included in the review, the paper must have included a measure of functional 
disability. This outcome is of interest because most interventions, especially those with a 
psychological component, aim to improve functioning rather than reduce pain, and disability is 
often the primary outcome of MSK trials (e.g. Burton et al 1999; Frost et al 2004). This measure 
could be a measure of performance, such as a timed walking test, or subjective report, using a 
questionnaire such as the RMDQ (Roland-Morris Disability Questionnaire; more detail about this 
measure is available in Chapter 5). 
 
The recommendations for obtaining the best evidence for mediation analysis outlined in Chapter 
3 suggest that intervention studies, and in particular randomised controlled trial (RCT) designs, 
are better able to account for the assumptions made in mediation research such as causality and 
temporality than cross-sectional or cohort study designs. In this review, any intervention study 
design was included providing that a control or comparator group was also included. 
 
These criteria were deliberately kept broad in order to obtain the maximum number of potential 
studies to include. No limit was placed on the setting of the study as it was anticipated that few 
would have been conducted in primary care. Papers that were not available in English were 
excluded, as were any papers for which a full text or peer-reviewed paper was not available.  
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Box 4.1 Summary of inclusion criteria for studies 
 
 
 
 
 
 
 
 
4.4.2 Search methods for study identification 
Four electronic databases were searched from inception to February 2012 and then again from 
2012 to August 2015, using the Ovid and NHS Library interfaces (see Box 4.2). This chapter 
presents the combined results from the original and updated searches. Each of the databases has 
a slightly different focus and contains a different range of psychology and pain journals, which is 
why it was necessary to search more than one database when conducting the review. 
 
 
 
 
 
 
 
 
 
 
Adult MSK pain populations (aged 18 years or above) 
The intervention should aim to change psychological factors and measure these factors over time 
The study should include a comparator or control group 
The study should include a measure of disability as an outcome 
The study should include a method of mediation analysis and present results of the mediation 
analysis 
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Box 4.2 Electronic databases used to search literature 
PsycINFO (1806-Present) 
This database has a psychological focus, suggesting that it is the most likely of all the databases to pick up 
papers related to mediation analysis. Mediation has a number of different definitions in different disciplines 
so papers picked up in other databases may use terms related to “mediation” in a number of different 
contexts that may not always be relevant to this search. This database includes a number of journals 
relating to pain, as well as psychology-specific journals. 
 
MEDLINE (1950-Present) 
This is a general medical database, covering a wide variety of medical and life science journals relevant to 
healthcare professionals. Searching this database would identify papers published in more general medical 
journals rather than psychology-specific periodicals. 
 
AMED (1985-Present) 
This database covers journals relevant to complementary and allied healthcare. Again, this slightly different 
focus may find papers from journals not indexed in the other databases. It also covers a number of 
physiotherapy and spine journals which may contain relevant papers. 
 
CINAHL (1981-Present) 
This database has a focus on nursing and other allied health professions. This will also include journals that 
are not indexed in the previous databases that may contain papers relevant to this search. 
 
Other databases were also available to search within the Ovid and NHS Library for Health 
platforms, such as EMBASE. However, after checking the journals indexed within EMBASE, it was 
found that many journals relevant to the search were also indexed in the databases already 
chosen for inclusion. EMBASE also has more of a pharmacological focus and covers a very large 
number of topics, suggesting that this would generate a large number of hits that may not be 
relevant to the search. To keep the search manageable, only the four databases described above 
were used.  
 
4.4.3 Search strategy 
A search strategy for electronic databases was developed based on Medical Subject Heading 
(MeSH) terms and free text terms for the type of study or analysis likely to have been carried out, 
different terms used for mediation analysis taken from previously identified key papers, and 
terms to identify MSK pain. The usual procedure for developing a search strategy is to include 
terms for the population of interest, the intervention and control groups, and the outcome.  
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However, while the population can be defined, no specific psychological intervention or type of 
control was specified. This is because there were not likely to be a large number of intervention 
studies that have conducted mediation analysis, so it was decided that the search should be kept 
as broad as possible in this area. In terms of outcome, there was also a problem with how 
disability was defined. When words for disability were entered as MeSH terms within each 
database, it became clear that this term was indexed in terms of physical or mental disability, 
rather than functional disability. Therefore, no specific section was added to the search to identify 
disability outcomes, but terms for MSK pain were entered to identify studies of patients with MSK 
pain which are likely to measure functional disability as an outcome, as mentioned in Section 
4.4.1.  
 
Several iterations of the search strategy were tested using key papers already identified to try and 
ensure that a comprehensive, yet manageable search could be carried out. The search strategy 
was tested in PsycINFO as this was felt to be the most relevant database for papers investigating 
mediation. Papers previously identified as performing mediation analysis on interventions for 
MSK pain patients were then searched for within the results generated by the search strategy to 
see if they were being picked up. Several versions of the strategy were tested in order to pick up 
the largest number of key papers. The final strategy for PsycINFO is shown in Box 4.3 below. 
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Box 4.3 Search strategy for PsycINFO 
exp treatment outcome/ OR intervention$.ti,ab OR correlat$.ti,ab OR regress$.ti,ab OR 
“structural equation modelling”.ti,ab OR “structural equation modeling”.ti,ab OR “SEM”.ti,ab 
 
AND 
 
mediat$.ti,ab OR “process variable”.ti,ab OR (process adj2 evaluation).ti,ab OR (treatment$ adj2 
effect$).ti,ab OR indirect effect$.ti,ab OR “indirect effect”.ti,ab OR (mediat$ and analysis).ti,ab 
 
AND 
 
exp pain/ OR exp musculoskeletal disease/ OR musculoskeletal.ti,ab OR pain.ti,ab 
 
LIMIT TO 
 
Humans and English Language 
 
 
4.4.4 Study selection 
The results of each electronic search were downloaded into reference management software 
(Refworks). Duplicates were removed and the titles of all unique references were screened to 
remove any that were obviously irrelevant. The remaining abstracts were then obtained and any 
that clearly did not meet the inclusion criteria were removed. A second reviewer (Jonathan Hill) 
also reviewed the abstracts, and any disagreements about inclusion were discussed until 
consensus was achieved. If an abstract appeared to meet the inclusion criteria, or if it was not 
possible to tell this from the abstract alone, the full text of the article was obtained. 
 
Some references related to conference proceedings or dissertations. Where these were found, a 
separate electronic search was made for publications relating to the reference. Checks for 
publications were conducted in Web of Knowledge using the author’s name and keywords 
relating to the article. If no result was found, the full title of the dissertation or conference 
abstract was searched for electronically using Google. If no publication was found the reference 
was automatically excluded, as only peer reviewed publications were to be included in the review. 
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If a publication was found and the abstract was thought to be relevant, the full text of that 
publication was included as a potential paper, instead of the original dissertation or conference 
proceeding. 
 
A number of papers picked up by the electronic search were protocols for intervention studies. 
Citation checks were therefore performed on any that met the main inclusion criteria to check 
whether a paper containing the analysis and results had subsequently been published. 
 
Once relevant full texts had been identified from the literature, the reference lists of each paper 
were scanned for further relevant papers. Each paper was also identified in Web of Knowledge, in 
order to find papers that had cited the article that may also be relevant to the present review. 
Finally, experts identified from the literature were contacted to ask for any further papers that 
had not already been identified.  
 
4.4.5 Data extraction and critical appraisal 
A data extraction tool, created using Microsoft Word, was used to record the essential details 
from each paper. This included information on the design and setting of the study, the pain 
condition being examined, details of the intervention and control group, and details of the 
mediation analysis conducted. In studies of treatment mediation, it is important to know the 
details of any control or comparison used in the intervention, as this may have an effect on the 
potential mediator. 
 
Critical appraisal of the mediation analysis was conducted using a tool adapted from systematic 
reviews of mediation analysis in behaviour change intervention studies (Cerin et al 2009; Lubans 
et al 2008). Many of the points in the original tool relate to aspects of mediation study design and  
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analysis suggested to be important in Chapter 3, but some modifications were necessary to make 
this tool relevant to the current topic. The original tool (Lubans et al 2008) comprised a checklist 
of eight items which covered areas such as whether or not the study used a theoretical 
framework and whether or not the psychometric properties of the measures used were tested. 
The authors reported that studies that scored 0-3 were low quality, studies that scored 4-6 were 
medium quality and those that scored 7-8 were high quality. However, this original checklist 
focused more on general aspects of study quality which, although important, did not really 
examine mediation methodology. Cerin et al (2009) adapted this tool to look more specifically at 
issues relating to treatment mediation, while still keeping the tool broad enough to include a 
range of different types of mediation analysis. They removed questions specific to Luban et al’s 
original study question (mediators of the effect of physical activity) and replaced them with 
questions on whether the study tested the psychometric properties of the outcome measure as 
well as the mediating variable, whether steps for testing the validity of behaviour change theories 
had been reported and whether changes in the mediating variables preceded changes in the 
outcome variables. Cerin et al used the same scoring system as that used by Lubans et al.  
 
In the present review three further questions were added to check whether a) the study tested 
for differences between baseline and follow-up scores in the outcome and potential mediator 
variables; b) whether change in the potential mediator was related to change in outcome (which 
were found in Chapter 3 to be important in deciding whether or not to further test a variable as a 
mediator); and c) whether the study controlled for potential confounding variables. This last point 
relates to the suggestion that even in RCTs, confounding factors can have an effect on the path 
between the potential mediator and outcome (e.g. Emsley et al 2010) (see Chapter 3). A summary 
of these changes can be found in Appendix 4.1. It was also decided that no overall score would be 
given for the quality of the mediation analysis, and that included studies would remain in the  
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review regardless of quality. This was because studies may score differently on different aspects 
of the critical appraisal tool. However, the scoring system was used to describe methodological 
strengths and weaknesses of each of the included papers. Consistency of critical appraisal which 
was carried out independently by two reviewers (Gemma Mansell and Jemma Cowen) was 
assessed by comparing scores for each of the 12 items. The modified tool used in this review is 
given in Table 4.1.
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Table 4.1 Modified critical appraisal tool 
Criteria How Item 
Scored 
 
Guidance for Scoring 
1. Did the study cite a theoretical 
framework? 
Y/N Does the study mention any 
psychological theory as a 
base for the intervention? 
2. Did the study use an experimental 
design? 
Y/N Any design which includes 
an intervention and a 
comparator group 
3. Were pilot studies conducted/ reported 
to test the effect of the intervention on 
the mediators? 
Y/N  
4. Were the psychometric characteristics 
of the outcome measure reported AND 
were they within acceptable ranges (i.e. 
test-retest reliability or Cronbach’s 
alpha >0.60)? 
Y/N Half a point given for each 
item, so that if both sub-
items included the papers 
has a score of 1 
5. Were the psychometric characteristics 
of the mediator measure reported AND 
were they within acceptable ranges (i.e. 
test-retest reliability or Cronbach’s 
alpha >0.60)? 
Y/N Half a point given for each 
item, so that if both sub-
items included the papers 
has a score of 1 
6. Did the study report a statistically 
significant change between baseline 
and follow-up for the potential 
mediator? 
Y/N  
7. Was the change in the potential 
mediator correlated with change in 
outcome? 
Y/N 
 
 
 
8. Were the study methods/procedures 
designed to influence mediating 
factors? 
Y/N A statement or hypothesis 
that the intervention 
procedure focuses on 
affecting the potential 
mediator(s) 
9. Did the study report a power 
calculation, and was the study powered 
to detect mediation? 
Y/N A statement of a power 
calculation reported in the 
paper 
10. Were statistically 
appropriate/acceptable methods of 
data analysis used? 
Y/N A statement that the test of 
the indirect effect was 
performed using the 
product of coefficients 
approach and included 
bootstrapped CIs 
11. Did the study control for possible 
confounding factors? 
 
Y/N 
 
 
 
 
 
12. Did the study ascertain whether 
changes in the mediating variable 
preceded changes in the outcome 
variable? 
Y/N  
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The data extraction and critical appraisal tool were combined into a single instrument (see 
Appendix 4.2 for the template). This was piloted on several papers external to the review to 
ensure all necessary information was being recorded and the two reviewers agreed on the 
interpretation and judgment of items.  
 
 
4.5 Results 
When the electronic search was conducted, 10,163 unique references were downloaded. The 
titles of these references were scanned, and 1826 abstracts of articles thought to be possibly 
relevant were obtained. A number of these abstracts (50) were found to be either protocols or 
thesis dissertations, none of which were found to be relevant. After reading through all of the 
abstracts, 180 full papers were retrieved and nine papers were found to meet the inclusion 
criteria. Reference and citation checks were carried out on these papers and one further paper 
was identified from the reference check, resulting in a total of 10 papers being included. No 
further papers were identified through contact with experts. A flowchart outlining how studies 
were excluded at each stage of the review process is given in Figure 4.1. The studies were 
heterogeneous in nature with different study populations being recruited, different methods of 
mediation analysis used and a range of different interventions being investigated. In all but five 
studies (Nicassio et al 1997; Smeets et al 2006; Leeuw et al 2008; Robinson et al 2013; Wicksell et 
al 2013) the mediation analysis was carried out as secondary analysis or as a secondary objective, 
rather than being the primary focus of the study. 
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Figure 4.1 Flowchart presenting search results and selection of studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10163 unique references downloaded from 
electronic search 
Excluded = 1632: 
Not an intervention study = 
518 
No psychological component in 
intervention/Not psychological 
intervention = 476 
Not available in English = 9 
Not MSK pain population = 291 
Review article = 285 
Dissertation with no 
publication = 43 
No mediation analysis = 1 
No control group = 1 
No disability outcome = 8 
1826 abstracts 
obtained 
180 full texts 
obtained 
Excluded = 178 
No comparator/No RCT = 26 
No mediation analysis = 58 
No psychological 
component/measures = 18 
Not an intervention = 30 
Not adult musculoskeletal pain 
population = 7 
Disability not a study outcome = 39 
Citation checks from protocols = 26 
Excluded = 26 
No paper found = 11 
No mediation analysis = 13 
Disability not a study outcome = 1 
No psychological component = 1 
Dissertation publications found = 
24 
Excluded = 24 
No paper found = 3 
No mediation analysis = 9 
No comparator/RCT = 1 
Disability not a study outcome = 6 
Not an intervention study = 3 
No psychological component = 2 
Full texts 
included = 10 
Citation checks of included papers = 
11 
Excluded = 11 
Disability not a study outcome = 2 
No mediation analysis = 5 
Not an intervention study = 2 
No comparator/Not an RCT = 2 
Papers obtained from 
experts = 0 
Reference checks of included 
papers = 23 
Excluded = 22 
No mediation analysis = 8 
Disability not a study outcome = 6 
No comparator/Not an RCT = 8 
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4.5.1 Summary of studies 
The majority of the studies (Nicassio et al 1997; Focht et al 2005; Turner et al 2007; Seymour et al 
2009; Robinson et al 2013) were conducted in the USA. Three (Spinhoven et al 2004; Smeets et al 
2006; Leeuw et al 2008) were conducted in the Netherlands and two (Wicksell et al 2010; Wicksell 
et al 2013) were carried out in Sweden. 
 
Four studies (Smeets et al 2006; Turner et al 2007; Leeuw et al 2008; Wicksell et al 2013) were 
conducted in secondary care, and the remaining papers examined community populations or 
patient groups (for example, Wicksell et al 2010 recruited patients from an organisation for 
patients with Whiplash Associated Disorder (WAD)). 
 
The papers also focused on a range of painful MSK conditions. Three (Spinhoven et al 2004; 
Smeets et al 2006; Leeuw et al 2008) investigated patients with chronic LBP. The other papers 
examined fibromyalgia (Nicassio et al 1997; Wicksell et al 2013), WAD (Wicksell et al 2010; 
Robinson et al 2013), Temporomandibular Disorder (TMD) (Turner et al 2007), knee osteoarthritis 
(OA) (Focht et al 2005) and hip and/or knee OA (Seymour et al 2009). 
 
The number of participants involved in the studies ranged from 21 in Wicksell et al’s (2010) study 
to 351 in Seymour et al’s (2009) study. Several studies included more than one active intervention 
group (Spinhoven et al 2004; Focht et al 2005; Smeets et al 2006; Leeuw et al 2008). Interventions 
lasted for between three and 12 weeks with the exception of Focht et al (2005), in which the 
intervention lasted for 18 months. Length of follow-up was reported as four months (Wicksell et 
al 2010; Wicksell et al 2013), six months (Nicassio et al 1997; Seymour et al 2009) or 12 months 
(Spinhoven et al 2004; Turner et al 2007; Leeuw et al 2008), and the remaining three studies did  
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not follow patients up after the intervention had ended. Table 4.2 gives a summary of the 
included studies. 
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Table 4.2 Summary of papers included in the systematic review 
Reference Country, Setting & 
Design, Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Focht et al 
2005 
USA; Community; 
RCT 
 
Patients with 
radiographic 
evidence of knee 
OA aged 60 years 
and over; BMI of 28 
or over; self-
reported knee pain 
on most days; less 
than 20 minutes 
exercise a week in 
the last 6 months; 
self-reported 
difficulties with 
daily activities 
Exercise (n=80): 
Aerobics and 
resistance 
training 
 
Dietary weight 
loss (n=82): 
Based on group 
dynamics and 
social cognitive 
theory – 
education, self-
regulatory skills 
training 
 
Combination 
therapy (n=76): 
Completion of 
both 
programmes 
 
 
 
 
Healthy 
Lifestyle 
(n=78): 
Designed to 
provide an 
attention 
control 
6 months, 
18 months 
Mediators: 
Walking self-
efficacy, Stair-
climbing self-
efficacy 
 
Outcomes: 
Mobility 
(walking and 
stair climbing), 
Pain 
ANCOVA Stair-climbing 
self-efficacy was 
reported to 
mediate 
performance-
based mobility in 
the Combination 
therapy group 
(ANCOVA result 
F(3,192)=2.78, 
p=0.0425); 
Unclear which 
time point was 
used in the 
change scores 
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Reference Country, Setting & 
Design,  Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Nicassio 
et al 1997 
USA; Community; 
Randomised trial 
 
Patients with 
diagnosed 
fibromyalgia (63f, 
8m); average age 
53.1 (range 24-78) 
Behavioural 
treatment 
(n=48): 
Education, 
relaxation 
training, goal-
setting, support 
person 
Education 
(n=38): 
Lectures, group 
discussion 
Post-
treatment 
(10 
weeks); 
6 months 
Mediators: 
Helplessness, 
Pain coping, 
Social support 
 
Outcomes: 
Disability, 
Depression, 
Pain (observed 
and self-
reported), 
Myalgia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“series of 
simple 
regression 
analyses” 
Helplessness and 
passive coping 
were not found 
to mediate 
disability in either 
the treatment or 
control group (no 
statistics 
reported for this 
outcome) 
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Reference Country, Setting & 
Design,  Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Leeuw et 
al 2008 
Netherlands; 
Secondary care; 
RCT 
 
Patients with 
chronic LBP; mean 
age 45.32; 51.8% 
male 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GEXP (Graded 
Exposure in 
vivo) (n=42): 
Establishment 
of a graded 
hierarchy of 
fear-inducing 
activities and 
gradual 
exposure to 
these activities 
starting with 
the least fearful 
GA (Graded 
Activity) 
(n=43): Aimed 
to improve 
physical 
function by 
positively 
reinforcing 
healthy 
behaviour and 
activity goals 
set by the 
patient 
12 months Mediators: Pain 
catastrophising, 
perceived 
harmfulness of 
activities 
 
Outcomes: 
Functional 
disability, main 
complaints 
Joint 
significance 
test 
“The main effect 
of EXP relative to 
GA on functional 
disability was 
significantly 
mediated by 
decreases in pain 
catastrophising 
and perceived 
harmfulness of 
activities, as 
demonstrated by 
a marginal effect 
of treatment on 
outcome once 
both mediators 
were included in 
the model” 
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Reference Country, Setting & 
Design,  Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Robinson 
et al 2013 
USA; Community 
physician/self-
referral; RCT 
 
Patients with WAD 
grades I and II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exposure 
therapy (n=70): 
Patients asked 
to rate fear-
provoking 
activities from 
least to most 
fearful, then 
over the 
treatment 
period asked to 
first imagine 
then actually 
perform those 
activities, 
starting with 
the least fearful 
Information 
booklet only 
(n=57): Booklet 
given on 
whiplash injuries 
and associated 
pain – 
information 
given on gradual 
increase of 
activity but no 
emphasis on 
exposure 
 
Information 
booklet plus 
didactic lecture 
(n=64): In 
addition to 
booklet, patients 
received 
educational 
sessions from a 
psychologist, 
physiotherapist 
and physician 
Post-
treatment 
(within 10 
days of 
final 
treatment 
session) 
Mediator: Fear 
of specific neck 
movements 
 
Outcome: Neck 
disability 
Product of 
coefficients, 
95% 
bootstrapped 
CIs 
Fear of activity 
was found to 
significantly 
mediate the 
effect of 
treatment on 
outcome (-3.82, 
95% CI 1.70 to 
6.34) 
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Reference Country, Setting & 
Design,  Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Seymour 
et al 2009 
USA; Community; 
Before and after 
study 
 
Patients with 
hip/Knee OA; no 
complicated 
surgery or steroid 
injections in 
previous 6 months; 
mean age 71; 80%f 
Fit & Strong! 
Programme 
(exercise 
therapy) 
delivered by 
physiotherapists 
Same 
programme, 
delivered by 
certified 
exercise 
instructors 
Two 
months, 
six months 
Mediators: Self-
management 
elf-efficacy 
(exercise, pain 
management, 
symptom 
management), 
Exercise 
adherence self-
efficacy 
(barriers 
adherence, 
time 
adherence), 
Attendance, 
Exercise 
maintenance 
 
Outcomes: 
Function 
(muscle 
strength and 
exercise 
capacity, 
physical 
function), Pain 
Random 
effects model 
Exercise 
adherence and 
self-efficacy 
mediated 
disability 
outcomes in 
physiotherapy 
delivered care at 
two months 
(main effect 
0.246, 1.49 
(0.135); 
interaction 1.12, 
3.44 (0.001) but 
not at six months 
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Reference Country, Setting & 
Design, Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Smeets et 
al 2006 
Netherlands; 
Primary care; RCT 
 
Participants with 
chronic non-specific 
LBP (three months 
or more in 
duration); aged 
between 18-65 
Cognitive-
behavioural 
therapy (n=55): 
Problem-solving 
training and 
graded activity 
 
Active Physical 
Therapy (n=52): 
Aerobic and 
endurance 
exercise 
 
Combined 
Therapy (n=55): 
Combination of 
both therapies 
 
 
 
 
 
 
 
 
 
Waiting List 
(n=49) 
Post-
treatment 
(10 weeks) 
Mediators: Pain 
catastrophising, 
Internal pain 
control 
 
Outcomes: 
Disability, Pain, 
Depression, 
Patient-specific 
complaints 
Baron & 
Kenny, plus 
Sobel test 
Internal pain 
control not found 
to mediate 
disability in any 
treatment 
condition; Pain 
catastrophising 
found to mediate 
disability in all 
treatment 
conditions (Sobel 
test = -2.754, 
p=0.006 for APT; -
2.269, p=0.023 
for CBT; -2.278, 
p=0.022 for CT) 
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Reference Country, Setting & 
Design, Study 
Population 
 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Spinhoven 
et al 2004 
Netherlands; 
Primary care; RCT 
 
Patients with 
chronic LBP (six 
months or more 
duration); 54m and 
94f; mean age 39.8 
(range 18-64) 
Operant 
Behavioural 
Treatment with 
Cognitive 
Coping Skills 
(n=59): 
Enhancing self-
control and 
relaxation skills, 
plus homework 
for 
reinforcement 
 
Operant 
Behavioural 
Treatment with 
Group 
Discussion 
(n=58): Aimed 
to provide an 
attention-
control for 
other 
intervention 
 
 
Waiting List (n= 
31) 
12 months Mediators: 
Catastrophising, 
Pain coping, 
Internal pain 
control, 
External pain 
control 
 
Outcomes: 
Activity 
tolerance, Pain 
(intensity and 
behaviour), 
Depression 
Baron & 
Kenny 
Catastrophising 
found to partially 
mediate activity 
tolerance 
(magnitude of 
semi partial 
correlation (-.15 
significantly 
(p<0.05) smaller 
than zero-order 
correlation (-
0.40). Unclear 
how this relates 
to mediation. 
Treatment 
conditions were 
collapsed into 
one group for 
analysis so not 
clear which 
intervention 
resulted in the 
mediating 
effects.  
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Reference Country, Setting & 
Design, Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Turner et 
al 2007 
USA; Secondary 
care; RCT 
 
Patients with 
diagnosed TMD 
(no further detail) 
Cognitive-
Behavioural 
Therapy (n=55): 
No detail given 
Education/ 
Attention 
(n=60): No 
detail given 
Post-
treatment 
(eight 
weeks), six 
months, 
12 months 
Mediators: Self-
efficacy, Pain 
beliefs 
(disability, harm 
and control), 
Catastrophising, 
Coping 
(Relaxation) 
 
Outcomes: 
Jaw use 
limitation, Pain 
(intensity and 
activity 
interference) 
Baron & 
Kenny, plus 
Sobel and 
bootstrapping 
Pain beliefs, coping  
and catastrophising 
mediated activity 
interference at 12 
months in the CBT 
group (disability 
subscale (indirect 
effect = -1.18, CI -
1.80 to -0.78), 
harm subscale 
(indirect effect = -
0.70, CI -1.22 to -
0.34) and control 
subscale (indirect 
effect = -1.18, CI -
1.87 to -0.56)), pain 
catastrophising 
(indirect effect = -
0.59, CI -1.11 to -
0.31),coping 
(rumination 
subscale (indirect 
effect = -0.23, CI -
0.61 to -0.01) and 
self-efficacy 
(indirect effect -
0.87, CI -1.55 to -
0.49). 
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Reference Country, Setting & 
Design, Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Wicksell 
et al 2010 
Sweden; 
Community – WAD 
support group; RCT 
 
Patients diagnosed 
with whiplash-
associated disorder 
(WAD) of three 
months or more 
duration; aged 20 
years or over 
Acceptance and 
Commitment 
Therapy (n=11): 
Acceptance as 
alternative to 
avoidance, 
assessment of 
individual 
values, graded 
activity 
Treatment as 
usual (n=10) 
Post-
treatment 
(eight 
weeks), 
four 
months 
Mediators: Pain 
intensity, 
Anxiety, 
Depression, 
Self-efficacy, 
Fear-avoidance, 
Psychological 
inflexibility 
 
Outcomes: 
Pain disability, 
Life satisfaction 
Baron & 
Kenny, plus 
cross-product 
of 
coefficients 
and 
bootstrapping 
Psychological 
flexibility 
mediated 
disability at post-
treatment but 
not at four 
months follow-up 
in the ACT group 
(bootstrapped 
indirect effect = 
7.69, CI 0.24-
17.19) 
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Reference Country, Setting & 
Design, Study 
Population 
Intervention(s) Control Follow-up Mediator(s) 
and 
Outcome(s) 
Tested 
Mediation 
Analysis 
Method 
Conclusion 
Wicksell 
et al 2013 
USA; Secondary 
care, Fibromyalgia 
 
All female patients; 
mean age 45.1 
years 
Acceptance and 
Commitment 
Therapy (n= 23): 
12 weekly 
group sessions 
on preparing for 
behavioural 
change, shifting 
perspective to 
increase 
functioning 
despite pain, 
and identifying 
behavioural 
goals 
Waiting list Four 
months 
post-
treatment 
Mediator: 
Psychological 
inflexibility 
 
Outcome: Pain 
disability 
Product of 
coefficients 
with 
bootstrapped 
95% CIs 
Psychological 
inflexibility was 
found to mediate 
the relationship 
between 
treatment and 
disability (-3.65, 
95% CI -11.52 to -
0.54) 
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4.5.2 Summary of critical appraisal 
Two reviewers (Gemma Mansell and Jemma Cowen) used the critical appraisal tool to assess each 
study. Overall, complete agreement was achieved with three of the included studies; in the 
remaining papers disagreements occurred with either one or two of the 12 critical appraisal items 
(items 1, 4 or 7 in Table 4.1). These discrepancies were discussed between the reviewers and the 
papers were re-examined in order to achieve consensus. The quality of the studies in terms of 
mediation analysis was poor overall. The key points for design and analysis, and the overall critical 
appraisal of each of the studies, are given below. 
 
Cognitive-behavioural therapy (CBT) was cited most often as a basis for the intervention 
(Spinhoven et al 2004; Smeets et al 2006; Turner et al 2007; Leeuw et al 2008; Wicksell et al 2010; 
Robinson et al 2013; Wicksell et al 2013). Basing the intervention on a theoretical framework 
(item 1) is seen as a key area for improvement in mediation analysis studies (e.g. Kazdin 2007) 
(see Chapter 3). However, while CBT is based on principles of cognitive-behavioural theory, the 
techniques used to treat patients vary widely. For example Spinhoven et al (2004), Smeets et al 
(2006) and Leeuw et al (2008) used operant behavioural techniques in their trials, but while the 
Smeets and Leeuw trials focused on aspects of graded activity, the Spinhoven trial only mentioned 
trying to increase “healthy” behaviours without giving specific detail as to how this was done. 
Turner et al’s (2007) trial focused on pain management training. Wicksell et al’s trials were based 
on a specific form of CBT (Acceptance and Commitment Therapy (ACT)). They describe ACT as an 
“exposure-based behaviour therapy” (p.2) where patients are taught to accept negative thoughts 
without having to alter personal values. ACT also does not aim to reduce patients’ levels of pain or 
distress (Wicksell et al 2010). Focht et al (2005) cited social cognitive theory as the basis for their 
intervention with a focus on increasing self-regulatory skills, but did not explain the model or 
which aspects were key to the intervention. The final papers (Nicassio et al 1997; Seymour et al  
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2009) did not specifically state a particular intervention, but Nicassio et al did cite previous studies 
based on cognitive-behavioural principles and their intervention did include giving information 
based on the gate control theory of pain. Seymour et al’s study was the only paper not to mention 
any type of theoretical basis despite including self-efficacy as a potential mediator, which is a key 
component of social cognitive theory. The variety of techniques and principles employed in each 
of these studies and the different variables that were chosen as potential mediators to investigate 
highlights the potential difficulties in using broad theoretical frameworks and not deciding a priori 
how the theory might work in an intervention context. 
 
Smeets et al (2006), Leeuw et al (2008) and Wicksell et al (2013) reported information on the 
psychometric characteristics of both the potential mediator measures (item 4) and outcome 
measures (item 5). Focht et al (2005) and Wicksell et al (2010) reported data regarding 
psychometric properties for their outcome measures only and Spinhoven et al (2004) and 
Robinson et al (2013) only reported psychometric properties of their mediator measures. Only 
Smeets et al (2006) and Spinhoven et al (2004) reported tests of internal consistency within their 
study population, rather than using values taken from other studies. These were all found to be 
above 0.60 for Cronbach’s alpha as specified in the critical appraisal tool, indicating good internal 
consistency. 
 
In terms of the mediation methodology used, all the included studies were designed to test the 
influence of potential mediator variables on treatment outcome, and all reported that patient 
scores on the mediator measures changed between baseline and post-treatment/follow-up but 
only four (Nicassio et al 1997; Spinhoven et al 2004; Wicksell et al 2010; Wicksell et al 2013) 
reported correlation analysis to show that this change was associated with change in the outcome 
measure (item 7). This suggests that in some studies, the variable’s potential to mediate outcome 
may not have been adequately assessed prior to the mediation analysis being conducted. 
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Only four papers conducted mediation analysis that has been shown to be appropriate according 
to current evidence (Wicksell et al 2010; Wicksell et al 2013; Turner et al 2007; Robinson et al 
2013) in that tests of indirect effect were conducted with non-parametric bootstrapping, as the 
indirect effect is rarely normally distributed (item 10). However, only Turner et al (2007) reported 
that their analysis was carried out using SEM. No study reported a power calculation to show that 
the study was powered to detect mediating effects (item 9) and many studies recruited small 
samples (for example, only 21 participants were included overall in Wicksell et al’s 2010 study). 
This suggests that the samples may not have been large enough to adequately perform mediation 
analysis. 
 
Acknowledging the influence of other measured variables is also seen as important in establishing 
the effects of the variables being tested as mediators (see Chapter 3). Only four studies (Smeets 
et al 2006; Focht et al 2005; Leeuw et al 2008; Robinson et al 2013) reported that they controlled 
for potential confounding variables in their mediation analysis (item 11). A summary of the results 
of the critical appraisal can be found in Table 4.3.
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Table 4.3 Summary of the results of the critical appraisal of mediation analysis 
Reference 1 
Intervention 
based on 
theory 
2 
Experimental 
design used 
3  
Pilot 
study 
conducted 
4  
Psychometric 
characteristics 
of outcome 
measures 
reported 
5 
Psychometric 
characteristics 
of mediator 
measures 
reported 
6  
Change 
recorded 
between 
baseline 
and 
follow-up 
in 
potential 
mediators 
7  
Change in 
mediator 
correlated 
with 
change in 
outcome 
8  
Study 
designed 
to 
influence 
mediating 
variables 
9 
Study 
powered 
to detect 
mediation 
10 
Appropriate 
mediation 
analysis 
conducted 
11 
Confounders 
controlled 
for 
12 
Ascertainment 
of change in 
mediator(s) 
before change 
in outcome 
Focht et al 
2005 
Y Y N Y N Y N Y N N Y – Baseline 
values 
N 
Leeuw et 
al 2008 
Y Y N Y Y Y N Y N N Y - 
Treatment 
N 
Nicassio 
et al 1997 
N Y N N N Y Y Y N N N N 
Robinson 
et al 2013 
Y Y N N Y Y N Y N Y Y – Age and 
attorney 
involvement 
N 
Seymour 
et al 2009 
N Y N N N Y N Y N N N N 
Smeets et 
al 2006 
Y Y N Y Y Y N Y N N Y – Age, 
gender, 
treatment 
centre, 
baseline 
scores of 
mediator 
and 
outcome 
variables  
N 
Spinhoven 
et al 2004 
Y Y N N Y Y Y Y N N N N 
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Reference 1 
Intervention 
based on 
theory 
2 
Experimental 
design used 
3  
Pilot 
study 
conducted 
4  
Psychometric 
characteristics 
of outcome 
measures 
reported 
5 
Psychometric 
characteristics 
of mediator 
measures 
reported 
6  
Change 
recorded 
between 
baseline 
and 
follow-up 
in 
potential 
mediators 
7  
Change in 
mediator 
correlated 
with 
change in 
outcome 
8  
Study 
designed 
to 
influence 
mediating 
variables 
9 
Study 
powered 
to detect 
mediation 
10 
Appropriate 
mediation 
analysis 
conducted 
11 
Confounders 
controlled 
for 
12 
Ascertainment 
of change in 
mediator(s) 
before change 
in outcome 
Turner et 
al 2007 
N Y N N N Y N Y N Y N N 
Wicksell 
et al 2010 
Y Y N Y N Y Y Y N Y N N 
Wicksell 
et al 2013 
Y Y N Y Y Y Y Y N Y N N 
Y = Yes; N = No
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4.5.3 Results of the mediation analysis performed in each study 
The majority of the included papers stated that they had used the Baron & Kenny (1986) causal 
steps approach to conduct their mediation analysis, or had used some other form of regression 
analysis. Smeets et al (2006) reported using Baron & Kenny’s method to conduct their mediation 
analysis, and included the Sobel (1982) test to examine the indirect effect. This study tested 
whether catastrophising thoughts and internal pain control were treatment mediators of 
functional disability (among other outcome measures) in 211 patients with low back pain who 
took part in either cognitive-behavioural therapy (CBT), active physical therapy (APT), a 
combination of CBT and APT, or a waiting list control group. Patients in the APT group took part in 
aerobic and endurance exercises, while those in the CBT group received problem-solving training 
and graded activity exercises. All treatments lasted for 10 weeks. Measures of the outcome and 
mediator variables were taken at baseline and post-treatment (as soon as the 10-week treatment 
period had ended). The authors found that internal pain control did not change significantly over 
the 10-week period in either the CBT or APT treatment, and therefore did not test this variable 
further. Experts (e.g. MacKinnon et al 2007) do state that if a variable does not change over time 
(i.e. is not modifiable) then it is unlikely to be a potential mediator, so this decision by Smeets et 
al is supported by expert opinion. Pain catastrophising was found to be a mediator of change in 
disability, with significant (p<0.05) Sobel t-test values reported in all three active treatments. The 
authors suggested that this finding could be due to the APT helping to show participants that they 
were able to participate in activities that they previously felt they could not do, which led to a 
reduction in their catastrophising scores. They also suggested that the changes in catastrophising 
seen in previously reported studies of CBT interventions may actually be due to other aspects of 
treatment.  
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A similar study was conducted by Leeuw et al (2008), which examined mediators of the 
relationship between two CBT-based treatments (exposure in vivo and graded activity) and 
disability outcome in 85 patients with chronic LBP. Exposure in vivo involved gradual exposure to 
a set of fearful activities, graded by the patient from least to most fearful. Graded activity, based 
on operant behavioural techniques, aimed to improve function in patients through positive 
reinforcement of activity goals set by the patient. Pain catastrophising and perceived harmfulness 
of activities were assessed as mediators of both treatments, with mediation analysis being 
conducted via the joint significance test, which Leeuw et al describe as the significance of the 
association between the treatment and mediator (a path) and mediator and outcome (b path) 
adjusting for treatment. This study found that exposure in vivo was not significantly more 
effective than graded activity in affecting disability outcome, but that pain catastrophising and 
perceived harmfulness were mediators of the difference between the two treatments (graded 
exposure had more of an effect on these two mediators than graded activity). This study is 
strengthened by its adjustment for baseline values of the mediating variables, but the reliance of 
the mediation analysis on statistical significance is problematic and no actual mediating effect is 
provided. 
 
Wicksell et al (2010) also used the Baron & Kenny method, but included the cross-product of 
coefficients approach and obtained bootstrapped confidence intervals (CIs) to test for the 
mediating effect. Bootstrapping, the process of resampling the original data many times over, 
helps to account for the often non-normal distribution of the mediating effect estimate (see 
Chapter 3 for a more detailed explanation). This study compared Acceptance and Commitment 
Therapy (ACT) plus treatment as usual to only receiving treatment as usual in a group of 21 
patients with WAD recruited from a community WAD support group, and tested a number of 
potential mediators; pain intensity, anxiety, depression, fear-avoidance beliefs, self-efficacy and  
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psychological inflexibility. Change scores were calculated for the outcome measures but in the 
analyses only the post-treatment (eight-week) scores of each mediator variable were used. The 
authors carried out analyses to look at mediation between pre-treatment and post-treatment 
change in the outcome measures, and between pre-treatment and four-month follow-up change 
in the outcome measures. They found that psychological inflexibility was the only variable to 
significantly mediate change in disability, but the confidence intervals of the effect were very 
wide (7.69, bootstrapped 95% CI 0.24 to 17.19), and this only occurred between pre-treatment 
and post-treatment;  the effect was not present by four-month follow-up. Also, the authors stated 
that they used post-treatment scores of the potential mediators in their analysis rather than 
change scores because they expected psychological flexibility to predict positive outcomes. The 
more recent included paper by Wicksell et al (2013) reported conducting analysis in the same way 
as that carried out by Wicksell et al (2010), but this later study included only female patients with 
fibromyalgia and tested only psychological inflexibility (pre- to post-treatment change) as a 
mediator of disability outcome (pre-treatment to four-month follow-up change). ACT was 
compared with waiting list control group, with 12 weekly group sessions of ACT being prescribed. 
They found that change in psychological inflexibility did have a statistically significant mediating 
effect on the relationship between treatment allocation and change in disability outcome (-3.65, 
bootstrapped 95% CI -11.52 to -0.54), but the wide CI again suggests a lack of precision.  
 
Robinson et al (2013) also used the product of coefficients approach with bootstrapped 95% CIs 
to test reduction in fear of activity as a mediator of the relationship between treatment allocation 
(exposure therapy versus an information booklet versus information booklet plus didactic 
discussion) and disability outcome in 191 patients with WAD. The exposure intervention was 
carried out weekly for three weeks. Patients were asked to first imagine, then actually perform a 
set of activities they had previously graded from least to most fearful over the three sessions. Fear 
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of activity was found to significantly mediate the relationship between exposure therapy and 
disability outcome (3.82, bootstrapped 95% CI 1.70 to 6.34). 
 
Turner et al (2007) also obtained bootstrapped 95% CIs for their estimates of the mediating 
effect. This was the only included study to report the use of structural equation modelling (SEM), 
although no latent variables were used in the analysis. This study compared CBT to an education 
control group over an eight-week period for the treatment of temporomandibular disorder (TMD) 
(n=115), and investigated a range of mediators. They found that self-efficacy (-0.87, bootstrapped 
95% CI -1.55 to -0.49), pain beliefs (disability subscale (-1.18, bootstrapped 95% CI -1.80 to -0.78), 
harm subscale (-0.70, bootstrapped 95% CI -1.22 to -0.34) and control subscale (-1.18, 
bootstrapped 95% CI -1.87 to -0.56)), pain catastrophising (-0.59, bootstrapped 95% CI -1.11 to -
0.31) and coping (rumination subscale (-0.23, bootstrapped 95% CI -0.61 to -0.01)) were 
mediators of jaw use limitation. However, despite being fairly precise estimates according to the 
reported confidence intervals these only appear to be small coefficients, although it should be 
noted that there is no clear guidance on how big an effect should be before it is judged as ‘large’ 
in the context of mediation analysis (Kelley & Preacher 2012). No details were given in the paper 
about the content of either intervention, although a previous paper (Turner et al 2006) stated 
that the CBT involved pain management training, delivered by a psychologist, to improve patient-
specific activity goals. The education group involved a self-care management programme and was 
designed to act as an attention control for the CBT condition. 
 
Spinhoven et al (2004) also used the Baron & Kenny method to conduct their analysis in a sample 
of 148 patients with chronic LBP. In this study all patients received operant-behavioural therapy 
(OBT) over 10 weeks, but 59 were randomised to receive cognitive coping skills treatment in 
addition to OBT, 58 were randomised to group discussion in addition to OBT and the remaining 31  
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were randomly allocated to a waiting list control group. The coping skills training involved 
patients undergoing three separate phases; one to enhance their self-control, one to teach 
relaxation techniques and finally reinforcement of these skills via homework assignments. The 
authors hypothesised that catastrophising and internal pain control would mediate disability 
change. The group discussion condition was to provide an attention-control condition. All 
potential treatment mediators were assessed via subscales of the Pain Coping and Cognition List: 
catastrophising, pain coping, internal pain control and external pain control. Residualised change 
scores for each variable were used in the analysis and correlations were conducted to check that 
change in the potential mediators was related to change in outcome (a detailed explanation of 
residualised change is given in Chapter 5). The authors found that change in catastrophising did 
partially mediate change in activity tolerance, which was used as a measure of disability. 
However, in this study no mediating effect was calculated, and the treatment groups were 
collapsed together for the analysis because the authors found no differences between the 
treatment groups for any potential mediator. They also acknowledge that the two treatment 
groups both received the same ‘base’ treatment which focused on the same principles, which may 
explain why no difference was found between the two active interventions.  
 
Nicassio et al (1997) compared a behavioural intervention consisting of education, relaxation 
training, goal-setting and prompting with an educational/control intervention involving lectures 
and group discussion in 86 patients with fibromyalgia. Both conditions were implemented over a 
10-week period. Disability was assessed via the Quality of Well-Being Scale, and three potential 
treatment mediators were tested: helplessness, pain coping and social support. The authors did 
compute change scores for all included variables and found that change in each potential 
treatment mediator was correlated with change in outcome. However, the results of the 
mediation analysis were more difficult to interpret. After conducting regression analyses using the  
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change scores to assess each potential mediator variable as a predictor of change in outcome, the 
authors examined “low” and “high” change in helplessness as mediators of depression and pain. 
They found that change in helplessness and coping was not associated with improvement in 
disability, so this outcome was not tested further. Change in helplessness was reported as a 
mediator of change in pain and depression. However, although the authors reported this as a test 
of mediation, it is not clear exactly how this was conducted and no test of the mediating effect 
was given. 
 
Two papers used methods that were not previously identified as methods of mediation analysis. 
Focht et al (2005) used analysis of co-variance (ANCOVA) to test self-efficacy as a mediator of the 
effects of two separate interventions (dietary weight loss and exercise) in terms of improving 
mobility in knee OA patients (n=252). Both interventions were implemented over an 18-month 
period. In this study the weight loss intervention involved psychological principles, such as goal 
setting, problem solving and cognitive restructuring. The authors do report that self-efficacy 
mediated mobility, but it is unclear whether using ANCOVA is an appropriate way of testing for 
this and how this tests mediation. The authors reported that they first tested whether changes in 
self-efficacy and pain independently affected outcome and found that they were both significant 
predictors. They then tested the effect of the intervention on change in outcome after controlling 
for change in self-efficacy and pain. They state that this latter analysis resulted in a reduction of 
the main effect for stair-climbing self-efficacy and pain, but not for walking self-efficacy and pain. 
This method seems to be similar to the causal steps approach, but the Baron & Kenny (1986) 
paper is not referred to by the authors. 
 
Finally, Seymour et al (2009) investigated a behaviour change intervention using either 
physiotherapists or certified exercise instructors, to explore whether the instructor had an impact 
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 on hip/knee OA patient outcomes. 351 patients were recruited and the intervention was carried 
out over eight weeks. The authors looked at self-efficacy, exercise adherence, attendance and 
exercise maintenance as potential mediators and stated that self-efficacy was a mediator for both 
types of instruction post-treatment (two months after the baseline assessment), although not by 
follow-up (six months after the baseline assessment). However, no method of mediation analysis 
was formally stated. A random effects model was described in the methods and results, giving 
values for the main effect and interaction, but not stating any mediating effects. 
 
 
4.6 Discussion 
4.6.1 Summary of psychological constructs identified in previous MSK pain mediation 
analyses 
This review aimed to examine the evidence for psychosocial factors that have been tested as 
treatment mediators in MSK pain populations, and to examine what methods had been used to 
conduct this analysis. Ten papers were found to meet the criteria for the review, covering a wide 
range of populations, MSK conditions and interventions. Several factors were found to mediate 
the effect of treatment on measures of disability across the studies; reduced helplessness, 
reduced passive coping, reduced catastrophising, reduced fear-avoidance, reduced psychological 
inflexibility, improved self-efficacy and a reduction in negative pain beliefs and perceived 
harmfulness of activity, with the most evidence available for catastrophising, pain coping and self-
efficacy. However, the range of different methods used to carry out the mediation analysis in the 
different papers makes it difficult to ascertain the strength of any of these constructs in terms of 
their mediating effect. For example, of the four studies that investigated self-efficacy, one used 
ANCOVA, one used a random effects model and two used linear regression to analyse the 
mediating effect, all of which give different statistics to interpret. Also, the quality of the 
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mediation analysis used to identify these factors was generally poor with only two studies 
conducting appropriate analyses, making it difficult to draw strong conclusions. There were also 
issues with the design of some of the interventions or aspects of the mediation analysis that could 
have impacted on the findings of the studies. The key issues are outlined below. 
As suggested in Chapter 3, using a theoretical basis for any intervention will give support to the 
hypothesised temporal order of the variables when conducting the analysis, help researchers to 
choose appropriate variables to test as mediators and provide evidence to support or refute 
theoretical models about how an intervention works. Wicksell et al (2010) and Wicksell et al 
(2013) were the only included papers to use an intervention that was explicitly based on a 
theoretical model (ACT). Other studies (Smeets et al 2006; Spinhoven et al 2004; Turner et al 
2007; Leeuw et al 2008; Robinson et al 2013) included CBT as an intervention which is based on 
principles of cognitive-behavioural theory, but the papers did not explain how the intervention 
related to this theory. The remaining studies (Focht et al 2005; Nicassio et al 1997) cited a 
theoretical framework but did not provide information on how it was used in the intervention, 
and one study (Seymour et al 2009) did not specify any theoretical basis for their intervention. 
 
Evidence for the psychometric properties of the measures of outcomes and potential mediators 
was inconsistent across the studies. This is unfortunate as the evidence gathered in Chapter 3 
highlighted the importance of only using well validated measures of constructs, as the analysis 
methods used to carry out mediation analysis often assume there to be no measurement error 
(see Chapter 3). Information about the characteristics of measures used and whether they have 
been validated in the population being studied is crucial to assess and report. 
 
In order for a variable to be considered as a potential mediator it needs to be shown to be 
modifiable and to be shown to be related to change in outcome (MacKinnon 1994). Among the 
studies included in this review, evidence of such preliminary analysis was inconsistent with most 
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studies reporting only tests for one or the other of these criteria. Performing such analysis prior to 
the more complex tests for mediation would be beneficial in terms of helping to decide which 
variables to focus on, and could possibly be done outside of the confines of a trial, for example in 
a cohort study (see Chapter 3). 
 
Currently, the evidence suggests that the product of coefficients approach carried out using SEM 
and obtaining bootstrapped CIs to give an idea of the precision of the indirect (mediating) effect is 
the most appropriate way to perform mediation analysis. In the present review only four of the 10 
included papers conducted their analysis in this way (Turner et al 2007; Wicksell et al 2010; 
Wicksell et al 2013; Robinson et al 2013) and only Turner et al (2007) reported using SEM to 
perform their analysis. Further work which performs mediation analysis according to these 
criteria would help provide more robust evidence for mediating factors. 
 
As explained in Section 4.4.5 (and in more detail in Chapter 3), even in RCTs there is potential for 
the relationship between the potential mediator and outcome to be affected by unmeasured or 
confounding factors. Only four studies (Focht et al 2005; Smeets et al 2006; Leeuw et al 2008; 
Robinson et al 2013) explicitly reported that they had adjusted for confounding factors. A 
theoretical framework would be helpful in terms of identifying potential factors to adjust for or 
include in future mediation analysis studies. 
 
A number of authors (e.g. Kazdin 2007) (see Chapter 3) have suggested that at least three 
assessments of outcome and potential mediators should be carried out in mediation studies, and 
where such studies involve an intervention assessments need to be conducted during the 
intervention as well as pre-and post-intervention. This is so that temporality can start to be 
established. In this review, the majority of studies conducted assessments at three or more time 
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points but no study conducted assessments while the intervention was taking place. This is a key 
area for improvement in future mediation studies. 
 
A final point is that none of the studies included in this review provided a power calculation to 
show that their sample size allowed them to detect a mediating effect. As discussed in Chapter 3, 
guidance is available on calculating power in mediation studies (Fritz & MacKinnon 2007; 
Thoemmes et al 2010) which shows that for studies using the Baron & Kenny causal steps 
approach a sample of more than 20,000 is required to detect an effect of 0.8, while studies using 
the product of coefficients approach require a sample of 500 to detect the same effect size (Fritz 
& MacKinnon 2007). The bias-corrected bootstrap has been found to be the most powerful test of 
the size of the mediated effect (Fritz & MacKinnon 2007; Hayes & Scharkow 2013), although this 
difference between tests in terms of power decreases as sample size increases (Hayes & Scharkow 
2013). The largest study included in this review recruited 351 patients (Seymour et al 2009); most 
had used the Baron & Kenny approach (of which two had included bootstrapped CIs) and three 
had used the product of coefficients approach (all of which included bootstrapped CIs). It is 
acknowledged that recruiting large sample sizes for trials is difficult and that funding for larger 
trials may be difficult to obtain, which highlights the importance of choosing an appropriate 
mediation approach so that an effect can be obtained (if it exists) with the smallest possible 
sample size.  
 
4.6.2 Comparison with existing literature 
Systematic reviews in other areas (Cerin et al 2009; Lubans et al 2008; Stanton et al 2013) also 
failed to draw clear conclusions as to what factors mediated outcome. However, these reviews 
stated that there was evidence for self-efficacy being a mediator across different interventions. 
The present review provides some support for these previous findings with three out of the four 
studies testing self-efficacy reporting that it was a mediator of the relationship between 
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treatment and disability, suggesting that mediating factors may not be specific to certain fields. 
The papers included in the present review often tested a range of mediators within their studies. 
 
In terms of the quality of the mediation analysis, the studies included in this review are also 
similar to those included in the Cerin et al (2009) and Lubans et al (2008) reviews. The criteria 
added by Cerin et al (2009) which asked whether changes in the mediator preceded changes in 
outcome was not reported in any paper included in either the present review or Cerin et al’s 
(2009) paper. This point has been noted by other authors in the mediation field (e.g. Kazdin 2009) 
as being a key area for future research. Being able to establish whether the mediator changes 
before the outcome is crucial in terms of establishing whether the link between the two is likely 
to be causal, rather than simply an association. The studies included in the previous reviews were 
more often based on a specific theoretical framework than those included in the present review. 
This is also an important area for future research – theory-based interventions allow specific 
hypotheses to be tested and help give evidence to support or refute current theoretical models 
(Michie et al 2008). Mediation analysis can also help to refine theory by identifying which aspects 
are most important to focus intervention efforts on. 
 
4.6.3 Overview of methods of mediation analysis used 
One of the objectives of this review was to identify which methods of mediation analysis had 
been used to conduct mediation analysis in MSK pain populations and explore whether the 
method used may have impacted on the study findings. It was not possible to identify from the 
studies included here whether the method used had an impact on their results as even though 
several studies had used the same method of analysis, each study tested different variables as 
potential mediators and included assessments at different time points. Chapter 3 described a 
number of different methods of conducting mediation analysis and outlined the problems with  
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each. It is clear from the evidence gathered for this systematic review that the suggestions for 
improvement in methods and the problems identified by experts in the mediation analysis 
literature are not yet recognised in the applied literature. The regression analysis procedure 
outlined by Baron & Kenny (1986) was by far the most popular method of mediation analysis used 
within these studies, despite the limitations of this method being widely cited. Some authors did 
correct for some of the shortcomings of this approach, for example, by including bootstrapped CIs 
(Turner et al 2007; Wicksell et al 2010), but problems were still identified in every paper, meaning 
that confidence in these results may be limited.  
 
4.6.4 Potential limitations of the systematic review 
This review was intentionally very broad because of the expected paucity of studies that would 
have conducted mediation analysis in primary care LBP populations. This has caused 
complications in terms of being able to compare the studies, but does highlight the need for 
further research in this area especially in terms of improving the quality of the mediation analysis 
conducted. There were also some problems with the search strategy in terms of making it 
sensitive enough to pick up relevant papers but specific enough to ensure appropriate material 
was found. Methodological terms were included specifically in the search strategy which could 
have led to only papers that used and described these specific methods in the title or abstract 
being included. However, extensive citation and reference checking and contact with experts in 
the literature suggested that no large or influential studies investigating treatment mediation in 
patients with MSK pain were missed. 
 
The critical appraisal tool used to judge specific aspects of mediation analysis in each of the 
included papers may not have provided enough information to objectively assess the studies. 
Each item was only scored according to whether or not the paper provided the necessary  
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information, and it could be that certain aspects, such as psychometric properties of measures 
and the appropriateness of the mediation analysis were simply not reported in sufficient detail. 
Lubans et al (2008) who used their own version of this tool also reported problems in terms of 
assessing whether or not a study had conducted pilot trials, and that assessing Cronbach’s alpha 
was only one, limited way of assessing the psychometric properties of included measures. The 
cut-off for Cronbach’s alpha suggested by this tool, 0.60, is also lower than other reported cut-offs 
(for example Terwee et al (2007) recommend a cut-off of 0.70 as a minimum value). However, the 
items assessed are all aspects of mediation study design and analysis that are reported in the 
wider literature to be crucial in terms of providing robust evidence for mediation. It is therefore 
important that future studies of mediation analysis in MSK pain populations specifically report 
these aspects so that the quality of the analysis can be accurately assessed. 
 
 
4.7 Conclusion 
This review has shown that, although several factors (reduction in helplessness, passive coping, 
catastrophising, fear-avoidance beliefs, psychological inflexibility, increase in self-efficacy and a 
reduction in negative pain beliefs and perceived harmfulness of activity) have been found to 
mediate disability outcomes in MSK pain intervention studies, the quality of the mediation 
analysis is too weak to draw firm conclusions as to the evidence for psychological mediators of 
treatment effect on disability outcomes. It also highlights the paucity of studies that have carried 
out mediation analysis in MSK and LBP intervention studies.  
 
The literature review in Chapter 3 identified a number of areas where future research can be 
improved. This review shows that in MSK pain mediation studies in particular, further work is 
needed to improve the quality of the mediation analysis conducted and to design intervention  
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studies with strong proposed underlying mechanisms that are appropriate for exploring mediating 
factors, before robust evidence for psychological mediators can be collated. Specifically, future 
studies should specify a theoretical basis for the intervention, use reliable, previously tested 
measures and conduct mediation analysis to the standard currently seen as appropriate (i.e. using 
the product of coefficients approach and including bootstrapped CIs of the indirect (mediating) 
effect).  
 
Another aspect identified in Chapter 3 was including at least three assessment points. In this 
review, five of the ten studies included at least three assessment points but these assessments all 
occurred at baseline and then at post-treatment or follow-up. One of the key recommendations 
from the literature was that assessments of change in outcome and change in the potential 
mediators should be made during treatment to help establish issues around causality and 
temporality (see Chapter 3). This should be a focus of future mediation research in MSK pain 
populations.  
 
A final point that was identified in Chapter 3 and also highlighted as a key issue at a workshop on 
design aspects of mediation analysis at the Low Back Pain Forum XII conference in 2012 (Mansell 
et al 2012) is the concept of mediation analysis as a programme of work, starting with qualitative, 
exploratory methods to identify key mediating factors; using cohort study data to test the 
preliminary mediation steps of whether or not a factor is modifiable and whether change in the 
potential mediator is related to change in outcome; and only then moving on to test those factors 
most likely to be mediators of treatment outcome in intervention studies. No study included in 
this review reported conducting pilot studies prior to their intervention study, but such 
preliminary work would be valuable in helping researchers get the most out of mediation analysis 
nested within intervention studies. 
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The next step in this thesis is to apply the appropriate mediation analysis methods to cohort study 
data and RCTs of interventions to improve functioning in MSK pain patients, to add to the 
evidence base in this area. Although this analysis will not be able to address all of the issues 
identified in this review and in Chapter 3, the issues pertaining to the analysis will be focused on 
as an area for improvement. The analysis will include several of the factors found by the review to 
be mediators of disability measures. 
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Chapter 5: Using Observational Data to Identify Potential Treatment 
Mediators of Functional Outcome in a Primary Care Musculoskeletal Pain 
Population 
 
5.1 Introduction 
Chapter 3 discussed design issues of conducting mediation analysis and concluded that identifying 
treatment mediators involves a process of research which may also include observational studies 
to identify potential mediation constructs. This chapter will therefore focus on mediation research 
conducted in observational studies of patients with musculoskeletal (MSK) pain, and will also 
provide an example of the use of observational data to explore potential mediating factors in 
primary care consulters with low back pain (LBP), in preparation for treatment mediation analysis 
using trial data reported in Chapter 6. In this thesis, ‘observational studies’ are studies that 
employ a cross-sectional or longitudinal design and participants may receive any type of 
intervention in the context of usual care, rather than a specific intervention as part of the study. 
This means that mediation analysis does not concern mediators of a specific treatment effect but 
of the association between two key variables of interest. While such observational studies cannot 
establish which variables are treatment mediators, they can provide important information on 
which variables change over time and which are related to the outcome of interest, and help build 
evidence for particular factors as possible mediators of treatment outcome.  
 
5.1.1 Mediation analysis in observational studies 
This section outlines the evidence for mediating factors in MSK pain populations that has been 
previously conducted. This is not an exhaustive review, but instead provides examples of 
previously published mediation analyses using observational data and the different analysis  
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techniques and study designs employed.  
 
The majority of studies in MSK pain populations conducting mediation analysis in its broadest 
sense (i.e. examining mediators of treatment or other (causal) pathways) have used a cross-
sectional or cohort design. The participants in these studies were mostly recruited from secondary 
or tertiary care pain clinics or physiotherapy departments, although the studies themselves did 
not provide any specific form of treatment. In these types of studies, the construct of self-efficacy 
has been commonly investigated for its role as a mediator in pathways to functional outcomes. 
For example, this construct was tested as a mediator of the relationship between pain and 
disability (Arnstein et al 1999; 2000; Söderlund & Åsenlöf 2010; Costa et al 2011), between pain-
related fear and disability (Woby et al 2007), between pain catastrophising and disability (Shelby 
et al 2008), and between resilience and disability (Johnson Wright et al 2008). Other variables 
investigated as potential mediators include acceptance as a mediator of the relationship between 
catastrophising and disability (Vowles et al 2008), pain beliefs and attitudes as a mediator 
between pain and disability (Alcantara et al 2010), anxiety and depression as a mediator between 
pain and disability (Arnstein 2000; Wegener et al 2011), pain catastrophising as a mediator 
between pain and disability (George et al 2011), and fear-avoidance beliefs as a mediator 
between catastrophising and disability (Leeuw et al 2007b) and between self-efficacy or conflict 
and disability (Karoly et al 2008). However, often only one study has tested a particular 
psychological factor in a particular pathway, and many of these different psychological constructs 
are likely to overlap, making it difficult to draw conclusions as to the true mediating effects of 
these variables on outcome and how they inter-relate to explain change in disability. Most 
recently, a systematic review and meta-analysis of observational studies summarised the results 
of 12 studies investigating mediators of the relationship between pain and disability (Lee et al 
2015), reporting evidence for pain self-efficacy, psychological distress and fear-avoidance beliefs  
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as potential mediators of treatment effect. 
 
There are some difficulties when testing mediators in observational data, especially when using 
cross-sectional data. For example, Costa et al (2011) tested self-efficacy as a mediator of the 
association between pain and disability, and compared this with fear-avoidance beliefs. These 
variables were chosen to help test two theoretical models: social learning theory (Bandura 1977), 
which suggests confidence in one’s ability to do things is related to one’s ability to achieve goals; 
and the fear-avoidance model (Vlaeyen & Linton 2000), which suggests that people who 
experience pain and perceive it to be as a result of injury may be afraid to move in case they 
cause further damage, leading to disuse and disability. This study involved data at two time 
points, allowing the authors to examine mediation in terms of change as well as cross-sectionally 
using linear regression analysis. The sample involved patients with a back pain episode of more 
than three months duration (n=184). Interestingly, the authors reported that both self-efficacy 
and fear-avoidance beliefs were found to be mediators of the association between pain and 
disability when analysing cross-sectional baseline data, but when mediation analysis was 
conducted using change in the potential mediators and change in disability (from baseline to 12-
month follow-up), only change in self-efficacy (not fear-avoidance beliefs) was found to partly 
explain changes in function. The authors do not offer a potential explanation for this finding but it 
may be due to fear-avoidance beliefs changing less between baseline and 12-months than self-
efficacy (mean values for fear-avoidance beliefs 40.5 at baseline and 39.1 at follow-up; self-
efficacy 44.4 at baseline and 49.0 at follow-up). If there is no or little change over time in a 
variable, it is unlikely to be mediating any change seen in the outcome. More variance in the 
outcome was explained in the cross-sectional models than the longitudinal models (53% for 
baseline self-efficacy and 34% for change in self-efficacy), which suggests other factors may be 
affecting outcome over time. This shows how potentially different results can be obtained when  
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follow-up points are included in a study; cross-sectional associations may appear to be stronger 
because they do not take into account how variables may change over time. Temporality (the 
order in which variables change), an issue discussed in detail in Chapter 3, is also very important 
in mediation analyses which explore a causal association between the mediator and outcome. 
Results of cross-sectional studies should therefore be interpreted with caution as these studies do 
not provide evidence of temporality and associations are likely to be weaker when investigated in 
longitudinal or intervention study designs. 
 
The statistical approaches used to test for mediation have also differed across previous mediation 
studies in this field, which could have influenced the results found. The majority of studies 
employed linear regression, often citing Baron & Kenny’s causal steps approach (Arnstein et al 
1999; Costa et al 2011; Woby et al 2007; Leeuw et al 2007b; George et al 2011; Söderlund & 
Åsenlöf 2010; Alcantara et al 2010). However, several problems with using this method have been 
identified (see Chapter 3). For example, in the cross-sectional study by Leeuw et al fear-avoidance 
beliefs were tested as a mediator of the relationship between catastrophising thoughts and 
disability as proposed by the fear-avoidance model (Vlaeyen & Linton 2000). Fear-avoidance 
beliefs did not meet the first criterion of the Baron & Kenny (1986) regression analyses, with 
catastrophising not having a direct effect on disability, so no further analysis was performed using 
this variable. It has been suggested that this first step is not always necessary to perform 
mediation analysis, and indeed requiring this can reduce the power to detect mediation 
(MacKinnon et al 2007 – see Chapter 3). Many of these studies employed an additional test of the 
mediating effect but the majority used the Sobel (1982) test which assumes the effect is normally 
distributed. This could potentially mean that the results presented by these studies do not 
accurately represent the mediating effects of the tested variables. Only two studies (Shelby et al 
2008; Vowles et al 2008) employed a test of the mediating effect that is seen as appropriate by  
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key authors in the mediation analysis field (e.g. Hayes 2009; MacKinnon 2004) (see Chapter 3), 
where the likely non-normal distribution of the indirect effect is accounted for by the use of 
bootstrapping. The sample sizes included by the studies also appeared to be small (n≤100 in some 
cases (George et al 2011)) which could also impact on the power of the analysis to detect 
mediating effects. In their systematic review, Lee et al (2015) also noted limitations of the 
included studies, including a lack of consideration of potential confounding factors, use of 
inappropriate mediation analysis techniques and a lack of consideration or testing of the temporal 
order of the variables. 
 
However, a strength of the observational mediation research discussed above is that almost all 
based their analysis on a strong theoretical model, in particular Vlaeyen & Linton’s fear-avoidance 
model (Johnson Wright et al 2008; George et al 2011) and Bandura’s model of social-cognitive 
theory (Arnstein 2000; Arnstein et al 1999; Woby et al 2007). Even though most of the research 
described above is cross-sectional, a theory or hypothesis behind why variables are linked in a 
particular way is helpful for exploring associations and building an evidence base for potential 
mediators to be tested in further research. 
 
To summarise, the majority of the previous studies of mediation analysis in MSK pain populations 
have carried out the analysis on observational data. This has provided some support for 
theoretical models of pain, but the methods were often flawed and few variables had been 
extensively tested. The work presented in this chapter used observational data for a different 
purpose; to identify what factors could be potential treatment mediators and should therefore be 
tested in a randomised controlled trial (RCT).  
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5.2 Aim 
The overall aim of this thesis was to explore methodological issues in conducting mediation 
analysis in MSK pain intervention studies. By using observational study data to decide which 
variables to test as treatment mediators in RCT data, this chapter demonstrates how the 
investigation of mediators involves a process of research to build up evidence for particular 
factors before they are tested as mediators of treatment effect. The purpose of such studies is to 
allow the selection of variables for mediation analysis that are likely to show change and are 
related to change in outcome. 
 
The aim of the secondary analysis presented in this chapter was to investigate which 
psychological factors are likely to contribute to change in functional outcome, and might 
therefore be useful to test as treatment mediators in an RCT. To answer this, associations were 
investigated between changes in psychological predictor variables and changes in outcome 
between baseline and each follow-up point. The study which was used for this analysis, the 
BeBACK study, is described in more detail in Section 5.5. 
 
 
5.3 Specific Objectives 
1. To provide descriptive data on the outcome (disability) and each of the predictor 
(potential mediator) variables at baseline and each follow-up point (three months, six 
months and 12 months); 
2. To explore the relationships between change in each of the predictor (potential mediator) 
variables and change in the outcome measure (disability). 
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5.4 Hypothesis 
Change in the following prognostic variables: self-efficacy, measures of coping (catastrophising 
thoughts, diversion, re-interpretation, cognitive coping), fear-avoidance beliefs, anxiety, 
depression and illness perceptions (identity, personal control, acute-chronic timeline, 
consequences, timeline cyclical, illness coherence, treatment control, emotional representation, 
psychological attribution, risk factors, immunity and accident/chance) is significantly related to 
change in the outcome variable (disability) at three-month, six-month and 12-month follow-up. 
 
 
5.5 Beliefs about Back Pain (BeBACK) Study 
The BeBACK study is a prospective, observational cohort study of adult patients consulting their 
GP with LBP. The purpose of the original study was to investigate which of 20 psychological 
factors, previously found to be associated with LBP, were related to LBP at presentation in the 
present sample and also which were predictive of changes in disability (Foster et al 2010). The 
Roland-Morris Disability Questionnaire (RMDQ) (Roland & Morris 1983) and a self-reported global 
rating of change were used as primary outcome measures. The main prognostic variables included 
in the analyses were illness perceptions as measured by the Illness Perceptions Questionnaire 
Revised (IPQ-R) (Moss-Morris et al 2002), as these were the main focus of the study (Foster et al 
2008). However, other measures, including self-efficacy, impact and severity of pain, coping 
strategies, anxiety, depression, bothersomeness, fear-avoidance beliefs and pain severity were 
also included, along with demographic and work information. Foster et al (2010) found that out of 
the 20 measures tested in a multivariate regression analysis, only four were found to be 
independently predictive of disability and global rating of change at six-month follow-up. These 
were self-efficacy and three illness perceptions (personal control, acute/chronic timeline and  
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identity). In the original study, the main aim of the analysis was to test all of the variables as 
predictors of longer-term outcome, rather than as potential mediators, so associations between 
baseline values of the psychological factors with follow-up assessments of outcome were tested. 
 
However, Foster et al (2010) also reported that they explored the association between change in 
each of the psychological constructs and change in outcome, and found statistically significant 
associations for eight out of the 20 constructs of which change in only three were independently 
predictive of change in disability (illness identity, pain self-efficacy and depression), which 
explained 42.4% of the variance of change in disability. These variables were therefore suggested 
to be potential mediators of disability outcome, although the authors acknowledged that this 
could not be assumed to indicate a causal relationship. This analysis did not control for baseline 
level of the outcome measure (disability), which is generally highly predictive of outcome. Further 
analysis which controls for this potential confounding factor is therefore warranted.   
 
Further analysis of the BeBACK study was undertaken to investigate whether the prognostic 
factors identified previously were also potential treatment targets (mediating factors). This study 
has a number of strengths in that it is sufficiently large, includes several time points (three, six and 
12 months follow-up), and measured a large number of psychological variables that can be 
examined for potential mediating effects. However, unlike in the studies discussed in Section 
5.1.1, no formal test of mediation analysis was carried out on the BeBACK data, as the variables in 
this study were only be tested for their potential to mediate treatment outcome. The purpose of 
this analysis was to explore which variables changed over time and which were related to change 
in disability, the outcome of interest.  
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The analysis presented here includes the RMDQ as an outcome variable at three-, six- and 12-
month follow-up. This is comprised of a list of 24 statements related to the ability to carry out 
movements or everyday activities, which the respondent checks if they feel that particular 
statement applies to them on the day they complete the questionnaire. A higher score therefore 
indicates higher back-pain-related disability.  
 
All of the psychological variables included in the original study were included in the present 
analysis as potential mediating variables (Table 5.1). These were self-efficacy (Pain Self-Efficacy 
Questionnaire (PSEQ)) (Nicholas 2007), illness perceptions (Illness Perceptions Questionnaire – 
Revised (IPQ-R)) (Moss-Morris et al 2000), fear-avoidance beliefs (Tampa Scale of Kinesiophobia 
(TSK)) (Kori et al 1990), pain catastrophising and coping (Coping Strategies Questionnaire-24 (CSQ-
24)) (Harland & Georgieff 2003), and anxiety and depression (Hospital Anxiety and Depression 
Scale (HADS)) (Zigmond & Snaith 1983).  
 
The PSEQ contains a list of 10 items that are scored on a six-point Likert scale. Respondents rate 
each item in terms of how confident they are in their ability to do things such as socialising and 
household chores despite their pain. The CSQ contains four subscales for catastrophising, 
diversion, re-interpretation and cognitive coping, all of which are scored on a seven-point Likert 
scale to indicate how often a particular coping strategy is used. This scale is a shortened version of 
the original Coping Strategies Questionnaire developed by Rosenstiel & Keefe (1983). The TSK is 
made up of 17 items which are each rated on a four-point Likert scale, with a higher score 
indicating higher fear-avoidance beliefs; a score of 37 or above has been documented as a cut-off 
for high fear (Vlaeyen et al 1995a; Bränström & Fahlström 2008) and a reduction in score by four 
points as showing clinically significant improvement (Woby et al 2005). The HADS contains 14 
items, with seven items each for anxiety and depression. These are also scored on a four-point  
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Likert scale, with a higher score indicating higher anxiety and/or depression. Finally, the IPQ-R is 
also made up of a number of subscales which assess various illness perceptions and is designed so 
that the statements can be made specific to the illness being studied. The Identity subscale 
requires respondents to answer ‘yes’ or ‘no’ to whether they think a number of different 
symptoms were related to their illness. The items of the remaining subscales (Personal Control, 
Acute-Chronic Timeline, Consequences, Timeline Cyclical, Illness Coherence, Treatment Control, 
Emotional Representation, Psychological Attribution, Risk Factor, Immunity, and 
Accident/Chance) are scored using five-point Likert scales which require respondents to rate how 
strongly they agree or disagree with certain statements. A summary of each of the measures is 
provided in Table 5.1 below.
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Table 5.1 Description of outcome and potential mediator measures 
Questionnaire/Sub-scale 
 
Reference How scored 
Outcome measure 
Disability: Roland-Morris Disability Questionnaire 
(RMDQ) 
Roland & Morris 
(1983) 
Add up number of ‘Yes’ rated responses – higher number of ‘Yes’ responses indicates higher level of 
disability (score of 0-24) 
Potential mediators  
Self-efficacy: Pain Self-efficacy Questionnaire 
(PSEQ) 
Nicholas (2007) Likert scale to record responses – higher scores indicate higher self-efficacy  
Coping: Coping Strategies Questionnaire (CSQ24): 
Catastrophising subscale 
Harland & 
Georgieff (2003) 
6 items on a 7 point scale (0=never use it; 6=always); score of 0-36; Higher score indicates a higher 
frequency of the coping style 
Coping: CSQ24: Diversion Subscale Harland & 
Georgieff (2003) 
6 items on a 7 point scale (0=never use it; 6=always); score of 0-36; Higher score indicates a higher 
frequency of the coping style 
Coping: CSQ24: Re-interpretation subscale Harland & 
Georgieff (2003) 
6 items on a 7 point scale (0=never use it; 6=always); score of 0-36; Higher score indicates a higher 
frequency of the coping style 
Coping: CSQ24: Cognitive coping subscale Harland & 
Georgieff (2003) 
5 items on a 7 point scale (0=never use it; 6=always); score of 0-30; Higher score indicates a higher 
frequency of the coping style 
Fear-avoidance beliefs: Tampa Scale for 
Kinesiophobia (TSK) 
Kori et al (1990) 17 items on a 4-point Likert scale “strongly agree”-“strongly disagree”; Higher score indicates higher fear-
avoidance 
Anxiety: Hospital Anxiety and Depression Scale 
(HADS) 
Zigmond & Snaith 
(1983) 
7 items on a 4 point scale (0-3); Higher score indicates higher level of anxiety 
Depression: HADS Zigmond & Snaith 
(1983) 
7 items on a 4 point scale (0-3); Higher score indicates higher level of depression 
Illness Perceptions: Illness Perceptions 
Questionnaire-Revised (IPQ-R): Identity subscale 
Moss-Morris et al 
(2002) 
14 items, each answered either “yes” or “no”; Sum all “Yes” rated responses to each commonly 
experienced symptom – Higher score indicates stronger beliefs about the number of symptoms attributed 
to the illness 
Illness Perceptions: IPQ-R: Personal Control 
subscale 
Moss-Morris et al 
(2002) 
6 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree) Add up IP12-IP17 (Section C) – 
higher score indicates more positive beliefs about controllability of illness 
Illness Perceptions: IPQ-R: Acute-Chronic Timeline 
subscale 
Moss-Morris et al 
(2002) 
6 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree) Add up IP1-IP5 + IP18 (Section C); 
Higher score indicates stronger beliefs about the chronicity of the illness 
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Questionnaire/Sub-scale 
 
Reference How scored 
Illness Perceptions: IPQ-R: Consequences subscale Moss-Morris et al 
(2002) 
6 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items IP6-IP11 (Section C); 
Higher score indicates more of an effect of the illness on the patient 
Illness Perceptions: IPQ-R: Timeline Cyclical 
subscale 
Moss-Morris et al 
(2002) 
4 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items IP29-IP32 (Section C); 
Higher score indicates stronger beliefs about the cyclical nature of the condition 
Illness Perceptions: IPQ-R: Illness coherence 
subscale 
Moss-Morris et al 
(2002) 
5 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items IP24-IP28 (Section C); 
Higher score indicates positive personal understanding of condition 
Illness Perceptions: IPQ-R: Treatment Control 
subscale 
Moss-Morris et al 
(2002) 
5 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items IP19-IP23 (Section C); 
Higher score indicates higher beliefs in treatment control 
Illness Perceptions: IPQ-R: Emotional 
representation subscale 
Moss-Morris et al 
(2002) 
6 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items IP33-IP38 (Section C); 
Higher score indicates more negative emotion as a result of the illness 
Illness Perceptions: IPQ-R: Psychological 
attribution subscale 
Moss-Morris et al 
(2002) 
6 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items 1, 9, 10, 11, 12 and 
17 (Section D); Higher score indicates higher number of psychological attributions 
Illness Perceptions: IPQ-R: Risk factor subscale Moss-Morris et al 
(2002) 
7 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items 2, 4, 6, 8, 13, 14 and 
15 (Section D); Higher score indicates higher number of perceived risk factors 
Illness Perceptions: IPQ-R: Immunity subscale Moss-Morris et al 
(2002) 
3 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items 3, 7 and 18 (Section 
D); Higher score indicates perceived poor immunity 
Illness Perceptions: IPQ-R: Accident/Chance 
subscale 
Moss-Morris et al 
(2002) 
2 items on a 5-point Likert scale (Strongly Agree to Strongly Disagree); Add up items 5 and 16 (Section D); 
Higher score indicates higher attribution to chance 
Shaded subscales: Items can be modified to suit particular illnesses (Moss-Morris et al 2002) 
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The psychometric properties of these measures have been reviewed. The IPQ-R was found to 
have good internal consistency and test-retest reliability by the authors who originally re-
developed the tool (Moss-Morris et al 2002; Hill 2010) although these properties were not tested 
specifically in a LBP population. The PSEQ has been tested in a LBP population and was found to 
have strong internal consistency, test-retest reliability and unidimensionality (Nicholas 2007; van 
Hartingsveld et al 2010). The CSQ-24 has been reported to have good internal consistency and a 
consistent factor structure in MSK pain populations (Harland & Georgieff 2003; Harland & Martin 
2014). A systematic review of the psychometric properties of the TSK located very few studies 
that had investigated the 17-item version of the tool – several other versions exist including a 13-
item and 11-item version (Lundberg et al 2011). The authors of this review noted that none of the 
studies included had measured the responsiveness of the TSK, and that overall validity was low 
(Lundberg et al 2011). Studies have also cast doubt on the factor structure of the TSK, with a two-
factor structure (Goubert et al 2004; French et al 2007) and a five-factor structure found 
previously (Lundberg et al 2004). However, this evidence is not consistent and several authors 
found poor fit for the two-factor structure (see Tkachuk & Harris 2012 for a review). Others have 
found support for the TSK being a unidimensional construct (Damsgård et al 2007). For the HADS, 
less evidence exists for the tool’s psychometric properties in MSK pain populations, and this 
measure was originally developed for a secondary care rather than a primary care population. 
Internal consistency (Cronbach’s alpha) for the HADS in mental health populations has been 
reported as 0.76 and 0.80 for the depression and anxiety subscales respectively (Mykleton et al 
2001) and a review by Bjelland et al (2002) noted good sensitivity and specificity in primary care 
populations. However, recently there have been calls to abandon use of the HADS over its 
inability to distinguish between anxiety and depression (Coyne & van Sonderen 2012). The tool’s 
power to predict LBP and disability in primary care studies is mixed, with some suggesting the tool 
is predictive (Foster et al 2010) and others suggesting not (Campbell et al 2013a). Finally, the 24- 
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item RMDQ has been found to have good psychometric properties overall in LBP populations, 
with studies indicating adequate construct (Roland & Fairbank 2000; Grotle et al 2005) and 
content (Roland & Morris 1983; Roland & Fairbank 2000; Ostelo & de Vet 2005) validity, good 
test-retest reliability over short time periods (Roland & Morris 1983; Streiner & Norman 2008; 
Smeets et al 2011) and high internal consistency (Roland & Fairbank 2000). Responsiveness in 
terms of minimal clinically important change (MCIC) yields different results within different 
populations (Bombardier et al 2001), although Jordan et al (2006) found that a 30% reduction in 
score is indicative of clinically important change in a primary care population. It should be noted 
that clinically important absolute change is highly dependent on baseline RMDQ score (Cleland et 
al 2010). 
 
 
5.6 Methodology 
All analyses were carried out using SPSS PASW statistics package version 18. A flowchart 
summarising this analysis can be seen in Figure 5.1. 
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Figure 5.1 Flowchart describing the steps of analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.6.1 Preliminary analyses (Objective 1) 
Descriptive statistics (means and standard deviations (SDs)) for numerical measures, or 
frequencies for binary or categorical measures were calculated for each potential mediator 
variable and the outcome measure at baseline and each follow-up point (Step 1.1 in Figure 5.1). 
This was to see if the measures showed a pattern of change over time.  
 
Analysis to detect potential attrition (non-response) bias due to selective loss to follow-up was 
conducted by examining differences in baseline characteristics between participants responding 
and not responding at six-month and 12-month follow-up (Step 1.2). This was important given the 
high dropout rate over the study’s follow-up periods. Comparisons between responders and non-
1. 
Preliminary 
Analysis 
1.1 Descriptive Statistics 
1.2 Analysis of Potential Non-
Response Bias 
1.3 Creation of Residualised Change 
Scores 
 
2. Testing 
Criteria for 
Potential 
Mediation 
2.1 Analysis of whether there was 
change between baseline and each 
follow-up time point for the potential 
mediator and outcome variables 
2.2 Analysis of the association 
between changes in the potential 
mediator and changes in outcome 
Pearson’s Bivariate Correlations 
Examination of percentage mean 
change; Repeated Measures 
ANOVAs 
Linear Regression Analysis: Save 
Standardised Residuals 
Calculation of Means, SDs and 
Percentages 
Description of characteristics of 
responders and non-responders 
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responders were made for age, sex, baseline disability score, and baseline scores on each of the 
potential mediator variables.  
 
Residualised change scores were then calculated for each potential mediator and outcome 
measure for each follow-up point (Step 1.3). These scores represent the difference between the 
score a person receives at follow-up compared to what was predicted at baseline (Streiner & 
Norman 2008). Raw change scores (follow-up score subtracted from baseline score) such as those 
used in the original BeBACK analysis do not account for the predictive power of baseline score. 
This means that residualised change scores are less prone to error than raw change scores 
(George et al 2008) and give a more accurate picture of the change that actually occurred 
between the measured time points. Residualised change scores are calculated by running a linear 
regression analysis with the follow-up score as the outcome, and baseline score as the predictor 
variable. Residuals (the difference between the observed value at follow-up and the predicted 
value) are then saved, and it is these values that are then used in the analysis. 
 
5.6.2 Testing criteria for potential mediation (Objectives 2 and 3) 
Mean percentage change between baseline and each follow-up mean score for all included 
measures was calculated and the magnitude of change that occurred at each point was examined. 
Repeated measures Analysis of Variance (ANOVA) was then conducted to test if change in each of 
the outcome and potential mediator measures was statistically significant between baseline and 
follow-up. This is an important requirement for showing a process of change (Vowles et al 2007). 
ANOVA tests whether there is a difference in group means; here, a repeated measures ANOVA 
was used because the means are not between two separate groups but rather a comparison 
between different means measured in the same participants over time. However, because of the 
large sample size in the BeBACK dataset it is likely that even small changes will be statistically  
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significant. Therefore, the mean change in each variable, expressed as a percentage, was 
presented alongside the repeated measures ANOVAs to give more information as to the 
magnitude of this change. Mean scores at baseline, three-month, six-month and 12-month follow-
up for each variable were entered into the repeated measures ANOVA to test whether there was 
a significant change across all the time points. 
 
The residualised change score of each potential mediator variable was then correlated with the 
residualised change score of the outcome measure at each time point using Pearson’s bivariate 
correlations, to examine the relationship between change in the potential mediators and change 
in outcome. Again, showing a relationship between change in the potential mediator and change 
in outcome is important for establishing whether a variable has the potential to mediate 
outcome. 
 
 
5.7 Results 
5.7.1 Preliminary analyses (Objective 1) 
Participants were sent a baseline survey which asked for consent for further contact. Only those 
who responded at baseline and then consented to further contact were sent follow-up 
questionnaires. The baseline population (n=1591) contained 41% male and 59% female 
participants, with a mean age of 43.9 (SD 10.3) years. Pain duration was measured in categories of 
Less than 1 month, 1-3 months, 4-6 months, 7 months-3 years or More than 3 years, with similar 
proportions of patients in each category. Of the participants who responded at baseline, 54% 
(n=856) responded at three-month follow-up, 51% (n=810) at six-month follow-up and 30% 
(n=473) at 12-month follow-up. The results of the analysis of potential non-response bias is 
presented below, using means and SDs or percentages where appropriate. Analysis of baseline  
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characteristics showed that responders at three-month follow-up tended to be slightly older, have 
higher self-efficacy, catastrophising thoughts, cognitive coping, identity, psychological attribution 
and risk factor scores and lower treatment control and accident/chance scores compared to non- 
responders, but these differences appear very small, with often less than one point difference 
between responders and non-responders. Some of the scales, particularly the illness perceptions 
subscales, only include a few items but the differences between responders and non-responders 
for these scales (Timeline Cyclical, Immunity and Accident/Chance) were all less than one point. 
By six-month follow-up a greater percentage of responders were female but there still appeared 
to be only small differences between baseline values for responders and non-responders. By 12-
month follow-up there was a bigger difference between responders and non-responders for 
baseline distribution of sex, pain duration of 7 years or more, self-efficacy, cognitive coping and 
fear-avoidance beliefs in particular, with more females and those with more favourable scores on 
psychological measures remaining in the study. These results are summarised in Table 5.2.
Chapter 5 BeBACK Analysis Page 127 
 
Table 5.2 Analysis of potential non-response bias in BeBACK participants (baseline characteristics of responders and non-responders to follow-up 
questionnaires) 
Measure Baseline values 
(mean (SD)) or 
n(%) 
(n=1591) 
Baseline values (Mean (SD)) at 
three-month follow-up 
Baseline values (Mean (SD)) at six-
month follow-up 
Baseline values (Mean (SD)) at 12-
month follow-up 
Resp (n=856) Non-resp (n=735) Resp (n=810) Non-resp (n=781) Resp (n=473) Non-resp (n=1118) 
Age 43.88 (10.31) 45.31 (9.82) 42.23 (10.63) 45.54 (9.75) 42.16 (10.61) 46.23 (9.57) 42.89 (10.46) 
Sex 58.5% f 58.8% f 58.1% f 61.1% f 55.7% f 60.9% f 57.4% f 
Pain duration Less than 1 
month 
288 (18.1) 138 (16.1) *** 129 (15.9) 115 (14.2) 75 (15.9) 62 (13.1) 
1-3 months 329 (20.7) 173 (20.2) *** 156 (19.3) 86 (10.6) 96 (20.3) 54 (11.4) 
3-6 months 243 (15.3) 132 (15.4) *** 134 (16.5) 46 (5.7) 78 (16.5) 36 (7.6) 
7 months -3 
years 
347 (21.8) 199 (23.2) *** 190 (23.5) 156 (19.3) 107 (22.6) 85 (18.0) 
More than 3 
years 
338 (21.2) 199 (23.2) *** 186 (23.0) 174 (21.5) 108 (22.8) 118 (24.9) 
RMDQ score 8.64 (6.04) 8.76 (5.91) 8.49 (6.19) 8.71 (5.79) 8.57 (6.29) 8.36 (5.82) 8.76 (6.13) 
Self-efficacy score 37.81 (14.64) 38.21 (14.33) 37.34 (14.83) 38.43 (14.17) 37.16 (15.00) 40.0 (13.74) 36.88 (14.81) 
Coping: Catastrophising score 9.96 (7.87) 9.63 (7.55) 10.34 (8.43) 9.65 (7.60) 10.29 (8.33) 9.38 (7.29) 10.21 (8.24) 
Coping: Diversion score 15.51 (8.24) *** *** 15.62 (8.18) 15.38 (8.31) 15.41 (8.40) 15.55 (8.17) 
Coping: Re-interpretation score 7.83 (6.99) *** *** 7.59 (6.81) 8.09 (7.18) 7.49 (6.85) 7.98 (7.05) 
Coping: Cognitive score 16.27 (6.48) *** *** 16.78 (6.19) 15.72 (6.74) 17.13 (6.01) 15.89 (6.65) 
Fear-avoidance beliefs score 39.67 (6.89) *** *** 39.36 (6.86) 40.00 (6.91) 38.89 (6.83) 40.01 (6.89) 
Anxiety score 8.26 (4.55) *** *** 8.25 (4.44) 8.28 (4.67) 8.11 (4.37) 8.33 (4.63) 
Depression score 6.53 (4.37) *** *** 6.38 (4.15) 6.68 (4.58) 6.15 (4.06) 6.69 (4.48) 
Identity score 4.03 (2.38) *** *** 4.11 (2.32) 3.95 (2.43) 4.08 (2.20) 4.01 (2.45) 
Personal control score 20.52 (3.79) 20.93 (3.78) 20.02 (3.74) 21.00 (3.79) 20.05 (3.74) 21.27 (3.87) 20.19 (3.71) 
Acute-chronic timeline score 19.64 (5.85) 20.02 (5.86) 19.26 (5.81) 19.81 (5.84) 19.46 (5.85) 19.82 (5.81) 19.57 (5.87) 
Consequences score 17.33 (5.48) 17.45 (5.48) 17.17 (5.47) 17.34 (5.45) 17.31 (5.51) 17.06 (5.42) 17.44 (5.50) 
Timeline cyclical score 13.04 (3.39) 13.07 (3.35) 13.00 (3.45) 13.05 (3.32) 13.03 (3.48) 12.83 (3.33) 13.13 (3.42) 
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Measure Baseline values 
(mean (SD)) or 
n(%) 
(n=1591) 
Baseline values (Mean (SD)) at 
three-month follow-up 
Baseline values (Mean (SD)) at six-
month follow-up 
Baseline values (Mean (SD)) at 12-
month follow-up 
Resp (n=856) Non-resp (n=735) Resp (n=810) Non-resp (n=781) Resp (n=473) Non-resp (n=1118) 
Illness coherence score 13.77 (4.99) 13.62 (5.06) 13.94 (4.89) 13.45 (3.10) 14.10 (4.84) 12.99 (5.08) 14.10 (4.91) 
Treatment control score 16.99 (3.36) 17.03 (3.37) 16.95 (3.36) 17.17 (3.29) 16.81 (3.43) 17.46 (3.29) 16.80 (3.37) 
Emotional representation score 16.71 (5.23) 16.71 (5.23) 16.71 (5.24) 16.68 (5.20) 16.76 (5.27) 16.46 (5.10) 16.82 (5.28) 
Psychological attribution score 11.93 (4.11) *** *** 11.73 (4.01) 12.14 (4.21) 11.55 (4.01) 12.09 (4.15) 
Risk factor score 15.02 (4.15) *** *** 14.29 (4.01) 15.13 (4.29) 14.84 (4.00) 15.10 (4.21) 
Immunity score 5.33 (1.95) *** *** 5.22 (1.90) 5.44 (2.00) 5.13 (1.86) 5.52 (1.98) 
Accident/Chance score 5.98 (1.92) *** *** 6.02 (1.93) 5.94 (1.90) 6.01 (1.95) 5.96 (1.90) 
f = female; ***=Not measured
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The above analysis suggests that there are differences between responders and non-responders 
for some of the measures that will be analysed, but these differences are small and unlikely to 
strongly influence the results of the associations presented in this chapter. Therefore, despite the 
high loss to follow-up and loss of precision all of the measures used in the subsequent analysis 
were based on participants with complete data. Imputation of missing values was not considered 
for this analysis, as it would involve imputing 50-70% of data. 
 
The skewness and kurtosis values were also examined for each variable and histograms were 
produced (see Appendix 5.1). This is because all of the analyses conducted in this chapter will 
assume normal distribution of the variables. This analysis was carried out on both baseline, 
follow-up values and residualised change scores as all types of scores were used in the 
subsequent analysis. Some variables did have values of skewness (three-month, six-month and 
12-month follow-up mean scores in pain catastrophising; 12-month mean score in disability) or 
kurtosis (residualised change at three-months in self-efficacy, personal control, pain 
catastrophising, treatment control; residualised change at six months in fear-avoidance, identity, 
emotional representation, treatment control, psychological attributions, risk attributions and 
immunity; residualised change at 12 months in pain catastrophising, depression, personal control, 
identity, treatment control and immunity) that exceeded 1. Non-normality was also indicated by 
examination of the histograms, although this was less marked in the residualised change scores 
(see Appendix 5.1). This indicated that the assumption of normality was not always met, which 
could have introduced bias into the analysis. 
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5.7.2 Testing criteria for potential mediation (Objectives 2 and 3) 
The means and SDs of the outcome measure and each potential mediator variable for all of the 
time-points are shown in Table 5.3. The percentage of mean change from baseline to each follow-
up time point is also given, as well as the F ratio from the repeated measures ANOVA and whether 
this represented a statistically significant (p<0.05) change overall.  
 
Not all variables were measured between baseline and three-month follow-up, but out of those 
that were, the largest percentage mean change from baseline score was in disability (23.5%) and 
catastrophising (14%), with very small changes of less than 10% in the other variables measured 
at this time point.  
Chapter 5 BeBACK Analysis Page 131 
 
Table 5.3 Change over time in potential mediator and outcome variables in BeBACK participants  
Measure Baseline 
(Mean (SD)) 
(n=1591) 
Three-month 
follow-up 
(Mean (SD)) 
(n=856) 
Proportion 
of change 
from 
baseline (%) 
Six-month 
follow-up 
(Mean (SD)) 
(n=810) 
Proportion of 
change from 
baseline (%) 
12-month 
follow-up 
(Mean (SD)) 
(n=473) 
Proportion of 
change from 
baseline (%) 
ANOVA (F)  
RMDQ 8.64 (6.04) 6.61 (6.09) 23.5% 6.19 (6.14) 28.4% 5.83 (6.12) 32.5% 71.21** 
Self-efficacy 37.81 (14.56) 39.96 (14.11) 5.7% 40.80 (14.15) 7.9% 42.17 (14.07) 11.5% 10.52** 
Coping Catastrophising 9.96 (7.97) 8.50 (7.95) 14.0% 8.70 (7.51) 12.7% 8.19 (7.20) 17.8% 16.15** 
Diversion 15.51 (8.24) *** *** 15.49 (8.71) 0.1% 14.68 (8.42) 5.4% 0.31 
Re-interpretation 7.83 (6.99) *** *** 8.71 (7.29) 11.2% 6.83 (7.00) 10.2% 5.01** 
Cognitive coping 16.27 (6.48) *** *** 17.29 (6.28) 6.3% 17.74 (6.26) 9.0% 2.92 
Fear-avoidance beliefs 39.67 (6.89) *** *** 38.38 (6.30) 3.3% 37.80 (6.11) 4.7% 10.94** 
Anxiety 8.26 (4.55) *** *** 6.60 (4.57) 20.1% 6.31 (4.48) 23.6% 74.79** 
Depression 6.53 (4.37) *** *** 5.08 (4.28) 22.2% 4.67 (4.32) 28.5% 54.76** 
Illness 
perceptions 
Personal control 20.51 (3.79) 20.77 (4.17) 1.3% 20.93 (4.16) 2.1% 21.26 (4.27) 3.7% 0.70 
Acute-chronic 
timeline 
19.64 (5.84) 20.92 (5.81) 6.5% 21.00 (5.80) 6.9% 21.38 (5.91) 8.9% 17.40** 
Identity 4.03 (2.37) *** *** 3.14 (2.41) 22.1% 3.02 (2.23) 25.1% 83.32** 
Consequences 17.33 (5.48) 17.06 (5.82) 1.6% 16.49 (5.80) 4.9% 16.07 (5.88) 7.3% 11.10** 
Timeline cyclical 13.04 (3.39) 13.02 (3.40) 0.2% 12.82 (3.52) 1.7% 12.85 (3.31) 1.4% 0.39 
Illness 
coherence 
13.77 (4.99) 12.72 (4.91) 7.6% 11.88 (4.61) 13.7% 11.41 (4.49) 17.1% 22.33** 
Treatment 
control 
16.99 (3.36) 16.51 (3.52) 2.8% 16.58 (3.62) 2.4% 16.68 (3.55) 1.8% 9.13** 
Emotional 
representation 
16.71 (5.23) 16.52 (5.20) 1.14% 15.69 (5.29) 6.1% 15.23 (5.18) 8.9% 18.24** 
Psychological 
attribution 
11.93 (4.11) *** *** 11.94 (4.25) 0.1% 11.86 (3.94) 0.6% 1.03 
Risk factors 15.02 (4.15) *** *** 15.42 (3.95) 2.7% 15.53 (3.86) 3.4% 7.95** 
Immunity 5.33 (1.95) *** *** 5.29 (1.96) 0.8% 5.17 (1.86) 3.0% 0.08 
Accident/Chance 5.98 (1.92) *** *** 5.86 (1.92) 2.01% 6.00 (2.01) 0.3% 0.27 
*** Not measured; **p<0.01; *p<0.05
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Between baseline and six-month follow-up, the most substantial mean change was again in 
disability (28.4%) but a large change was also seen in depression (22.2%), the illness perception of 
identity (what symptoms a patient experienced and whether they felt these were related to their 
back pain) (22.1%) and anxiety (20.1%). Much smaller changes were observed in the other 
variables, particularly the coping skills of diversion and cognitive coping, fear-avoidance beliefs, 
and the remaining illness perceptions.  
 
Finally, between baseline and 12-month follow-up, the largest percentage mean change was again 
for disability (32.5%), depression (28.5%), identity (25.1%) and anxiety (23.6%), with the 
remaining variables showing only a very small mean change. The repeated measures ANOVAs 
showed that disability, self-efficacy, fear-avoidance beliefs, catastrophising, re-interpretation, 
anxiety, depression, acute-chronic timeline, identity, consequences, illness coherence, treatment 
control and emotional representation were all found to change significantly, while the remaining 
variables (cognitive coping, diversion, personal control, timeline cyclical, psychological attribution, 
immunity and accident/chance) did not.  
 
This suggests that, even without manipulation through a specific treatment, there is potential for 
variables to change over time. Demonstration of change is an important pre-requisite for 
mediation. This change was not demonstrated in all the variables measured in the BeBACK study, 
and Table 5.3 also shows that the changes seen in this study, while statistically significant, were 
small in magnitude for several potential mediators. Diversion, cognitive coping, personal control, 
timeline cyclical, psychological attribution, accident/chance and immunity were not found to 
change substantially overall. This could indicate that they are stable characteristics that are not 
likely to change, but none were directly manipulated in this study. It could be that direct 
manipulation in an RCT would result in more change in all of the measured variables. 
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The next step in the analysis was to investigate whether change in the potential mediators was 
related to change in the outcome variable. Pearson’s bivariate correlations were performed using 
the residualised change scores. The results showed that change in the self-efficacy measure had a 
fairly strong negative correlation with change in disability score (increasing self-efficacy was 
associated with reducing disability) and changes in catastrophising, anxiety, and depression had 
quite strong positive correlations (increasing, less favourable scores were associated with 
increasing disability), but that change in the remaining variables was only weakly associated with 
disability change at each follow-up point (see Table 5.4; variables that are shaded indicate a 
strong correlation). The criterion used to judge which factors were the strongest potential 
mediators was a combination of the correlations presented in Table 5.4 and the magnitude of 
change presented in Table 5.3, so that only variables which showed a large proportion of change 
as well as a strong correlation with change in outcome are highlighted. 
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Table 5.4 Associations between residualised changes in the potential mediator variables and 
residualised change in RMDQ score in the BeBACK study (Pearson’s bivariate correlation 
coefficient) 
Measure Three-month 
follow-up 
Six-month follow-up 12-month follow-up 
 
Self-efficacy∆ -.55** -.52** -.58** 
Catastrophising∆ .45** .38** .45** 
Diversion∆ *** .10* .08 
Re-Interpretation∆ *** .03 .08 
Cognitive Coping∆ *** -.17** -.18** 
Fear-avoidance beliefs∆ *** .31** .33** 
Anxiety∆ *** .45** .41** 
Depression∆ *** .57** .55** 
Personal control∆ -.22** -.25** -.25** 
Acute-chronic Timeline∆ .14** .18** .21** 
Identity∆ *** .31** .35** 
Consequences∆ .37** .37** .40** 
Timeline Cyclical∆ -.04 -.01 .01 
Illness Coherence∆ .12** .09* .06 
Treatment Control∆ -.14** -.23** -.20** 
Emotional Representation∆ .31** .33* .40** 
Psychological Attribution∆ *** .02 .13** 
Risk factors∆ *** .01 .04 
Immunity∆ *** .05 .10* 
Accident/Chance∆ *** .02 .09 
∆
 Residualised change score; *p<0.05; **p<0.01; *** Not available 
 
 
 
The above analysis suggests that while many of the tested variables change significantly over 
time, this change is not necessarily strongly associated with change in outcome. This is important, 
as if the change is not related to change in the outcome measure it is not likely to be a mediator 
of that change. Of all the variables tested, self-efficacy, catastrophising thoughts, anxiety and 
depression appear to be the best candidates for treatment mediation analysis. 
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5.8 Discussion 
5.8.1 Summary 
The BeBACK study was originally designed to test which psychological variables were predictive of 
future back pain outcomes such as disability and therefore of importance in estimating prognosis. 
The original findings indicated that a small number of variables were strong independent 
predictors of outcome (self-efficacy, personal control, acute-chronic timeline and identity), and 
when examining whether change in all the psychological variables was associated with change in 
disability, change in identity, self-efficacy and depression were found to be independently 
predictive. The secondary analysis presented here did not perform regression analysis as the aim 
was not to test the variables as predictors; instead, each variable was tested to investigate 
whether it was able to change over time and whether this change was associated with change in 
outcome, using residualised change scores rather than the raw change scores used by Foster et al 
(2010). The results of this secondary analysis suggest that catastrophising thoughts, identity, 
anxiety, and depression were the variables with the biggest mean score change over time and 
that residualised change in self-efficacy, catastrophising thoughts, anxiety, and depression are 
most strongly related to residualised change in disability. The discrepancy in results 
(catastrophising and anxiety were not considered to be potential mediators of disability by Foster 
et al) may be due to the type of change score used in the analysis. Foster et al (2010) used raw 
change scores while the results presented here used residualised change scores. The findings 
from the previous study may therefore be due to baseline score having a confounding effect. This 
is important to acknowledge and may add to the argument for residualised change scores being 
used more widely when conducting this type of analysis.  
 
These findings show that although some variables can change over time, this change is not always 
strongly related to outcome and crucially, variables that have been shown to be strong predictors  
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are not necessarily candidates for mediation. This is particularly true of the illness perception 
variables which on average appeared to remain very stable over time. Clinically, this is an 
important finding as it suggests that interventions that focus only on trying to change variables 
that have been shown to be strong predictors may not show large treatment effects while 
interventions that attempt to change factors that have been shown to be modifiable even when 
not directly manipulated (such as in the observational data presented here) are likely to show 
much larger effects. It also highlights that the number of potential mediator variables is likely to 
be smaller than the number of predictor variables, so the number of variables that may be 
suitable targets for treatment may be smaller than previously thought. This suggests that simpler 
interventions that focus on one or two factors may perhaps be more efficient than complex 
interventions that attempt to address a large number of factors. It is important to note that the 
proportion mean change was calculated using raw change, rather than residualised change; the 
residualised change will be far smaller, so the results from the Pearson’s bivariate correlations are 
reflective of these smaller changes. 
 
5.8.2 Comparison with previous findings 
The finding that self-efficacy is a potential mediator of outcome was unsurprising. The evidence 
from previous observational studies described in Section 5.1.1 noted self-efficacy as a variable 
often tested for mediation, with positive findings overall. However, the BeBACK study by far 
provides the largest sample in which to test self-efficacy compared to the previous literature and 
also has the advantage of being a prospective cohort rather than a cross-sectional study, which is 
crucial to assess change. This adds further weight to the argument for self-efficacy being a 
potential mediator. This analysis also adds to the evidence base for anxiety, depression and 
catastrophising thoughts in particular being potential mediators of functional outcomes. 
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Whilst the changes seen over time in self-efficacy in this study were small (less than 12% at any 
time point), residualised change in this variable had one of the strongest relationships with 
residualised change in disability. It must be acknowledged that the measure of self-efficacy used 
in the BeBACK study is very closely correlated with the measure of disability used, as the 
questions used in both scales are very similar. This could potentially be the reason for the strong 
correlations that are consistently found between self-efficacy and function. Investigation of this 
relationship is beyond the scope of this thesis, but further investigation of the psychometric 
properties of these tools and whether the measures have good content and construct validity is 
warranted. 
 
5.8.3 Comparison with theoretical framework 
The original aim of the BeBACK study was to test illness perceptions as assessed via the IPQ-R, 
based on the Self-Regulation model (Leventhal et al 2003), by investigating how well they predict 
clinical outcome. The original study found several illness perceptions to be strong predictors, in 
line with other research that used the IPQ-R (Kaptein et al 2010; Bijsterbosch et al 2009; 
Frostholm et al 2007) and looked at illness perceptions over longer periods of time (two years 
(Frostholm et al 2007) and six years (Kaptein et al 2010; Bijsterbosch et al 2009)). However, the 
present study provided little support for illness perceptions being potential mediators. This could 
again be due to the type of analysis, as none of the other studies used residualised change scores, 
meaning that baseline score could be responsible for the predictive power seen. Also, these 
studies aimed to assess the predictive value of illness perceptions rather than whether they can 
potentially explain causal associations, similar to the original BeBACK study, so were likely to draw 
different conclusions to those found in the present analysis. Predictive factors can be stable over 
time, while mediating factors need to be modifiable in order for them to be successfully targeted 
during treatment. 
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5.8.4 Potential limitations of the BeBACK secondary analysis 
This analysis was conducted on a primary care LBP dataset which included a large number of 
variables to test as potential mediators. It may be suggested that focusing on only the factors 
found to be independently predictive of outcome by the original BeBACK study might have been 
more informative, but the point of this analysis was to add to the existing evidence base and 
identify which variables could potentially be mediators of treatment outcome. As this could have 
led to spurious associations being found between the variables, the magnitude of the changes and 
strength of associations were focused on, rather than statistical significance which was tested 
across all time-points. Also, few studies of mediators of treatment outcome exist (see Chapter 4), 
so using observational study data to get a sense of what might potentially mediate outcome was 
seen to be important. 
 
It is also not clear from the analysis whether the variables did not change because they cannot 
change (i.e. are stable characteristics), or simply because they have not been directly manipulated 
in any way. This is a limitation of all mediation studies using observational data, and could explain 
the mixed results seen for tested variables in previous literature. It should also be highlighted that 
this analysis does not provide evidence for causal associations between the potential mediators 
and outcome; while the data used is longitudinal, temporality was not established, and 
adjustment for confounding was not carried out as part of this analysis. This highlights the 
importance of formal tests of mediation being carried out in RCT data, where causality can be 
more firmly investigated. 
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5.9 Conclusion 
Psychological factors have the potential to mediate outcome and have been shown to do so in 
previous literature. As demonstrated in this secondary analysis of the BeBack data, variables 
found to be predictive of outcome do not necessarily also change over time or are strongly 
related to change in outcome. This highlights the importance of identifying modifiable variables 
and testing them appropriately as potential mediators in future randomised studies.  
 
Conducting mediation analysis in observational studies cannot answer the important question of 
whether actually conducting an intervention which is designed to manipulate variables such as 
self-efficacy can lead to change in outcome. The next step therefore is to conduct mediation 
analysis on an intervention study that specifically targeted psychological variables during 
treatment to investigate whether the direct manipulation of psychological variables has an impact 
on patient outcome.  
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Chapter 6: Using RCT Data to Investigate Potential Mediators of Treatment 
Outcome  
Part I: STarT Back trial 
 
6.1 Introduction 
The systematic review outlined in Chapter 4 located only a small number of articles of mediation 
analysis in musculoskeletal (MSK) pain intervention studies across a range of settings. Limitations 
were highlighted with the methods of mediation analysis employed, the psychometric properties 
of the tools used to measure the variables of interest, a lack of theoretical basis and no or limited 
measurement of variables over time. However, the review highlighted the emerging evidence for 
a number of psychological mediators of pain-associated disability outcomes such as pain 
catastrophising and pain self-efficacy. This supports the BeBACK secondary analysis (Chapter 5) 
which demonstrated that changes in several psychological factors were associated with changes 
in disability. The present chapter will explore how specifically targeting some of these 
psychological variables during an intervention might have an impact on outcome within the 
context of a randomised controlled trial (RCT), and thus enable a formal test as to whether these 
variables are mediators of the effect of treatment. 
 
6.1.1 The Stratified Targeted Treatment approach: STarT Back Trial 
The STarT Back trial was an RCT that compared stratified care with current best care in primary 
care patients consulting with low back pain (LBP) (Hill et al 2011). Specifically, the authors 
investigated whether targeting treatment according to levels of risk of a poor outcome 
(prognostic stratification) resulted in greater functional improvements than non-targeted care. 
Allocation to either the treatment or control group was on a 2:1 ratio basis in order to increase 
the number of patients receiving the intervention (Hay et al 2008), using block randomisation. If 
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patients were assigned to stratified care, treatment was matched to the patient’s prognostic 
profiles using a brief prognostic index, the STarT Back tool (Hill et al 2008). This tool consists of 
nine questions relating to eight physical and psychological factors known to be predictors of 
persistent LBP-related disability (Table 6.1). Scores on both the overall tool score and the five-
item psychological subscale score allocated patients to low-, medium- or high-risk targeted 
treatment groups (Table 6.2). Patients allocated to the low-risk group (low complexity) who 
received a score of three or fewer on the tool received a minimal package of evidence-based first-
line care including advice and reassurance that their back problem was not serious and would 
resolve without intervention. Medium-risk patients, who received a score of four or higher on the 
tool but three or fewer on the psychological subscale were referred for standardised “best-
practice” physiotherapy. A score of four or higher on the tool, and four or more on the 
psychological subscale specifically, meant that the patient was psychologically distressed and 
typically more complex to treat, and therefore at higher risk of a poor treatment outcome. These 
high-risk (complex) patients went on to receive psychologically informed physiotherapy (Main et 
al 2012). The high-risk intervention was delivered by physiotherapists who had undergone a series 
of training sessions (six days) focused on skills to help them address psychosocial barriers to 
patient recovery. The psychological factors discussed as part of this training included those 
measured in the STarT Back Tool such as fear-avoidance beliefs, catastrophising thoughts, anxiety 
and depression. Although the high-risk training was based on a cognitive-behavioural framework, 
the training did not constitute full-blown cognitive behaviour therapy (which would have required 
much more intensive training), but aimed to establish psychologically informed practice (PIP), 
where physiotherapists felt confident to address patients’ unhelpful beliefs, emotions and 
behavioural responses to pain (Main et al 2012).  
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Table 6.1 STarT Back Tool items 
 
Item (Where the 
question was taken 
from) 
How Asked How Measured 
 
Referred leg pain 
(Single item) 
My back pain has spread down my leg(s) at some 
time in the last 2 weeks 
 
Disagree = 0; Agree = 1 
Co-morbid pain 
(Single item) 
I have had pain in the shoulder or neck at some 
time in the last 2 weeks 
 
Disagree = 0; Agree = 1 
 
Disability 
(Roland-Morris Disability 
Questionnaire (RMDQ)) 
I have only walked short distances because of my 
back pain 
 
Disagree = 0; Agree = 1 
 
In the last 2 weeks, I have dressed more slowly 
because of my back pain 
 
Disagree = 0; Agree = 1 
 
Catastrophising thoughts 
(Pain Catastrophising 
Scale (PCS)) 
I feel that my back pain is terrible and it’s never 
going to get any better 
 
Disagree = 0; Agree = 1 
 
Fear-avoidance beliefs 
(Tampa Scale for 
Kinesiophobia (TSK)) 
It’s not really safe for a person with a condition 
like mine to be physically active 
 
Disagree = 0; Agree = 1 
Anxiety 
(Hospital Anxiety and 
Depression Scale (HADS)) 
Worrying thoughts have been going through my 
mind a lot of the time 
 
Disagree = 0; Agree = 1 
 
Depression 
(HADS) 
In general I have not enjoyed all the things I used 
to enjoy 
 
Disagree = 0; Agree = 1 
 
Bothersomeness 
(Single item) 
Overall, how bothersome has your back pain 
been in the last 2 weeks? 
Likert scale 1-5 Not at all – 
Extremely (Dichotomised 
to 0 (0-3 on Likert scale) or 
1 (4-5 on Likert scale)) 
 
Shaded items: Psychological subscale 
 
Table 6.2 Scoring system for STarT Back tool 
Score on STarT Back Tool Risk Group Allocation 
≥4/9 & ≥4 on Psychological subscale High 
≥4/9 & ≤3 on Psychological subscale Medium 
≤3/9 Low 
 
At baseline, 851 patients were randomised (568 to intervention and 283 to control), with a mean 
age of 50 years (SD 14.8). Of this population 58.8% were female and 41.2% were male. Pain 
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duration was categorised in the same way as in the BeBACK dataset. In the present study similar 
proportions of patients were in each category at baseline (Less than one month =151 (17.7%), 1-3 
months=190 (22.3%), 4-6 months=123 (14.5%), 7 months-3 years=209 (24.6%), More than 3 
years=178 (20.9%)), suggesting similar numbers of patients would be classified as having acute or 
more persistent pain. For the high-risk group in particular (of interest in this thesis), the 
proportions were similar (Less than one month=22 (15.9%), 1-3 months=28 (20.3%), 4-6 
months=23 (16.7%), 7 months-3 years=30 (21.7%), More than 3 years=35 (25.4%)). Descriptive 
data on the outcome measures and potential mediator variables is provided in Table 6.5 (page 
162). Socio-demographic data were collected to assess baseline similarity across the intervention 
arms. The primary outcome in the STarT Back trial was back pain disability at 12 months 
(measured by the Roland-Morris Disability Questionnaire (RMDQ)), and secondary outcomes 
included catastrophising thoughts, fear-avoidance beliefs, anxiety and depression, health-related 
quality of life, general health (12-item Short-Form Health Survey (SF-12)), perception of change in 
back pain, pain intensity, number of pain-related days off work, satisfaction with treatment, and 
risk reduction using STarT Back subgroup (Hill et al 2011). In the study presented in this chapter, 
two measures of physical function (RMDQ and SF-12 – Physical Component Subscale (SF-12 PCS)) 
were selected as function is the outcome of interest in this thesis. The RMDQ is a measure related 
to back pain disability specifically, while the SF-12 PCS provides a more general measure of 
physical function. As the back pain-specific measure (RMDQ) relates more strongly to the outlined 
conceptual model presented in this chapter, only the results for this outcome will be presented 
here. The results for the SF-12 PCS are given in Appendix 6.1. 
 
Participants allocated to the stratified intervention arm demonstrated a significant improvement 
in function at four- and 12-month follow-up compared to the control group receiving best current 
care. Of these two time-points the greatest differences in disability improvement were at four- 
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month follow-up (see Table 6.5, page 162). Table 6.5 presents the baseline scores and absolute 
change at four-month follow-up for both the intervention and control arms over time with the 
information split by prognostic subgroup. 
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6.1.2 Conceptual model 
The high-risk training given to physiotherapists in the trial, although based on cognitive-
behavioural principles, was not explicitly based on a theoretical model of pain or behaviour 
change. Although there is support for such models in whole or in part (see Chapter 1), it is likely 
that in a heterogeneous primary care population the level of individual patients’ complexity will 
be variable. Even in pre-defined subgroups such as the high-risk group in this trial, where all 
patients scored highly on the brief psychological subscale of the screening tool, it is likely that 
patients vary widely in terms of the complexity and nature of their psychological distress. During 
the training, physiotherapists were taught to recognise psychological obstacles to recovery 
through their conversation with the patient and to deal with them accordingly (Main et al 2012) 
rather than explore and address each of the psychological factors in a systematic way using a 
formal measure. The intervention for high-risk patients was therefore hypothesised to work by 
giving therapists skills to reduce psychological distress through clear communication, reassurance 
and activity promotion, depending on how these factors were manifesting in an individual 
patient’s story and causing the overall level of distress, in order to improve physical function. It 
therefore seemed appropriate to test whether the observed treatment effect was mediated by 
changes in patients’ psychological distress (complexity) rather than by the individual psychological 
factors. 
 
 
6.2 Aim 
To test whether the wider concept of psychological distress (complexity) can be measured using 
the observed psychological variables measured in the STarT Back trial, and whether change in  
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psychological distress was a mediator of the beneficial stratified treatment effects for high-risk 
patients’ disability outcomes observed at four-month follow-up. 
 
6.3 Specific Objectives 
1. To describe change over time (between baseline and four-month follow-up) for the 
functional outcome of interest (RMDQ); 
2. To identify non-psychological variables that may potentially provide an alternative 
explanation for any mediation associations observed; 
3. To assess the internal consistency of each of the psychological measures included in the 
mediation analysis; 
4. To test each psychological distress variable targeted broadly by the intervention to ensure 
they meet the criteria for being a potential mediator; 
5. To conduct mediation analysis to establish whether the latent variable of psychological 
distress is a mediator of disability outcome. 
 
 
6.4 Hypothesis 
Improvements in disability scores of patients in the high-risk subgroup of the STarT Back trial were 
a consequence of change in psychological distress (complexity).  
 
The high-risk group was focused on in this mediation analysis because patients in this subgroup 
received an intervention (psychologically informed physiotherapy) which specifically aimed to 
target psychological distress to reduce disability. The medium- and low-risk subgroups were also  
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subject to the same analysis, in order to allow for comparison across the whole trial population, 
although the results for these groups will only be briefly referred to in this chapter (see Appendix 
6.2 for full details of the mediation models). It was hypothesised that any mediating effect found  
in these groups would be lower than that in the high-risk group, because psychological distress 
was not specifically targeted by treatment in the medium- and low-risk groups. 
 
The final model to be tested is shown below (Figure 6.1). This analysis involves a number of steps 
which are outlined in Section 6.5, beginning with a description of structural equation modelling 
(SEM), the procedure used to carry out the analysis. 
 
Figure 6.1 Final model to be tested 
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6.5 Methodology 
6.5.1 Structural Equation Modelling (SEM) 
Much of the analysis in this chapter relates to structural equation modelling, or SEM. SEM is a 
confirmatory (theory based) approach that allows us to map out diagrammatically the paths 
between observed and unobserved variables, taking into account error variance (Byrne 2010). The 
benefits of using this technique for mediation analysis are set out in Chapter 3, but to summarise:   
 
SEM combines linear regression and factor analysis (Tabachnick & Fidell 2007) which allows the 
inclusion of more than one variable as a measure of a particular construct, and helps account for 
measurement error; it can test more complex mediation models than traditional regression 
techniques; and it can compare different mediation models easily. SEM models comprise two 
parts: a measurement model, examining how the observed variables (psychological variables: in 
this analysis, anxiety, depression, catastrophising thoughts and fear-avoidance beliefs) relate to 
an unobserved (latent) psychological distress factor; and a structural model, examining the 
relationship between the unobserved factors only (Tomarken & Waller 2005). This latter part of 
the model separates SEM from confirmatory factor analysis (CFA), where only the measurement 
model is examined, but it is recommended that both parts of the model are analysed in a two-
step approach (Anderson & Gerbing 1988; Cole & Maxwell 2003) so that each part can be 
assessed separately. In this chapter, SEM was chosen to perform the analysis as it allowed the 
testing of a latent distress variable (psychological distress) which is not possible when using 
standard regression techniques.  
 
SEM can also provide the product of coefficients for the mediating effect with bias-corrected 
bootstrapped 95% confidence intervals (CIs), which is currently seen as an optimal way of  
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performing mediation analysis (see Chapter’s 3 and 4). As explained in Chapter 3, bootstrapping is 
a way of re-sampling the data numerous times to create a new sampling distribution, which 
corrects for the often non-normal distribution of the indirect (mediating) effect. The number of 
bootstrapped samples recommended for performing this analysis is unclear, with papers 
reporting anything from 1,000 to 5,000 samples (e.g. Gaudiano et al 2010; Wicksell et al 2010). In 
this analysis, 1,000 bias-corrected bootstrapped samples were used. 95% CIs have been 
recommended over p values for assessment of the magnitude of the mediating effect (Hayes 
2009). When performing mediation analysis using AMOS software, these CIs can only be 
calculated with complete case data. For this reason, only cases with complete data for all of the 
above variables were used in the analysis. This significantly reduced the number of cases included 
in the analysis (n=138 rather than the 236 patients who were in the high-risk group). Imputation 
was considered but it was not clear how latent variables (which were generated as part of the 
analysis) would be affected by imputation. As a sensitivity analysis, SEM model estimates without 
confidence intervals were generated from an analysis using the full sample (n=236 in the high-risk 
group), which are provided for comparison in Appendix 6.3.  
 
All analyses were conducted using SPSS PASW statistics package version 18 and AMOS (add-on 
statistics package to SPSS) version 19. An overview of all the analyses performed can be seen in 
Figure 6.2.  
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Figure 6.2 Flowchart describing steps of analysis 
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6.5.2 Preliminary analysis (Step 1) 
Prior to conducting the mediation analysis a number of preliminary analyses were required: 
descriptive statistics were presented for the variables to be used in the analysis (Step 1.1 of Figure 
6.2); potential confounding factors were explored (1.2); the measurement properties of the 
included variables were examined (1.3); residualised change scores were created for use in the 
analysis (1.4); and investigations were carried out to test whether the psychological factor of 
interest met the basic requirements for mediation (1.5). 
 
Descriptive statistics (means and standard deviations (SDs)) were calculated for baseline and four-
month follow-up for the outcome and potential mediator variables for each of the three 
prognostic subgroups, and distributions checked for normality. The psychological factors 
emerging as the most promising potential mediators from the BeBack analysis in Chapter 5 were 
self-efficacy, catastrophising thoughts, anxiety and depression. Self-efficacy was not measured in 
STarT Back and therefore could not be included in this analysis. Fear-avoidance was considered to 
be an important prognostic factor and potential mediator by the STarT Back study team, and did 
meet the criteria for mediation in Chapter 5 although the associations were weaker than for the 
other factors mentioned above. Therefore, four of the psychological factors used in the STarT 
Back tool (catastrophising thoughts, fear-avoidance beliefs, anxiety and depression) were 
analysed via factor analysis to see whether they represented a single factor of psychological 
distress which could be used in the mediation model. Full scale reference standard measures of 
these constructs were used, rather than the single items used in the tool. For these four 
constructs, standardised measures were available that were deemed to have sound psychometric 
properties in LBP populations. Details of the outcome and potential mediator variables are 
presented in Table 6.3.  
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Table 6.3 Description of outcome and predictor measures 
  Reference How Scored 
 
Outcome 
measure 
Back specific physical 
function (Roland Morris 
Disability 
Questionnaire - RMDQ) 
Roland & Morris 
(1983) 
Add up number of ‘Yes’ rated 
responses – higher number 
of ‘Yes’ responses indicates 
higher level of disability 
Potential 
mediators 
Catastrophising 
thoughts (Pain 
Catastrophising Scale - 
PCS) 
Sullivan et al (1995) Higher score indicates high 
level of catastrophising  
Fear-avoidance beliefs 
Tampa Scale of 
Kinesiophobia - TSK) 
Kori et al (1990) 4-point Likert scale ‘strongly 
agree-strongly disagree’ - 
Higher scores indicate higher 
fear-avoidance 
Anxiety (Hospital 
Anxiety and Depression 
Scale - HADS) 
Zigmond & Snaith 
(1983) 
Higher score indicates higher 
level of anxiety 
 
Depression (HADS) Zigmond & Snaith 
(1983) 
Higher score indicates higher 
level of depression 
Pain 
intensity 
Least pain 
in last two 
weeks 
- 11-point numeric rating scale 
(NRS) (0 = “no pain” to 10 = 
“pain as bad as could be”) 
Average 
pain in 
last two 
weeks 
- 11-point NRS (0 = “no pain” 
to 10 = “pain as bad as could 
be”) 
Current 
pain 
intensity 
- 11-point NRS (0 = “no pain” 
to 10 = “pain as bad as could 
be”) 
Potential 
confounders 
Age - Actual age of patient 
recorded 
Sex - Coded as 1 (Female) or 2 
(Male) 
Pain Duration (“How 
long since you have 
experienced a whole 
month without back 
pain?” 
- Coded as 1 (less than one 
month), 2 (one-three 
months), 3 (four-six months), 
4 (seven months – three 
years) and 5 (more than 
three years) 
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Many factors are known to have an impact on function, and may provide an alternative 
explanation to any mediating effects of the psychological variables. Although STarT Back is an RCT 
and therefore patients in both groups should be similar at baseline, confounding can still occur in 
the b path of the mediation model (see Chapter 3). Age, sex (Thomas et al 1999) and pain 
duration (Bekkering et al 2005) have all been found to be associated with future outcomes, 
including disability, and may therefore act as confounders when analysing potential mediators 
(e.g. Smeets et al 2006; Kole-Snijders et al 1999; Morlion et al 2011). Although the evidence for 
their effect is mixed, with studies reporting inconsistent results regarding the predictive value of 
these variables, it was decided that they should be tested as possible confounders by analysing 
their relationship with each of the outcome measures (Step 1.2).  
 
Pain intensity is thought to have an important role in patient outcomes (Morley et al 1999), is a 
strong prognostic factor, and often included as an outcome measure in studies of prediction and 
mediation. In the original STarT Back trial (Hill et al 2011), pain intensity was not specifically the 
focus of the high-risk training, but in primary care populations where many patients consult with 
acute pain, pain is a focus of treatment. Pain is strongly linked with psychological factors; the 
biopsychosocial model of pain described in Chapter 1 (Section 1.2) emphasised the 
multidimensional aspects of pain and that psychological factors are closely interlinked with the 
pain experience (e.g. Turk & Okifuji 2002). Pain intensity does therefore need to be examined as a 
potential alternative explanation to any mediating effects of the psychological variables. Pain 
intensity was measured during the STarT Back trial using three separate 11-point numerical rating 
scales which asked about least and average pain over the last two weeks, and pain on the day the 
participant completed the questionnaire. In this analysis the three separate scores of pain 
intensity available in the STarT Back dataset were explored using factor analysis to create a latent 
variable of low back pain. 
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Age, sex and pain duration were all previously identified as potentially being associated with 
outcome, and therefore might be confounders of any mediating effects of psychological distress.  
Pearson’s bivariate correlations, point-biserial correlations and Spearman’s correlations were 
used to examine the relationships between potential confounders and change in each of the 
outcome measures. Different types of correlation analyses were used depending on the different 
type of variable being examined; as age was measured as a numerical variable and was normally 
distributed (see Appendix 6.4) a Pearson’s correlation was appropriate; as sex is a discrete 
dichotomy, a point-biserial correlation was carried out; and as pain duration was measured on a 
categorical scale, a Spearman’s correlation, which is a non-parametric measure, was used to 
analyse this variable. Variables strongly related to residualised change in RMDQ scores were 
included in the mediation analysis as potential confounders. 
 
Step 1.3 of the preliminary analysis involved examining the internal consistency of each of the 
psychological measures that were used to create the latent variable of psychological distress 
(complexity) using Cronbach’s alpha (Cronbach 1951). Internal consistency is one way of assessing 
the unidimensionality of a measure, providing that the tool only represents a single scale and not 
multiple subscales (Field 2009). This is a potential issue with the TSK (fear-avoidance beliefs), the 
factor structure of which has been debated with 2- (Goubert et al 2004; Roelofs et al 2004; 2007) 
and 5-factor (Lundberg et al 2004) solutions being found previously. However, as this measure 
was used as a unidimensional construct in the original STarT Back trial, this is the structure that 
will be tested here. The two subscales of the HADS, representing anxiety and depression, were 
analysed separately. Testing internal consistency within this particular population is important as 
this measurement property is likely to vary somewhat between populations (Streiner 2003). A 
general guideline for interpreting the results of alpha is that a value of 0.70 or above is generally 
acceptable and suggests that the scale has appropriate levels of internal consistency within the  
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population being examined (Field 2009). This analysis was carried out using the whole scale or 
subscale of each measure at baseline in the STarT Back dataset. 
 
Residualised change scores were then calculated for each potential mediator and outcome 
measure between baseline and four-month follow-up (Step 1.4). The rationale and procedure for 
this is described in Chapter 5 (Section 5.6.1). Residualised change scores are commonly used to 
look at mediating factors (e.g. George et al 2008; Skidmore et al 2015) but are more difficult to 
interpret. A sensitivity analysis using raw change scores is therefore provided for comparison with 
the results presented in this chapter (Appendix 6.5). 
 
In order to check whether the four psychological factors met prerequisites for potential 
mediation, the absolute change that occurred between baseline and four-month follow-up was 
calculated and examined (Step 1.5). Linear regression analyses were then performed to 
investigate the relationships between residualised change in each of the identified potential 
mediator variables and residualised change in the outcome measure, and also to investigate the 
relationships between treatment group allocation (treatment or control) with change in each of 
the potential mediators. The three measures of pain intensity were also tested in this way to 
assess their relationships with the disability outcome measure, and investigate whether pain 
intensity could potentially mediate treatment effect.  
 
6.5.3 Pre-mediation analysis (Step 2) 
Structural Equation Modelling (SEM) was used to conduct the mediation analysis on this dataset. 
This type of analysis requires multiple variables or items per factor (latent variable), which allows 
the factor to be measured with greater reliability (Anderson & Gerbing 1988; Stephenson &  
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Holbert 2003). Exploratory factor analysis (EFA) and subsequently confirmatory factor analysis 
(CFA) was conducted with the four potential psychological mediators to see if the different 
measures represented a single ‘psychological distress’ factor (Step 2.1 of Figure 6.2). EFA was also 
conducted on the pain intensity measures to see if they represented a single factor of ‘low back 
pain’. However, as EFA requires at least three measures of a potential latent factor, this analysis 
could not be repeated with the outcome measures (only RMDQ and SF-12 PCS were available as 
measures of physical function/disability). Each outcome was therefore investigated separately 
using observed rather than latent factors (RMDQ presented here; SF-12 PCS in Appendix 6.1). 
 
The aim of exploratory factor analysis (EFA) is to identify the latent constructs that represent a set 
of measured variables (Fabrigar et al 1999). This is the difference between EFA and principal 
components analysis (PCA), for which the primary aim is to reduce the number of measured 
variables to a smaller number of components. In this study, since the objective is to explore 
whether potential mediators that were measured can be represented by a single factor, EFA is 
appropriate. The number of variables (or items) required for each factor is a matter of debate, 
with some authors suggesting six items (Fabrigar et al 1999) and others suggesting at least three 
(DeCoster 1998). The more items that are included, the more precise the EFA will be (Tinsley & 
Tinsley 1987).  
 
Two important considerations when undertaking EFA are the number of cases available for 
analysis and the degree of correlation between the items or scales being analysed. There are a 
number of tests available to examine these; in this analysis, the Kaiser-Meyer-Olkin (KMO) 
statistic (Kaiser 1970, cited in Field 2009) was used to test whether the number of cases was 
adequate for the analysis to be performed, and Bartlett’s test of sphericity tests whether the 
correlations were too low for the analysis to be valid (Field 2009). The KMO statistic produces a  
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value between 0 and 1, with values of 0.70 or above seen as showing an acceptable number of 
cases for analysis (Field 2009), while a statistically significant Bartlett’s test indicates that 
correlations between the items are large enough for the factor analysis to be robust. However,  
Field (2009) acknowledges that the statistical significance of this test is dependent on sample size, 
so the correlation matrices should be checked by eye for any correlations being too small or very 
high. He also acknowledges the subjectivity of checking the size of correlations, and points out 
that although there are some guidelines relating to coefficients that are too small or too large, 
such values will be dependent on sample size and other properties unique to the dataset being 
analysed. This emphasises the importance of ensuring that the data used for EFA is sufficiently 
robust for this type of analysis.  
 
There are several different procedures that can be used to fit an EFA model. Although all 
procedures will produce similar results, Maximum Likelihood (ML) provides the most information 
relating to inferential statistics such as model fit indices and confidence intervals (Fabrigar et al 
1999) and is the recommended extraction method (Costello & Osborne 2005). ML has therefore 
been chosen for this particular analysis. 
 
When an EFA is undertaken, several different tests can be used to determine the number of 
factors to extract (Fabrigar et al 1999), which include the estimation of eigenvalues (a measure of 
the explained variance of a factor (Kahn 2006)), where values above 1 are generally extracted, 
and Cattell’s scree plot, in which the eigenvalues are plotted onto a graph in descending order. 
The point where the graph levels out is judged to be attributable to error, while any factors 
plotted before that point are judged to be factors (Tinsley & Tinsley 1987). Both these measures 
are widely used and accepted, and considering both tests together may provide a better solution 
than relying on one test (Tinsley & Tinsley 1987). A further test which may provide a more  
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accurate result is parallel analysis (Velicer & Jackson 1990, cited in Costello & Osborne 2005; Kahn 
2006), in which a combination of both eigenvalues and the scree plot from a random dataset with 
the same number of items and cases are plotted (Russell 2002) and compared with those 
generated from the real data (Schmitt 2011). Parallel analysis is recommended as the best 
method to use (Schmitt 2011), however it is for use on item-level data which were not used in this 
analysis (see below for further detail). In the present analysis therefore, the eigenvalues and scree 
plot were used to judge the results of the analysis. 
 
Finally, factor solutions must often be rotated to try and make sense of the factors identified. 
There are a number of different methods of factor rotation available, depending on the data 
being analysed. Orthogonal rotation methods assume that any generated factors are 
uncorrelated, while oblique methods allow correlated factors to be used (Fabrigar et al 1999). 
Oblique methods of rotation are likely to provide more realistic solutions and estimate 
correlations among factors, which can aid interpretation (Fabrigar et al 1999) and are most often 
recommended for use with psychological and social science data (Schmitt 2011; Gaskin & Happell 
2014). In fact some have argued that orthogonal methods should never be used when analysing 
psychological data (Field 2009). When using large data sets, the values computed using the 
various methods are almost identical and so comparisons between results of studies using 
different rotational methods are only marginally affected by the type of rotation. There are 
several methods of oblique rotation available, which have been reported to produce similar 
results (Fabrigar et al 1999). In this analysis, oblique rotation using direct oblimin was preferred, 
as this has been reported to be an appropriate rotation method for psychological variables 
showing correlation (Conway & Huffcut 2003).   
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EFA was firstly conducted on the STarT Back dataset as a whole, and then repeated using 50% of 
cases that were randomly selected from the STarT Back dataset. Residualised change scores for 
catastrophising thoughts (PCS), fear-avoidance beliefs (TSK) and anxiety and depression (HADS) 
were entered. The residualised change scores were used instead of full baseline measures 
because the full SEM models were used to test whether change in psychological distress was 
related to change in outcome. The final analysis involved a CFA which was performed on the 
remaining 50% of the dataset not used in the EFA. This analysis was repeated to create a latent 
variable for low back pain, using residualised change in the three measures of pain intensity used 
in the STarT Back trial (least pain in last two weeks, average pain in last two weeks and current 
pain). 
 
CFA is used to test a hypothesised model between observed and latent variables (Byrne 2010). 
CFA forms the measurement model of SEM. Unlike in EFA, the number of factors is pre-
determined based on theory and/or previous research. EFA and CFA are often used together, with 
EFA being conducted on one dataset and CFA being used on another, in order to verify the 
structure created in EFA (Fabrigar et al 1999). Alternatively, a dataset can be randomly split to 
allow an EFA to be performed on one half, and a CFA to be performed on the other. The statistical 
package AMOS allows a hypothesised model such as that shown in Figure 6.3 to be tested. The 
hypothesised latent variable is represented by a circle, the measured variables are represented by 
rectangles, and error is also accounted for in the model (represented by circles). Unidirectional 
arrows represent the hypothesised effect of one variable on another, as causality cannot be 
determined using this type of analysis. 
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Figure 6.3 Example of CFA modelling in AMOS 
 
 
 
 
 
 
 
In SEM, the software will only test paths where they are specifically added to the model. If no 
path between particular variables is present, then it assumes there is no relationship between the 
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may also mean that the two latent variables are representing the same factor, and would be 
better represented as a single, overall latent variable. It was therefore important to test whether 
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6.5.4 Mediation analysis (Step 3) 
SEM, as outlined in Section 6.5.1, allows the relationships between observed and latent variables 
to be analysed. The CFA carried out as part of the pre-mediation analysis makes up the 
measurement model in SEM. Full SEM involves testing the relationships between the 
measurement model(s) and other variables of interest, which together make up the structural 
model (Step 3.1). 
 
The output from SEM provides several goodness-of-fit indices that can be used to assess how well 
the proposed model fits the available data. The most common of these is the Chi-square (X
2
 
(CMIN)) statistic, which tests whether the proposed model exactly fits the data tested (Tomarken 
& Waller 2003). However, this test is seen as overly strict in testing for exact fit and it is also 
affected by sample size, with large samples often resulting in ‘bad’ fit (Tomarken & Waller 2003). 
It also gives less information about how well the model fits the data compared with other indices 
(Holbert & Stephenson 2002; Tomarken & Waller 2003). Dividing the X
2
 value by the degrees of 
freedom in the model (CMIN/df) is suggested as a way to reduce the dependence of the X
2
 on 
sample size (Truchon et al 2008). A number of alternative indices have also been proposed, 
including the goodness of fit index (GFI), normed fit index (NFI), comparative fit index (CFI), root 
mean squared error of approximation (RMSEA) and standardised root mean squared residual 
(SRMR). The GFI and NFI have been dismissed by some as poor indices (Hu & Bentler 1998; Hu & 
Bentler 1999) because of issues related to sample size and insensitivity (MacCullum & Austin 
2000). A number of different indices are necessary to report as each has different strengths and 
weaknesses, and the use of several complementary statistics is recommended (Bentler 2007; 
Byrne 2010). For example, SRMR and RMSEA are recommended with samples over 250 and SRMR 
in combination with any of the other indices are recommended for use with smaller samples  
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(Holbert & Stephenson 2002). The RMSEA in particular gives more information about model fit by 
providing confidence intervals around the value. It also provides a p value for the model’s 
closeness of fit (PCLOSE).The suggested cut-offs for each of the indices that will be used in the 
present analyses are given in Table 6.4 below. 
 
Table 6.4 Goodness-of-fit statistics for SEM and their cut-off values 
Index Description Additional Values 
to Include 
Indication of Good 
Model Fit 
 
X
2
 (Chi Square) The likelihood of the 
specified model being 
true 
X
2
/df (CMIN) X
2
 = p<0.05 
X
2
/df = between 2-5 
CFI (Comparative Fit 
Index) 
Comparison of X
2 
values 
of specified and null 
models 
None >0.95 = adequate fit 
RMSEA (Root Mean 
Square Error of 
Approximation) 
Measure of the degree 
of misfit in the proposed 
model (Chen et al 2008) 
PCLOSE, CIs <0.05 = good fit 
<0.08 = acceptable fit 
(Byrne et al 2008) 
SRMR (Standardised Root 
Mean Square Residual) 
Absolute measure of fit 
– standardised 
difference between the 
observed and predicted 
correlations 
None <0.08 = acceptable fit 
 
Several authors have advised caution when examining the fit statistics, as they have no empirical 
basis (McDonald & Ho 2002), with some authors going as far as to say their use is meaningless 
(Barrett 2007). There is no way of choosing which fit statistic is ‘superior’ and therefore it is 
difficult to make a decision if one index suggests good fit and others do not (McDonald & Ho 
2002). Others have noted that goodness-of-fit indices may relate to the measurement model 
rather than the structural model, meaning that the indices might be misrepresentative (O’Boyle & 
Williams 2011). Therefore, these indices must be interpreted with caution and seen as a guide to 
model fit, rather than giving an objective conclusion. 
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SEMs were generated for each of the risk strata in the STarT Back trial (low, medium and high) 
with both treatment and control cases being included within the model. The outcomes of back 
pain-specific and general physical function were each represented by a single measure, as no 
other variables measuring these constructs were available in the dataset. It was therefore  
assumed that the observed variable provided a perfect measure of the construct (Schumacker & 
Lomax 2010). Models are presented for each outcome separately (SF-12 PCS in Appendix 6.1). 
 
6.6 Results  
6.6.1 Preliminary analysis 
Table 6.5 contains the mean scores at baseline and mean change at four-month follow-up for all 
of the potential mediator variables. There was a difference between the amounts of change in 
potential mediators observed in the treatment groups at four-month follow-up compared to the 
control group. These differences in change were most marked in the high-risk group, where 
scores were higher at baseline, with a 4.4 point difference in change being observed between 
treatment and control for catastrophising thoughts and a 5.8 point difference in change for fear-
avoidance beliefs. Anxiety, depression and the three pain measures showed less substantial 
differences. The SDs for all mediators were quite large, suggesting large variability in change 
within the high-risk group.  
 
As all further analysis is based on parametric tests that assume that the data are normally 
distributed, it is important that this assumption is tested. Kurtosis and skewness values were 
therefore examined, along with histograms and normal probability plots (see Appendix 6.6). 
Analyses were conducted on baseline and four-month follow-up scores, but also on the 
residualised change scores as these were used in the majority of the analysis. For the treatment  
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arm in the high-risk group, skewness values were between 0.02 and -0.95, and kurtosis values 
were between -0.08 and 1.46. In the control group, skewness values ranged from -1.18 to 1.02, 
and kurtosis values ranged from -1.11 to 1.84. These values suggest that there is some deviation 
from normality in some of the variables to be used for analysis. Inspection of the histograms and 
probability plots confirmed the non-normality of some of the variables, although the probability 
plots do not show such a strong departure. These tests indicate that the findings presented here 
may not be generalisable to other populations as the estimates produced in the regression and 
SEM models that follow in this chapter may not be robust (Field 2009).
Chapter 6 STarT Back Analysis Page 165 
 
Table 6.5 Baseline means and SDs and mean change at four-month follow-up for potential mediator variables in the STarT Back dataset 
 Baseline Score (Mean and SD) 
 
Four-month follow-up (Mean change and SD) 
Treatment (n=370) 
 
Control (n=179) Treatment (n=370) Control (n=179) 
L  
(n=100) 
M 
 (n=177) 
H  
(n=93) 
L  
(n=50) 
M 
(n=84) 
H  
(n=45) 
L 
(n=100) 
M 
(n=177) 
H 
(n=93) 
L 
(n=50) 
M 
(n=84) 
H 
(n=45) 
Outcome 
Disability 4.08 
(3.20) 
9.93 
(4.65) 
14.41 
(4.31) 
3.96 
(3.60) 
9.75 
(4.66) 
14.07 
(4.88) 
1.52 
(3.21) 
5.23 
(5.67) 
7.49 
(6.48) 
0.80 
(4.04) 
3.98 
(4.80) 
3.62 
(4.38) 
Potential Mediators 
Catastrophising 
thoughts 
7.89 
(5.31) 
14.79 
(8.00) 
25.24 
(10.49) 
7.28 
(5.48) 
12.82 
(8.22) 
25.88 
(10.54) 
2.83 
(5.93) 
6.09 
(8.05) 
11.07 
(12.95) 
0.84 
(8.01) 
4.37 
(8.42) 
6.64 
(10.26) 
Fear-avoidance beliefs 36.07 
(4.70) 
39.25 
(4.63) 
46.21 
(5.17) 
35.96 
(5.98) 
39.72 
(4.58) 
45.52 
(5.85) 
3.47 
(5.63) 
5.07 
(6.15) 
9.24 
(7.56) 
3.00 
(6.23) 
3.22 
(4.13) 
3.40 
(4.68) 
Anxiety 4.93 
(2.93) 
6.85 
(3.58) 
10.01 
(4.39) 
5.56 
(3.63) 
7.10 
(3.77) 
10.31 
(3.59) 
0.61 
(2.50) 
1.77 
(3.20) 
3.39 
(4.10) 
1.28 
(3.03) 
0.72 
(3.09) 
2.49 
(3.95) 
Depression 3.06 
(2.71) 
5.44 
(3.19) 
8.77 
(4.34) 
2.86 
(2.57) 
5.60 
(3.84) 
8.40 
(3.70) 
0.52 
(2.19) 
1.81 
(3.32) 
3.55 
(4.05) 
0.14 
(2.75) 
1.16 
(3.31) 
1.69 
(3.55) 
Pain 
Intensity 
Least 2.44 
(1.83) 
4.25 
(2.48) 
6.16 
(2.58) 
2.46 
(1.85) 
4.04 
(2.61) 
5.96 
(3.25) 
0.76 
(2.01) 
1.89 
(2.88) 
2.98 
(2.87) 
0.48 
(2.10) 
1.56 
(2.49) 
1.76 
(3.19) 
Average 4.45 
(2.08) 
6.99 
(2.05) 
7.72 
(2.12) 
4.62 
(2.36) 
6.82 
(2.06) 
8.18 
(1.80) 
1.64 
(2.81) 
3.36 
(3.15) 
3.90 
(3.24) 
1.50 
(2.38) 
2.82 
(3.09) 
2.56 
(2.62) 
Current 2.98 
(2.05) 
4.95 
(2.41) 
6.40 
(2.33) 
2.98 
(2.10) 
4.48 
(2.43) 
6.51 
(2.64) 
1.30 
(2.25) 
2.40 
(2.95) 
3.00 
(2.88) 
0.80 
(2.45) 
1.44 
(2.75) 
1.62 
(3.00) 
L=Low-risk; M-Medium-risk; H=High-risk
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The next stage of the analysis was to investigate whether age, gender, and pain duration could be 
potential confounders of the results of the mediation analysis. Pearson’s correlations were 
conducted with baseline values of age, point bi-serial correlations with sex and Spearman’s 
correlations with pain duration and residualised change in low back pain disability (RMDQ) and 
general physical function (SF-12 PCS). The results in Table 6.6 show that age and sex had very 
weak relationships with each outcome measure in that the correlation coefficients were below 
0.50 and not statistically significant for either treatment arm or any risk group. For pain duration, 
the coefficients were generally higher (longer pain duration was associated with increased 
disability), especially in the high-risk group, and some of these coefficients were statistically 
significant, but were small in magnitude. Given these findings it was decided not to include these 
potential confounders in the subsequent mediation analysis. 
 
Table 6.6 Correlation coefficients for the association of potential confounding variables with 
change in RMDQ and SF-12 PCS 
Outcome Variable Treatment 
Allocation 
Four-month follow-up 
 
Low-risk group Medium-risk 
group 
High-risk group 
 
RMDQ
∆
 Age Treatment -0.01 0.11 0.08 
Sex 0.11 -0.09 -0.02 
Pain 
duration 
0.06 0.19 0.33** 
Age Control -0.05 0.01 -0.00 
Sex -0.00 -0.17 0.22 
Pain 
duration 
0.04 0.28* 0.37* 
p<0.05; **p<0.01, 
∆
residualised change 
 
The test of Cronbach’s alpha for each included measure, carried out on the entire dataset rather 
than just the high-risk group, showed that each measure met the criteria for internal consistency 
(Cronbach’s alpha of 0.70 or above), suggesting that they are appropriate for use in the SEM  
Chapter 6 STarT Back Analysis Page 167 
 
analysis. Table 6.7 below gives the alpha value for each measure. These values are similar to those 
calculated in other LBP populations (e.g. 0.84 for the 17-item TSK (French et al 2007 – secondary 
care population); 0.70 for the Dutch version of the 17-item TSK (Swinkels-Meewisse et al 2003 – 
primary care population); 0.92 for the PCS (Osman et al 2000 – chronic pain outpatient 
population)). 
 
Table 6.7 Cronbach’s alpha values for each psychological measure 
Measure Number of cases analysis 
based on 
Cronbach’s alpha 
value 
 
Pain Catastrophising Scale (PCS) 839 0.94 
Tampa Scale of Kinesiophobia (TSK) 819 0.73 
Hospital Anxiety and Depression Scale – 
Depression (HADS-D) 
851 0.85 
Hospital Anxiety and Depression Scale – 
Anxiety (HADS-A) 
850 0.82 
 
 
After calculating residualised change scores, linear regression analyses for all of the potential 
mediator variables with both of the outcome measures were performed (Table 6.8; results for the 
SF-12 PCS presented in Appendix 6.1). The results indicated that in the high-risk treatment group, 
residualised change in the psychological variables strongly predicted residualised change in RMDQ 
and accounted for between 25% and 39% of the variance in this outcome. However, residualised 
change in the pain variables included for comparison with the psychological variables were shown 
to be stronger predictors; they accounted for between 51% and 63% of the variance of 
residualised change in RMDQ. In the control group, all potential mediators also accounted for a 
large amount of variance of residualised change in RMDQ. This shows support for the 
psychological factors as well as the pain variables to potentially mediate treatment outcome, as 
these variables do show change over time and are associated with outcome (b path), especially in 
the high-risk subgroup.
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Table 6.8 Univariable associations of changes in each potential mediator with change in functional 
outcomes in STarT Back participants: Linear regression analyses – High-risk group 
Outcome Predictor Treatment 
Allocation 
Change at four-month follow-up 
Unstandardised 
B (SE) 
95% CI Standardised 
β  
R-square 
change 
RMDQ
∆
 Catastrophising 
thoughts
∆
 
Treatment 
(n=93) 
0.49 (0.09) 0.31 to 0.67 0.50 0.25 
Fear-avoidance 
beliefs
∆
 
0.57 (0.09) 0.40 to 0.74 0.57 0.33 
Anxiety
∆
 0.59 (0.09) 0.40 to 0.77 0.56 0.31 
Depression
∆
 0.66 (0.09) 0.48 to 0.83 0.62 0.39 
Least pain
∆
 0.77 (0.08) 0.62 to 0.93 0.72 0.51 
Average pain
∆
 0.77 (0.07) 0.63 to 0.91 0.74 0.55 
Current pain
∆
 0.84 (0.07) 0.71 to 0.98 0.80 0.63 
Catastrophising 
thoughts
∆
 
Control 
(n=45) 
0.58 (0.11) 0.37 to 0.80 0.64 0.41 
Fear-avoidance 
beliefs
∆
 
0.73 (0.12) 0.05 to 0.97 0.67 0.45 
Anxiety
∆
 0.46 (0.10) 0.27 to 0.65 0.59 0.35 
Depression
∆
 0.58 (0.09) 0.40 to 0.75 0.71 0.50 
Least pain
∆
 0.45 (0.10) 0.26 to 0.65 0.59 0.34 
Average pain
∆
 0.50 (0.11) 0.28 to 0.72 0.57 0.32 
Current pain
∆
 0.47 (0.10) 0.27 to 0.68 0.58 0.34 
∆
Residualised change scores 
 
Finally, it was important to also test the a path, or the relationship between treatment allocation 
and each of the potential mediators. If the treatment had little effect on the potential mediating 
variables then the variables are unlikely to be the mechanism through which the treatment was 
successful. Linear regression analyses were performed with treatment allocation as the predictor 
variable and residualised change in each of the potential mediators as outcome variables. The 
results in Table 6.9 show that a small proportion of variance (between 2 and 12%) of residualised 
change is explained by treatment allocation (stratified care versus control) for each of the 
potential mediators. For residualised change in anxiety in particular, the beta value is very small 
and the association is not statistically significant, as indicated by the 95% CI. The standardised 
beta values indicate that treatment allocation has the strongest association with residualised 
change in fear-avoidance beliefs. 
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Table 6.9 Univariable associations of change in treatment allocation with change in each potential 
mediator: Linear regression analyses - High-risk group 
Outcome Predictor Unstandardised 
B (SE) 
 
95% CI Standardised 
β  
R-square 
change 
Catastrophising 
thoughts
∆
 
Treatment 
Allocation 
0.41 (0.18) 0.06 to 
0.76 
0.19 0.04 
Fear-avoidance 
beliefs
∆
 
Treatment 
Allocation 
0.72 (0.17) 0.39 to 
1.06 
0.34 0.12 
Anxiety
∆
 Treatment 
Allocation 
0.28 (0.18) -0.08 to 
0.63 
0.13 0.02 
Depression
∆
 Treatment 
Allocation 
0.47 (0.18) 0.12 to 
0.82 
0.22 0.05 
Least pain
∆
 Treatment 
Allocation 
0.44 (0.18) 0.08 to 
0.79 
0.21 0.04 
Average pain
∆
 Treatment 
Allocation 
0.58 (0.18) 0.23 to 
0.92 
0.27 0.07 
Current pain
∆
 Treatment 
Allocation 
0.52 (0.18) 0.17 to 
0.87 
0.25 0.06 
∆
=residualised change 
 
In summary, these preliminary analyses show support for the hypothetical model, in that the four 
psychological variables to be included in the mediation model (catastrophising thoughts, fear-
avoidance beliefs, anxiety and depression) changed significantly between baseline and follow-up 
and that residualised change in each of these measures is predictive of residualised change in 
disability in those receiving the intervention. Treatment allocation was also found to be predictive 
of residualised change in all of the potential mediator variables, with the exception of anxiety. All 
of these measures were also found to be internally consistent for the STarT Back population. 
Baseline measures of non-psychological variables (age, sex and pain duration) were found not to 
be strongly related to residualised change in either functional outcome measure, suggesting that 
they were unlikely to confound the results of the mediation analysis. These variables were 
therefore excluded from subsequent analyses. However, the measures of pain intensity did 
change over time and residualised change in each pain measure was predictive of residualised 
change in both outcome measures, indicating that these measures may potentially help explain  
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change in outcome. These variables were therefore taken forward as planned as an alternative 
mediating pathway of the relationship between treatment allocation and residualised change in 
functional outcome. 
 
6.6.2 Pre-mediation analysis: Exploratory factor analysis of latent mediator variables 
591 cases were included when the whole dataset was analysed, which is adequate for EFA. This 
was verified by the KMO statistic, which gave a value of 0.766. Bartlett’s test of sphericity 
indicated that the correlations between the scores were also high enough for EFA to be 
performed (X
2
(6) = 698.10, p<0.05) (see Section 6.5.4 for an explanation of these tests). 
 
For the psychological measures, one factor was extracted, confirmed by the scree plot (Figure 
6.4), and accounted for 50% of the variance. The factor matrix shown below (Table 6.10a) 
indicates that all measures included in the analysis have strong factor loadings of well above 0.30 
(a usual minimum requirement for retention (Field 2009)) with the extracted factor. 
 
Table 6.10a Factor matrix (EFA) for the psychological distress latent variable: Entire STarT Back 
population (n=591) 
Measure Factor loading 
Residualised change in depression (HADS-D) 0.82 
Residualised change in anxiety (HADS-A) 0.73 
Residualised change in catastrophising thoughts (PCS) 0.63 
Residualised change in fear-avoidance beliefs (TSK) 0.62 
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Figure 6.4 Scree plot (EFA) for the psychological distress latent variable: Entire STarT Back 
population 
 
 
In order to perform a CFA of the generated models, the STarT Back dataset was split into two 
randomly selected halves using the ‘Select Cases’ function in SPSS. The software package selected 
394 cases for the EFA. The KMO statistic of 0.753 suggested that this was adequate for EFA to be 
performed. Bartlett’s test also indicated that correlations between variables were high (X
2
(6) = 
474.57, p<0.05). Extracting one factor from this half of the dataset explained 50% of the variance. 
This was confirmed by the scree plot (Figure 6.5), and the factor loadings were similar to those 
generated for the whole dataset (Table 6.10b). 
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Table 6.10b Factor matrix (EFA) for the psychological distress latent variable: Randomly selected 
50% of STarT Back population (n=394) 
Measure Factor loading 
Residualised change in depression (HADS-D) 0.85 
Residualised change in anxiety (HADS-A) 0.75 
Residualised change in fear-avoidance beliefs (TSK) 0.61 
Residualised change in catastrophising thoughts (PCS) 0.58 
 
 
Figure 6.5 Scree plot (EFA) for the psychological distress latent variable: Randomly selected 50% 
of the STarT Back population 
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e1 
For the CFA, a model was generated with a single factor, labelled “Psychological distress” (Figure 
6.6). The model fit statistics for the CFA are given below, all of which matched the criteria for 
adequate to good model fit with the exception of the CMIN/DF, so it was felt that overall the 
model provided an adequate fit to the data (Table 6.11). The results of the EFAs in both the full 
and random half of the dataset, as well as the CFA suggest that it was appropriate to use a single 
psychological distress factor to represent the four potential psychological mediators. 
 
Table 6.11 Model fit statistics for CFA of the psychological distress factor 
Model Index Current Model (CIs) Good Model Fit 
 
CMIN* 1.14 Non-significant result 
DF 2 
P .57 
CMIN/DF 0.57 Between 2-5 
CFI 1.0 >0.95 
RMSEA 0.00 (0.00-0.14) (PCLOSE 0.67) <0.08 
SRMR 0.01 <0.08 
 
 
Figure 6.6 CFA of psychological distress as a latent variable 
 
 
 
 
 
 
 
 
 
 
Psychological 
distress
Δ
 
0.74 
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∆
 e2 
0.84 
Catastrophising thoughts
∆
 
0.92 
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∆
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The analysis was then repeated to create a latent variable of “Low back pain”. In this analysis, the 
software package selected 588 cases for analysis. This was verified as appropriate by the KMO 
statistic (0.746) and Bartlett’s test of sphericity was also significant, indicating that the 
correlations between each scale were adequate (X
2
(3) = 1038.707, p<0.05). The factor analysis 
showed that the three measures explain 74% of the variance for the generated factor (confirmed 
by the scree plot (Figure 6.7)), and the strong correlations in Table 6.12 below indicate that the 
three measures represent the extracted factor well. 
 
Table 6.12 Factor matrix (EFA) for the low back pain latent variable: One-factor extraction model, 
entire STarT Back population (n=588) 
Measure Factor loading 
Residualised change in Average Pain 0.90 
Residualised change in Current pain 0.84 
Residualised change in Least pain 0.84 
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Figure 6.7 Scree plot (EFA) for the low back pain intensity latent variable: One -factor extraction, 
entire STarT Back population 
 
 
The two latent variables were then both included in a CFA model to test for co-variance between 
them. The model created in AMOS below (Figure 6.8) indicated a high correlation of 0.70 between 
the latent variables of low back pain and psychological distress. The model fit statistics (Table 
6.13) do not clearly indicate whether this model is a good fit to the data. The CMIN/DF, CFI and 
SRMR values all indicate good or adequate model fit, while the RMSEA and X
2
 (CMIN) do not. As 
noted above, the goodness-of-fit values and the judgement made based upon them is subjective. 
As the majority of the fit indices indicated good fit, the judgement here was that the model 
provides an adequate fit to the data. 
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Figure 6.8 CFA of co-variation between psychological distress and low back pain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.13 Model fit statistics for the relationship between the latent variables of psychological 
distress and low back pain 
Model Index Current Model Good Model Fit 
CMIN* 41.81 Non-significant result 
DF 13 
P 0.00 
CMIN/DF 3.22 Between 2-5 
CFI 0.96 >0.95 
RMSEA 0.13 (0.09 to 0.17), PCLOSE 
0.00 
<0.08 
SRMR 0.06 <0.08 
 
e6
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Because of the strong relationship between the latent variables, an EFA was performed to see 
whether the observed pain measures were also represented by the psychological distress factor. 
The EFA was carried out on the whole STarT Back dataset, using the ML method and direct 
oblimin rotation. 561 cases were included in the analysis. The adequacy of this was verified by the 
KMO statistic (0.85). Bartlett’s test of sphericity indicated that the correlations between the 
scores were high enough for the analysis to be conducted (X
2
(21) = 1953.78, p<0.01). No set 
number of factors was requested for extraction from this dataset. The analysis extracted two 
factors, which together explained 61% of the variance. The rotated pattern matrix (Table 6.14) 
clearly indicates two separate factors, with the pain measures separate from the original 
measures of psychological distress. This analysis demonstrated that despite the high correlation 
between the latent variables, the observed measures of low back pain are still distinct from the 
measures used for psychological distress and were therefore treated as two separate factors in 
the mediation analysis. 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 6 STarT Back Analysis Page 178 
 
Table 6.14 Factor matrix (EFA) including measures of pain as well as psychological distress: Direct 
oblimin rotation 
Measure Factor loadings 
Factor 1 Factor 2 
Residualised change in Average pain 0.92  
Residualised change in Least pain 0.84  
Residualised change in Current pain 0.80  
Residualised change in Depression (HADS-D)  0.84 
Residualised change in Anxiety (HADS-A)  0.79 
Residualised change in Fear-avoidance beliefs (TSK) 0.12 0.50 
Residualised change in Catastrophising thoughts (PCS) 0.23 0.49 
 
This pre-mediation analysis showed that each of the four psychological variables that were found 
to meet the criteria for being potential mediators all loaded onto a single psychological distress 
factor in an EFA analysis, which was confirmed by a CFA analysis on a randomly selected half of 
the STarT Back dataset. This supports the hypothesis underlying the STarT Back intervention that 
psychological variables may represent facets of an overall measure of psychological distress. The 
three measures of pain were found to represent a single latent factor of low back pain. Although 
the latent variables of psychological distress and low back pain were found to be highly 
correlated, when an EFA was performed on all of the measures together the pain measures 
loaded onto a separate factor from the psychological distress measures. This suggests that 
although the factors are related, they are measuring different constructs. In the mediation 
analysis therefore, an arrow to represent co-variation between the two latent variables was 
included in the SEM models. 
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6.6.3 Mediation analysis 
The mediation model with residualised change in disability (RMDQ) as an outcome is shown 
below (Figure 6.9) for the high-risk group. The statistics of model fit (Table 6.15b) suggests that 
this model, with co-variation between the two latent variables, provides adequate fit to the data 
although the RMSEA and X
2
 indicate inadequate fit. When a binary variable is included in the 
model (in this case, treatment allocation), the value between this variable and the next variable in 
the pathway is denoted as an average treatment effect, or the effectiveness of treatment 
compared to outcome (Emsley et al 2010) (if control is allocated a value of 0 and treatment a 
value of 1, as is the case here). For example, in Figure 6.9, change in psychological distress at four-
month follow-up is 0.27 standardised units higher for the intervention arm than for the control 
arm, suggesting that more change occurred in the mediator variable in the treatment group than 
in the control group. The effects of the model (see Table 6.15a) show that the total effect of the 
model is 0.30. As described in Chapter 1, this total effect can be broken down into the direct and 
indirect effects, with the direct effect being the effect of treatment on outcome and the indirect 
effect being the effect of treatment on outcome through the mediating pathway. The direct effect 
of treatment on outcome appears to show only a small, non-significant treatment effect of 0.05, 
because once the mediator variables (combined for psychological distress and low back pain) 
were added to the model the pathways of these variables explained a considerable proportion of 
the treatment effect; a statistically significant indirect (mediating) effect of change in the latent 
variables was found for the relationship between treatment allocation and change in disability 
(standardised indirect effect 0.25, bootstrapped 95% CI 0.09 to 0.39).  
 
The values for each path in the model indicated that both change in psychological distress and 
change in low back pain have strong, significant relationships with change in disability, and a 
weaker but similar relationship was found between treatment allocation and change in the  
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psychological mediators. The standardised beta values for the association of the back pain latent 
variable with outcome are larger than for the psychological distress variable, suggesting that pain 
intensity explains more of the treatment effect than the psychological factors.  
 
Figure 6.9 Full SEM model for mediating effect of changes in psychological distress and pain 
intensity on change in disability: High-risk group 
 
 
 
 
 
 
 
 
∆
residualised change 
*p<0.05 
**p<0.01 
 
All values are standardised 
 
 
Table 6.15a Total, direct and indirect effects of the mediation model on change in disability for 
high-risk patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% 
CI) 
RMDQ
∆
 Total (ć) 0.30 (0.14 to 0.43) 0.63 (0.29 to 0.94) 
Direct (c) 0.05 (-0.05 to 0.16) 0.11 (-0.11 to 0.33) 
Indirect (ab) 0.25 (0.09 to 0.39) 0.52 (0.19 to 0.85) 
∆
residualised change 
 
 
Back Pain-specific 
Disability
∆ 
 
 
Treatment 
(Intervention/Control) 
0.05 
c 
Low back 
pain
∆
 
Psychological 
distress
∆
 
a 
b 
ć 
0.27* 0.40** 
0.27* 0.50** 
0.30 
0.68** 
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Table 6.15b Model fit statistics for mediation model of change in disability for high-risk patients 
Model Index Model Good Model Fit 
 
CMIN* 54.36 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.36 Between 2-5 
CFI 0.96 >0.95 
RMSEA 0.10 (0.07 to 0.13), PCLOSE .01 <0.08 
SRMR 0.05 <0.08 
 
Appendix 6.3 provides a comparison of the model presented in Figure 6.9 above (complete case 
analysis) and an analysis using all available data. This analysis used Full Information Maximum 
Likelihood (FIML), which is a missing data procedure that enables the use of all available data in 
the dataset to estimate values to be used in the analysis.  This sensitivity analysis resulted in much 
weaker coefficients on the a and c paths than when complete case data only was used, and a very 
small total effect was found. Subsequent non-response bias to investigate this (Appendix 6.7) 
suggested that there were differences between responders and non-responders at four-month 
follow-up in terms of age (responders were older), baseline values of the outcome measure 
(responders were less disabled) and baseline scores on the psychological measures (responders 
were less fear-avoidant, catastrophised less and were less depressed). These differences suggest 
attrition bias in the complete case data sample, which is likely to affect the results. However, the 
FIML analysis assumes data are missing at random, and the estimates presented in Appendix 6.3 
may still therefore contain bias.  
 
Appendix 6.5 provides the mediation analysis using raw change scores, rather than the 
residualised change scores presented above. This is because raw change scores are more intuitive 
than residualised change, which give much smaller values for analysis. The analysis of raw change 
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showed that the coefficients are similar, and while the effects do differ in terms of the values 
provided the interpretation of them is the same. 
 
When using general physical function (SF-12 PCS) as the outcome the indirect effects indicated a 
weaker but statistically significant mediating effect of change in psychological distress and low 
back pain on change in outcome (standardised indirect effect -0.21, 95% CI -0.34 to -0.08), and 
here as well, the association between change in pain with change in function appeared to be 
stronger than for change in psychological distress. The model fit statistics were similar to those for 
low back pain-specific disability change, suggesting that overall the model provided an adequate 
fit to the data (see Appendix 6.1). 
 
The models for the medium- and low-risk groups supported the hypothesis that less variance 
would be explained by the latent variables in these groups, and the associations were generally 
weaker along each pathway compared to the high-risk models. As hypothesised the associations 
were weakest in the low-risk subgroup, as this group had the lowest scores on the psychological 
factors in the STarT Back tool and the targeted low-risk intervention was not designed to 
specifically address psychological distress (Appendix 6.2). 
 
 
6.7 Discussion 
6.7.1 Summary 
The STarT Back trial was originally designed to test whether a model of stratified care consisting of 
targeted treatment matched to prognostic subgroups would lead to improved patient outcomes 
such as self-reported disability compared to best current primary care for back pain. The aim of 
the secondary analysis in the present study was to test the hypothesis that the observed 
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favourable outcomes of the stratified intervention in the STarT Back high-risk group were 
mediated by changes in psychological distress. It was hypothesised that the strongest mediating 
effects would be found in the high-risk group, as patients in this group were the most distressed 
and (if allocated to the intervention arm) received treatment designed to target this psychological 
distress. 
 
This secondary analysis involved a series of preliminary analyses before the mediation analysis 
itself could be carried out. To summarise, the preliminary analyses described in Sections 6.5 and 
6.6 above demonstrated that four of the psychological variables used in the STarT Back trial met 
the criteria as potential mediators of outcome (that is, they changed over time and this change 
was associated with change in outcome for each potential mediator variable, and treatment 
allocation was also associated with a change in each potential mediator). Alternative explanations 
for any mediating effects were also explored, and residualised change in pain intensity emerged 
as a possible alternative candidate construct to include in the mediation analysis. Once it was 
clear which variables were going to be included in the mediation analysis, the next step was to see 
if latent variables could be successfully created, which was demonstrated using EFA and CFA 
(measurement model) for the potential mediator (psychological distress) and the alternative 
mediation explanation (low back pain). Finally, the SEM models were run to test whether the 
relationship between patients’ allocation to the high-risk treatment group in the STarT Back trial 
and change in their score on the disability and general physical function outcome measures (i.e. 
the effect of the STarT Back intervention on physical function outcomes) was mediated by either 
psychological distress or low back pain (structural model). For the high-risk analysis, psychological 
distress and low back pain did have statistically significant indirect (mediating) effects on both 
functional outcome measures and the hypothesis that this effect would be weaker in the 
medium- and low-risk groups was supported.  
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6.7.2 Comparison with conceptual model 
Overall, the results of the analyses provide some support for the conceptual model proposed. The 
factor analysis performed on the four psychological measures suggested that they all correlated 
highly with each other and loaded onto a single factor of psychological distress. Also, the 
psychological variables did have a stronger mediating effect in the models where patients were 
classified as high-risk and went on to receive the high-risk treatment (if allocated to the treatment 
arm), compared to the analysis in the medium- and low-risk groups. Action and conceptual theory 
described in Chapter 1 would describe the stronger associations between psychological distress 
and disability (conceptual theory) as showing that targeting psychological distress was important, 
but that the weaker associations between treatment allocation and psychological distress (action 
theory) suggest that the psychologically informed physiotherapy did not target these factors as 
strongly as they could have done. This possibly reflects the fact that this treatment, although 
targeting psychological factors, did not target them as specifically as a more intensive treatment 
delivered by psychologists, such as CBT. 
 
The alternative explanation to change in psychological distress tested in this study, change in low 
back pain intensity, was found to be more strongly associated with disability outcome and was a 
stronger mediator of the relationship between pain and disability than psychological distress. The 
two latent variables of psychological distress and low back pain were also found to have a strong 
relationship with each other. However, change in the variables was analysed as occurring in 
parallel rather than testing whether improvement in one leads to improvement in the other. The 
focus of this study was to test whether the trial authors’ theory of how the trial worked was 
correct rather than test a more complex model of multiple mediating factors. The goodness-of-fit 
statistics provided for the mediation model presented above did not all meet the criteria for good 
fit, indicating that the hypothesised pathways may not be the only explanation for the effect of  
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treatment on change in disability. Future research could test a more complicated model which 
includes more potential mediators in a single pathway, to show a process of change in several 
variables as part of the treatment process. This would also allow testing of other variables that 
might be important in leading to a change in outcome, such as treatment expectations, that may 
help to further explain how the treatment worked. 
 
Fritz et al (2012) suggest that in terms of power, it may be better to focus on increasing the 
strength of the conceptual theory, or focusing on the link between the mediator and the 
outcome, than it is to focus on trying to improve the action theory, or how the intervention can 
affect the mediator. They state that this may be most important in studies with small sample 
sizes. However, it has been suggested that the strength of the associations of the various paths 
has an effect on the study’s power to detect a mediating effect, with a larger ‘a’ path resulting in a 
larger sample size needed to test the ‘b’ and ‘c’ paths, due to more variance being explained by 
the intervention and therefore less variance available to be explained by the other paths (Frazier 
et al 2004). In this study, the sample size was not large because only the high-risk group was 
focused on and complete case analysis was used. It could therefore be that the smaller a path 
seen in this study is a result of the small sample size of the study. However, when comparisons 
were made between the analysis with all available data and the complete case analysis (Appendix 
6.3) it appeared that the coefficients on the a path were larger in the complete case analysis, 
suggesting that sample size does not explain the smaller coefficients seen. 
 
6.7.3 Comparison with previous findings 
Few studies of treatment mediation in MSK pain populations have been conducted to date. The 
systematic review conducted as part of this thesis (see Chapter 4) located only 10 studies, and few 
of these had conducted mediation analysis according to the ‘gold standard’ as currently reported  
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in the literature. Despite the limitations of the analysis conducted here (see Section 6.7.4), it adds 
important information to the current evidence base. The indirect (mediating) effects for the high-
risk STarT Back intervention appear weaker than those reported in studies included in the 
systematic review (Chapter 4) (standardised indirect effect of 0.25 reported in Table 6.17a; -3.82 
reported by Robinson et al 2013; -0.23 to -1.18 reported by Turner et al 2007; -3.65 reported by 
Wicksell et al 2013), but these studies used more intensive therapies, such as CBT and ACT. The 
STarT Back intervention was deliberately designed to be a less intensive “light-touch” therapy that 
could still address psychological factors. The results found in this analysis therefore make sense, in 
that less intense psychological therapy will have a smaller indirect effect on outcome than studies 
with a more intensive intervention. It could also be that the way change was examined in each 
study had an impact on the strength of the findings. The present study used residualised change 
scores whereas Wicksell et al (2010) and Turner et al (2007) used either post-intervention scores 
or raw change scores. It is likely that stronger effects would be found with the methods used by 
other authors, as the calculated change would be greater. However, the purpose of mediation 
analysis is to specifically look at whether change in factors targeted by the intervention led to the 
change seen in the outcome. Only examining change that occurred as a result of treatment is 
therefore important. Residualised change scores are uncorrelated with baseline scores (Gillespie 
et al 1994) which are known to be strong predictors of future outcome, so the results presented 
here only show change that is not accounted for by baseline scores (Gillespie et al 1994). While in 
an RCT differences between intervention groups in baseline scores are accounted for, from a 
mediation perspective this only holds for paths a and c, and not for the b path as the mediator 
score is an outcome of randomisation (see Chapter 3 for a detailed discussion of this). The use of 
residualised change has been criticised for being difficult to interpret (Wurm & Fisicaro 2014), but 
a sensitivity analysis performed on this data using raw change scores (high-risk group only, 
complete case analysis) found that the results and their interpretation were similar to that using 
residualised change (see Appendix 6.5).  
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6.7.4 Potential limitations 
The FIML (sensitivity) analysis and subsequent non-response bias analysis (presented in 
Appendices 6.3 and 6.7) suggested that the participants included in the complete case analysis 
differed substantially from those who were excluded. This was particularly apparent in the 
psychological measures, where responders at four-month follow-up had lower baseline scores of 
fear-avoidance beliefs, catastrophising and depression compared to non-responders. It is known 
that participants who had higher fear-avoidance beliefs at baseline were more likely to drop out 
of the control group if their fear-avoidance beliefs were not being managed effectively (J Hill, 
personal communication) but this suggests that people with higher scores on several key factors 
in both arms dropped out if their baseline scores were higher. This attrition bias means that the 
results presented above need to be interpreted with caution, as they represent only a subsample 
of the high-risk population included in the trial.  
 
The psychometric properties of measures to be used for mediation analysis are important to 
assess to ensure the measures are suitable for inclusion in the analysis (see Chapter 3 Section 
3.3.3). In this study, only one property (internal consistency) was formally tested. The importance 
of this in relation to mediation analysis is that we need to be confident that the tool we are using 
to measure a construct is an accurate representation of the construct we believe to be mediating 
outcome, and that this measure can detect change over time. For the TSK and PCS, reviews of 
psychometric properties exist and show support for these tools being responsive (Woby et al 
2005) and having good test-retest reliability (Sullivan et al 1995). The PCS has three subscales of 
Rumination, Magnification and Helplessness (Sullivan et al 1995) but can also be used as a total 
score (Severeijns et al (2002) reported a similar fit for the three- and one-factor structures in LBP 
patients). As the scale was used as a single measure in the STarT Back trial it was used as such in 
the present study also.  
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The HADS has less evidence for its reliability and validity in MSK pain populations, with mixed 
evidence for its ability to predict disability (see Chapter 5). However, as the HADS was the only 
measure of anxiety and depression available in this dataset, and items from this tool were used in 
the STarT Back tool, this measure was included in the present analysis. A related point is that the 
Cronbach’s alpha value in the internal consistency analysis for the Pain Catastrophising Scale was 
very high, suggesting potential item redundancy. However, the purpose of the analysis was to 
include and investigate all of the factors measured in the STarT Back tool, as these were the 
factors which categorised patients as high-risk. Future analysis could examine whether the 
catastrophising measure is needed.  
 
Responsiveness may also be important to assess in mediation studies to ensure the measures can 
adequately show minimal important change, although sensitivity to change was assessed in this 
study as part of the analysis by investigating associations between residualised change in the 
mediator and residualised change in outcome, suggesting that this is adequate for each of the 
measures included in the analysis. However, the mediation analysis focused on latent variables 
rather than these individual constructs. One of the strengths of SEM is its ability to include several 
measures of a construct by creating latent variables. The factor analyses conducted as part of the 
preliminary analysis (EFA and CFA) showed that the variables used to create the latent constructs 
of psychological distress and pain intensity loaded strongly onto the constructs and provided 
stronger measures than each of the measures individually. These analyses therefore 
demonstrated convergent and discriminant validity of these two constructs, which assess whether 
the items of interest represent the same construct and whether the constructs can be 
distinguished from each other. Using additional measures may ensure the construct is measured 
with more accuracy and therefore increase construct validity. 
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All participants in the STarT Back trial, including those in the control arm, received half an hour 
with a physiotherapist prior to them commencing treatment. This could have had a significant 
impact on the outcome of this study. The time could have been very beneficial for the patients in 
the control group and answered any queries or worries they may have had, which could have 
reduced their scores on the distress measures and improved the effect of the control 
intervention. This means that the difference between the two treatment arms may have been 
smaller than what would have been expected had a control arm receiving no treatment or usual 
primary care been used.   
 
Also, patients were not categorised based on their pain duration. Different levels of pain duration 
may have affected patients in different ways – patients with new pain episodes are likely to have 
lower levels of catastrophising thoughts or fear-avoidance beliefs, while patients with persistent 
pain may have higher levels of distress. One way of testing this would be to carry out a moderated 
mediation analysis (e.g. Baron & Kenny 1986). However, it was felt that subgrouping patients 
further when some of the risk subgroups only contained small numbers would have affected the 
reliability and robustness of the analysis. Pain duration was examined as a possible confounding 
factor in Section 6.6.1, and found to have only weak, if statistically significant, relationships with 
the outcome measures used in this study. 
 
It is possible that the number of follow-up points and the timings of when these follow-ups took 
place may have had an important influence on estimation of the mediating effects. In the STarT 
Back trial, as with many intervention studies, patients completed measures at baseline and then 
post-intervention. It is likely that mediating effects were missed because not enough 
measurements were taken from participants, or perhaps because no measurements were taken 
while the intervention was being delivered. It is important to acknowledge that the STarT Back  
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trial was not designed to test mediating effects. The issues discussed above could be resolved by 
designing trials to directly assess mediation from the outset with optimal time points for 
assessment, rather than conducting post hoc analyses. 
 
Related to this is the fact that temporality cannot be established in this study, even though the 
data is taken from an RCT. This is because the analysis presented, while complex, still only shows 
change between the mediator and outcome variables at the same time points. It therefore cannot 
be established whether the hypothesised order of the variables as presented in the models above 
is correct. Additional measurements of all variables of interest would therefore help to establish 
when change occurs and the order in which it occurs. 
 
It is also unclear whether the right constructs were chosen for the analysis, as many other factors, 
both psychological and non-psychological, could also be on the mediating pathway. For example, 
it is likely that other factors such as clinician confidence, self-efficacy, or social factors such as 
emotional support play an important role but are often not measured or are difficult to measure 
within a trial. As mentioned in section 6.7.2, the goodness-of-fit statistics generated for the 
mediation model presented in this chapter suggest that fit was not optimal and that it is likely 
that there are other unmeasured mediating pathways that could be explaining the treatment 
effect. However, the psychological measures included in this analysis were chosen because of the 
strength of the evidence suggesting their prognostic value, which was gained from the available 
literature and also from the analysis presented in Chapter 5. The preliminary analysis presented in 
both Chapter 5 and the present chapter also showed how the variables included in this analysis 
met criteria for mediation prior to being included in the mediation analysis.  
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Another point for consideration is whether a different method of mediation analysis may have 
resulted in a different conclusion. Chapter 3 gives an overview of the different approaches to 
mediation analysis available. SEM was chosen because it has several strengths over other 
methods, but it is a complex form of analysis and many preliminary steps must be taken before it 
can be conducted. An alternative method of mediation analysis, such as linear regression, may 
have given different results. However, the point of this analysis was not to compare different 
methods of mediation analysis, as this has been done previously (MacKinnon et al 2002; Hayes & 
Scharkow 2013). Instead, the aim was to use the most appropriate method to answer the 
hypothesis under investigation. In STarT Back, the hypothesis was that psychological distress 
(rather than a single psychological construct such as depression) would be reduced by the 
psychologically informed intervention offered to the high-risk group, leading to the reduction in 
disability. Therefore SEM, with its ability to assess latent variables, was the most appropriate 
method to use in this study. Alternative methods such as linear regression or latent growth 
modelling were not possible to conduct as a comparison because they would not have been able 
to account for the latent factor of psychological distress. 
 
The analysis presented in this chapter set out to capture a broad concept of psychological distress 
rather than the more specific constructs (e.g. fear-avoidance beliefs, anxiety) that were used to 
measure this latent variable. Such composite variables have been found to show mediating 
effects in previous studies (e.g. Wegener et al 2011) and while each construct is distinct, it is likely 
that self-report measures of psychological factors are related. Indeed, the preliminary analysis 
presented in this chapter found that changes in the psychological variables tested were very 
strongly correlated with each other. The use of a latent variable rather than individual 
psychological measures also reflects the conceptual model of the STarT Back trial, which did not 
aim to assess individual constructs. This sets the trial apart from other psychological treatments 
for LBP in primary care, such as the Progressive Goal Attainment Program (PGAP) approach (e.g. 
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Sullivan & Simon 2012) and the Back In Action approach (Von Korff et al 2005) which also target 
psychosocial barriers to recovery, but focus more specifically on fear-avoidance beliefs. The Von 
Korff study is analysed in more detail in Chapter 7.  
 
 
6.8 Conclusion 
The psychological variables that physiotherapists attempted to manipulate during the STarT Back 
high-risk intervention explained part of the outcome effectiveness seen in the trial. The BeBACK 
analysis presented in Chapter 5 provided a strong empirical basis for the selection of the variables 
included in the analysis presented here, highlighting the value of observational study data in 
helping choose appropriate potential mediators of treatment effect. The present analysis also 
emphasises the importance for intervention studies to be underpinned by a clear theoretical or 
conceptual model. However, this analysis only looked at change between two time points which 
was not enough to assess the temporal order of the variables in the model. Trials that are 
designed to adequately test for mediating effects, with variables being measured at appropriate 
time points which fit in with that model, are required. 
 
The next chapter builds on the analysis outlined here, and tries to address some of the issues and 
limitations that could have affected the mediation analysis of the STarT Back trial. It will also test 
an alternative method of analysis, recommended in the literature summarised in Chapter 3, which 
extends SEM to include more assessment time points. 
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Chapter 7: Using RCT Data to Investigate Potential Mediators of Treatment 
Outcome  
Part II: Back In Action trial 
 
7.1 Introduction 
This chapter builds on the previous chapter which presented a mediation analysis of a randomised 
controlled trial (RCT) investigating a stratified care approach for low back pain (LBP) including a 
psychologically-informed intervention for those at a high risk of poor outcome (STarT Back). The 
present chapter will also outline analysis of an RCT, which is arguably more suited to a mediation 
analysis because the intervention had a more explicit psychological conceptual framework 
underpinning the mechanism by which the active treatment was thought to lead to 
improvements in functional outcomes. In addition, in this RCT there were more assessments 
made over time, and the intervention itself was more specifically focused on a key potential 
psychological mediator (fear-avoidance beliefs). This specificity of focus on a core mechanism 
facilitates consideration of mediation.  This chapter investigates longitudinal associations 
between the potential mediator and outcome variables through the use of latent growth curve 
modelling (LGM) in order to carry out mediation analysis.  
 
 
7.2 Rationale for Study 
Temporality (change over time) has previously been identified in this thesis as being fundamental 
in establishing whether a proposed mediator of treatment outcome is on a causal pathway. The 
review in Chapter 3 highlighted that in order to truly establish how changes in factors are related 
over time, at least three measurements should be taken over different time points (e.g. Kazdin  
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2007). Typically in intervention studies, measures are only taken pre- and post-intervention which 
only gives information on whether a change takes place or not, and gives little information about 
how a factor changes over time as a result of the intervention. The purpose of this chapter was 
therefore to investigate a way of analysing intervention study data where data has been collected 
at multiple time points. 
 
The Back In Action study (Von Korff et al 2005) compared a psychological intervention with 
treatment as usual in 240 patients with LBP. The intervention centred on addressing patient’s 
fear-avoidance beliefs and helping to improve their functioning, and it was hypothesised by the 
trial authors that this would lead to a reduction in fear-avoidance beliefs and improved functional 
outcomes. Measures of psychological factors and function were taken at baseline and four follow-
up points, and incorporating all of these into the mediation analysis provided more information 
on longitudinal associations between psychological factors and disability than just looking at 
changes in mediators and outcomes between two of those time points. The present mediation 
analysis investigated fear-avoidance beliefs as a potential mediator variable of self-reported 
disability. 
 
It should be stated at this point that although five measurement points were available for analysis 
in the present study, none of these were made during the intervention period. This means that 
the issue of temporality and therefore causality, as discussed in detail in Chapter 3, still cannot be 
truly established for changes occurring during the treatment period. However, the purpose of this 
thesis as a whole is to investigate how best to conduct mediation analysis and provide guidance as 
to how to design future studies to best test for mediators of treatment effect. Therefore, while 
the analysis presented in this chapter cannot confirm a mediating pathway informed by repeated 
assessments during the course of treatment, it can provide evidence for a particular analysis  
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technique which could potentially be useful in future studies. Latent growth modelling (LGM) is a 
technique which allows the inclusion of multiple time points, thereby providing a more accurate 
estimate of change (Byrne et al 2008). It has been recommended that analyses using LGM 
requires a sample size of at least 200 (Byrne et al 2008), and the Back In Action study meets this 
criterion. 
 
 
7.3 Back In Action Trial 
The Back In Action trial was an RCT designed to compare an intervention addressing fear-
avoidance beliefs with treatment as usual for chronic LBP in order to improve patient function (as 
estimated by reduction in self-reported disability). The trial recruited 240 adult participants (119 
in the treatment group and 121 in the control group) aged between 25 and 64 years suffering 
with chronic LBP from primary care settings in Seattle, Washington State, US. Assessments took 
place at baseline and then post-intervention at two-, six-, 12- and 24-month follow-up. The 
numbers of males and females and the levels of education, pain intensity, fear-avoidance beliefs 
and disability were similar across both groups at baseline, indicating successful randomisation 
(see Table 7.1). 
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Table 7.1 Baseline characteristics of study population (n=240) 
Variable 
 
Treatment (n=119) Control (n=121) 
Age in years, mean (SD) 49.67 (9.02) 49.82 (9.77) 
Sex, % female  64.7%  60.3%  
Education in years*, median 
(range) 
6.00 (3-8) 6.00 (3-8) 
Pain Intensity 
(1-10), mean 
(SD) 
Average last 
three months 
5.71 (1.84) 5.83 (1.82) 
Today 3.45 (2.49) 3.45 (2.57) 
Pain duration (days), mean 
(SD) 
110.50 (60.72) 97.39 (62.34) 
Fear-avoidance beliefs (TSK – 
10 item version), mean (SD) 
41.47 (8.79) 41.25 (8.22) 
Disability (RMDQ-23 item 
version), mean (SD) 
12.10 (5.49) 11.36 (5.67) 
*Education was graded in eight levels by asking participants what the highest grade of year of school they 
completed. This ranged from 1 (less than eight years) to 8 (postgraduate) 
 
The overall aim of the original study was to test whether the proposed model of ‘activation’ 
(addressing fears and encouraging resumption of normal activities (Von Korff et al 2005)) could 
feasibly be employed in primary care. A secondary aim was to assess whether the proposed 
intervention led to a reduction in fear-avoidance beliefs and disability compared to usual care. It 
was this secondary aim that was of interest in the present study, as this related to how the 
authors proposed the trial was working. 
 
7.3.1 Intervention: Conceptual model 
The intervention used in the study was based on a suggested framework by Balderson et al (2004) 
of assessing and addressing a patient’s fear-avoidance beliefs, anxiety and activity limitations, 
performing a clinical assessment to rule out red flags (physical signs suggestive of the need for an 
urgent surgical opinion) and providing treatment recommendations in line with goals set by the 
patient. The intervention involved four face-to-face visits, two with a psychologist and two with a 
physiotherapist, with the first session focusing on goal-setting and putting together an action plan 
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and the remaining sessions focusing on how to achieve those goals and addressing barriers to 
achieving the action plan. The three physiotherapists involved in the study received half a day 
formal training from the study psychologist but most of the training was informal (B Balderson, 
personal communication) and no formal evaluation of the training was recorded. A summary of 
the intervention components is given in Box 7.1. In addition to these visits, patients also received 
a book on back pain self-management (Moore et al 1999, cited in Von Korff et al 2005) and a 40 
minute video on back pain (Patient Education Media Inc. 1996, cited in Von Korff et al 2005). The 
control group received treatment as usual, which Von Korff et al acknowledged could be very 
diverse and included medication and physiotherapy sessions. 
 
Box 7.1. Back In Action (BIA) intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Visit 1: Psychologist (90 minutes) 
• Identified and addressed patient fears about pain 
• Discussed resuming normal activities 
• Set activity and exercise goals 
• Developed action plan (in collaboration with the patient) on how to achieve those 
goals 
Visit 2: Physiotherapist (60 minutes) 
• Standardised physical examination of the back 
• Discussion of any unresolved concerns from the first visit 
• Taught stretches and exercises relevant to patient’s goals and action plan 
• Offered guidance in overcoming barriers to carrying out action plan 
Visit 3: Physiotherapist (30 minutes) 
• Focused on action plan and exercises relevant to that plan 
Visit 4: Psychologist (20 minutes) 
• Review of patient’s progress 
• Encouraged use of relaxation techniques 
• Discussion of managing flare-ups and resuming normal activities when these occurred 
Chapter 7 Back In Action Page 198 
 
7.3.2 Measures 
The trial included a number of different outcome measures, with the primary outcome measure 
being low back pain-specific disability, measured using the Roland-Morris Disability Questionnaire 
(RMDQ). This was a modified, 23-item version of the original 24-item RMDQ in which five of the 
original items had been deleted and replaced by four other items reported to better detect 
changes in pain (Patrick et al 1995). The trial also measured fear-avoidance beliefs using a 
modified version of the Tampa Scale for Kinesiophobia (TSK) which contained 10 of the original 17 
items. Von Korff et al (2005) stated in their paper that this tool was scored by multiplying the 
mean item score by 17 (the number of items in the original tool) so that the scores from the 
shortened version and the original version would be comparable. Both modified tools were still 
scored in the same direction as the original versions, with higher scores indicating higher disability 
or fear-avoidance beliefs. As described in Chapter 5, a score of 37 or above on the TSK has been 
documented as a cut-off for high fear (Vlaeyen et al 1995a; Bränström & Fahlström 2008) and a 
reduction in score by four points can be taken as representing a clinically significant improvement 
(Woby et al 2005). For the RMDQ a reduction in score of 30% has been found to show clinically 
significant improvement (Jordan et al 2006). Other outcome measures included back pain worry, 
pain intensity and mental and physical functioning. 
 
7.3.3 Conclusions of original study 
The intervention was successful in reducing disability across all time points compared with the 
control group, but the authors do acknowledge that the intervention group received more 
therapeutic contact than the control group, which could have enhanced the treatment effect 
along with other non-specific effects. They also state that the results cannot identify which part(s) 
of the intervention were most effective. 
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7.4 Aim 
To test whether change in fear-avoidance beliefs is a mediator of the relationship between 
allocation to the active treatment intervention and change in disability. 
 
 
7.5 Specific Objectives 
1. To describe the baseline characteristics of the study population and the measurement 
properties of the mediator and outcome measures; 
2. To examine the change in both the mediator (fear-avoidance beliefs) and outcome 
(disability) variables in the treatment and control groups and derive well-fitting LGMs for 
each variable; 
3. To examine the effect of treatment group allocation on change in both the mediator and 
outcome variables; 
4. To estimate the mediating effect of change in fear-avoidance beliefs on the relationship 
between the active intervention arm and change in disability. 
 
All analyses were carried out using Microsoft Excel, SPSS PASW Version 18 and AMOS Version 19. 
A summary of the analyses performed is given in Figure 7.1. 
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Figure 7.1 Flowchart describing the steps of analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Non-response analysis  
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2. Preliminary 
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3. Mediation 
Analysis  
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internal consistency of key 
measures 
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outcome variables 
3.2 Combination of models of 
mediator and outcome 
variables 
3.3 Mediation analysis 
Calculation of Means, SDs 
and Percentages; Cronbach’s 
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Latent Growth 
Modelling 
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7.6 Methodology I: Imputation 
7.6.1 Missing data 
Missing data is a common occurrence in longitudinal data due to dropout, death or unavailability 
at follow-up (Collins 2006). If data is missing completely at random (MCAR), then the values of the 
missing data are not related to the values of the collected data (Enders et al 2001a) and are 
missing completely by chance (Sinharay et al 2001). This is unlikely to result in biased estimates 
and the remaining data can still be seen as representative. Data that is missing at random (MAR) 
is likely to be related to other observed variables (Sinharay et al 2001; Enders 2001b; Enders 
2011). Data that are not missing at random (NMAR) have missing values that are related to the 
value that would have been seen had the information not been missing (Sinharay 2001), and are 
therefore most likely to result in biased estimates. 
 
Several methods have been proposed to deal with missing data. Complete case analysis, where 
cases with missing values are simply removed from the analysis (as used in Chapter 5), is 
commonly used and simple to implement. However, current recommendations advise against this 
due to loss of power and potentially biased results (Collins 2006). Single imputation methods such 
as Last Observation Carried Forward or Mean Value Substitution help reduce the power problem, 
but do not account for any uncertainty or change in the data (Karahalios et al 2012), meaning the 
data is still likely to be biased. These approaches are therefore also not recommended (Li et al 
2014). Some single imputation methods such as Maximum Likelihood (ML) estimation have been 
found to yield unbiased estimates if data is missing MCAR or MAR, although sensitivity analyses 
are recommended to check the stability of the results (Enders 2011). Multiple imputation (MI) 
(Rubin 1987) has recently been recommended as the most appropriate method of imputation 
(Olinsky et al 2003). This method involves replacing the missing values with a given number of 
alternative values, which are analysed separately and the estimates and standard errors are then  
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combined using Rubin’s rules to give overall estimates for the results (Schafer & Olsen 1998; 
Sinharay et al 2001). This ensures that the results acknowledge the fact that there is some 
uncertainty about the true values of the missing data (Sinharay et al 2001). However, MI is 
complex and beyond the scope of this thesis. Expectation Maximisation (EM), a form of ML 
estimation, was therefore the method chosen to perform imputation in this analysis (see Section 
7.6.2). 
 
Whether or not the data is MCAR can be established via Little’s MCAR test (Little 1988), which will 
be non-significant if the data is MCAR. However if the test is significant there is no way of 
establishing whether the data is then MAR or NMAR. This means a decision needs to be made as 
to whether the data from that time point are to be excluded as they may introduce bias, or 
included with the acknowledgement that some bias may be present. In addition to this test, 
baseline characteristics of responders and non-responders at each assessment point (split to 
show treatment and control groups separately) were also provided to examine differences 
between responders and non-responders at each time point. If, for example, patients who had 
higher scores on the TSK at baseline were more likely to drop out of the control group if their 
fear-avoidance beliefs did not greatly improve (which happened in the STarT Back trial, (J Hill, 
personal communication)), this suggests that there is a high risk of attrition bias. 
 
7.6.2 Imputation 
Imputation was necessary because of attrition over time in the follow-up assessments (Step 1 of 
Figure 7.1). By the 24-month follow-up point 79% of those who participated at baseline provided 
data, although participants were able to ‘skip’ a follow-up point and still be involved in the other 
assessments. This means that there is potentially a risk of bias if only cases with complete data 
are used for analysis. Incomplete data is restrictive when using SEM and LGM as certain goodness- 
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of-fit indices (i.e. Standardised Root Mean-square Residual (SRMR)) can only be used with 
complete data. Confidence intervals for the mediated effect, a requirement for studies of 
mediation (e.g. MacKinnon et al 2004; Hayes 2009) can also only be obtained on data with no 
missing values. As explained in Section 7.7.1 above, while complete case analysis allows us to 
analyse ‘real’ data collected during the study, it lacks power and potentially suffers from bias 
because of selective missing data (Vergouw et al 2012). Imputation was therefore carried out, but 
in line with current recommendations (e.g. Powney et al 2014) the complete case analysis is 
included in Appendix 7.1 for comparison. 
 
EM was used to impute the data. EM involves predicting the missing values from the assumed 
parameter values of the data model, and then using those predictions to improve the parameter 
estimates (Schafer & Olsen 1998). EM also takes people’s characteristics into account when 
computing the estimates, resulting in less biased, more reliable estimates than the complete case 
data (Collins 2006). This process of prediction is repeated several times until the best estimates 
for the missing data are found for inclusion (Schafer & Olsen 1998). This differs from multiple 
imputation, where several different datasets are created and then merged; EM instead only 
provides a single imputed value from the process described above and does not include error in 
the generated estimate, so therefore should only be used with small amounts of missing data 
(Tabachnick & Fidell 2007). EM assumes that the data is normally distributed and the missing 
values are MAR (Newman 2003). Cheung (2007) reported potential problems using EM with LGM 
in that the standard errors were often underestimated, but in the present analysis this particular 
statistic is not of key interest. In this dataset, only small amounts of missing data were present 
(less than 30 people at each follow-up point in either treatment arm out of the 240 included at 
baseline), so it is likely that bias as a result of EM imputation will be minimal. 
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7.7 Methodology II: Preliminary Analysis 
7.7.1 Descriptive statistics 
Before conducting the mediation analysis, descriptive characteristics of each of the key variables 
were obtained for the treatment and control groups (Step 2.1 of Figure 7.1). As explained in 
Chapter 4 (Sections 4.5.2 and 4.6.1), the psychometric properties of the tools used in mediation 
analyses are important to consider – the measure should adequately measure what it is supposed 
to measure (validity) and the measure should be consistent and reliable over time. This is so that 
if a change (or no change) is found in a mediating relationship, we can be more certain that this is 
a true reflection of the data and not a consequence of problems with the tool used to measure 
the constructs of interest. However, testing each of these properties within each dataset is often 
not possible, and data from other studies of the same population is often relied upon to provide 
information on the validity and reliability of a tool within our population of interest. One property 
which can be tested is the internal consistency of the measures used in the analysis. It is 
important that the items in the scale are correlated, as if this is not the case, it might affect the 
interpretation of the results. Other properties of the measures of interest in this chapter not 
already reviewed in Chapters 5 or 6 were reviewed in the literature and are commented on in 
Section 7.10.2. 
 
 
7.8 Methodology III: Mediation Analysis: Latent Growth Modelling 
LGM allows the examination of variables across time, both within and between participants 
(Cheong et al 2003; Kosma et al 2012; Witkiewitz et al 2012). It can be carried out using SEM, like 
the previous mediation analyses in Chapter 6. This means advantage can be taken of the strengths 
of SEM, including the use of goodness-of-fit indices (explained fully in Chapter 6 and summarised 
below in Section 7.9.1). 
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LGMs consist of an intercept latent factor and a slope latent factor (Curran & Muthén 1999). The 
intercept factor represents the starting point for the trajectory of a factor (its baseline status) 
while the slope represents the growth (or change) in the trajectory of that factor over time. The 
use of the term “trajectory” in this context refers to the path each individual’s fear-avoidance 
beliefs and disability scores take over the measured time points. Although in this analysis it is the 
slope that is the factor of interest, the intercept is also important as where a person starts in an 
intervention will have an impact on their scores at subsequent points (e.g. people who start with 
very high scores will have more room for improvement than people who had low baseline scores). 
Figure 7.2 shows a basic LGM with three time points to help illustrate how an LGM is put 
together. 
 
The mediation analysis was carried out according to the steps set out by Cheong et al (2003) and 
Roesch et al (2009), described below, and also according to guidance by Byrne (2010) on testing 
for differences within models. Separate LGMs for the mediator and outcome were created to 
examine changes over time in each variable (Step 3.1 in Figure 7.1), and then both models were 
incorporated into a single model which examined whether the intervention was associated with a 
change in the observed trajectory of the mediator variable, and whether the observed trajectory 
of the potential mediator was associated with a change in the observed trajectory of the outcome 
variable (Step 3.2). LGM differs from Latent Class (Growth) Analysis, a technique which can also 
be used to model trajectories, because LGM uses the mean slope across all cases at each time 
point (Roesch et al 2009) rather than grouping people into different trajectories based on 
similarities in scores over multiple time-points. 
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Co-variance 
Figure 7.2. Generic LGM with three time points 
 
 
 
 
 
 
 
 
 
As in a standard SEM model, latent and measured variables and error are included in the model. 
However, in an LGM, the latent variables are the intercept and slope factors and the measured 
variables are each time point a variable was measured at. The numbers against each of the lines 
represent factor loadings, which are important in specifying the model. As the intercept is the 
point at which each individual starts, all the factor loadings from the intercept to each time point 
are set to the same value. Factor loadings for the slope factor need to represent both the 
trajectory of change in the measured variable over time and also reflect the time intervals 
between each of the measures (Cheong et al 2003). In Figure 7.2 above for example, the factor 
loadings of 0, 1 and 2 reflect linear growth at equally spaced intervals in time. The values chosen 
are arbitrary and not reflective of the actual change in scores on the measures included in the 
model.  
 
LGMs can incorporate models where growth is not linear and where assessment intervals are not 
equally spaced, providing that all participants have been assessed at the same time points 
(Cheong et al 2003; Byrne 2010). It is also possible to allow the model to estimate certain factor 
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loadings when the trajectory of a measure is not clear (Cheong et al 2003), meaning that not all of 
the slope loadings need to be pre-specified before the model is run. 
 
Both the intercept and slope factors also have a mean and variance value associated with them 
that are estimated from the data. In this case, the means represent the parameter values for the 
group, while the variances represent the individual variation of each person around the group 
means, so that larger variance suggests more individual difference in growth (Curran & Muthén 
1999). In a standard LGM, co-variance between the intercept and slope factors is also included. 
This gives an indication of whether people who start at lower or higher scores on a measure also 
change at lower or higher rates. 
 
7.8.1 Goodness-of-fit indices 
Model fit indices show how well the hypothesised model fits the observed data (Schermelleh-
Engel et al 2003). The goodness-of-fit indices used in LGMs are the same as those available in 
SEM, so the indices chosen for use in the previous chapter (Chi-square (CMIN), comparative fit 
index (CFI), root mean square error of approximation (RMSEA) and SRMR) were also used here. 
These indices are described in detail in Chapter 6 (section 6.5.4). However, although the CMIN is 
recommended to be reported as an indicator of model fit, it is often statistically significant in large 
samples (Byrne 2010) and may therefore not be an appropriate measure upon which to base 
judgements of goodness-of-fit (Schermelleh-Engel et al 2003; Byrne et al 2008; Williams et al 
2009). Therefore, while it is reported here, the decision of whether or not a model provides a 
good fit to the data will be based on the other reported indices. 
 
If the goodness-of-fit indices do not indicate good fit, steps can be taken to try and improve the 
model. It is recommended that the standardised residual co-variances of the model are inspected  
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for any values that exceed ± 1.96 (Schermelleh-Engel et al 2003), as this would indicate that the 
model shows variance values which are substantially different to the observed data, and so is not 
representative of the study sample. If any paths do exceed this value they could be allowed to 
freely estimate (i.e. the path is not given a factor loading) to try and improve model fit 
(Schermelleh-Engel et al 2003). Alternatively, modification indices can be examined to check 
whether the hypothesised model could be improved by adding or removing factor loadings on 
specified paths (Byrne 2010). Modification indices show the overall decrease in X
2
 value that 
would occur if the factor loading for a particular path was not specified (Byrne 2010), with a large 
value indicating a larger improvement in model fit.  
 
It is emphasised that changes to the original model should only be made if the modification 
makes theoretical sense and would substantially improve the model (Byrne 2010). For models 
that did not provide a good fit to the data in the present analysis, standardised residuals and 
modification indices were examined and both the original and modified model fit indices are 
provided for comparison. 
 
7.8.2 Step 3.1: Investigate the shape of the observed growth trajectory for the mediator 
and outcome variables 
This first step involved estimating growth trajectories, or change over time, for both the mediator 
and outcome variables separately from the observed data. The aim of this step was to ensure that 
the factor scores for the slope factor represented the observed trajectory (seen when plotting the 
mean values of each variable across the measurement points) and provided a good fit to the data. 
It also allowed examination of whether these trajectories were different in the treatment and 
control groups, which would be the case if the intervention had been effective (Cheong et al 
2003).  
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As the Back In Action intervention had produced larger changes in the mediator and outcome 
variables in people in the intervention group compared to the control group, it was anticipated 
that the observed trajectories in each of these groups would differ. However, because the follow-
up points were all measured after the intervention had finished (at two, six, 12 and 24 months) it 
was not expected that the decrease in fear-avoidance beliefs and disability scores would be linear 
over the entire follow-up period; it was considered more likely that an initial steep decrease 
between baseline and two-month follow-up would level out over time. This is shown in the 
original paper and in Table 7.2, which presents means for both variables at all measurement 
points in the treatment and control groups. 
 
Table 7.2. Changes over time (means and SDs) for potential mediator and outcome variables in 
the Back In Action trial 
Variable Treatment 
(n=119) 
Baseline Two-month 
follow-up  
Six-month 
follow-up 
12-month 
follow-up 
24-month 
follow-up 
 
RMDQ (23-item 
version) 
12.10 
(5.49) 
10.02 (6.27) 8.91 (6.60) 8.46 (6.90) 7.76 (6.41) 
TSK (10-item 
version) 
41.47 
(8.79) 
36.41 (9.51) 34.99 (9.65) 35.27 (10.32) 34.11 (9.41) 
 
 
RMDQ (23-item 
version) 
Control 
(n=121) 
11.36 
(5.67) 
11.44 (5.81) 10.01 (6.25) 8.99 (5.96) 9.02 (6.87) 
TSK (10-item 
version) 
41.25 
(8.22) 
39.96 (9.62) 39.17 (9.47) 37.55 (8.91) 38.58 (9.19) 
 
 
7.8.3 Step 3.2: Combine both LGMs from Step 3.1 and model hypothesised relationships 
between the intervention and both LGMs 
At this step the LGMs of the mediator and outcome were combined into a single model so that 
the relationships between both LGMs and intervention allocation could be investigated (Cheong 
et al 2003). This is described as a parallel process model, where the observed trajectories of the 
two measured variables are viewed as two separate processes that occur over the same period of 
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time (Cheong et al 2003). Including treatment group allocation as a co-variate also enables 
examination of the differences between scores in the intervention and control groups. In the 
Cheong paper, differences between the intervention and control groups were investigated using a 
two-group model, to see whether the factor loadings were appropriate to be used across both 
treatment groups (i.e. the factor scores used provided good fit to the data). However, as the 
overall mediation LGM would include treatment allocation as a co-variate to account for the 
different trajectories of the two groups, it was felt that this step was not necessary and that 
simply plotting the trajectories and choosing factor scores that best represented an overall 
trajectory for both groups in terms of model fit would be sufficient.  
 
7.8.4 Step 3.3: Full mediation model and estimates of mediated effect (with bootstrapped 
CIs) 
Cheong et al (2003) describe this step as using the parallel process model to estimate the 
mediating effect using the product of coefficients approach. As this approach, in conjunction with 
bias-corrected bootstrapped confidence intervals (CIs), was described as the most appropriate 
method of estimating mediation effects in Chapter 3, this was the approach adopted in the 
present analysis. Briefly, this step involves investigating a model which includes relationships 
between the intervention allocation and mediator variable (a path described in Figure 1.1 of 
Chapter 1) and between the mediator and outcome variable (b path). The two coefficients from 
each of these pathways are multiplied together to give a product of coefficients, or the mediated 
effect (ab). Including bootstrapped CIs helps to account for the often non-normal distribution of 
the mediated effect (Hayes 2009). In this analysis, 1,000 bias-corrected bootstrapped samples 
were used to estimate 95% CIs. 
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7.9 Results I: Non-response analysis and Imputation 
Table 7.3 below shows how many people completed the key variables of interest at each time 
point. Overall, follow-up rates were good in this study, with less than 30 participants being lost to 
follow-up by 24 months in each group. The numbers of responders and non-responders was 
similar in both treatment and control groups with a maximum difference of three cases between 
responders and non-responders over the five time points. There were differences in baseline 
levels of pain intensity, fear-avoidance beliefs, disability and pain duration between responders 
and non-responders in the two treatment groups. However, these differences  were not 
consistent, with the fear-avoidance beliefs scores of those in the treatment group being higher at 
baseline for responders to the earlier follow-up points and lower at baseline for those responding 
to later follow-up points. For disability, responders in the treatment group at two-month and six-
month follow-up were more disabled at baseline and those responding at 12 and 24 months in 
the treatment group were less disabled compared to non-responders. For pain duration (days 
with pain), responders in the treatment group had fewer days of pain than non-responders at 
baseline for all time points except six-month follow-up. Overall, there does not seem to be a clear 
pattern of characteristics of non-responders in either the treatment or control group. However, 
the differences seen, while small and inconsistent, could potentially bias the results of the 
mediation analyses. 
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Table 7.3 Baseline characteristics (Means and SDs) of responders versus non-responders at two-, six-, 12- and 24-month follow-up 
Variable Baseline Baseline values at two-month 
follow-up 
Baseline values at six-month 
follow-up 
Baseline values at 12-month 
follow-up 
Baseline values at 24-month follow-
up 
Treatme
nt n=119
Control 
n=121 
Treatment Control Treatment Control Treatment Control Treatment Control 
R 
n=110 
N  
n=9 
R  
n=120 
N  
n=1 
R  
n=110 
N 
n=9 
R 
n=110 
N 
n=11 
R  
n=99 
N  
n=20 
R 
n=98 
N  
n=23 
R 
n=94 
N n=25 R 
n=93 
N n=28 
Age Mean 
49.67 
(SD 
9.02) 
Mean 
49.82 
(SD 
9.77) 
 
49.92 
(8.85) 
46.67 
(11.0
3) 
49.9
2 
(9.75
) 
38.00 
(0.00) 
49.88 
(8.87) 
47.11 
(11.01
) 
49.77 
(9.87) 
50.27 
(9.14) 
50.18 
(8.78) 
47.15 
(9.98) 
50.19 
(9.71) 
48.22 
(10.08) 
50.40 
(8.92) 
46.92 
(9.05) 
50.87 
(9.02) 
46.32 
(11.43) 
Sex 64.7% 
female 
60.3% 
female 
33.6% 
male 
55.6
% 
male 
40% 
male 
1 
male 
33.6% 
male 
55.6% 
male 
36.4% 
male 
72.7% 
male 
33.3
% 
male 
45.0% 
male 
37.8% 
male 
47.8% 
male 
33% 
male 
44% 
male 
38.7% 
male 
42.9% 
male 
Education Media
n 6.00 
(range 
3-8) 
Media
n 6.00 
(range 
3-8) 
7.00 
(9.00) 
4.00 
(5.00) 
6.50 
(6.00
) 
5.00 
(0.00) 
6.00 
(5.00) 
7.00 
(9.00) 
6.50 
(6) 
6.00 (6) 7.00 
(5.00) 
6.00 
(9.00) 
7.00 
(6) 
6.00 (5) 7.00 
(5.00) 
5.00 
(9.00) 
7.00 
(6) 
6.00 (6) 
Pain 
Intensity 
Average 
last 
three 
months 
Mean 
5.71 
(SD 
1.84) 
 
Mean 
5.83 
(SD 
1.82) 
4.90 
(1.96) 
3.56 
(2.40) 
5.30 
(1.93
) 
0.00 
(0.00) 
4.19 
(1.96) 
3.44 
(2.83) 
4.72 
(2.21) 
2.82 
(2.60) 
4.04 
(2.28) 
4.15 
(3.45) 
4.72 
(2.14) 
4.39 
(3.49) 
4.26 
(2.07) 
3.60 
(3.11) 
4.61 
(2.49) 
4.18 
(3.27) 
Today Mean 
3.45 
(SD 
2.49) 
Mean 
3.45 
(SD 
2.57) 
2.87 
(2.35) 
2.33 
(2.69) 
3.14 
(2.51
) 
2.00 
(0.00) 
2.76 
(2.49) 
1.56 
(3.32) 
3.05 
(2.63) 
3.00 
(2.37) 
2.49 
(2.67) 
3.55 
(3.61) 
2.73 
(2.54) 
3.43 
(3.22) 
2.34 
(2.46) 
2.52 
(3.08) 
2.77 
(2.86) 
3.29 
(3.18) 
Pain Duration 
(days) 
Mean 
110.50 
(SD 
60.72) 
 
Mean 
97.39 
(SD 
62.34) 
113.46 
(64.25) 
122.6
0 
(69.0
1) 
101.
80 
(63.5
0) 
144.2
3 
(0.00) 
94.99 
(74.98
) 
32.42 
(94.61
) 
88.67 
(68.86
) 
98.79 
(118.51
) 
93.29 
(72.94
) 
140.64 
(329.64
) 
91.52 
(71.48
) 
67.48 
(121.90
) 
82.56 
(75.99
) 
129.07 
(298.74
) 
73.45 
(72.07
) 
68.57 
(113.67
) 
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Variable Baseline Baseline values at two-month 
follow-up 
Baseline values at six-month 
follow-up 
Baseline values at 12-month 
follow-up 
Baseline values at 24-month follow-
up 
Treatment Control Treatment Control Treatment Control Treatment Control 
Treat
ment 
n=119 
Contro
l 
n=121 
R  
n=110 
N  
n=9 
R  
n=120 
N  
n=1 
R  
n=110 
N 
n=9 
R 
n=110 
N 
n=11 
R  
n=99 
N  
n=20 
R 
n=98 
N  
n=23 
R 
n=94 
N n=25 R 
n=93 
N n=28 
Fear-Avoidance 
beliefs (10-item 
TSK) 
Mean 
41.47 
(SD 
8.79) 
Mean 
41.25 
(SD 
8.22) 
36.38 
(9.27) 
37.37 
(14.58
) 
39.89 
(9.66) 
47.23 
(0.00) 
35.13 
(9.86) 
30.74 
(9.30) 
39.21 
(9.66) 
37.60 
(9.07) 
34.28 
(9.95) 
42.40 
(23.94) 
37.39 
(9.46) 
36.07 
(9.37) 
34.21 
(9.70) 
37.60 
(10.80) 
38.44 
(9.89) 
37.81 
(7.76) 
Disability (23-item 
RMDQ) 
Mean 
12.10 
(SD 
5.49) 
Mean 
11.36 
(SD 
5.67) 
10.24 
(6.32) 
7.60 
(8.11) 
11.47 
(5.83) 
6.99 
(0.00) 
9.23 
(6.56) 
2.90 
(10.42
) 
10.13 
(6.39) 
10.87 
(6.48) 
8.43 
(6.96) 
13.09 
(22.64) 
9.10 
(6.34) 
10.53 
(7.12) 
8.09 
(6.46) 
9.69 
(21.49) 
9.14 
(7.16) 
10.05 
(10.41) 
R=Responder; N=Non-responder
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EM imputation was therefore carried out cross-sectionally on the baseline and each follow-up 
dataset. Little’s MCAR test was non-significant for the baseline, six-month, 12-month and 24-
month datasets but produced a statistically significant result in the two-month dataset.  
 
 
7.10 Results II: Preliminary analysis 
7.10.1 Preliminary analysis: Descriptive statistics 
The mean (SD) scores for the potential mediator and outcome variables in the two intervention 
groups are given in Table 7.2. As expected, the biggest mean change in the intervention group 
was between baseline and the first follow-up point of two months for both the potential mediator 
and the outcome variable. The reduction in fear-avoidance beliefs and disability over the two-
month intervention period was smaller for the control group receiving usual care compared to the 
intervention group. The numbers lost to follow-up were similar in both the treatment and control 
groups (see Table 7.3), suggesting that the control group were as engaged in their treatment as 
the treatment group. The skewness and kurtosis values (explained in Chapter 5) were below 1.0 
for all variables except for kurtosis at two months (-1.00), six months (-1.15) and 12 months (-
1.21) for RMDQ score in the treatment group, and kurtosis at six months (-1.01) and 24 months (-
1.23) for RMDQ score in the control group. Overall, these scores suggest that the variables were 
normally distributed, which is an assumption underlying LGM with maximum likelihood (ML) 
estimation. 
 
7.10.2 Psychometric properties of the TSK (10-item) and RMDQ (23-item) 
As described in Chapter 5, the 24-item RMDQ has been found to have good psychometric 
properties overall in LBP populations (e.g. Roland & Morris 1983; Roland & Fairbank 2000). The 
23-item version of the RMDQ used in Von Korff et al’s (2005) study has received less attention in  
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terms of its psychometric properties, although studies do exist which show it to have good test-
retest reliability and internal consistency in a primary care LBP population (Dunn et al 2003; Dunn 
& Cherkin 2007). In the present study, Cronbach’s alpha showed that the 23-item RMDQ had a 
good internal consistency (0.88) in this population (Table 7.4).  
 
There has been much debate over the factor structure of the original version of the TSK 
(described fully in Chapter 5). The version of the TSK used in the present study was modified by 
the original study authors (Von Korff et al 2005) and was assumed to have a single factor 
structure. In the present analysis this version of the tool was found to have an internal 
consistency value of 0.66 (Table 7.4). Cronbach’s alpha values of 0.70 or above are seen as 
showing adequate internal consistency. This means that this measure may not be reliable, as 
suggested by studies on the factor structure of other versions of this tool. Reports of internal 
consistency for other versions of the tool have been inconsistent, with values of between 0.73 
(Lamé et al 2008) and 0.84 (French et al 2007) found in samples of chronic LBP patients using the 
original TSK, but these values will be influenced by the larger number of items in the original 
measure. However, as it is the only available measure of fear-avoidance beliefs in the dataset, it 
will still be used in the present analysis and kept in the single-factor structure used in the original 
study. 
 
Table 7.4. Measures of internal consistency 
Measure No. of Cases Analysis Based on 
 
Cronbach’s Alpha Value 
TSK (10-item version) 240 0.66 
RMDQ (23-item version) 240 0.88 
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7.11. Results III: Mediation Analysis: Latent Growth Modelling 
7.11.1 Observed trajectories of mediator and outcome variables (Step 3.1) 
The observed trajectories of mean fear-avoidance beliefs scores for the treatment and control 
groups based on all measured time points are presented in Figure 7.3a. The results show that, due 
to successful randomisation, the scores were very similar at baseline (less than one-point 
difference between treatment and control) but that the scores in the treatment group decreased 
substantially by two-month follow-up compared to the control group. This difference in scores 
was smaller at 12-month follow-up but larger again by 24-month follow-up. However, it is clear 
from the graph that neither observed trajectory followed a linear pattern. 
 
Figure 7.3a Course of 10-item TSK scores (mediator variable) for intervention and control groups 
over two years follow-up 
 
 
The observed trajectories of the outcome measure in the treatment and control groups were then 
examined (Figure 7.3b). The treatment group showed a linear decrease in disability scores 
compared to the control group, which showed no change in disability over the first two months 
and also no change between 12-month and 24-month follow-up. The mean RMDQ scores at 
baseline showed a small difference (0.7 point) despite randomisation. 
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Figure 7.3b. Course of 23-item RMDQ scores (outcome variable) for intervention and control 
groups over two years follow-up 
 
 
In LGM, these observed trajectories were incorporated by the slope factor of the model using the 
factor loadings, or factor scores (see Figure 7.2). The intervals at which the measures were taken 
also need to be taken into account when estimating these scores. Figure 7.2 shows potential 
factor loadings if the measures were taken at equal time intervals and if the scores represented a 
positive linear trend. However, the Back In Action trial does not have equally spaced 
measurement intervals and the observed course of scores for the two intervention groups did not 
follow a linear trend. To take account of this, the factor scores of the slope factors for the 
mediator and outcome were estimated based on the observed trajectories, taking into account 
the unequal measurement points (see Figures 7.4a and 7.4b).  
 
The factor scores were based on the observed trajectory for both the treatment and control 
groups combined. This will result in a better-fitting model than if just the treatment group scores 
were used, as the groups will be compared using the co-variate of treatment group allocation in 
the full mediation model. The factor scores for both the mediator and outcome trajectories 
appeared to provide an adequate fit to the data, as indicated by the goodness-of-fit statistics  
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(Tables 7.5a and 7.5b). CMIN was statistically significant, indicating poor fit. The RMSEA value also 
indicated poor fit. However, the remaining indices suggested good fit, so overall it was agreed 
that the model provided adequate fit to the data. Judgement of model fit statistics is subjective as 
no one index is superior to any other, so a decision was made based on the results of all the 
indices collectively. 
 
Figure 7.4a. LGM model for fear-avoidance beliefs (10-item TSK) 
 
 
 
 
 
 
 
 
 
 
Table 7.5a. Model fit statistics for growth curve model of 10-item TSK 
Model Index Current Model Good Model Fit 
 
CMIN (Chi Square) 62.53 Non-significant result 
DF 14 
P 0.00 
CMIN/DF 4.47 Between 2-5 
CFI 0.95 >0.95 
RMSEA 0.12 (90% CI 0.09 to 0.15), p<0.01 <0.08 
SRMR 0.05 <0.08 
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Figure 7.4b. LGM model for disability (23-item RMDQ) 
 
 
 
 
 
 
 
 
 
 
Table 7.5b. Model fit statistics for growth curve model of 23-item RMDQ 
Model Index Current Model Good Model Fit 
 
CMIN (Chi Square) 49.95 Non-significant result 
DF 14 
P 0.00 
CMIN/DF 3.57 Between 2-5 
CFI 0.96 >0.95 
RMSEA 0.10 (90% CI 0.07 to 0.14), p<0.01 <0.08 
SRMR 0.04 <0.08 
 
7.11.2 Latent Growth Modelling: Parallel Process Models (Step 3.2) 
The next step was to run the models together to test for co-variances between each of the 
Intercept and Slope factors and explore how the potential mediator and outcome variables relate 
to each other, before adding the intervention variable to complete the model. Crucially, it is 
important to test whether change in the potential mediator is related to change in the outcome 
variable, as this is a necessary preliminary step in mediation analysis. At this stage, while this 
model examines how change in the potential mediator and outcome variables is related, it does  
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Within-domain Co-variance 
Between-
domain Co-
variance 
not look at differences between the intervention and control groups. A simplified model is shown 
in Figure 7.5 below. This figure does not include the measurement part of the model or error 
terms, but these are the same as those presented in Figures 7.4a and 7.4b. The model fit statistics 
in Table 7.6 indicated that this model provided only an average fit to the data overall, so further 
investigation was needed to see if model fit could be improved. The standardised residuals were 
all within the ±1.96 threshold for the original model, suggesting that all were within the 
acceptable range. Modification indices were therefore examined, and it was found that allowing 
co-variation between the error terms for the TSK and RMDQ 12-month follow-up scores and 
between the error terms for the TSK and RMDQ two-month follow-up scores slightly improved 
model fit (see Table 7.6). As it is likely that each of the measurement points are related to each 
other, and that this may be reflected in related error variance (Campbell et al 2013b), it was 
decided that allowing these co-variances made theoretical sense. Further modifications did not 
appear to be theoretically plausible and therefore no further changes to the model were made. 
 
Figure 7.5 Simplified LGM model to show relationships between mediator and outcome variables 
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Table 7.6 Model fit statistics for parallel process model without treatment group allocation as a 
co-variate 
Model Index Original Model Modified Model Good Model Fit 
 
CMIN* (Chi Square) 217.71 154.88 Non-significant result 
DF 51 49 
P 0.00 0.00 
CMIN/DF 4.27 3.16 Between 2-5 
CFI 0.91 0.94 >0.95 
RMSEA 0.12 (90% CI 0.10 to 
0.13), p<0.01 
0.10 (90% CI 0.08 to 
0.11), p<0.01 
<0.08 
SRMR 0.05 0.05 <0.08 
 
Table 7.7 gives the results of the means, co-variances and variances between the intercept and 
slope of each variable. The mean change in both TSK and RMDQ indicated a slight, statistically 
significant decrease over time in both variables. The within-domain co-variance, relating to the 
intercept and slope of the same construct (Byrne 2010), showed a positive estimate between TSK 
intercept and slope and a negative estimate between RMDQ intercept and slope. This suggested 
that people who scored highly on the TSK at baseline had a higher rate of decrease in scores than 
those who scored lower, while for the RMDQ, people who scored higher at baseline had a lower 
rate of decrease in scores. However, both of these estimates were very small and did not reach 
statistical significance. The between-domain co-variances gave much higher, statistically 
significant values. The high value between the TSK and RMDQ slope factors suggested that as TSK 
scores change the RMDQ scores also change. The high value between the two intercepts 
suggested that people who scored highly on the TSK are likely to also score highly on the RMDQ. 
Finally, the statistically significant variances for each latent factor indicated strong individual 
variation amongst participants, especially in the initial scores. This is likely to be due to the fact 
that primary care patients with chronic LBP are a very heterogeneous population who are likely to 
have variable levels of disability and fear-avoidance beliefs. To test for an intervention effect, the 
next step is to add treatment group allocation as a co-variate in the analysis.  
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Table 7.7 Means, co-variances, correlations and variances between mediator and outcome 
variables 
 Variables 
 
Estimate Standard Error p-value 
Means TSK Intercept (baseline value) 41.14 0.56 0.00 
TSK Slope  
(change over all time points) 
-3.06 0.32 0.00 
RMDQ Intercept 11.81 0.36 0.00 
RMDQ Slope -1.38 0.15 0.00 
Co-variances TSK Intercept <-> TSK Slope β= 1.06 
b= 0.05 
2.71 0.49 
TSK Intercept <-> RMDQ Intercept β= 20.79 
b= 0.60 
3.10 0.00 
TSK Slope <-> RMDQ Slope β= 3.64 
b= 0.86 
0.68 0.00 
RMDQ Intercept <-> RMDQ Slope β= -0.31 
b= -0.04 
0.79 0.69 
Variances  TSK Intercept  52.05 6.69 0.00 
TSK Slope 7.93 2.30 0.00 
RMDQ Intercept 23.06 2.81 0.00 
RMDQ Slope 2.24 0.50 0.00 
β = Unstandardised estimate 
b = Standardised estimate 
 
Figure 7.6 shows the LGM for the mediator with treatment group allocation as a co-variate. This 
model is identical to the previous model but provides additional information about whether the 
initial status and change in the mediator and outcome variables differ as a result of treatment 
group allocation. The model provided a very similar fit to the data as the model without the 
treatment group allocation variable (Table 7.8). The standardised residual co-variances were 
therefore examined, which suggested that a large number of parameters should be 
unconstrained. However, too many co-variances exceeded the ±1.96 threshold for changes to be 
feasible. Modification indices were therefore examined, which indicated that allowing co-
variation between the error terms for TSK and RMDQ scores at 12-month follow-up, TSK score at 
12-month follow-up and RMDQ score at two-month follow-up, and TSK and RMDQ scores at two-
month follow-up would result in a better fitting model (see Table 7.8). The co-variation between 
TSK score at 12-month follow-up and RMDQ score at two-month follow-up is less intuitive than 
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co-variances between the variables at the same time points, but could reflect a relationship 
between early change in disability and later change in fear-avoidance beliefs. 
 
In the present analysis the values of interest are the regression coefficients between treatment 
allocation and the slopes and intercepts for the mediator and outcome (Byrne 2010). Table 7.9 
shows that intervention group allocation significantly predicted the rate of change for both the 
TSK and RMDQ measures, but not the initial status, which is expected given random allocation of 
participants to intervention groups. As the intervention variable was coded 0 for the control 
group and 1 for the intervention group, the slope values for TSK and RMDQ suggest that change in 
the TSK and RMDQ measures was substantially higher in the intervention group, particularly for 
the change in TSK. This is indicated by the estimates of -0.26 and -0.65 for TSK and RMDQ scores 
respectively (see Table 7.9), showing how they have decreased over time in the intervention 
group compared to the control group. 
 
Figure 7.6 Simplified LGM model to show relationships between mediator and outcome variables, 
with treatment group allocation as a co-variate 
 
 
 
 
 
 
 
 
 
TSK 
Intercept 
TSK Slope 
RMDQ 
Intercept 
RMDQ 
Slope 
Intervention 
(Control=0; 
Intervention=1) 
Chapter 7 Back In Action Page 224 
 
Table 7.8 Model fit statistics for parallel process model with treatment group allocation co-variate 
Model Index Original Model Modified Model Good Model Fit 
 
CMIN (Chi Square) 237.21 172.17 Non-significant result 
DF 57 54 
P 0.00 0.00 
CMIN/DF 4.16 3.19 Between 2-5 
CFI 0.91 0.94 >0.95 
RMSEA 0.12 (90% CI 0.10 to 
0.13), p<0.01 
0.10 (90% CI 0.08 to 
0.11), p<0.01 
<0.08 
SRMR 0.05 0.04 <0.08 
 
Table 7.9 Mean values for mediator and outcome, related to treatment group allocation 
 Variables 
 
Estimate Standard Error p-value 
Regression 
Coefficients 
TSK Intercept β = 0.10 
b= 0.01 
1.12 0.93 
TSK Slope β= -0.26 
b= -0.45 
0.61 0.00 
RMDQ Intercept β=0 .21 
b= 0.02 
0.72 0.77 
RMDQ Slope β= -0.65 
b= -0.22 
0.29 0.02 
β = Unstandardised estimate 
b = Standardised estimate 
 
7.11.3 Latent growth modelling: Mediation analysis (Step 3.3) 
Finally, the full mediation model was tested by adding a path between the mediator and outcome 
variables. The bold lines on Figure 7.7 below highlight the mediating pathway. Each of the beta 
coefficients shown on this Figure represent the direct effect of each variable on the other, as 
indicated by the direction of the arrow. However, it must be acknowledged that LGM, like SEM, is 
a correlational technique and therefore it cannot be established whether the effect is in the 
hypothesised direction. The standardised coefficients show that the intervention is associated 
with a decrease in the TSK slope (-0.44) and that this decrease is associated with a decrease in the 
RMDQ slope (-0.79). There is a small direct effect (0.12) on RMDQ slope but this is not in the same 
direction (positive) as the other coefficients. Table 7.10a shows that the mediated effect (product 
of coefficients; in this case, -0.44 * -0.79 = -0.35 (95% CI -0.47 to -0.24)) was statistically 
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significant, indicating that differences between intervention and control in change in the observed 
trajectory of the fear-avoidance beliefs variable mediated some of the change in the observed 
trajectory of the outcome measure. However, none of the model fit statistics for this final model 
suggest that it provided a good fit to the data (see Table 7.10b) and modifying the model using 
the standardised residual co-variances and modification indices did not help to improve fit. This 
means that the model as currently hypothesised does not fully explain how the treatment worked 
for this particular patient population, as there is key information missing. The study hypothesis, 
that allocation to the activation intervention arm was associated with a reduction in fear-
avoidance beliefs and that this reduction was associated with a reduction in disability outcome, 
was therefore partially supported, but suggests that other mediating factors must be considered. 
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Figure 7.7 Full mediation model: Change in fear-avoidance beliefs (10-item TSK) as a mediator 
between treatment allocation and change in disability outcome (23-item RMDQ) 
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Table 7.10a Mediating effect of change in fear-avoidance beliefs (10-item TSK) on the relationship 
between treatment allocation and change in disability (23-item RMDQ)  
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
RMDQ (23-item)
∆
 Total (ć) -0.22 (-0.40 to -0.02) -0.66 (-1.20 to -0.08) 
Direct (c) -0.11 (-0.11 to 0.33) -0.31 (-0.31 to 1.01) 
Indirect (ab) -0.35 (-0.48 to -0.23) -1.03 (-1.49 to -0.67) 
∆
=residualised change 
 
Table 7.10b Model fit statistics for full mediation model 
Model Index Full Mediation Model Good Model Fit 
 
CMIN (Chi Square) 1095.17 Non-significant result 
DF 63 
P 0.00 
CMIN/DF 17.38 Between 2-5 
CFI 0.46 >0.95 
RMSEA 0.26 (90% CI 0.25 to 0.28), p<0.01 <0.08 
SRMR 0.36 <0.08 
 
 
7.12 Discussion 
7.12.1 Summary 
The focus of this chapter was to test an analytical approach, recommended by the literature, in a 
dataset from an RCT and also to test the study’s hypothesis that change in fear-avoidance beliefs 
helped to explain the reduction in disability scores seen in the intervention arm of the trial (i.e. 
that change in fear-avoidance beliefs was a mediator of the relationship between treatment 
allocation and disability improvement).  
 
The technique of LGM used to carry out this analysis proved a useful, if complex, technique for 
mediation analysis. It allowed for the conduct of the preliminary steps outlined in the previous 
chapters, but unlike the previous analyses it allowed a number of time points to be included 
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simultaneously in the model. As one of the requirements for future trials set out in Chapter 3 was 
an increased number of time points to be included in studies, this technique is likely to prove 
useful in future mediation analysis studies. 
 
The results of this analysis showed that there were associations between the intervention and 
change in fear-avoidance beliefs, and between change in fear-avoidance beliefs and change in 
disability. There was a significant mediating effect of change in fear-avoidance beliefs on the 
relationship between treatment allocation and change in disability. This suggests that targeting 
fear-avoidance beliefs in an intervention for chronic LBP patients would be beneficial. However, 
the final mediation model provided a poor fit to the data, suggesting that key information is likely 
to be missing from the hypothesised model and that other mediating factors should be 
considered.  
 
7.12.2 Comparison with previous findings 
This analysis adds to a currently small evidence base for treatment mediators of LBP interventions 
(see Chapter 4). It is the first study, to the author’s knowledge, that has used LGM for analysing 
mediators in a LBP intervention study. Having a specific focus during an intervention, in this case 
on addressing fear-avoidance beliefs, may help make the study more suitable for mediation 
analysis, provided the variable of interest is well measured and measured often, and may also be 
more likely to demonstrate a stronger mediating effect than an intervention which has a less 
specific focus on a particular construct.  
 
This study also adds to the small but growing number of studies that have used LGM as a 
technique for examining mediation with RCT data. Guidelines from previous LGM studies in other 
areas of health psychology were followed (Cheong et al 2003; Roesch et al 2009). However, it is 
difficult to compare the mediating effects found in these studies with those found in the present 
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study as different populations were examined and the intervention length differed (for example 
Cheong et al’s study included booster sessions to help participants retain knowledge of the 
intervention and Roesch et al’s intervention lasted 12 months), which could have an effect on the 
strength of any mediating effects found. A recent study also claimed to use Cheong et al’s 
technique to carry out their mediation analysis on a RCT data from an intervention to prevent 
child behavioural problems (Piehler et al 2014), but while this study utilised LGM they obtained 
their mediating effect using the Baron & Kenny approach rather than using the product of 
coefficients. 
 
7.12.3 LGM as a mediation analysis technique 
Using LGM to test for mediating effects has several advantages over using SEM, specifically the 
advantage of being able to study change across more than two time points. This gives it the 
potential to address a key problem with current mediation studies, temporality (see Section 
7.12.4) which is not currently adequately addressed. However, the use of LGM alone, as this study 
shows, cannot address temporality without including an adequate number of time points that will 
capture change when it occurs. Also, unlike SEM it cannot include latent variables in the analysis. 
This does have the disadvantage of assuming no measurement error in the tools used to assess 
the variables of interest, an assumption which is difficult to make when assessing psychological 
factors (See Chapter 3, Section 3.2.5). The specific measures used in this study, particularly the 
measure used for the potential mediator (10-item TSK), were not well validated in this population 
(see Section 7.10.2), and the low internal consistency value found for the modified TSK (0.66) 
suggests that the measure may not be reliable. The use of such a different technique in the 
present analysis also precludes comparison with the SEM analysis carried out in Chapter 6, which 
included latent variables and fewer time points. However, the purpose of this analysis was to use 
the method most suited to answering the study hypothesis as to how the intervention worked,  
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and also to improve the validity of the mediation analysis by using optimal methods, rather than 
compare results across different studies. The study hypothesis and design of this study is different 
to that used in the STarT Back trial (Chapter 6) and therefore required different analysis methods.  
 
One problem encountered when conducting this analysis was the lack of studies that had applied 
this technique to mediation analyses of intervention studies previously, and it was the first time 
that this approach had been used in this topic area. This meant that there was little guidance 
around how to carry out the analysis (Cheong et al 2003; Roesch et al 2009; Byrne 2010) so time 
had to be taken to adequately develop and apply the model in order to produce robust results. 
Some of the decisions made in this analysis, such as which factor score values to assign to the 
slope factors, are based on personal judgement on what best seemed to fit the data. Whilst it was 
felt that such decisions were justifiable and sensitivity analyses to compare other models was 
carried out (see Appendix 7.2) it is possible that these models may not be generalisable to other 
intervention studies. 
 
7.12.4 Potential limitations 
Similar to the STarT Back trial the intervention in this trial was complex, involving several sessions 
with a multidisciplinary team and several different components. While several of these sessions 
did focus on reducing fear-avoidance beliefs, much of the intervention actually focused on goal-
setting and on plans to achieve those goals. These are likely to be highly variable depending on 
the individual patient, and could depend on factors such as self-efficacy or internal control, or the 
patient’s relationship with their therapist. These factors could also potentially be treatment 
mediators along with fear-avoidance beliefs but they were not considered as mediating factors in 
the original study and no measures of them were provided, so they could not be tested. 
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It could also be that the population included in the intervention did not score particularly highly 
on the fear-avoidance beliefs measure used. However, little information is available on an 
acceptable cut-off for a ‘high’ TSK score, and no information is available on the 10-item measure 
used in this study. Previous studies using the Swedish and Dutch versions of the 17-item TSK have 
recommended a cut-off of 37 for ‘high’ fear (Vlaeyen et al 1995a; Vlaeyen et al 1995b; Lundberg 
et al 2006). In this study, the trial authors scored the 10-item TSK in a way that made it 
comparable with the 17-item version. If these cut-offs are applied to the present study, it would 
appear that both the treatment and control groups have high fear at baseline (mean score over 
37) and while in the treatment group this score decreases (below 37 at each follow-up point), in 
the control group the scores at each follow-up point remain above this cut-off. 
 
The tools used to measure the variables of interest in this study, the RMDQ (functioning) and TSK 
(fear-avoidance beliefs), were modified versions of the original tools. The RMDQ provided an 
adequate value of internal consistency and other aspects of its psychometric properties are 
supported by evidence from other sources (see Section 7.10.2) but the modified version of the 
TSK used in this study did not. This finding is supported by literature on the factor structure of 
other versions of the TSK. However, internal consistency is only one property that can affect a 
measure’s performance; responsiveness is another important measurement property when 
looking at mediation, as we are looking at change over time, and this property warrants further 
investigation for the TSK. This study did demonstrate that significant change occurred across the 
time points used in the study, but this is based on how well the measures assessed change. In 
future studies therefore, the measurement properties of the tools used in mediation analysis 
ideally should be assessed prior to their inclusion in the study as they may have an impact on the 
results of the analysis.  
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One of the key reasons given in the literature for using LGM for mediation analysis is that it allows 
the inclusion of several time points. This helps to better assess temporality, or when the variables 
change in relation to each other. Despite its increased complexity compared to the analyses 
presented in Chapters 5 and 6, this analysis still cannot address the issue of temporality, as 
although the model hypothesised that the intervention led to a change in fear-avoidance beliefs 
which in turn led to a change in disability, it could perhaps be that the change in disability 
occurred before or concomitantly with the change in fear-avoidance beliefs. This was because 
while the Back In Action study collected data across five time points, it did not collect any data 
while the intervention was taking place. This limits the true assessment of treatment-mediated 
effects as it is likely that the follow-up scores show a more diluted effect of the intervention than 
at the time of participants receiving it. Figures 7.3a and 7.3b show that the change in both fear-
avoidance beliefs and disability happens early on, but it is still not possible to see when these 
variables changed and crucially, which changed first. One way of potentially addressing this issue 
would have been to look at the intercept of the mediating variable and the slope of the outcome, 
rather than the slopes of both variables (to see whether baseline levels of fear-avoidance beliefs 
predict change in disability) (Selig & Preacher 2009), but that would have been illogical in this 
analysis as the hypothesis was around change in the mediator as well as the outcome. Looking at 
change in the mediator at an earlier stage than change in the outcome is another option, but 
again not possible in this analysis as the first follow-up point was two months post-treatment, at 
which any change that was expected to happen in both the mediator and outcome variables 
would have already occurred. However, such analysis is possible using LGM provided that there 
are enough time points to allow examination of early and later change. This again stresses the 
need for assessment points during treatment. 
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Imputation was carried out on this dataset in order to obtain statistics required for mediation 
(bias-corrected bootstrapped CIs) and model fit (SRMR). Overall there was only a small amount of 
missing data throughout the follow-up periods, but the test for whether or not data was missing 
at random indicated that at two-month follow-up, data was not MCAR but MAR or possibly 
NMAR. However, the dropout at the two-month follow-up point was very small (n=10 (8% of total 
sample)), so this follow-up point was still included in the analysis as it was felt that the risk of bias 
due to dropout at this follow-up point would be low.  
 
The issue of model fit in SEM and LGM is challenging. No consensus exists over which indices are 
most useful to focus on, and different authors give different cut-off points for good fit which adds 
to the uncertainty and subjectivity when attempting to interpret these values. If a model does not 
fit well and improvements cannot be made to it to improve the fit, it is unclear whether the 
answer is to reject the hypothesised model outright (i.e. change in fear-avoidance beliefs is not a 
mediator of the effect of treatment allocation on change in disability); to accept that the model 
does not provide the complete picture as to what factors mediate the effect of treatment 
allocation on outcome in this study (i.e. fear-avoidance beliefs is a mediator but is not the only 
factor in the pathway - a highly likely conclusion in any mediation study); or whether there are 
other issues that have impacted on model fit such as methodological errors (e.g. timing of 
measurements, or inadequate internal consistency of the potential mediator). Byrne (2005) states 
that a lack of model fit implies implausible relationships between the variables, but it is still 
unclear whether this means there is information missing from the model or whether the model is 
simply wrong. It is also unclear what level of importance should be given to the fit indices – 
equivalent models may fit just as well (Tomarken & Waller 2003), and even if a model fits well it 
may still be misspecified (Tomarken & Waller 2003; Hayduk 2014). Many authors have expressed 
caution over making modifications to models that do not fit well (e.g. Tomarken & Waller 2003;  
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Byrne 2010), as additional paths may mean the model cannot be generalised to other samples 
(Tomarken & Waller 2003). In the present analysis, attempts were made to modify the models 
where necessary at each stage to improve fit, but these modifications were only made if it was 
felt that the modification made theoretical sense. The final full mediation model in the present 
study did not fit the data sufficiently, despite attempts to improve fit through the use of 
modification indices. I have interpreted this as suggesting that the model is incomplete, with key 
mediating variables missing from the model. This means that the hypothesis that allocation to the 
treatment arm would lead to a reduction in fear-avoidance beliefs and subsequently to an 
improvement in disability was partially supported, as while fear-avoidance beliefs is clearly not 
the sole variable on the mediating pathway it is still an important mediating factor.  
 
7.12.5 Clinical Implications 
Clinically, the findings from this study suggest that fear-avoidance beliefs play a role in the 
explanation of treatment outcome when a treatment specifically focuses on targeting this factor. 
Future treatments should perhaps include only patients who are found to be highly fear-avoidant, 
or tailor treatment to focus fear-avoidance belief reduction on patients who are most severe. 
However, this analysis represents only one study and more research is needed to support these 
findings, preferably research that accounts for the limitations discussed above. Few additional 
variables that could have played a key role in the success of this intervention (such as self-
efficacy) were measured, and the role of other factors in this intervention are therefore unclear. 
Another concern is that the measure of fear-avoidance beliefs available in this dataset has not 
been validated previously, and its internal consistency in this dataset was poor. A stronger 
measure of fear-avoidance beliefs, to ensure more confidence that this construct is indeed a 
mediator of outcome, is required in future studies. 
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In order to improve the delivery of future interventions, it would also be helpful to see which 
aspect of the intervention led to a change in fear-avoidance beliefs. For example, if this was after 
the first session, when fear of pain was explicitly discussed, it could be that this session was the  
one that was important in changing fear-avoidance beliefs. Measurements taken during the 
treatment period would give much more information on key variables that the intervention aimed 
to change, so that future interventions can be tailored to only include sessions found to impact on 
factors of importance. 
 
 
7.13 Conclusion 
Using LGM to investigate mediating factors was found to be a valid and useful technique when 
investigating studies with multiple time points. This type of analysis will be useful in future studies 
of mediation to allow exploration of the temporal nature of variables of interest. The reduction of 
fear-avoidance beliefs through a multidisciplinary intervention appeared to be a mediating factor 
for the reduction of disability in chronic LBP patients. However, a key problem still not resolved by 
this study is that of temporality. While this study included multiple time points and showed that 
LGM can be used to assess all of these time points when testing for treatment mediation, none of 
the assessments were made during the intervention period. The next chapter in this thesis 
provides analysis of assessments made during the intervention period by means of a diary study, 
which will help answer the final thesis objective of exploring treatment processes.  
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Chapter 8: Using Diary Data to Examine the Importance of Measuring 
During Treatment for the Analysis of Mediating Factors: IMPACT Dataset 
 
8.1 Introduction 
This chapter builds on previous chapters which highlighted the main issues encountered when 
conducting mediation analysis and the different methods that can be used to try and counteract 
these problems. The present chapter examines a particular issue, temporality, which has been 
difficult to address so far. One of the main reasons for this difficulty is the lack of studies that have 
measured key mediators and outcomes during the treatment process. The analysis presented 
here includes constructs that were measured at weekly intervals during the participants’ 
treatment period, as well as at pre-treatment, post-treatment and three-month follow-up. The 
purpose of this chapter is to examine whether temporality can potentially be established by the 
inclusion of measures during treatment, as stated in the literature, and also whether the inclusion 
of such measures will help improve future treatment mediation analyses. 
 
 
8.2. Rationale for Study 
Several authors have highlighted that a key design issue in studies of mediation of treatment 
effect is establishing temporality, or change over time. Many have recommended that a larger 
number of repeated assessments should be included in randomised controlled trials (RCTs) so we 
can establish not only efficacy, but also the processes of change (Kazdin 2007; Laurenceau et al 
2007; Burns et al 2015). Assessing variables only at pre- and post-treatment, as is typically done in 
RCTs, cannot tell us anything about how factors change over time. In fact, it leads us to assume a 
linear relationship between potential mediators and outcome which is unlikely to be the case 
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(Laurenceau et al 2007). Examining individual trajectories of change over time may therefore be 
more meaningful in identifying mediators (Kraemer et al 2002; Laurenceau et al 2007).  
 
A related and important aspect is when these assessments take place. It is important that the 
hypothesised timing of when mediators are likely to change is taken into account when deciding 
when to assess variables in the study (Laurenceau et al 2007; Preacher 2015), as the use of 
different measurement intervals are likely to expose or miss relationships between variables 
(Collins & Graham 2002) depending on the true underlying mediating process. For example, if 
measurements are taken too far apart in time or too early on, relationships might be missed as 
the effects may take some time to emerge. It is therefore very important to decide a priori when 
the best measurement time-point is for each variable of interest (Laurenceau et al 2007). 
Assessing variables at only two time points also raises issues around measurement error 
(Laurenceau et al 2007). While adding a mid-point assessment has been suggested as a way of 
improving this issue, this point is often arbitrary and not based on theory or research findings  
(Laurenceau et al 2007) meaning that mediating effects may still be missed. 
 
However, it is also acknowledged that the decision of when to measure key variables is not easy 
to make currently, as there is little available evidence to support any a priori decisions (Collins & 
Graham 2002). Repeated assessments have therefore been recommended as a way of best 
establishing when factors change. Longitudinal designs that incorporate large numbers of 
assessments through the use of monitoring forms and diary studies allow the collection of a large 
amount of data on specific questions and help minimise recall bias (Laurenceau et al 2007). They 
also allow greater flexibility, with a choice of measurement points to better investigate change 
over time (Collins & Graham 2002). However, repeated assessments increase costs in terms of 
materials and patient burden which may reduce study uptake and/or increase dropout rates 
(Laurenceau et al 2007). 
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The use of diary data, where a small amount of information on each construct of interest is 
collected several times, may be one way of balancing responder burden and costs with the need 
to collect data more frequently. Bolger et al (2003) summarise the many advantages of diary 
studies for investigating how people change over time, the within- and between-person variances 
in such changes, and the processes underlying these changes. They also emphasise the 
importance of temporality and how the decision of when to measure particular constructs must 
be based on theoretical understanding of when the construct of interest is most likely to change. 
Bolger et al also acknowledge that in many cases there may be little evidence of when constructs 
may be likely to change, and in these cases advocate a priori, well thought-out decisions on when 
would be the best time to measure specific constructs of interest are required. However, they 
suggest that more frequent intervals might be better than less frequent intervals, which may lead 
to greater responder burden. 
 
In summary, the addition of measurements collected during the treatment period has been 
suggested as a way to improve mediation studies by giving more information on when potential 
mediators change and whether this is before or after change in the outcome of interest. Using 
diaries to collect this information, which often contain only single questions per construct, may be 
a way of collecting information during treatment in a way that leads to minimal increase in 
responder burden. 
 
 
8.3 Current Study 
The purpose of this analysis was to investigate whether including information on key mediators of 
interest during treatment as well as pre- and post-treatment can improve future mediation 
analyses. The objectives were three-fold:  
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• To investigate at what point potential mediating factors might change (improve), and the 
type of improvement observed, in order to help inform where the optimal measurement 
points might be in future mediation studies;  
• To investigate whether the inclusion of data measured during treatment provides more 
information than pre-post analysis, thus helping to answer the question of whether 
measuring factors of interest during treatment is necessary; 
• To compare those who did well (less disability at post-treatment) with those who did not, 
and investigate to what extent change in potential mediating factors is associated with 
this change (i.e. what was key/important in leading to improved outcome). 
 
 
8.4 Study Sample: IMPACT Service 
The IMPACT programme is a locally delivered NHS psychological group treatment programme 
based on Acceptance and Commitment Therapy (ACT), a form of cognitive-behavioural therapy, 
for people with chronic pain. This treatment is explained in detail in Chapter 1. Patients are either 
referred by their GP or from secondary care pain or musculoskeletal (MSK) services and therapy is 
delivered in groups. Diary data on factors relevant to the treatment programme (what the ACT 
programme is aimed at changing) is collected weekly as part of the patient’s therapy, and the 
scores are discussed as part of team meetings about each patient’s individual progress. No data 
was available on these patients’ demographic characteristics from the IMPACT service to preserve 
confidentiality. Data were available for 80 patients at baseline (pre-treatment) (see Table 8.1). 
This data is not part of an RCT (so no control group is included), and all patients received the same 
treatment programme. 
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In the IMPACT service, patients are seen in groups of a maximum of 12, although some groups 
may be as small as two patients if dropout occurs over the programme period (J Levell, personal 
communication). There is no set content for each session, with areas being revisited as needed or 
as requested by patients. Measures of several of the core processes in ACT were taken, and are 
described below. 
 
The analyses presented in this chapter utilised data collected between January 2011 and May 
2012. Patients in this dataset therefore were part of different treatment groups and started and 
finished their treatment at different times depending on what group they were in. However, in 
this analysis the patients were analysed as a single group cohort, as it was not clear which 
patients belonged to which group. No important changes were made to the programme during 
the period of time these data were collected so all patients received the same treatment 
programme. All patients were provided with an information sheet explaining that any information 
they provided in the questionnaires may be used for research and gave consent for their 
information to be used in this way. Approval was provided by Staffordshire Research Ethics 
Committee in 2011 (Ref 10/H1203/57). 
 
Table 8.1 Baseline (pre-treatment) characteristics of study population (n=80) 
Variable Mean (SD) or % 
Completed treatment 96.3% (n= 77) 
Current Pain at baseline (0-10) 5.9 (1.7) 
Average Pain at baseline (0-10) 7.3 (1.59) 
Least Pain at baseline (0-10) 4.8 (1.98) 
Sickness Impact Profile (SIP) Disability score at 
baseline (0-1) 
0.22 (0.15) 
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8.4.1 Measures 
The measures of interest in this study were disability (outcome) measured at pre-treatment, post-
treatment and at three-month follow-up using the Physical Disability subscale of the Sickness 
Impact Profile (SIP (Bergner et al 1981)), and the five potential mediators which were taken 
weekly before each treatment session (see Table 8.2). These questions were not taken from a 
validated questionnaire but instead were devised by the IMPACT team. Some of the potential 
mediators map directly onto some of the key ACT processes, for example Struggle is a measure of 
cognitive defusion, Willingness is a measure of acceptance, Values is a measure of valued action 
and Workability is a measure of committed action. 
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Table 8.2 Summary details of outcome and process measures 
Questionnaire/Sub-scales When measured How scored 
Sickness Impact Profile (SIP) Pre-treatment, post-treatment and three-month follow-up Scores on each subscale range from 0 to 1 – score closer to 
1 indicates greater disability (Vowles et al 2013) 
Distress (Rate how upset and/or distressed you 
were overall in the past week) 
Pre-treatment, weekly during treatment, post-treatment 
and three-month follow-up 
0-10 Likert scale (0=None/Not at all to 10=Most/Worst 
Willingness (Rate how willing you were to have 
pain and distress in the past week) 
Pre-treatment, weekly during treatment, post-treatment 
and three-month follow-up 
0-10 Likert scale (0=None/Not at all to 10=Most/Worst) 
Struggle (Rate how much effort you put into 
making pain or upsetting thoughts, feelings or 
memories go away this past week) 
Pre-treatment, weekly during treatment, post-treatment 
and three-month follow-up 
 
0-10 Likert scale (0=None/Not at all to 10=Most/Worst) 
Workability (Rate how effective you were in taking 
actions that contributed to a better, more vital, 
quality of living in the past week) 
Pre-treatment, weekly during treatment, post-treatment 
and three-month follow-up 
0-10 Likert scale (0=None/Not at all to 10=Most/Worst) 
Valued Action (Rate how effective you were this 
past week in making progress in the areas of your 
life that matter to you) 
Pre-treatment, weekly during treatment, post-treatment 
and three-month follow-up 
0-10 Likert scale (0=None/Not at all to 10=Most/Worst) 
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8.5 Methodology 
All analyses were carried out using SPSS PASW Version 19. Because an increase in distress score 
originally meant a negative change (more distress) in the dataset, the distress item was reverse 
scored so that a higher score in distress indicated a positive change (improvement). This is to 
make the scoring consistent with the other potential mediator variables. 
 
8.5.1 Missing data 
Of the 80 patients who initially enrolled in the treatment, only three did not complete treatment. 
Reasons for this included stress and further investigations for health problems. However, a 
further six patients did not complete the post-treatment follow-up questionnaires and a total of 
32 patients did not complete the three-month follow-up questionnaires (40% of the original 
sample). Response bias analysis was therefore conducted to see whether those who did not 
respond at post-treatment and three-month follow-up differed substantially at pre-treatment 
(baseline) from those who did respond. Descriptive statistics were provided for responders and 
non-responders at pre-treatment to describe the differences between each group. Comparisons 
between responders and non-responders were made for baseline disability score and baseline 
values of depression, pain-related anxiety and each of the potential mediator variables. 
Depression and anxiety were included because, while these were not key targets for treatment in 
ACT and therefore not included in the analysis, it was felt that these factors might be important in 
describing the population. 
 
8.5.2 Descriptive analysis 
Descriptive statistics (means and standard deviations (SDs)) were calculated for each potential 
mediator variable and the outcome measure at pre-treatment, post-treatment and three-month 
follow-up. This was to see if the measures showed a pattern of change over time. Percentage 
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change from pre-treatment score was also calculated for each variable to show the proportion of 
change occurring at post-treatment and three-month follow-up. 
 
8.5.3 Analysing change 
This analysis examined change over time to investigate when this occurs and whether the 
inclusion of assessments during treatment is useful. Leffondré et al (2004) describe 27 different 
ways of examining change, which they grouped into five categories: basic descriptives, including 
the range and examining means over time; elementary measures, which examine change between 
the first and last score (such as the difference between the first and last score, or the slope in a 
latent growth model (LGM)); the examination of non-linearity and inconsistency of change, which 
are based on the change between two consecutive scores in the same case (such as SD of the first 
differences or mean of absolute first differences), with a high value being indicative of non-
linearity and inconsistency respectively; the examination of sensitivity to abrupt short-term 
fluctuations, or the difference between two consecutive first differences (i.e. if a large increase in 
score is followed immediately by a large decrease), which include the maximum absolute second 
differences (a large value would indicate at least one important abrupt change); and finally 
contrasting early and late change, which compares changes in early and later follow-up (such as 
the ratio between early and later change, or early and total change). For this analysis, it was 
decided that descriptive analyses and regression analyses should be produced to look at several 
different types of change that were identified in the Leffondré paper to address each of the 
objectives outlined above.  
 
Objective 1 involved classifying patients into groups to investigate different types of change. The 
categories of examining non-linearity and inconsistency of changes and examining sensitivity to 
non-monotonicity and to abrupt short-term fluctuations as described by Leffondré were thought  
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to be useful to examine, as it was anticipated that the changes across the time points would not 
necessarily be linear. Leffondré et al (2004) reported 14 different ways of measuring these 
categories of change, and provided criteria to help decide on the most appropriate measure to 
use for the present data. The authors also mention measures contrasting early vs. later change as 
important to examine. In the present analysis, cut-offs to describe change were based on clinically 
relevant cut-offs decided upon by the study team, rather than statistical cut-offs, to examine 
differences between individuals who changed early or later on in treatment, reported large or 
small change and reported consistent or inconsistent change. This was because the aim was to 
investigate clinically relevant change. In addition to this, change between pre- and post-treatment 
(elementary change) was examined to see how many patients reported improvement by post-
treatment. How the data were classified is described in Box 8.1 below. 
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Box 8.1 Types of change in potential mediators examined in the IMPACT dataset 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D1-D4= Diary assessment points weeks 1 to 4 (during treatment) 
 
Objective 2 involved comparing mean changes between pre-and post-treatment assessment with 
changes observed during treatment. Means and SDs were calculated for each measure at each 
available time point to see whether there was change over time for the cohort as a whole.  
Early vs. Late vs. None vs. Both Early and Late  
o 0 = No Improvement (< 1 point positive change at any time point) 
o 1 = Early Improvement (≥ 1 point positive change at D1 – PreTreat or D2 – D1) 
o 2 = Late Improvement (≥ 1 point positive change at D3 – D2, D4 – D3 or PostTreat – D4) 
o 3 = Both Early and Late Improvement (≥ 1 point positive change at D1 – PreTreat, D2 – D1, D3 
– D2, D4 – D3 or PostTreat – D4) 
 
Large vs. Small (change of 2 points at any point over the 4-week period) 
o 0 = Small Improvement (< 2 points positive change at any time point, includes no change and 
worsening) 
o 1 = Large Improvement (≥ 2 points positive change at any time point) 
 
Consistent vs. Not Consistent (for at least 2 time points) 
o 0 = Not Consistent Improvement (< 1 point positive change or ≥ 1 point positive change for 
less than 2 consecutive time points – includes worsening) 
o 1 = Consistent Improvement (≥ 1 point positive change for ≥ 2 consecutive time points – no 
worsening) 
 
Improved vs. Worsening vs. No Change (pre-post) 
o 0 = No Change (< 1 point at any time point) 
o 1 = Worsening (≥ 1 point decrease between pre- and post-treatment (negative change)) 
o 2 = Improvement (≥ 1 point increase between pre- and post-treatment (positive change)) 
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Individual scores were also plotted for each variable to get a sense of the amount of between-
patient variability in scores pre- and post-treatment and also during treatment. It was hoped that 
LGMs could be built here to make use of all the available time points, but the available sample 
size in the present analysis was too small (see Section 8.7 for further discussion). 
 
Objective 3 examined whether the potential mediators of interest were associated with 
improvement in outcome, as measured by residualised change in the SIP physical function 
subscale. Although this cannot establish whether the variable was a mediator, it will clarify its 
potential to mediate outcome by testing whether change in that variable was associated with 
change in outcome. Univariable linear regression analyses were used to compare how the 
different measures of change used in Objective 1 described the association between each of the 
potential mediators and change in the outcome (disability). As linear regression assumes normal 
distribution in the outcome variable, this was tested prior to the analysis. The % R
2
 change, F ratio 
and beta (b) are the statistics of interest in this analysis. These statistics give an indication of the 
amount of variance explained by the model (%R
2
), whether the model provides a good fit to the 
data (F ratio) and the strength of the relationship between the predictor and outcome (b) (Field 
2009). 
 
 
8.6 Results 
8.6.1 Missing data 
Table 8.3 shows the means and SDs for baseline characteristics of those who responded and did 
not respond at post-treatment and three-month follow-up. There were significant differences 
between the groups, with non-responders being more physically disabled, depressed, and anxious 
about their pain compared to responders at both post-treatment and three-month follow-up. This  
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demonstrated the likelihood of a degree of bias in the results, meaning that the findings may not 
be applicable to all patients with chronic pain, particularly those who are less likely to have a 
favourable outcome. 
 
Within the dataset there was also a substantial amount of missing data for a particular item in the 
diary study (Willingness), with between 25% and 56% missing data at each assessment point. On 
discussion with members of the IMPACT study team it was found that many patients struggled 
with the Willingness question, even by the end of treatment, and preferred not to give an answer 
to this question (J Levell, personal communication). The decision was therefore made to not 
include this particular item in the analysis, due to the small number of cases who had responded 
and the likely bias in these responses.  
 
Table 8.3 Baseline characteristics (Means and SDs) of responders versus non-responders at post-
treatment and three-month follow-up 
Measure Baseline assessment 
(Mean (SD)) (n=80) 
Post treatment  
Baseline values (Mean 
(SD))  
Three month follow-up 
Baseline values (Mean 
(SD))  
Resp 
(n=69) 
Non-resp 
(n=10) 
Resp 
(n=48) 
Non-resp 
(n=30) 
Physical Disability (SIP 
Subscale) Range 0-1 
0.2 (0.2) 0.22  
(0.2) 
0.3  
(0.2) 
0.2 
(0.2) 
0.3 
(0.2) 
Depression (British 
Columbia Major Depression 
Inventory (BCMDI)) Range 
0-80 
33.3 (12.4) 33.4 
(11.9) 
32.8 
(15.5) 
32.2 
(11.0) 
34.8 (14.2) 
Pain-related Anxiety (Pain 
Anxiety Symptoms Scale 
(PASS)) Range 0-100 
48.8 (19.0) 49.1 
(18.3) 
46.7 
(24.1) 
49.7 (18.9) 47.5 (19.3) 
Distress (0-10) 3.2 (2.5) 6.9  
(2.5) 
6.3  
(2.5) 
6.8 
 (2.6) 
6.9  
(2.4) 
Struggle (0-10) 7.1 (2.6) 7.2  
(2.5) 
6.6  
(3.0) 
6.5  
(2.8) 
7.9  
(2.0) 
Workability (0-10) 5.7 (2.4) 5.6  
(2.4) 
6.0  
(2.9) 
5.8 
(2.2) 
5.5  
(2.7) 
Valued Action (0-10) 4.8 (2.7) 4.8  
(2.7) 
4.6  
(3.1) 
4.8  
(2.8) 
5.0 
(2.7) 
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For the remaining data in the study, cases were classified as ‘missing’ if no data was available for a 
particular person at any follow-up time point. Cases were also classified as missing if less than one 
score was available for Early vs. Late Improvement and Small vs. Large Improvement (i.e. no score 
available for the first or last two measurements taken during treatment), or if less than two scores 
were available for Non-Consistent vs. Consistent Improvement. This was because for the first two 
types of change, at least one score during treatment is needed to see where change occurred and 
how large this was, and for the last type of change two scores were needed to establish whether 
the change was consistent. 
 
8.6.2 Descriptive analysis 
Table 8.4 shows the mean scores and SDs at each assessment period for the potential mediators 
and outcome measures. The proportion of change in the variable (follow-up score minus pre-
treatment score) is also expressed as percentage change. The percentages show that for Struggle, 
there was very little change at any time point; for Workability the largest proportions of change 
occurred at weeks 2 and 4 of treatment; and for Distress and Valued Action the most change 
occurred in the final weeks of treatment. Disability (measured only at pre- and post-treatment) 
improved by 27%.
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Table 8.4 Mean score (SD) and proportion change (%) at each assessment period for the outcome (SIP) and each potential mediator variable 
  Pre-
treatment 
(T2) Mean 
and SD 
 
Week 
1 (D1) 
Mean 
(SD) 
Proportion 
of change 
from pre-
treatment 
(%) 
Week 
2 (D2) 
Mean 
(SD) 
Proportion 
of change 
from pre-
treatment 
(%) 
Week 3 
(D3) 
Mean 
(SD) 
Proportion 
of change 
from pre-
treatment 
(%) 
Week 4 
(D4) 
Mean 
(SD)  
Proportion 
of change 
from pre-
treatment 
(%) 
Post-
treatment 
(T3) Mean 
(SD) 
Proportion 
of change 
from pre-
treatment 
(%) 
SIP Disability 
subscale (0-1) 
Higher score 
= less 
disability 
(reverse 
scored) 
0.22 (0.15) *** *** *** *** *** *** *** *** 0.16 (0.14) 27.2% 
Distress (single 
item diary question 
– 0-10 scale) 
Higher score 
= better 
functioning 
(reverse 
scored) 
3.2 (2.47) 3.4 
(2.70) 
6.3% 3.4 
(2.58) 
6.3% 4.0 
(2.50) 
25% 5.0 
(2.93) 
56.3% 5.4 (2.70) 68.8% 
Struggle (single 
item diary question 
– 0-10 scale) 
Higher score 
= more effort 
(positive) 
7.1 (2.56) 7.0 
(2.58) 
1.4% 6.8 
(2.20) 
4.2% 6.4 
(2.53) 
9.9% 6.4 
(2.80) 
9.9% 6.6 (2.59) 7.0% 
Workability (single 
item diary question 
– 0-10 scale) 
Higher score 
= more 
effective 
5.7 (2.44) 5.0 
(2.53) 
12.3% 5.3 
(2.40) 
7.0% 
 
5.8 
(2.26) 
1.8% 6.5 
(2.37) 
14.04% 7.0 (2.30) 22.8% 
Valued Action 
(single item diary 
question – 0-10 
scale) 
Higher score 
= more 
progress 
4.8 (2.72) 4.7 
(2.49) 
2.1% 5.4 
(2.17) 
12.5% 6.3 
(2.06) 
31.3% 6.9 
(2.26) 
43.8% 7.0 (2.35) 45.8% 
***=not measured 
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In Objective 1 the time at which change occurred in individuals who took part in the IMPACT ACT 
therapy was investigated by classifying individuals into groups to look at different types of change 
(see Box 8.1). For all of the potential mediator variables, change occurred later rather than earlier 
for the majority of patients (between 29% and 43% for the four variables - see Table 8.5) although 
change in Distress, Workability and Valued Action often occurred both early and later on (32.5% 
and 32.5% respectively for Distress; 38.8% and 28.8% respectively for Workability; 38.8% and 
33.8% respectively for Valued Action). A large change (improvement of two points or more) 
occurred for the majority of patients at some point during the treatment period (between 48% 
and 71% for the four variables), except for Struggle where there were similar numbers of patients 
experiencing large and small change (48% and 50% respectively). Change tended to be 
inconsistent for the majority of patients across each of the variables (between 58% and 89%). 
Finally, the percentages of those classified as Improved, Not improved or No change pre-post 
treatment suggested that there was improvement by post treatment (between 23% and 56% for 
the four variables), although the large amount of missing data for the post-treatment assessment 
(only n=50 remaining) could preclude any definitive conclusions for this final type of change. 
These changes are represented graphically in Figures 8.1a to 8.1d. 
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Figure 8.1a Percentages of participants classified as Early or 
Late improvement across the potential mediator variables
Distress (n=80) Struggle (n=78) Workability (n=79) Valued Action (n=77)
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Figure 8.1b Percentages of participants classified as Small or 
Large improvement across the potential mediator variables
Distress (n=80) Struggle (n=78) Workability (n=78) Valued Action (n=78)
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Figure 8.1c Percentages of participants classified as 
Consistent or Inconsistent change across the potential 
mediator variables
Distress (n=79) Struggle (n=73) Workability (n=75) Valued Action (n=74)
Chapter 8 IMPACT Page 253 
 
 
 
 
Repeated measures ANOVAs were also conducted to formally test for statistically significant 
changes over the within-treatment period for each of the potential mediator measures. It was 
found that Distress (F(3, 183)=10.57, p<0.05), Workability (F(3, 183)=7.67, p<0.05) and Valued Action 
(F(3, 183)=16.27, p<0.05) significantly improved during the treatment period, but Struggle (F(3, 
180)=1.67, p=0.17) did not. 
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Figure 8.1d Percentages of participants classified as 
Improved or Not improved across the potential mediator 
variables
Distress (n=67) Struggle (n=50) Workability (n=50) Valued Action (n=49)
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Table 8.5 Percentages of classification of change for individual patients in the IMPACT treatment cohort 
Type of Change Distress n (%) Struggle n (%) Workability n (%) Valued Action n (%) 
Early vs. Late No Improvement 15 (18.8%) 24 (30.0%) 19 (23.8%) 12 (15.0%) 
Early Improvement 13 (16.3%) 7 (8.8%) 6 (7.5%) 7 (8.8%) 
Late Improvement 26 (32.5%) 34 (42.5%) 31 (38.8%) 31 (38.8%) 
Both Early and Late Improvement 26 (32.5%) 13 (16.3%) 23 (28.8%) 27 (33.8%) 
% missing 0 2.5% 1.3% 3.8% 
Small vs. Large Small or No Improvement 28 (35.0%) 40 (50%) 25 (31.3%) 21 (26.3%) 
Large Improvement 52 (65.0%) 38 (47.5%) 53 (66.3%) 57 (71.3%) 
% missing 0 2.5% 2.5% 2.5% 
Non-Consistent vs. Consistent Non-Consistent Improvement 66 (82.5%) 71 (88.8%) 70 (83.5%) 65 (81.3%) 
Consistent Improvement 13 (16.3%) 2 (2.5%) 5 (6.3%) 9 (11.3%) 
% missing 1.3% 8.8% 6.3% 7.5% 
Improved vs. Not Improved No Change 7 (8.8%) 11 (13.8%) 5 (6.3%) 3 (3.8%) 
Worsening 13 (16.3%) 19 (23.8%) 16 (20.0%) 13 (16.3%) 
Improvement 47 (58.8%) 20 (25.0%) 29 (36.3%) 33 (41.3%) 
% missing 16.3% 37.5% 37.5% 38.8% 
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These analyses demonstrated that while patients tended to report at least one large change over 
the treatment period and improved on each of the variables by the end of treatment, this change 
tended to happen later on in the treatment period but was often inconsistent over time. The 
inconsistency could be indicative of error in the measures, and/or that the patients scored the 
measures arbitrarily. However, the potential mediators did show similar patterns across the 
different types of change, suggesting that the treatment delivered in the IMPACT programme was 
affecting each of the variables in a similar way. 
 
 
In Objective 2 the question of whether including data collected during treatment provided more 
information than using only pre- and post-treatment data was investigated. Descriptive analysis 
was firstly conducted, plotting the means at each time point. Figure 8.2a shows mean scores at 
pre- and post-treatment only and Figure 8.2b includes the data obtained during treatment. The 
graphs show how change occurs, at group level, during the treatment period. Overall, Distress had 
its biggest deterioration between weeks 2 and 3 of treatment, Valued action and Workability 
improved gradually throughout treatment, and Struggle deteriorated slightly during treatment 
and by post-treatment. The potential mediator measures indicated that change is not a 
straightforward process, and that some measures may take longer to shift than others. 
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Key: 0=Pre-treatment; 1-4=Diary data; 5=Post-treatment; 6=three-month follow-up 
 
Key: 0=Pre-treatment; 1-4=Diary data; 5=Post-treatment; 6=three-month follow-up 
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Figure 8.2a Mean scores of each potential mediator assessed at pre-
treatment, post-treatment and three-month follow-up
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Figure 8.2b Mean scores of each potential mediator assessed at pre-
treatment, weekly during treatment, post-treatment and three-
month follow-up
Distress Reverse scored Struggle Workability Valued Action
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An important point to note is that these changes only explored mean change, and did not allow 
for the investigation of change in individual patients. Data for individual patients was therefore 
graphically described for Distress as an example of the individual variation that occurred during 
treatment. Figures 8.3a and 8.3b below show how pre-post measures masked considerable 
individual variability among patients, by assuming linear change between pre- and post-treatment 
which in reality is non-linear. Only complete case data (where data was available at each included 
assessment point for a particular patient) was included here, hence the smaller numbers 
represented in Figures 8.3a and 8.3b. 
  
Key: 0=Pre-treatment; 1-4=Diary data; 5=Post-treatment; 6=three-month follow-up 
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Figure 8.3a Individual patient Distress scores at Pre-treatment, Post-
treatment and three-month follow-up (n=48)
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Key: 0=Pre-treatment; 1-4=Diary data; 5=Post-treatment; 6=three-month follow-up 
 
Finally, in Objective 3 each of the different types of within-treatment change was compared using 
linear regression to explore how the association between each potential mediator and the 
outcome was best described for each variable. Table 8.6 shows the results of the linear regression 
analyses to compare the different types of change. For this analysis, residualised change in SIP 
disability score between pre- and post-treatment was used as the outcome. This was because 
post-treatment SIP disability was not normally distributed, and the use of residualised change 
improved this (see Appendix 8.1). In the analysis of Early vs Late improvement, all analyses were  
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6
In
d
iv
id
u
a
l 
D
is
tr
e
ss
 S
co
re
Assessment time points
Figure 8.3b Individual patient Distress scores at Pre-treatment, weekly 
during treatment, post-treatment and three-month follow-up
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compared with the ‘no improvement’ category. The results showed that small proportions of 
variance in residualised change in disability were explained by early, late or early and late change 
in Distress, Workability and Valued Action. However, early and late improvement in Workability 
were both significantly associated with residualised change in SIP Disability score at post-
treatment, suggesting that improvement is partly explained by early or late change in this 
potential mediator. Worsening in valued action compared to no change was also found to be a 
significant predictor of residualised change in disability according to the 95% CI. However, none of 
the other types of change in potential mediators examined were shown to explain a significant 
proportion of the variance or were found to be significantly associated with residualised change 
SIP Disability score at post-treatment.  
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Table 8.6 Univariable linear regression analyses comparing the predictive value of each type of within-treatment change on predicting SIP Disability score at 
post-treatment 
Outcome: Indicators of residualised change in SIP Disability Score (Pre-treatment to Post-treatment) 
 
Type of Change 
 
Predictor in model % R
2
 F b (95% CI) (Unstandardised) 
Early vs Late Improvement 
(reference: No improvement) 
Distress 8.8% 1.85 (ns) Early improvement  -0.06 (-0.98 to 0.85) 
Late improvement  -0.64 (-1.40 to 0.12) 
Both early and late improvement  -0.68 (-1.44 to 0.08) 
Struggle 0.7% 0.15 (ns) Early improvement  0.24 (-0.84 to 1.33) 
Late improvement  -0.04 (-0.62 to 0.53) 
Both early and late improvement  0.12 (-0.61 to 0.85) 
Workability 8.8% 2.04 (ns) Early improvement  -0.59 (-1.61 to 0.43) 
Late improvement  -0.71 (-1.36 to -0.06) 
Both early and late improvement  -0.79 (-1.48 to -0.11) 
Valued Action 1.3% 0.27 (ns) Early improvement  0.05 (-1.05 to 1.15) 
Late improvement  -0.20 (-1.02 to 0.61) 
Both early and late improvement  
 
-0.28 (-1.10 to 0.55) 
Small vs Large Improvement 
(reference: Small improvement) 
Distress 5.3% 3.65 (ns) Large improvement  -0.51 (-1.05 to 0.02) 
Struggle 0% 0.02 (ns) Large improvement  0.04 (-0.44 to 0.52) 
Workability 3.1% 2.01 (ns) Large improvement  -0.38 (-0.92 to 0.16) 
Valued Action 0% 0.01 (ns) Large improvement  
 
-0.03 (-0.60 to 0.55 
Consistent vs Inconsistent Improvement  
(reference: Not consistent) 
Distress 0.5% 0.32 (ns) Consistent improvement  -0.18 (-0.81 to 0.46) 
Struggle 0.3% 0.16 (ns) Consistent improvement  0.28 (-1.14 to 1.70) 
Workability  0% 0.02 (ns) Consistent improvement  -0.07 (-1.09 0.95) 
Valued Action 0.1% 0.04 (ns) Consistent improvement  
 
 
0.08 (-0.67 to 0.82) 
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Outcome: Residualised change in SIP Disability Score (Pre-treatment to Post-treatment) 
 
Type of Change 
 
Predictor in model % R
2
 F b (95% CI) (Unstandardised) 
Improvement vs Worsening 
(Reference: No change) 
Distress 3.3% 1.03 (ns) Worsening  0.55 (-0.48 to 1.59) 
Improvement  0.14 (-0.79 to 1.06) 
Struggle 6.7% 1.58 (ns) Worsening  -0.29 (-1.04 to 0.47) 
Improvement  -0.63 (-1.39 to 0.12) 
Workability 5.6% 1.29 (ns) Worsening  0.64 (-0.32 to 1.61) 
Improvement  0.24 (-0.67 to 1.15) 
Valued Action 1.4% 3.09 (ns) Worsening  1.21 (0.04 to 2.38) 
Improvement  0.59 (-0.50 to 1.68) 
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8.7 Discussion 
8.7.1 Summary 
This descriptive analysis investigated whether including information collected during treatment 
could be used to improve future mediation analysis studies, as this recommendation has often 
been made in the mediation literature. Clinical data was provided from a tertiary treatment 
service implementing group ACT therapy for patients with chronic pain to improve physical 
functioning.  As well as full baseline (pre-treatment) and post-treatment data on physical 
functioning, data were also collected on factors that the therapy targeted for change at pre-
treatment, post-treatment and also at weekly intervals as part of treatment. These factors were 
therefore labelled as potential mediators in the analysis, although formal mediation analysis was 
not conducted due to the small number of cases available and the lack of a control group. 
 
Change over time in the potential mediators and outcome variable was firstly described to show 
whether change occurred over time and the magnitude of that change (expressed as a 
percentage). This showed that the factors clearly differed on when they changed during 
treatment, with some changing early on, some changing later and others not changing at all. 
While this was based on mean scores, this provides a helpful comparison with the ACT theoretical 
model and clinical opinion on when these factors are expected to change. The data was then 
classified into different types of change, based on consensus within the research team on what 
type of change would be clinically useful to examine. The frequencies of these different types of 
change for each of the potential mediator variables showed that most patients experienced at 
least one large change (of more than two points) on all factors and that most experienced 
improvement, but that improvement was inconsistent. This could be due to the measures used in 
the analysis (see further discussion in Section 8.7.4 below).  
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Next, comparisons were made between pre-post assessment only and the inclusion of 
assessments made during treatment. The means of each variable were first plotted which showed 
some differences between measurement at pre-post only and the inclusion of mid-treatment 
scores, but when individual patient scores were plotted this showed a much larger variability 
during treatment. This highlighted the need to also include analysis that could adequately 
incorporate this individual-level change as well as group-level change.  
 
Finally, the association of the different types of change with residualised change in physical 
function were investigated to explore whether a particular type of change may be important in 
leading to a change in outcome. This analysis showed that very little variance of change in 
physical function was explained by any of the types of change described. This suggests that none 
of these measures of change adequately reflect what occurs during treatment, or that change in 
the mediating factors during treatment is not strong enough to change disability outcome. It 
could also be a reflection of the small sample size available for analysis, which limits the ability to 
detect relevant difference and also precluded a stronger statistical analysis method such as LGM. 
 
8.7.2 Comparison with conceptual model 
ACT involves building acceptance and psychological flexibility using metaphors and stories to help 
patients apply the therapeutic concepts. The six processes outlined in Chapter 1 are described as 
‘overlapping’ and in practice are described as flexible (Hayes et al 2013). In the IMPACT service, 
concepts were revisited as and when needed and therapists expect an increase in Struggle initially 
and large changes at points where patients start to understand and apply the concepts, which are 
likely to vary from patient to patient (J Levell, personal communication). The results presented 
here are consistent with the expectation that large changes occur for most patients and change 
for most of the potential mediators occurred towards the end of the treatment period, which  
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again appears to be consistent with clinical expectations. However, the finding that Struggle in 
particular changed very little over time could suggest that the therapy is not targeting this 
variable strongly, or perhaps that it is not being captured well by the measure (see Section 8.7.4). 
 
8.7.3 Comparison with previous findings 
Vowles et al (2013) also carried out analysis on data collected from the IMPACT service with the 
aim of identifying treatment mediators of disability outcome. This study did not include any of the 
mid-treatment measures, and used full scale measures of variables related to ACT at pre- and 
post-treatment. Multi-level structural equation modelling (SEM) was used to take account of the 
fact that patients attended therapy in groups. Statistically significant mediating effects were 
found for almost all of their included potential mediators (pain acceptance, psychological 
flexibility, self-compassion and values) on disability as a latent variable (including observed 
measures of self-reported and observed physical function measures) but when physical disability 
(SIP Physical Disability subscale) only was investigated, only pain acceptance was found to have a 
statistically significant mediating effect with very small (-0.001) b path coefficients contributing to 
this. This highlights potential issues with this measure being used as an outcome. 
 
8.7.4 Limitations of the present study 
These analyses focused on exploratory, descriptive analysis because the small sample size 
available precluded more complex analysis. For example, it was originally planned that LGM could 
be performed to better compare change that occurred pre- and post-treatment with change that 
incorporated the mid-treatment assessments, but problems with model fit and the statistics 
produced indicated that the sample size was not large enough for robust results to be produced. 
The measurement of the outcome of interest only at pre- and post-treatment and not during 
treatment also precluded the use of potential alternative analyses, such as Generalised Estimated 
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 Equations (GEE), which also allows for multiple measurement and is specifically designed for use 
of repeated measures of non-normal data (Ballinger 2004). However, while the analyses 
presented in this chapter are less technical than in the previous chapters, important information 
can still be derived on when factors change that may be useful to the IMPACT team, and highlight 
the huge individual variability in patients and the need to account for this in future studies. 
 
The data collected in this study were based on self-report, which could be problematic in this 
study for a number of reasons. Firstly, as the data were collected as part of treatment and scores 
were discussed during treatment with the psychologist and other group members, this may have 
had an impact on what score patients’ chose to give (social desirability bias (Streiner & Norman 
2008)), and also patients previous scores may influence subsequent ones, as weekly time intervals 
may be short enough to allow patients to recall their previous score.  
 
It is also likely that the scores given on each of the questions represent more than a response to 
the question being asked – wide fluctuations in score across the treatment period for the same 
patient may reflect disengagement or frustration, for example, rather than actual feelings of 
‘valued action’. Related to this is the measures themselves – each variable was measured via a 
single item on a Likert scale, and while it is understandable that short measures were needed to 
reduce responder burden, the complexity of these concepts is unlikely to be adequately measured 
by a single question (for example, the question “Rate how effective you were in taking actions 
that contributed to a better, more vital, quality of living in the past week” is complex, and patients 
may have succeeded or struggled on different aspects or actions over the course of a week). This 
highlights a tension between being able to include and assess variables of interest adequately and 
repeatedly in a study while not overburdening patients or inadvertently introducing bias.  
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A final issue regarding the items used in the analysis is that they were not tested adequately for 
validity or reliability in the patient population of interest. These questions were used to collect 
data for clinical use primarily, but also for use within research studies. In line with the analyses 
presented in Chapters 5-7 in this thesis, a future recommendation is that strong measures are 
used to collect data that are comprehensible to patients and can be shown to have sound 
psychometric properties. 
 
Another issue related to measurement is that of correlations between repeated measures and 
also errors in those measurements, especially when measures are taken at short time intervals 
(Gibbons et al 2010). The descriptive data and linear regression analyses presented here cannot 
take account of this, but the other complex methods mentioned above (LGM, GEE) can account 
for this correlation (Gibbons et al 2010) and should therefore be considered for use in future 
studies. 
 
8.7.5 Clinical implications 
Clinically, these results showed that while most of the potential mediator variables improved 
during treatment, Struggle did not appear to change. This variable may be stable because it is not 
be targeted optimally by the ACT programme or because this particular factor is not amenable to 
change. It could also be that patients are not comfortable answering this question or that this 
measure is not particularly useful to include in treatment. The fact that change tended to occur 
later on for most of the variables is consistent with the IMPACT team’s expectations and with the 
ACT theoretical model, providing preliminary support for this model. 
 
In order to improve the quality and robustness of future analysis, more data and a larger sample 
size is required for more sophisticated analyses to be employed. Full measures of each of the  
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potential mediator variables, measured at the time when these variables are most likely to 
change, may be more beneficial than repeated shorter measures to capture complex concepts 
such as those used in ACT, or at the least developmental work should be done to ensure that 
answers reflect the concept being measured and not other aspects of treatment. 
 
 
8.8 Conclusion 
Insight into when variables of interest change was gained from descriptive analyses of data 
collected during treatment. This may help refine future studies of ACT in terms of when the 
optimal measurement points for specific variables would be. The individual variation seen in the 
measures of interest over time also underlines the importance of choosing analysis methods that 
can account for these individual differences. However, these analyses were preliminary and 
several issues with the measurement of the potential mediators and outcome used in this study 
means that further work is needed to confirm the usefulness of including measures during the 
treatment period. 
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Chapter 9. Overall Discussion 
 
9.1 Summary of Thesis 
This thesis has focused on the challenges of designing studies to analyse mediators of 
psychological treatments for patients with musculoskeletal (MSK) pain. Chapter 1 described the 
rationale for focusing on this population, describing MSK pain (and low back pain (LBP) 
specifically) as being a considerable burden in terms of its effect on quality of life and the financial 
impact on the NHS and workplaces. It was clear that identifying which factors (mediators) change 
during treatment and lead to improvement in functional outcomes might be an important step 
towards improving treatment effects. Psychological factors, the focus of this thesis, were found to 
be predictive of functional outcomes in observational studies of patients with MSK pain, 
suggesting they may also be useful factors to target during treatment. However, psychological 
treatments have only been found to have small or no effect on outcomes, calling into question 
whether psychological factors can be modified in a way that impacts on treatment outcome and if 
so, how this can be done to maximise their effect. Mediation analysis was therefore explored as a 
way of testing this. The overall aim and specific objectives of the thesis are described in Chapter 2. 
 
Chapter 3 outlined the current literature on mediation analysis, both within and outside of the 
MSK pain literature, in order to summarise current best practice for the design and analysis of 
mediation studies. Both design and analysis issues with current mediation practice were 
discussed. This chapter highlighted the complexities of mediation analysis, and that even though 
the question of ‘what makes a treatment work’ is on the surface a simple one, actually 
establishing what was indeed responsible for the success (or failure) of a treatment requires 
testing of causal associations, which is optimally done via a programme of research which builds 
up evidence for factors to be tested as part of a randomised controlled trial (RCT). However, a  
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number of recommendations were also derived from the literature about the best research 
design to test treatment mediation and the best methods for conducting the analysis. The aim of 
the research conducted in this thesis, then, was to evaluate methods of treatment mediation 
analysis in MSK pain populations, starting with a systematic review of previous treatment 
mediation analysis of psychological treatments for MSK pain and following on with secondary 
analysis conducted in different study designs and settings in order to test some of the 
recommendations made in the literature review. 
 
The systematic review presented in Chapter 4 identified 10 papers, three of which focused on LBP 
populations, which had carried out treatment mediation analysis of a psychologically-focused 
treatment aimed at reducing disability in patients with MSK pain. While several factors were 
identified as mediators, including pain catastrophising and pain self-efficacy, the design and 
methodology of each of the studies contained many of the flaws identified in Chapter 3, which led 
to a lack of confidence in the results overall. Such issues included a lack of clear theoretical basis 
for the intervention, not using strong measures of the psychological factors being tested as 
mediators or not reporting the psychometric properties of the measures used, and using 
substandard methods of mediation analysis. The findings were consistent with systematic reviews 
of treatment mediation in RCTs from other fields, including nutrition and oncology, which also 
reported problems with study design and analysis. This precludes strong conclusions as to what 
factors actually mediated outcome. The statistical mediation analysis presented in this thesis 
therefore (as far as possible) followed the recommendations made by the literature and 
systematic reviews in order to produce robust mediation analysis. 
 
In Chapter 5, the use of observational data to identify potential treatment mediators by 
generating information on which psychological factors were most likely to be modifiable and  
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change over time, and therefore most likely to potentially mediate treatment outcomes, was 
considered. Although not mediation analysis as such, the approach is in accordance with the 
recommendation of using existing evidence and building on non-intervention study data to 
identify factors to be tested as treatment targets. The analysis presented in this chapter was 
secondary analysis of the BeBACK study, which had previously identified four factors (self-efficacy 
and three different illness perceptions) as being independently predictive of disability outcome. 
However, the analysis presented in Chapter 5 investigated specifically whether the variables 
changed over time and were related to change in outcome, and the analysis revealed that not all 
of those factors found to be predictive in the original study were also potential mediators of 
disability outcome, demonstrating that just because a variable is a strong predictor of outcome, 
does not mean it is necessarily modifiable and related to change in that outcome. Four factors in 
particular (self-efficacy, anxiety, depression and pain catastrophising) were found to change over 
time, and change in each factor was strongly related to change in outcome. Three of these factors 
were then tested as mediators of a specific treatment effect in Chapter 6, providing an example of 
how observational study data can be used to identify potential treatment targets. 
 
In Chapter 6 secondary analysis of the STarT Back trial data was presented in order to test the trial 
authors’ hypothesis that the treatment, which involved patients with LBP who were at high risk of 
developing long-term disability receiving psychologically informed physiotherapy to target 
obstacles to recovery (if allocated to the treatment arm), successfully reduced disability, an 
important aspect of which was to reduce patients’ psychological distress. This analysis comprised 
mediation analysis using the recommended method (product of coefficients approach with bias-
corrected bootstrapped 95% CIs to ascertain the magnitude of the mediated effect). The study 
found that change in psychological distress was a strong mediator of both change in disability and 
general physical health (the functional outcomes of interest available in this dataset). There were  
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methodological limitations in the design of this study, such as the control group receiving 
treatment that might also have influenced distress, ‘psychological distress’ possibly being too 
broad a target, the potential for the results being affected by attrition bias, and assessments not 
being taken at enough time points to establish a causal relationship between the mediator and 
outcome. The latter suggests that interventions that are targeted to affect a specific factor, with 
at least three assessment points included in the analysis, may be a better design to test for 
mediating effects. 
 
Further secondary analysis was therefore conducted with another RCT of a psychologically 
focused intervention for patients with LBP, which addressed some of the limitations present in 
the analysis in Chapter 6 and met the criteria of targeting a specific factor (fear-avoidance beliefs) 
and assessing variables across more than three points in time (five assessment points were 
included). The secondary analysis of the Back In Action study presented in Chapter 7 also offered 
the opportunity to test an alternative, more novel form of mediation analysis seen as an 
important future direction in Chapter 3 (latent growth modelling (LGM)). This analysis found that 
change in fear-avoidance beliefs was found to be a strong mediator of change in disability in an 
intervention study that was designed to assess and address fear-avoidance beliefs. LGM, an 
analysis technique as yet rarely used to test mediation in applied studies, was found to be a viable 
way of testing for mediating factors. However temporality (timing of change) still could not be 
established as no assessments took place during the intervention period, so that while we know 
that change in fear-avoidance beliefs is related to change in disability, we cannot know when this 
change occurred, and whether change in fear-avoidance beliefs occurred first (as hypothesised) or 
whether in fact change in disability occurred before change in fear-avoidance beliefs. 
 
 
 
Chapter 9 Discussion Page 272 
 
Finally, in Chapter 8, exploratory analysis of clinical data collected as part of an Acceptance and 
Commitment Therapy (ACT) treatment programme for patients with chronic pain attending a pain 
clinic was conducted in order to investigate whether assessments made while an intervention is 
taking place might provide more information as to when factors change, to help improve claims 
for causality in studies of mediation. As in the BeBack analysis, this analysis was not mediation 
analysis but instead provided information on temporality, an important issue related to mediation 
analysis. Descriptive analyses were used to explore change at all time points (pre-, mid- and post-
treatment) using both raw change and also different types of clinically useful change 
(improvement, large change, early or late change and consistent change). The different types of 
change were also entered into linear regression analyses to compare the predictive value of each 
type on change in disability outcome. Both group- and individual-level data were considered. It 
was found that change tended to occur later on in treatment, which was consistent with the ACT 
theoretical model and clinician expectations, but that this change was inconsistent and did not 
explain a significant proportion of change in disability. In terms of comparing pre-post assessment 
with the inclusion of mid-treatment assessments, the mid-treatment assessments were found to 
give more information as to when the variables of interest were likely to change and the 
individual-level data highlighted significant variability in scores. These preliminary findings provide 
some support for the calls to include mid-treatment assessments and to perform analysis which 
incorporates between- and within-participant change. 
 
Overall, this thesis therefore makes a potentially important contribution to the literature on 
treatment mediation of psychological intervention studies for MSK pain through the identification 
of key design and analysis flaws in past treatment mediation research in this population and 
offers examples of mediation analysis using recommended design and analysis techniques. The 
aim of this final chapter is to outline guidance, based on the work presented here, on what steps  
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need to be taken to provide strong evidence of treatment targets in future psychologically 
oriented interventions for MSK pain, and specifically LBP. It will also highlight the limitations of 
the work carried out in the thesis and present its research and clinical implications. 
 
 
9.2 Guidelines for Future Treatment Mediation Analysis 
9.2.1 Theoretical basis for intervention 
The importance of theoretical models lies in the framework they provide for understanding how 
an intervention leads to change in specific factors. The choice of theoretical model therefore 
depends on the factors of interest, or what the researchers think the intervention is targeting. In 
this thesis, the importance of basing the treatment on a theoretical model, and using this to 
generate hypotheses as to how the treatment will work, when to best assess key variables of 
interest and crucially, what factors to measure as mediators have all been highlighted. Several 
models of pain and disability (such as the fear-avoidance model (FAM), acceptance and 
commitment therapy (ACT) and misdirected problem solving model) were reviewed in Chapter 1, 
where it was highlighted that while links between the different model components are often 
tested, the model as a whole and whether the temporal order of the model components is 
correct, are not. The systematic review in Chapter 4 suggested that many psychological 
interventions for LBP are based somewhat loosely on psychological theory, often not declaring 
specific hypotheses as to exactly what factors are expected to change and making it difficult to 
compare between treatments because of a focus on different targets for change. Chapters 6, 7 
and 8 in this thesis include analyses of studies where an a priori hypothesis as to how the 
intervention worked was included, although the ability to test this optimally was limited by 
different aspects of the study’s designs. The Back In Action study and IMPACT treatment 
programme (Chapter’s 7 and 8) in particular included measures that were closely linked with the  
Chapter 9 Discussion Page 274 
 
theoretical model being implemented (i.e. the factors that the model was trying to target). 
However, the lack of mid-treatment assessments in the Back In Action study and the lack of a 
control group in the IMPACT data means that caution is needed when interpreting the findings of 
these studies. Only the IMPACT data included in Chapter 8 explicitly tested any of the models 
outlined in Chapter 1 (ACT), which is consistent with the literature summarised in Chapter 1 that  
found few intervention studies explicitly based their intervention on a theoretical model. Despite 
this, the studies analysed highlight the importance of measuring the factors that are thought to be 
key in leading to change. Also, while most of the models outlined in Chapter 1 offer explanations 
for phenomena and how they develop (for example, the misdirected problem solving model 
hypothesises that persistent pain leads to worry and attempts to reduce pain, which if 
unsuccessful exacerbate the worry) they don’t necessarily provide information on techniques to 
change such behaviours or thought processes. The current evidence to support such models 
rarely tests for mediating links between the variables in each model; for example, of the models 
summarised in Chapter 1, the FAM was the only model for which good evidence of mediating 
factors and analyses of the model as a whole could be found. However, there are examples of 
studies which have successfully developed a theoretically-based intervention. One study by 
Siemonsma et al (2010) demonstrated how, by designing a trial with clearly stated theoretical 
assumptions, we can better answer the question about how the trial works by including measures 
of the key factors expected to change and the outcome that is most relevant to measure. Another 
more recent example of an intervention designed using the Medical Research Council (MRC) 
guidelines for complex interventions, part of which advises identifying appropriate theory to 
guide intervention design, demonstrated that theory could be helpful in deciding on what factors 
to focus on and how to go about trying to change them (Carnes et al 2013). The key message is 
that identifying models led to the identification of specific factors to focus on trying to change, 
and specific techniques to change behaviours. Further work to identify what can be changed and  
how the change can be brought about is required to improve and test existing theoretical models. 
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It should be acknowledged that these studies, and many of the models outlined in Chapter 1, 
were developed and tested in secondary care populations, as were the tools commonly used to 
measure the different constructs. This may mean that they are unlikely to be suitable for primary 
care populations in which the influence of psychological factors such as fear-avoidance beliefs and 
depression may be less marked than in patients attending secondary or tertiary care, although the 
evidence presented in Chapters 6 and 7 indicated that strong mediating effects can still be found 
in primary care populations. The original STarT Back analysis outlined in Chapter 6 did start to 
address this by stratifying patients into groups based on prognostic factors, where patients who 
were found to have higher scores on psychological factors were treated with psychologically 
informed physiotherapy. 
 
9.2.2 Validity and utility of the key psychometric measures 
Pincus et al (2002) emphasise the importance of strong psychometric properties of tools used to 
measure psychological constructs and ensuring that the measures chosen are appropriate for use 
within a particular population. There has also been some question as to the distinctiveness of 
different psychological constructs in terms of available measurement tools. Strong correlations 
between factors may indicate they are not conceptually distinct (Sullivan et al 2001; Campbell et 
al 2013b) although this may be due to the items in the tool rather than the factor itself. 
Psychological factors are rarely examined in isolation, and are usually investigated alongside other 
potentially important factors, making it difficult to judge the importance of a single factor. In the 
STarT Back analysis (Chapter 6), a measure of psychological distress was created using measures 
of anxiety, depression, catastrophising thoughts and fear-avoidance beliefs, and in this analysis 
these measures were found to be distinct from measures of pain intensity, although a strong 
relationship between pain and distress was present. Most recently, a study by Campbell et al 
(2013b) carried out a detailed exploratory and confirmatory factor analysis on five psychological 
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scales commonly used in LBP research and found they could be accounted for primarily by four 
factors (Pain-related distress, Causal beliefs, Coping cognitions and Perceptions of the future). 
Pain-related distress in particular was found to be associated with pain and disability in their 
clinical sample of patients with LBP (n=1591) and accounted for much of the variance (15% and 
28% for pain and disability respectively) while Causal beliefs and Perceptions of the future 
accounted for smaller proportions. The authors suggest that combining the various psychological 
constructs we routinely use in studies may make more useful markers for research, although this 
seems somewhat at odds with the recommendation of targeting specific factors seen elsewhere 
in the literature.  
 
Overall then, when conducting mediation analysis assessments should be made of the 
psychometric properties of the measures to be used in the study to ensure they are appropriate 
for use in the population of interest and can adequately capture change in the constructs. This will 
help ensure that any mediating effects present are identified and can be attributed to a particular 
factor. If instruments have not been used on the population under investigation, additional 
validation or cross-validation should be undertaken. Should it not be possible to validate an 
instrument satisfactorily it may be necessary to develop a new tool to measure the construct in 
question (although this strategy may render comparison with other studies problematic). 
 
9.2.3 Testing of potential mediator(s) and outcome during treatment 
The assessment of key factors during an intervention can provide important information as to 
whether the assumed causal association between mediator and outcome is likely to be correct 
and also on the selection of the optimum assessment points for both mediator and outcome. 
Such an analysis may also provide information on when factors are likely to change, and can help 
better design assessment points in future mediation studies. This issue of temporality has been  
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discussed in the thesis but unfortunately none of the studies included in the secondary analyses 
or the systematic review offered an adequate evaluation of it. Even when measures were 
available during the treatment period (Chapter 8 – IMPACT data), the outcome of interest was not 
measured at the same time points as the potential mediators meaning that it was not possible to 
conclude that change in the mediators occurred prior to change in disability. However, it was  
clear from this analysis that assessments made during treatment do provide more information on 
how patients are responding to particular treatment targets, which is useful both clinically (as an 
audit or therapeutic tool) and for research purposes (to help decide at what time point to best 
measure a variable in order to pick up any change likely to occur). 
 
 
9.3 Limitations of the Work Carried out for this Thesis 
9.3.1 Missing data 
As is to be expected in clinical studies of this type missing data has had to be accounted for in 
Chapters 5, 6, 7 and 8. This had to be dealt with in different ways for each analysis. In Chapters 5 
(BeBACK) and 8 (IMPACT) all available data was used but response bias analysis was conducted to 
check for differences between responders and non-responders. In Chapter 6 (STarT Back), 
complete case analysis was used and in Chapter 7 (Back In Action) expectation maximisation (EM) 
was used to impute missing values. These datasets did have a large proportion of loss to follow-
up, suggesting that a risk of bias was present. However the response bias analyses carried out on 
the data found few baseline differences between responders and non-responders on key 
variables of interest. In the STarT Back trial, the use of complete case analysis was due to the SEM 
software not being able to compute CIs for indirect effects and a specific goodness-of-fit index 
(SRMR) when the dataset contained missing data. A sensitivity analysis using all available data 
(but not providing confidence intervals) highlighted discrepancies in the data with responders to  
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the four-month follow-up point generally being ‘healthier’ at baseline (lower disability, 
catastrophising and fear-avoidance beliefs scores) compared to those who did not respond, 
suggesting that the results of the analysis are only representative of a specific group of patients. 
In the Back In Action study the analysis allowed imputation to be used more easily, and so this 
dataset was the only one where imputation was carried out.  
 
Ideally, all efforts should be made to ensure data is not missing at the point of collection. While 
this was possible in the STarT Back and Back In Action trials and indeed far less missing data was 
present in these studies, the IMPACT data was collected for clinical rather than research purposes 
and therefore attempts to chase up any missing data were less stringent, and in the BeBACK study 
the baseline survey asked respondents to consent to further contact and only those who 
consented were sent a follow-up questionnaire, rather than all those who responded to the 
baseline survey. Where missing data is present and missing at random, imputation is the 
recommended way of dealing with missing values as it reduces the risk of attrition bias, but this 
can be complex to perform. This thesis highlights that regardless of the method used, conducting 
sensitivity analyses is important in helping to assess the impact of missing data. 
 
9.3.2 Comparison of different mediation methods 
The different methods of mediation analysis were chosen based on their suitability for the dataset 
and the hypothesised mediators. This resulted in different methods of mediation analysis being 
used for each analysis chapter, making comparison between the different mediation models 
difficult. While mediating effects were produced for both the STarT Back and Back In Action 
studies using the product of coefficients approach, the studies included different measures of 
mediator and outcome variables and different assessment points. In the STarT Back trial, it was 
hypothesised that clinicians targeted a broader concept of psychological distress rather than  
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targeting specific constructs individually (the training that clinicians delivering the intervention 
received focused on how to recognise and address each of the major targets used in pain 
management if and when they presented in a patient, but were not given a systematic 
programme to follow where each of the targets was addressed in turn). To account for this, SEM 
analysis, which allowed for the testing and inclusion of such a latent variable, was used. However 
this analysis cannot take into account more than two time points, so it could not be used to carry 
out analysis on the Back In Action trial where the purpose was to test the utility of including 
multiple assessments of mediator and outcome variables. The LGM used for the Back In Action 
data could not be used with the STarT Back data because it cannot include latent constructs, and 
SEM could not be used with the Back In Action data because it could not take into account the 
multiple measures of fear-avoidance beliefs and disability available. It was therefore not possible 
in this thesis to compare whether one method is superior to the other. This highlights the 
importance of designing a study a priori to look at mediating factors, and thinking carefully about 
how to design the study in order to conduct the strongest form of mediation analysis, by having 
all the necessary data available. The use of different methods however has served to illustrate the 
flexibility of mediation analysis and its ability to incorporate different research questions, 
variables and designs.  
 
9.3.3 The measurement of change 
The analysis of change has been central to this thesis. However, there is debate around what type 
of change to use, error associated with change measures, and how different types of change are 
interpreted and compared. In the analyses presented in this thesis both residualised (Chapters 5, 
6 and 8) and raw change (Chapter 8) have been investigated, as well as growth trajectories 
(Chapter 7). While raw change is simple to understand and interpret, it does not account for 
baseline score which is often strongly predictive of outcome. Residualised change represents only  
Chapter 9 Discussion Page 280 
 
the change that occurred over and above baseline score, and numerous examples exist of 
residualised change scores in the applied literature of MSK pain research (e.g. George et al 2008; 
Bergbom et al 2012) that allow comparisons to be made across studies. However the values given 
by this change score are small in magnitude and more difficult to interpret, with some authors 
stating that this type of change is essentially representing error in the measure rather than any 
sort of change. Residualised change, like raw change, is also only between two assessment points 
whereas in this thesis it has been argued that analysis should include three or more assessment 
points in order to adequately capture change. Therefore, while residualised change scores have 
been found to be useful, future mediation studies should consider other, more sophisticated ways 
of analysing change. 
 
Minimisation of measurement error is important in analysing change, especially in psychological 
research where much of the assessment of key factors is based on self-report and subjective 
interpretation. When measures are made over time, error is associated with each measurement 
(Streiner & Norman 2008). This is especially likely to be a problem in Chapter 8 (IMPACT data) 
where assessments are made frequently over a short period of time. Chapter 8 contains a 
discussion on the problems of the drawbacks of multiple assessment, including responder burden 
and increasing complexity of the subsequent analysis. However, it has been recommended that 
such measures are made frequently in order to adequately assess when factors change and in 
what order this change occurs. Full measures of constructs are not required at all time points; the 
analysis carried out in Chapter 8 utilised weekly data of individual items for each construct, and 
emerging evidence of similar repeated assessments using text messaging or electronic diaries 
have been shown to be useful in terms of collecting limited information on pain and mood (e.g. 
Karoly et al 2014), which could help alleviate responder burden. Statistical analysis techniques 
which allow for measurement error, such as SEM and LGM, have been shown in this thesis to be 
appropriate and valid methods to approach mediation analysis. 
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9.3.4 Direction of causality (temporality) 
Key to mediation analysis is whether the hypothesised causal order of the variables can be shown 
to be correct. Each analysis chapter highlights different problems with establishing causality, 
although they progressively show more robust ways of looking at this issue. Chapter 8 provides an 
example of how temporality can possibly be investigated in future studies. However, all of the 
analyses presented are based on regression which makes strong assumptions about the causal 
links that can be made (see Chapter 3).  
 
More recent advances in mediation analysis from epidemiology and statistics advocate a causal 
inference approach using the potential outcomes framework, which attempts to make these 
assumptions more explicit. In this framework a causal effect can be inferred from the difference 
between two potential outcomes; one that occurs if a person receives an intervention, and one 
that occurs if they do not receive an intervention (Egleston et al 2010; Imai et al 2010a). For any 
one participant, only one of these effects can ever be observed – if the participant had the 
intervention, we do not know what their outcome would have been if they had not had the 
intervention. The unobserved outcome is referred to as a counterfactual. Because only one 
outcome is ever observable, we can only ever know the average causal effect in an experimental 
study. The average treatment effect is also how treatment mediation is interpreted in regression 
and SEM models (the a and c paths) but this framework makes this more explicit. In the context of 
mediation analysis, this approach estimates a mediated effect by analysing how much the 
outcome would change in the intervention group if the mediator changed from the level it would 
take in the control arm to the level it would take in the intervention arm (Valeri 2013). This 
approach can also be extended to models where the outcome is not measured on an interval 
scale, which is currently difficult to do with regression-based models. However, it should be 
acknowledged that this framework is not necessarily better than the regression approaches;  
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advocates of this approach acknowledge that it still makes many of the assumptions of the 
regression approach and currently cannot take into account change over time as easily as 
techniques such as LGM. It should perhaps therefore be seen as another tool that can be applied 
to mediation questions depending on the study question, design, and available data. 
 
 
9.4 Implications for the Design of Research 
The research presented in this thesis also allows reflection on what steps need to be taken to 
improve the design of treatment mediation studies and clinical trials in the future. Four important 
issues have been identified. First, a key issue in mediation analysis, highlighted by the systematic 
review in Chapter 4, is the lack of power to identify a mediating effect due to small numbers of 
participants. Fritz & MacKinnon (2007)’s review of the sample sizes needed with different 
mediation methods emphasised the need to use appropriate methods that have the most power 
to detect an effect (if one exists) with the smallest possible sample size; the authors found that 
the bias-corrected bootstrap required the smallest sample size of all the mediation methods 
tested (maximum of n=462 depending on the size of the path coefficients). Bigger trials, or 
analysis that involves several trials through individual patient data (IPD) analysis, are therefore 
needed to help detect smaller mediating effects. Second, related to this, is that consistent use of 
measures for both potential mediators and outcome are needed to allow the combination of data 
and also to build consistent evidence. Third, the mediation analyses undertaken as part of this 
thesis highlighted the challenges around conducting mediation analysis as secondary analysis, and 
the need to pay specific attention in particular to careful measurement of potential mediators and 
outcomes in the design of the study. Finally, as was illustrated in Chapter 4, despite evidence 
being available on appropriate ways to test for mediating factors, sub-optimal analyses have been 
undertaken previously, and there is a clear need for sufficient statistical expertise in mediation  
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methods and analysis. While interest in mediation analysis is growing, leading to more evidence 
available in the field to learn from, a lack of appropriate statistical expertise in different mediation 
methods could lead to a lack of clarity in trial protocols and publications, and confusion over the 
interpretation of results. Given that this is a problem not just in the MSK pain field but also more 
widely within health psychology, it would seem important to encourage discussion and 
collaboration between the different fields to see what could be learnt from other areas.  
 
Overall however, it is most important to recognise that the inclusion of mediation analysis is 
possible with just a few small changes to current trial design:  
1. Consideration of theoretical models and mediation analysis methods in the very early 
stages of the trial development to allow identification of key mediating factors and 
crucially when these should be measured;  
2. Cross-validation  of the measurement tools of the constructs of interest to ensure they 
adequately represent the construct of interest and can capture change over time; 
3.  The inclusion of a plan of how the mediation analysis will be conducted.  
 
Such considerations hopefully will help researchers to capture essential information on not just 
whether or not the intervention was effective but also why this was the case, enabling any future 
trials to build and improve on the results.  
 
9.5 Clinical Implications 
While specific comment on the nature of clinical interventions is beyond the remit of this thesis, 
the careful identification of treatment mediators has clinical as well as methodological 
implications. It might be anticipated that obtaining a clearer and more accurate evaluation of 
mediators will stimulate the development of more focused interventions, and provide  
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information on what parts of the intervention are key to changing outcome and when these 
changes occur. This in turn may help facilitate the identification of key targets for treatment, an 
essential prerequisite for the development of stratified care (Hill et al 2011; Foster et al 2014) 
now becoming a core feature of government policy. The identification of mediators (and 
moderators) might therefore be expected to be recognised as an important new direction in 
healthcare research.  
 
 
9.6 Suggestions for a Further Research Agenda 
As has been suggested, proper consideration of mediators will require a re-think of trial protocols, 
to include detail about mediating factors as early as possible. Thought needs to be given to what 
factors are likely to be treatment targets and how these will be influenced (a theoretical model is 
needed here to explain this process). Consideration of moderators (not a focus for this thesis) 
may help identify subgroups more likely to benefit from interventions. Moderated mediation 
analysis (e.g. Baron & Kenny 1986), or subgrouping patients in order to look at mediation in 
patients with specific characteristics, could help to see whether mediators could be more 
specifically targeted within these more homogenous groups. The STarT Back trial is one example 
of such stratified treatment, where patients were sub-grouped according to characteristics such 
as depression, fear-avoidance beliefs and comorbidity, but even when only people who scored 
highly on these factors were included in the analysis there was still considerable variability in 
terms of, for example, pain duration, age and treatment expectations. Investigating such 
heterogeneity further could perhaps identify more specific treatment targets. Moderated 
mediation analysis has not been discussed in this thesis but it is acknowledged that certain 
mediators may work better for patients with particular characteristics. However, there is a 
tension between identifying sub-groups for which specific mediating factors can be identified and  
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creating sub-groups so small that they are not practical for clinical or research use. Future 
research can start to address this by identifying broad subgroups based on a limited set of 
potential moderators and examining to what extent this improves the identification of mediating 
factors. 
 
It should be recognised however that collection of additional information or more careful 
appraisal of mediators carries a cost burden, although hopefully this will be outweighed by 
healthcare savings resulting from improved treatment outcomes. Some funding bodies do already  
acknowledge the importance of investigating mediating factors (e.g. the National Institute for 
Health Research (NIHR) Efficacy and Mechanisms Evaluation Programme) but more stringent 
criteria need to be put in place to ensure only work which can adequately assess mediating 
factors is funded through such streams. 
 
Three further research directions might be suggested. First, much of the research in treatment 
mediation in MSK pain studies focuses on factors known to be predictive of outcome but the work 
conducted in Chapter 5 of this thesis suggests that this does not necessarily mean these factors 
are good treatment targets and there is an opportunity for further work to be done in the 
validation of mediators. Qualitative approaches might be adopted to explore whether the factors 
often tested as mediators are truly mediators of outcome (i.e. are the factors that patients and 
clinicians see as key in leading to patient improvement) from both a patient and clinician 
perspective. This may help identify new potential mediators and give some evidence as to what 
factors are most important to test statistically as mediators. Second, the use of serial 
measurement, as in diary studies or single case designs, might provide a clearer picture of the 
temporal order and interdependence of key variables. Single case designs by definition include 
many repeated assessments of variables over time (Boersma et al 2004; Morley 2015), generating  
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detailed information on how the intervention worked for each individual participant (Flink et al 
2015). Such designs could allow for specific mediating factors to be identified, and have already 
been shown to be useful in the identification of specific treatment pathways in the treatment of 
fear-avoidance (Vlaeyen et al 2001; Boersma et al 2004).  
 
 
9.8 Conclusion 
The overall aim of this thesis was to identify and evaluate the methods and analyses used in 
treatment mediation analysis in MSK pain intervention studies. This thesis has explored numerous 
methodological challenges in conducting treatment mediation analysis by identifying and critically 
appraising previous work in this area and providing applied examples using the current best 
available methods. This thesis has focused on issues around methodology because this is a 
significant first step in leading to the design of studies that can best test for mediating factors in 
clinical populations. The thesis provides examples of different methods of mediation analysis 
applied to primary and secondary care MSK pain populations and provides guidance for future 
work that will impact directly on clinical research and practice. The work presented here provides 
a start-point for new treatment mediation research, with mediation analysis being considered as 
a main study objective rather than as post hoc analysis. The recommendations from this thesis 
can be put into practice through simple changes to current efficacy trial design as a result of 
careful preliminary work to identify the factors most likely to lead to patient improvement. It is 
important that these changes are made in order for us to learn as much as possible from each 
intervention trial and therefore continually improve the care given to patients with MSK pain. 
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Appendix 4.1 Summary of changes made to critical appraisal tool 
Lubans Cerin Mansell 
 
Did the study cite a theoretical framework? √ √ 
Were the study measures/procedures 
designed to influence mediating variables? 
√ √ 
Were pilot studies conducted/reported to 
test the effect of the intervention on 
mediators? 
X √ 
Was an objective measure of physical 
activity used? 
X X 
Were the psychometric characteristics of 
mediator variables reported and were they 
within accepted ranges (Cronbach’s alpha 
and test-retest reliability >.60)? 
√ √ 
Did the study report a power calculation 
and was the study adequately powered to 
detect mediation? 
√ √ 
Did the study use an experimental design? √  √ 
Was post-intervention physical activity 
controlled for baseline physical activity? 
X X 
 Were all 3 steps for testing 
validity of a theory of behaviour 
change performed? 
X 
 Were the psychometric 
characteristics of the outcome 
measure reported, and were 
they within acceptable ranges 
(i.e. test-retest or Cronbach’s 
alpha >.60?) 
√ 
 Were statistically 
appropriate/acceptable 
methods of data analysis used? 
√ 
 Did the study ascertain whether 
changes in the mediating 
variables preceded changes in 
the outcome variables? 
√ 
  Did the study report a 
change between baseline 
and follow-up for each 
mediator 
tested/reported? 
  Was the change in the 
potential mediator 
correlated with change in 
outcome? 
  Did the study control for 
possible confounding 
factors, e.g. baseline 
values? 
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Appendix 4.2 Template of data extraction form and critical appraisal tool 
Systematic review of mediation studies in MSK pain – Data extraction and critical appraisal form 
 
1
st
 Author & Year Published: ...........................  Reviewer Initials: .................... 
Country............................................................ 
 
Type of study: RCT    
  Before & After 
  Other (please specify)   ........................................................ 
  Unclear 
 
Study Setting:  Primary Care 
  Secondary Care 
  Tertiary Care 
  Other (please specify)   .........................................................  
  Unclear   
 
Patients suffering from:    Chronic  Sub-acute Acute 
MSK Pain   
 
Chronic Pain (Unspecified)  
 
Pain region (if given)……………………………………………………………………………………………………………………….. 
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Study Aims/Hypotheses: 
1. ……………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………
……… 
2. ……………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………
……… 
3. ……………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………
………. 
 
 
Critical Appraisal Item 1   Yes  No        Unclear/Not reported 
Did the study cite a theoretical framework? 
Critical Appraisal Item 2    Yes  No        Unclear/Not reported 
Did the study use an experimental design? 
 
Critical Appraisal Item 3    Yes  No        Unclear/Not reported 
Were pilot studies reported/conducted 
to test the effect of the intervention on 
mediators? 
 
 
 
 
 
Inclusion Criteria 
 
 
 
Exclusion Criteria 
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Intervention Group: What happened to participants in this group?  
• Number of 
participants………………………………………………………………………………………………………….. 
• Number who dropped 
out…………………………………………………………………………………………………….. 
• Who conducted the 
intervention…………………………………………………………………………………………… 
• Duration of 
intervention………………………………………………………………………………………………………… 
• Number of 
sessions……………………………………………………………………………………………………………….. 
 
What did the intervention involve? 
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Control / Comparator Group: What happened to participants in this group? 
• Number of 
participants………………………………………………………………………………………………………….. 
• Number who dropped 
out…………………………………………………………………………………………………….. 
• Who conducted the 
control/comparator………………………………………………………………………………. 
• Duration of 
control/comparator………………………………………………………………………………………….... 
• Number of 
sessions……………………………………………………………………………………………………………….. 
 
 
What did the control/comparator involve? 
 
 
Length of follow-
up…………………………………………………………………………………………………………………………… 
Follow-up 
points……………………………………………………………………………………………………………………………….. 
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Outcome 
Outcome Measure used (Full name and 
Acronym) 
Reference and Details of Measure 
 
 
  
 
 
  
 
 
  
 
Critical Appraisal Item 4    Yes             No         Unclear/Not 
reported 
Were the psychometric characteristics  
of the outcome measure reported, and  
were they within acceptable ranges  
(i.e. test-retest reliability or Cronbach’s α >.60?) 
 
Mediation 
Mediator Measure used (Full name and 
Acronym) 
Reference and Details of Measure 
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
Critical Appraisal Item 5     Yes             No      Unclear/Not 
reported 
Were the psychometric characteristics of the 
 mediator variables reported, and were they  
within acceptable ranges? 
 
Method(s) of mediation analysis 
used...................................................................................................... 
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Yes            No        Unclear/Not reported 
Was bootstrapping conducted? 
Details of 
bootstrapping…………………………………………………………………………………………………………………………… 
Yes            No        Unclear/Not reported 
Are CIs/effect sizes given? 
Details………………………………………………………………………………………………………………………………………… 
 
Preliminary analysis 
conducted………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………… 
 
 
Yes            No        Unclear/Not reported 
  
Were patient’s scores converted to    
change scores for analysis? 
 
Details of change 
scores………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………….. 
 
Critical Appraisal Item 6   Yes                  No                 Unclear/Not Reported 
Did the study report change between  
baseline and follow-up for the potential 
mediator(s)? 
 
Critical Appraisal Item 7   Yes                  No                 Unclear/Not Reported 
Was the change in the potential mediator(s)  
correlated with change in outcome? 
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Critical Appraisal Item 8                 Yes                  No                 Unclear/Not Reported 
Were the study methods/procedures  
designed to influence mediating variables? 
 
Critical Appraisal Item 9                   Yes                No                 Unclear/Not Reported 
Did the study report a power calculation, and 
was the study powered to detect mediation? 
 
Critical Appraisal Item 10   Yes                No                 Unclear/Not Reported 
Were statistically appropriate/acceptable  
methods of data analysis used? 
 
Critical Appraisal Item 11   Yes                No                 Unclear/Not Reported 
Did the study control for possible  
confounding factors, e.g. baseline values? 
 
 
Details………………………………………………………………………………………………………………………………………… 
 
 
 
 
Critical Appraisal Item 12   Yes                No                 Unclear/Not Reported 
 
Did the study ascertain whether changes in 
the mediating variable(s) precede changes in 
the outcome variable(s)? 
 
 
Findings 
Which of the tested variables were found to mediate outcome(s)? (If more than one outcome, 
please state which outcome you are referring to) 
..............................................................................................................................................................
..............................................................................................................................................................
.............................................................................................................................................................. 
 
Please add further comments/information relating to this study if necessary: 
………………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………… 
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Appendix 5.1 Skewness and kurtosis values for the variables included in the BeBACK secondary analysis 
Baseline and three-, six- and 12-month follow-up 
Measure Baseline 
(Mean 
(SD)) 
(n=1591) 
Skewness 
(SE) 
Kurtosis 
(SE) 
3-
month 
follow-
up 
(Mean 
(SD)) 
(n=856) 
Skewness 
(SE) 
Kurtosis 
(SE) 
6-
month 
follow-
up 
(Mean 
(SD)) 
(n=810) 
Skewness 
(SE) 
Kurtosis 
(SE) 
12-
month 
follow-
up 
(Mean 
(SD)) 
(n=473) 
Skewness 
(SE) 
Kurtosis 
(SE) 
RMDQ 8.64 
(6.04) 
0.40 
(0.06) 
-0.80 
(0.12) 
6.61 
(6.09) 
0.87 
(0.08) 
-0.25 
(0.17) 
6.19 
(6.14) 
0.98 
(0.09) 
-0.09 
(0.17) 
5.83 
(6.12) 
1.02 
(0.11) 
0.03 
(0.22) 
Self-efficacy 37.81 
(14.56) 
-0.38 
0.06) 
-0.69 
(0.12) 
39.96 
(14.11) 
-0.57 
(0.09) 
-0.46 
(0.19) 
40.80 
(14.15) 
0.02 
(0.10) 
0.90 
(0.20) 
42.17 
(14.07) 
-0.86 
(0.13) 
0.11 
(0.26) 
Coping Catastrophising 9.96 
(7.97) 
0.80 
(0.06) 
0.14 
(0.12) 
8.50 
(7.95) 
1.15 
(0.09) 
0.97 
(0.19) 
8.70 
(7.51) 
1.00 
(0.10) 
0.74 
(0.20) 
8.19 
(7.20) 
1.00 
(0.13) 
0.67 
(0.26) 
Diversion 15.51 
(8.24) 
0.08 
(0.06) 
-0.53 
(0.13) 
*** *** *** 15.49 
(8.71) 
0.07 
(0.10) 
-0.64 
(0.20) 
14.68 
(8.42) 
0.12 
(0.13) 
0.77 
(0.26) 
Re-interpretation 7.83 
(6.99) 
0.94 
(0.06) 
0.46 
(0.12) 
*** *** *** 8.71 
(7.29) 
0.86 
(0.10) 
0.18 
(0.20) 
6.83 
(7.00) 
0.90 
(0.13) 
0.77 
(0.26) 
Cognitive coping 16.27 
(6.48) 
-0.13 
(0.06) 
-0.37 
(0.12) 
*** *** *** 17.29 
(6.28) 
-0.12 
(0.10) 
-0.49 
(0.20) 
17.74 
(6.26) 
-0.30 
(0.13) 
-0.28 
(0.26) 
Fear-avoidance beliefs 39.67 
(6.89) 
0.23 
(0.06) 
0.77 
(0.13) 
*** *** *** 38.38 
(6.30) 
-0.04 
(0.10) 
0.59 
(0.20) 
37.80 
(6.11) 
0.05 
(0.13) 
0.75 
(0.26) 
Anxiety 8.26 
(4.55) 
0.30 
(0.06) 
-0.47 
(0.12) 
*** *** *** 6.60 
(4.57) 
-0.54 
(0.09) 
-0.23 
(0.18) 
6.31 
(4.48) 
0.56 
(0.11) 
-0.32 
(0.23) 
Depression 6.53 
(4.37) 
0.61 
(0.06) 
-0.18 
(0.12) 
*** *** *** 5.08 
(4.28) 
0.82 
(0.09) 
0.10 
(0.18) 
4.67 
(4.32) 
0.98 
(0.11) 
0.32 
(0.23) 
Illness 
perceptions 
Personal control 20.51 
(3.79) 
 
-0.10 
(0.06) 
-0.04 
(0.12) 
20.77 
(4.17) 
-0.26 
(0.08) 
0.42 
(0.17) 
20.93 
(4.16) 
-0.15 
(0.09) 
-0.05 
(0.18) 
21.26 
(4.27) 
-0.37 
(0.11) 
0.45 
(0.23) 
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Acute-chronic 
timeline 
19.64 
(5.84) 
-0.17 
(0.06) 
-0.68 
(0.12) 
20.92 
(5.81) 
-0.57 
(0.08) 
-0.14 
(0.17) 
21.00 
(5.80) 
-0.59 
(0.09) 
-0.14 
(0.18) 
21.38 
(5.91) 
-0.73 
(0.12) 
0.07 
(0.23) 
Identity 4.03 
(2.37) 
0.60 
(0.06) 
0.91 
(0.12) 
*** *** *** 3.14 
(2.41) 
0.23 
(0.09) 
2.13 
(0.18) 
3.02 
(2.23) 
0.58 
(0.11) 
2.34 
(0.23) 
Consequences 17.33 
(5.48) 
0.07 
(0.06) 
-0.69 
(0.12) 
17.06 
(5.82) 
0.09 
(0.08) 
-0.63 
(0.17) 
16.49 
(5.80) 
0.15 
(0.09) 
-0.73 
(0.18) 
16.07 
(5.88) 
0.28 
(0.11) 
-0.64 
(0.23) 
Timeline cyclical 13.04 
(3.39) 
-0.46 
(0.06) 
-0.15 
(0.12) 
13.02 
(3.40) 
-0.61 
(0.08) 
0.07 
(0.17) 
12.82 
(3.52) 
-0.59 
(0.09) 
-0.07 
(0.18) 
12.85 
(3.31) 
-0.62 
(0.12) 
0.33 
(0.23) 
Illness 
coherence 
13.77 
(4.99) 
0.23 
(0.06) 
-0.73 
(0.12) 
12.72 
(4.91) 
0.53 
(0.08) 
0.07 
(0.17) 
11.88 
(4.61) 
0.59 
(0.09) 
-0.05 
(0.18) 
11.41 
(4.49) 
0.73 
(0.11) 
0.19 
(0.23) 
Treatment 
control 
16.99 
(3.36) 
-0.36 
(0.06) 
0.37 
(0.12) 
16.51 
(3.52) 
-0.45 
(0.09) 
0.60 
(0.17) 
16.58 
(3.62) 
-0.27 
(0.09) 
0.52 
(0.18) 
16.68 
(3.55) 
-0.28 
(0.11) 
0.76 
(0.23) 
Emotional 
representation 
16.71 
(5.23) 
0.17 
(0.06) 
-0.42 
(0.12) 
16.52 
(5.20) 
0.14 
(0.08) 
-0.24 
(0.17) 
15.69 
(5.29) 
0.21 
(0.09) 
-0.35 
(0.18) 
15.23 
(5.18) 
0.26 
(0.11) 
-0.32 
(0.23) 
Psychological 
attribution 
11.93 
(4.11) 
0.42 
(0.06) 
0.23 
(0.12) 
*** *** *** 11.94 
(4.25) 
0.50 
(0.09) 
0.17 
(0.18) 
11.86 
(3.94) 
0.29 
(0.12) 
-0.22 
(0.23) 
Risk factors 15.02 
(4.15) 
0.14 
(0.06) 
0.48 
(0.12) 
*** *** *** 15.42 
(3.95) 
0.05 
(0.09) 
0.53 
(0.18) 
15.53 
(3.86) 
0.02 
(0.12) 
0.31 
(0.23) 
Immunity 5.33 
(1.95) 
0.43 
(0.06) 
-0.22 
(0.12) 
*** *** *** 5.29 
(1.96) 
0.47 
(0.09) 
-0.00 
(0.18) 
5.17 
(1.86) 
0.58 
(0.12) 
0.06 
(0.23) 
Accident/Chance 5.98 
(1.92) 
-0.13 
(0.06) 
-0.30 
(0.13) 
*** *** *** 5.86 
(1.92) 
-0.09 
(0.09) 
-0.29 
(0.18) 
6.00 
(2.01) 
-0.05 
(0.12) 
-0.42 
(0.24) 
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Residualised change scores 
 Baseline to three-
month residualised 
change 
Baseline to six-month 
residualised change 
Baseline to 12-month 
residualised change 
Measure Skewness 
(SE) 
Kurtosis 
(SE) 
Skewness 
(SE) 
Kurtosis 
(SE) 
Skewness 
(SE) 
Kurtosis 
(SE) 
RMDQ 0.14 
(0.08) 
0.88 
(0.17) 
0.03 
(0.09) 
0.60 
(0.17) 
-0.06 
(0.11) 
0.40 
(0.22) 
Self-efficacy 0.22 
(0.09) 
1.25 
(0.19) 
0.02 
(0.10) 
0.90 
(0.20) 
0.01 
(0.13) 
0.60 
(0.26) 
Coping Catastrophising 0.85 
(0.10) 
2.37 
(0.19) 
0.54 
(0.10) 
2.33 
(0.20) 
0.77 
(0.13) 
1.08 
(0.26) 
Diversion *** *** 0.06 
(0.10) 
0.35 
(0.20) 
0.20 
(0.13) 
0.15 
(0.26) 
Re-interpretation *** *** 0.61 
(0.10) 
0.79 
(0.20) 
0.48 
(0.13) 
0.32 
(0.26) 
Cognitive coping *** *** -0.16 
(0.10) 
0.79 
(0.20) 
-0.12 
(0.13) 
0.06 
(0.26) 
Fear-avoidance beliefs *** *** -0.47 
(0.10) 
1.01 
(0.21) 
-0.28 
(0.13) 
0.80 
(0.26) 
Anxiety *** *** 0.10 
(0.09) 
0.94 
(0.18) 
0.20 
(0.11) 
0.51 
(0.23) 
Depression *** *** 0.00 
(0.09) 
0.70 
(0.18) 
0.48 
(0.11) 
1.62 
(0.23) 
Illness 
perceptions 
Personal control -0.48 
(0.09) 
1.58 
(0.17) 
-0.06 
(0.09) 
0.98 
(0.18) 
-0.34 
(0.12) 
1.55 
(0.23) 
Acute-chronic 
timeline 
 
-0.24 
(0.08) 
0.84 
(0.17) 
-0.32 
(0.09) 
0.32 
(0.18) 
-0.38 
(0.12) 
0.58 
(0.23) 
Identity *** *** -0.74 
(0.09) 
5.25 
(0.18) 
-0.27 
(0.11) 
4.35 
(0.23) 
Consequences -0.08 
(0.09) 
0.99 
(0.17) 
-0.05 
(0.09) 
0.50 
(0.18) 
0.08 
(0.11) 
0.56 
(0.23) 
Timeline cyclical -0.53 
(0.09) 
0.98 
(0.17) 
-0.51 
(0.09) 
0.50 
(0.18) 
-0.38 
(0.12) 
0.18 
(0.23) 
Illness 
coherence 
0.15 
(0.08) 
0.55 
(0.17) 
0.28 
(0.09) 
0.29 
(0.18) 
0.30 
(0.12) 
0.44 
(0.23) 
Treatment 
control 
-0.67 
(0.09) 
3.00 
(0.17) 
-0.33 
(0.09) 
1.05 
(0.18) 
-0.53 
(0.12) 
2.39 
(0.23) 
Emotional 
representation 
-0.13 
(0.09) 
0.57 
(0.17) 
-0.07 
(0.09) 
1.58 
(0.18) 
0.10 
(0.12) 
0.43 
(0.23) 
Psychological 
attribution 
*** *** 0.39 
(0.09) 
1.48 
(0.18) 
0.25 
(0.12) 
-0.03 
(0.24) 
Risk factors *** *** 0.14 
(0.09) 
2.43 
(0.18) 
0.20 
(0.12) 
0.83 
(0.24) 
Immunity *** *** 0.42 
(0.09) 
1.23 
(0.18) 
0.61 
(0.12) 
1.15 
(0.24) 
Accident/Chance *** *** -0.20 
(0.09) 
0.43 
(0.19) 
-0.24 
(0.12) 
0.14 
(0.24) 
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Appendix 6.1 Results for SF-12 PCS Outcome (Complete case analysis) 
 
Summary Details of Outcome and Predictor Measures 
  Reference How Scored 
 
Outcome 
measure 
General physical function 
(SF-12 PCS) 
Ware et al (1996) Higher score indicates higher 
level of interference 
 
 
 
 
 
 
 Appendix 6.1 Page 375 
 
Unadjusted function outcomes at baseline and change by four-month follow-up (Means and SDs) in the STarT Back study 
Variable 
(scale 
range) 
Baseline means (SDs) Mean (SD) change at four-month follow-up 
Treatment (n=370) Control (n=179) Treatment (n=370) Control (n=179) 
L  
(n=100) 
M  
(n=177) 
H  
(n=93) 
L  
(n=50) 
M  
(n=84) 
H  
(n=45) 
L  
(n=100) 
M  
(n=177) 
H  
(n=93) 
L  
(n=50) 
M  
(n=84) 
H  
(n=45) 
SF-12 PCS 
(0-12) 
46.86 
(8.01) 
34.91 
(9.92) 
31.22 
(7.50) 
45.96 
(9.11) 
35.94 
(8.43) 
30.28 
(8.35) 
-2.35 (8.48) -8.78 
(10.22) 
-10.05 
(10.19) 
-1.97 
(8.60) 
-6.10 
(9.16) 
-5.16 
(9.95) 
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Correlation coefficients with potential confounding variables 
Outcome Variable Treatment 
Allocation 
4m 
 
Low Medium High 
 
SF-12 PCS
∆
 Age Treatment  -0.14 -0.18 -0.18 
Sex 0.00 0.05 0.00 
Pain duration -0.10 -0.14 -0.24* 
Age Control -0.01 -0.07 -0.27 
Sex -0.08 0.19 0.01 
Pain duration -0.12 -0.12 -0.09 
p<0.05; **p<0.01 
 
 
For residualised change in SF-12 PCS the same pattern emerged, with the amount of variance 
explained by each variable almost identical in the treatment group but less in the control group 
(Table 9).
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Contributions of changes in each potential mediator to change in functional outcomes in STarT Back participants: linear regression analyses – High risk 
group 
Outcome Predictor Treatment Allocation Change at 4m 
 
Unstandardised B (SE) 95% CI Standardised β R-square change 
SF-12 PCS
∆
 Catastrophising thoughts
∆
 Treatment -0.50 (0.08) -0.67 to -0.34 -0.54 0.29 
Fear-avoidance beliefs
∆
 -0.55 (0.80) -0.71 to -0.39 -0.58 0.34 
Anxiety
∆
 -0.50 (0.90) -0.68 to -0.32 -0.50 0.25 
Depression
∆
 -0.56 (0.09) -0.73 to -0.39 -0.56 0.32 
Least pain
∆
 -0.63 (0.08) -0.79 to -0.46 -.61 0.38 
Average pain
∆
 -0.62 (0.08) -0.78 to -0.46 -0.63 0.40 
Current pain
∆
 -0.67 (0.08) -0.83 to -0.52 -0.67 0.45 
Catastrophising thoughts
∆
 Control -0.24 (0.17) -0.57 to -0.10 -0.21 0.05 
Fear-avoidance beliefs
∆
 -0.57 (0.18) -0.94 to -0.20 -0.43 0.19 
Anxiety
∆
 -0.21 (0.14) -0.50 to -0.07 -0.22 0.05 
Depression
∆
 -0.37 (0.14) -0.65 to -0.08 -0.37 0.14 
Least pain
∆
 -0.55 (0.12) -0.79 to -0.32 -0.59 0.34 
Average pain
∆
 0.80 (0.11) -1.02 to -0.57 -0.74 0.55 
Current pain
∆
 -0.57 (0.13) -0.82 to -0.31 -0.56 0.32 
∆
Residualised change scores 
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Full SEM model for mediating effect of change in psychological distress on change in general 
physical function: High risk group 
 
 
 
 
 
 
 
 
 
∆
residualised change 
*p<0.05 
**p<0.01 
 
All values are standardised 
 
 
Total, Direct and Indirect Effects of each Potential Mediator on Change in General Physical 
Function for High Risk Patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
SF-12 PCS
∆
 Total -0.24 (-0.39 to -0.06) -0.51 (-0.85 to -0.13) 
 Direct -0.03 (-0.16 to 0.09) -0.05 (-0.34 to 0.20) 
 Indirect -0.21 (-0.34 to -0.08) -0.45 (-0.73 to -0.16) 
∆
residualised change 
 
 
 
 
Treatment 
(Intervention/Control) 
General Physical 
Function
∆
 
 
Low back 
pain 
intensity
∆
 
Psychological 
distress
∆
 
-0.02 
0.28 
0.27 
-0.20** 
-0.58** 
0.68** 
-0.24 
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Model Fit Statistics for Mediation Model of Change in General Physical Function for High Risk 
Patients 
Model Index Model Good Model Fit 
 
CMIN* 55.57 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.42 Between 2-5 
CFI 0.96 >0.95 
RMSEA 0.10 (0.07 to 0.14), PCLOSE 0.01 <0.08 
SRMR 0.06 <0.08 
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Appendix 6.2 Results for Medium and Low Risk Groups – Complete case 
analysis 
 
The model was then repeated using data for participants in the medium risk group. In this group, 
the percentage of variance explained by the mediation model was still high, explaining 70% of 
change in function overall. The pattern of correlations for change in disability in the high risk 
group was replicated with low, non-significant (p<0.05) beta values between treatment allocation 
and change in psychological distress and low back pain intensity. The correlations between 
change in psychological distress and change in disability score were slightly stronger in this group 
compared with the high-risk group, but weaker between change in low back pain intensity and 
change in disability. There is a weaker, but still statistically significant mediating effect of change 
in either latent variable on change in disability score than that seen in the high-risk models 
(standardised indirect effect 0.13 (95% CI 0.01 to 0.23)), and the model fit statistics also indicate a 
good fit of the model to the data. The weaker effect seen here was expected, as it was 
hypothesised that the stronger mediating effects would be in the high-risk group models where 
participants in the treatment arm received treatment to specifically target complexity. 
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Full SEM model for mediating effect of change in Psychological Distress on change in disability: 
Medium risk group 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
All values are standardised 
 
Total, Direct and Indirect Effects of each Potential Mediator on Disability Change for Medium Risk 
Patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
RMDQ
∆
 Total 0.11 (-0.01 to0 .22) 0.24 (-0.02 to 0.47) 
 Direct -0.01 (-0.09 to 0.07) -0.03 (-0.19 to 0.14) 
 Indirect 0.13 (0.01 to 0.23) 0.27 (0.03 to 0.49) 
∆
residualised change 
 
Model Fit Statistics for Mediation Model of Change in Disability Change for Medium Risk Patients 
Model Index Model Good Model Fit 
 
CMIN* 58.67 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.55 Between 2-5 
CFI 0.97 >0.95 
RMSEA 0.08 (0.05 to 0.10), PCLOSE 0.03 <0.08 
SRMR 0.04 <0.08 
 
 
 
Low back pain 
intensity
∆
 
Treatment 
(Intervention/Control) 
Function
∆
  
 
Psychological 
distress
∆
 
-0.01** 
0.0
0.45** 
0.57** 
0.11*
* 
0.1 0.47** 
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The model for change in general physical function for the medium risk patients also presented a 
similar picture to the model for high risk patients. A smaller amount of variance was explained by 
the model overall (r
2
=45%) and a weaker but statistically significant mediating effect of change in 
the latent variables was found (standardised indirect effect -0.11, 95% CI -0.19 to -0.01). Like the 
change in disability model for the medium risk group, the correlations between change in the 
latent variables and change in outcome were higher than the correlations between treatment 
allocation and the latent variables. The model fit statistics indicated an adequate fit to the data. 
 
Figure 12 Full SEM model for mediating effect of change in psychological distress on change in 
general physical function: Medium risk group 
 
 
 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
 
All values are standardised 
 
 
 
 
 
Psychological 
distress
∆
 
Treatment 
(Intervention/Control) 
General Physical 
Function
∆
 (r
2
=.45) 
Low back 
pain 
intensity
∆
 
-0.01 
0.18 
0.09 
-0.44** 
-0.29** 
0.63 
-0.12 
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Total, Direct and Indirect Effects of each Potential Mediator on General Physical Function Change 
for Medium Risk Patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
RMDQ
∆
 Total -0.12 (-0.23 to 0.02) -0.25 (-0.49 to 0.04) 
 Direct -0.01 (-0.11 to 0.09) -0.02 (-0.23 to 0.18) 
 Indirect -0.11 (-0.19 to -0.01) -0.22 (-0.42 to -0.03) 
∆
residualised change 
 
Model Fit Statistics for Mediation Model of Change in General Physical Function for Medium Risk 
Patients 
Model Index Model Good Model Fit 
 
CMIN* 49.66 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.16 Between 2-5 
CFI 0.97 >0.95 
RMSEA 0.07 (0.04 to 0.09), PCLOSE 0.13 <0.08 
SRMR 0.04 <0.08 
 
The model for the low risk group with change in disability as an outcome is shown below. This 
model explained the lowest amount of variance of any of the disability change models (51%). The 
indirect effect was also weakest out of all the disability models and not statistically significant 
(standardised indirect effect 0.06, 95% CI -0.08 to 0.21). The statistics for model fit suggested 
adequate fit of the model to the data. 
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Full SEM model for mediating effect of change in psychological distress on change in disability: 
Low risk group 
 
 
 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
 
All values are standardised 
 
Total, Direct and Indirect Effects of each Potential Mediator on Change in Psychological Distress 
for Low Risk Patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
RMDQ
∆
 Total 0.10 (-0.05 to 0.27) 0.21 (0.10 to 0.60) 
 Direct 0.04 (-0.09 to 0.17) 0.08 (-0.19 to 0.36) 
 Indirect 0.06 (-0.08 to 0.21) 0.13 (-0.14 to 0.47) 
∆
residualised change 
 
Model Fit Statistics for Mediation Model of Change Psychological Distress for Low Risk Patients 
Model Index Model Good Model Fit 
 
CMIN* 54.95 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.39 Between 2-5 
CFI 0.94 >0.95 
RMSEA 0.10 (0.06 to 0.13), PCLOSE 0.01 <0.08 
SRMR 0.06 <0.08 
Treatment 
(Intervention/Control) 
Disability
∆
  
 
Low back pain 
intensity
∆
 
Psychological 
distress
∆
 
0.04 
0.08 
0.11 
0.60** 
0.14** 
0.76 
0.10 
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The model for change in general physical function again showed no statistically significant 
mediating effect of change in the latent variables on change in SF-12 PCS score (standardised 
indirect effect -0.06, 95% CI -0.18 to 0.05). Like for the other models, this model provided an 
adequate fit to the data. The model as a whole also only explained 34% of the variance of change 
in general physical health, the lowest out of all the models with this outcome. 
 
Full SEM model for mediating effect of change in psychological distress on change in general 
physical function: Low risk group 
 
 
 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
 
All values are standardised 
 
Table 21a Total, Direct and Indirect Effects of each Potential Mediator on General Physical 
Function Change for Low Risk Patients 
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
RMDQ
∆
 Total -0.05 (-0.22 to 0.10) -0.11 (-0.49 to 0.20) 
 Direct 0.01 (-0.13 to 0.14) 0.02 (-0.27 to 0.30) 
 Indirect -0.06 (-0.18 to 0.05) -0.12 (-0.42 to 0.09) 
∆
residualised change 
Psychological 
distress
∆
 
Treatment 
(Intervention/Control) 
General Physical 
Function
∆
  
 
Low back 
pain 
intensity
∆
 
0.01 
0.07 
0.11 
-0.24** 
-0.38 
0.75 
-0.05 
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Table 21b Model Fit Statistics for Mediation Model of Change in General Physical Function for Low 
Risk Patients 
Model Index Model Good Model Fit 
 
CMIN* 47.93 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.08 Between 2-5 
CFI 0.95 >0.95 
RMSEA 0.09 (0.05 to 0.12), PCLOSE 0.05 <0.08 
SRMR 0.06 <0.08 
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Appendix 6.3 Full analysis of High-risk Group using all available data (FIML) 
 
Preliminary analysis 
Outcome measure Baseline score (Mean and SD) Four-month Follow-up (Mean 
change and SD) 
Treatment 
(n=157) 
Control 
(n=79) 
Treatment 
(n=131) 
Control 
(n=56) 
Disability 14.01 (4.64) 14.72 (4.40) 6.77 (6.81) 4.21 (5.03) 
General physical function 30.83 (7.60) 29.57 (8.25) -8.98 (10.36) -5.37 (9.93) 
 
Potential mediator Baseline score (Mean and SD) Four-month Follow-up (Mean change 
and SD) 
Treatment 
(n=157) 
Control 
(n=79) 
Treatment (n=131) Control (n=56) 
Catastrophising 
thoughts 
26.41 (10.63) 26.89 
(10.27) 
10.33 (12.36) 6.82 (10.41) 
Fear-avoidance 
beliefs 
45.81 (5.04) 45.96 (5.65) 8.55 (7.44) 3.67 (4.65) 
Anxiety 10.11 (4.15) 10.09 (3.77) 3.00 (3.95) 2.46 (3.90) 
Depression 8.90 (4.32) 8.91 (3.68) 3.13 (3.96) 1.56 (3.38) 
Least Pain 6.33 (2.56) 5.84 (3.04) 2.96 (2.87) 1.88 (3.29) 
Average Pain 7.94 (1.93) 8.05 (1.76) 3.87 (3.20) 2.51 (2.93) 
Current Pain 6.68 (2.20) 6.58 (2.40) 2.81 (2.81) 1.47 (2.89) 
 
Correlation Analysis – Potential Confounders 
Outcome Variable Treatment 
Allocation 
4 months 
 
High-risk group 
 
RMDQ
∆
 Age Treatment 0.08 
Sex -0.02 
Pain 
duration 
0.32** 
Age Control -0.00 
Sex 0.22 
Pain 
duration 
0.35** 
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Testing Criteria for Mediation – Linear regressions to show associations between change 
in potential mediator and change in outcome (b path) 
Outcome Predictor Treatment 
Allocation 
Change at 4 months 
Unstandardised 
B (SE) 
95% 
CI 
Standardised 
Β  
R-square 
change 
RMDQ
∆
 Catastrophising 
thoughts
∆
 
Treatment 0.54 (0.07) 0.40 
to 
0.67 
0.59 0.34 
Fear-avoidance 
beliefs
∆
 
0.58 (0.08) 0.42 
to 
0.74 
0.57 0.32 
Anxiety
∆
 0.56 (0.08) 0.40 
to 
0.73 
0.55 0.30 
Depression
∆
 0.58 (0.08) 0.43 
to 
0.73 
0.59 0.35 
Least pain
∆
 0.86 (0.09) 0.69 
to 
1.03 
0.69 0.47 
Average pain
∆
 0.88 (0.08) 0.72 
to 
1.04 
0.72 0.52 
Current pain
∆
 1.00 (0.07) 0.85 
to 
1.14 
0.79 0.62 
Catastrophising 
thoughts
∆
 
Control 0.53 (0.09) 0.35 
to 
0.71 
0.64 0.41 
Fear-avoidance 
beliefs
∆
 
0.63 (0.13) 0.37 
to 
0.88 
0.58 0.33 
Anxiety
∆
 0.48 (0.11) 0.27 
to 
0.69 
0.54 0.29 
Depression
∆
 0.57 (0.11) 0.34 
to 
0.80 
0.58 0.34 
Least pain
∆
 0.64 (0.12) 0.40 
to 
0.87 
0.62 0.38 
Average pain
∆
 0.70 (0.13) 0.45 
to 
0.96 
0.62 0.38 
Current pain
∆
 0.57 (0.12) 0.33 
to 
0.82 
0.55 0.30 
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Testing Criteria for Mediation – Linear regressions to show associations between 
treatment allocation and change in potential mediator (a path) 
Outcome Predictor Unstandardised 
B (SE) 
 
95% CI Standardised 
Β  
R-square 
change 
Catastrophising 
thoughts
∆
 
Treatment 
Allocation 
0.19 (0.22) -0.25 to 
0.63 
0.07 0.00 
Fear-avoidance 
beliefs
∆
 
Treatment 
Allocation 
0.23 (0.19) -0.15 to 
0.60 
0.10 0.01 
Anxiety
∆
 Treatment 
Allocation 
0.23 (0.18) -0.17 to 
0.62 
0.09 0.01 
Depression
∆
 Treatment 
Allocation 
0.04 (0.20) -0.35 to 
0.43 
0.02 0.00 
Least pain
∆
 Treatment 
Allocation 
0.38 (0.17) 0.05 to 
0.70 
0.18 0.03 
Average pain
∆
 Treatment 
Allocation 
0.52 (0.16) 0.20 to 
0.84 
0.25 0.06 
Current pain
∆
 Treatment 
Allocation 
-.40 (0.16) 0.18 to 
0.81 
0.23 0.05 
 
High-risk group 
FIML (n=236) 
 
 
 
 
 
 
 
∆
residualised change 
*p<0.05 
**p<0.01 
All values are standardised 
 
 
 
 
Disability
∆
 
 
Treatment 
(Intervention/Control) 
-0.13* 
0.04 
0.20* 
0.47*
* 
0.51** 
Pain 
Intensity
∆
 
Distress
∆
 
0.70** 
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Total, Direct and Indirect Effects of each Potential Mediator on Change in Disability for High Risk 
Patients 
 Effect Model 
 
Standardised Unstandardised 
RMDQ
∆
 Total -0.02 -0.04 
 Direct -0.13 -0.33 
 Indirect 0.11 0.29 
∆
residualised change 
*p<0.05 
 
Model Fit Statistics for Mediation Model of Change in Disability for High Risk Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 44.67  Non-significant result 
DF 23 
P 0.00 
CMIN/DF 1.94 Between 2-5 
CFI 0.97 Closer to 1 
RMSEA 0.06 (0.04 to 0.09, PCLOSE 0.20) <0.08 
SRMR - <0.08 
 
 
 
 
 
 
 
 
 
 
 
∆
residualised change 
*p<0.05 
**p<0.01 
All values are standardised 
 
Treatment 
(Intervention/Control) General Physical 
Health
∆
  
Pain 
Intensity
∆
 
Distress
∆
 
0.22** 
0.04 
-0.05 
-0.20** 
-0.50** 
0.69** 
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Total, Direct and Indirect Effects of each Potential Mediator on Change in General Physical Health 
for High Risk Patients 
 Effect Model 
 
Standardised Unstandardised 
SF-12 PCS
∆
 Total -0.17 -0.36 
 Direct -0.05 -0.10 
 Indirect -0.12 -0.25 
∆
residualised change 
*p<0.05 
 
Model Fit Statistics for Mediation Model of Change in General Physical Health for High Risk 
Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 47.58 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.07 Between 2-5 
CFI 0.97 Closer to 1 
RMSEA 0.07 (0.04 to 0.10, PCLOSE 0.17) <0.08 
SRMR - <0.08 
 
 
 
Medium Risk Group 
FIML (n=394)  
 
 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
 
Treatment 
(Intervention/Control
Disability
∆
  
Pain 
Intensity∆ 
Distress
∆
 
0.04 
0.11 
0.51** 
0.38** 
-0.08** 
0.68** 
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Total, Direct and Indirect Effects of each Potential Mediator on Disability Change for Medium Risk 
Patients 
 Effect Model 
 
Standardised Unstandardised 
RMDQ
∆
 Total -0.02 -0.04 
 Direct -0.08 -0.17 
 Indirect 0.06 0.13 
∆
residualised change 
*p<0.05 
 
Model Fit Statistics for Mediation Model of Change in Disability Change for Medium Risk Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 78.51 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 3.41  Between 2-5 
CFI 0.95 >0.95 
RMSEA 0.08 (0.06 to 0.10, PCLOSE 0.01) <0.08 
SRMR - <0.08 
 
 
 
 
 
 
  
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
Treatment 
(Intervention/Control
) 
General Physical 
Health
∆
 
Pain 
Intensity
∆
 
0.02 
0.09 
-0.09 
-0.44** 
-0.28** 
Disability
∆
 
0.68 
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Total, Direct and Indirect Effects of each Potential Mediator on General Physical Health Change 
for Medium Risk Patients 
 
 Effect Model 
 
Standardised Unstandardised 
SF12
∆
 Total -0.13 -0.28 
 Direct -0.10 -0.20 
 Indirect -0.04 -0.08 
∆
residualised change 
*p<0.05 
 
Model Fit Statistics for Mediation Model of Change in General Physical Health for Medium Risk 
Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 61.14 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.66 Between 2-5 
CFI 0.96 >0.95 
RMSEA 0.07 (0.05 to 0.09, PCLOSE 0.10) <0.08 
SRMR - <0.08 
 
Low Risk Group 
FIML (n=221) 
 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
 
 
 
Treatment 
(Intervention/Control) 
Disability
∆
 
Pain 
Intensity
∆
 
Distress
∆
 
-0.08 
0.13 
0.09 
0.59** 
0.19** 
0.76 
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Total, Direct and Indirect Effects of each Potential Mediator on Change in Distress for Low Risk 
Patients 
 
 Effect Model 
 
Standardised Unstandardised 
RMDQ
∆
 Total 0.07 0.10 
 Direct 0.09 0.13 
 Indirect -0.02 -0.03 
∆
residualised change 
*p<0.05 
 
Model Fit Statistics for Mediation Model of Change Distress for Low Risk Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 49.86 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.17 Between 2-5 
CFI 0.95 >0.95 
RMSEA 0.07 (0.05 to 0.10, PCLOSE 0.08) <0.08 
SRMR - <0.08 
 
 
 
 
 
 
 
 
 
 
∆residualised change 
*p<0.05 
**p<0.01 
 
 
 
 
 
 
Treatment 
(Intervention/Control
) 
General 
Physical 
Health
∆
  
Pain 
Intensity
∆
-0.07 
0.13 
-0.01 
-0.24** 
-0.38** 
Distress
∆
 
0.75 
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Total, Direct and Indirect Effects of each Potential Mediator on General Health Change for Low 
Risk Patients 
 
 Effect Model 
 
Standardised Unstandardised 
RMDQ
∆
 Total -0.05 -0.09 
 Direct -0.01 -0.03 
 Indirect -0.03 -0.07 
∆
residualised change 
 
Model Fit Statistics for Mediation Model of Change in General Health for Low Risk Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 41.47 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 1.80 Between 2-5 
CFI 0.96 >0.95 
RMSEA 0.06 (0.03 to 0.09, PCLOSE 0.26) <0.08 
SRMR - <0.08 
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Appendix 6.4 Descriptive Statistics for Age to check for normal distribution 
 
Statistics 
Age   
N 
Valid 138 
Missing 0 
Mean 53.89 
Std. Deviation 12.880 
Skewness -.259 
Std. Error of Skewness .206 
Kurtosis -.019 
Std. Error of Kurtosis .410 
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Appendix 6.5 Raw Change Scores – High Risk Analysis 
 
 
 
 
 
 
 
 
 
 
 
Total, Direct and Indirect Effects of each Potential Mediator on Change in Disability for High Risk 
Patients 
 Effect Model 
 
Standardised (95% CI) Unstandardised (95% CI) 
RMDQ
∆
 Total -1.53 (-0.43 to -0.15) -3.87 (-5.65 to -1.89) 
 Direct 0.07 (-0.18 to 0.07) 0.93 (-2.30 to 0.93) 
 Indirect -0.09 (-0.39 to -0.09) -1.09 (-5.01 to -1.09) 
 
Model Fit Statistics for Mediation Model of Change in Disability for High Risk Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 46.97 Non-significant result 
DF 23 
P 0.00 
CMIN/DF 2.04 Between 2-5 
CFI 0.95 Closer to 1 
RMSEA 0.09 (0.05 to 0.12, PCLOSE 0.05) <0.08 
SRMR 0.06 <0.08 
 
 
 
 
Disability Change 
 
Treatment 
(Intervention/Control) 
-0.29 
-0.26 
0.49*
* 
0.36** 
Pain 
Intensity 
Change 
0.62*
Distress
 
Change 
-0.06 
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∆
residualised change 
*p<0.05 
 
Total, Direct and Indirect Effects of each Potential Mediator on Change in Disability for High Risk 
Patients 
 Effect Model 
 
Standardised (95% CI) Unstandardised (95% CI) 
SF12 PCS Total 0.06 (0.06 to 0.37) 1.23 (1.23 to 8.28) 
 Direct 0.20 (-0.11 to 0.20) 4.60 (-2.54 to 4.60) 
 Indirect 0.32 (0.06 to 0.32) 7.02 (1.34 to 7.02) 
 
Model Fit Statistics for Mediation Model of Change in Disability for High Risk Patients 
Model Index Current Model Good Model Fit 
 
CMIN* 51.18 Non-significant result 
DF 23 
P .00 
CMIN/DF 2.23 Between 2-5 
CFI 0.94 Closer to 1 
RMSEA 0.10 (0.06 to 0.13, PCLOSE 0.02) <0.08 
SRMR 0.06 <0.08 
 
Treatment 
(Intervention/Control) 
General Physical Health 
Change  
Pain 
Intensity 
-0.26** 
0.29 
0.04 
-0.20** 
-0.44** 
0.63** 
Distress 
Change 
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Appendix 6.6 STarT Back Analysis: Tests of normal distribution (Complete 
case analysis)  
Baseline Scores: Treatment/Low Risk 
Variable Skewness (SE) Kurtosis (SE) 
Disability (RMDQ) 1.17 (0.24) 1.90 (0.48) 
General Physical Health (SF-12 PCS) -0.66 (0.24) 0.91 (0.48) 
Catastrophising (PCS) 1.62 (0.24) 4.35 (0.48) 
Fear avoidance (TSK) 0.02 (0.24) 0.73 (0.48) 
Anxiety (HADS A) 0.72 (0.24) 0.50 (0.48) 
Depression (HADS D) 1.12 (0.24) 0.47 (0.48) 
Pain Intensity Least 0.95 (0.24) 0.62 (0.48) 
Average -0.06 (0.24) -0.94 (0.48) 
Current 0.71 (0.24) -0.06 (0.48) 
 
Baseline Scores: Treatment/Medium Risk 
Variable Skewness (SE) Kurtosis (SE) 
Disability (RMDQ) 0.21 (0.18) -0.63 (0.36) 
General Physical Health (SF-12 PCS) 0.17 (0.18) -0.26 (0.36) 
Catastrophising (PCS) 0.67 (0.18) 0.31 (0.36) 
Fear avoidance (TSK) -0.03 (0.18) 0.78 (0.36) 
Anxiety (HADS A) 0.49 (0.18) -0.06 (0.36) 
Depression (HADS D) 0.66 (0.18) -0.34 (0.36) 
Pain Intensity Least 0.41 (0.18) -0.51 (0.36) 
Average -0.50 (0.18) 0.10 (0.36) 
Current 0.09 (0.18) -0.73 (0.36) 
 
Baseline Scores: Treatment/High Risk 
Variable Skewness (SE) Kurtosis (SE) 
Disability (RMDQ) -0.21 (0.25) -0.54 (0.50) 
General Physical Health (SF-12 PCS) 0.11 (0.25) -0.14 (0.50) 
Catastrophising (PCS) 0.03 (0.25) -0.34 (0.50) 
Fear avoidance (TSK) 0.29 (0.25) 1.22 (0.50) 
Anxiety (HADS A) -0.02 (0.25) -0.08 (0.50) 
Depression (HADS D) 0.28 (0.25) -0.46 (0.50) 
Pain Intensity Least -0.02 (0.25) -1.12 (0.50) 
Average -0.95 (0.25) 0.78 (0.50) 
Current -0.32 (0.25) -0.48 (0.50) 
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Baseline Scores: Control/Low Risk 
Variable Skewness (SE) Kurtosis (SE) 
Disability (RMDQ) 1.20 (0.34) 1.19 (0.66) 
General Physical Health (SF-12 PCS) -0.47 (0.34) -0.10 (0.66) 
Catastrophising (PCS) 1.20 (0.34) 2.19 (0.66) 
Fear avoidance (TSK) -1.15 (0.34) 2.01 (0.66) 
Anxiety (HADS A) 0.50 (0.34) 0.23 (0.66) 
Depression (HADS D) 1.82 (0.34) 4.24 (0.66) 
Pain Intensity Least 0.99 (0.34) 1.18 (0.66) 
Average 0.02 (0.34) -0.89 (0.66) 
Current 1.11 (0.34) 1.19 (0.66) 
 
Baseline Scores: Control/Medium Risk 
Variable Skewness (SE) Kurtosis (SE) 
Disability (RMDQ) -0.26 (0.26) -0.84 (0.52) 
General Physical Health (SF-12 PCS) 0.05 (0.26) 0.21 (0.52) 
Catastrophising (PCS) 0.98 (0.26) 0.36 (0.52) 
Fear avoidance (TSK) -0.39 (0.26) 1.96 (0.52) 
Anxiety (HADS A) 0.56 (0.26) -0.42 (0.52) 
Depression (HADS D) 1.44 (0.26) 2.15 (0.52) 
Pain Intensity Least 0.47 (0.26) -0.51 (0.52) 
Average -0.18 (0.26) -0.76 (0.52) 
Current 0.14 (0.26) -0.87 (0.52) 
 
Baseline Scores: Control/High Risk 
Variable Skewness (SE) Kurtosis (SE) 
Disability (RMDQ) -0.65 (0.35) 0.24 (0.70) 
General Physical Health (SF-12 PCS) 0.67 (0.35) -0.51 (0.70) 
Catastrophising (PCS) 0.04 (0.35) -0.51 (0.70) 
Fear avoidance (TSK) 1.02 (0.35) 2.75 (0.70) 
Anxiety (HADS A) 0.42 (0.35) -0.39 (0.70) 
Depression (HADS D) 0.71 (0.35) 1.84 (0.70) 
Pain Intensity Least -0.46 (0.35) -0.76 (0.70) 
Average -1.18 (0.35) 0.89 (0.70) 
Current -0.60 (0.35) -0.45 (0.70) 
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Four-month follow-up scores: Treatment/Low Risk 
Variable Skewness (SE) Kurtosis (SE) 
 
Original 
Score 
Residualised 
change score 
Original 
Score 
Residualised 
Score 
Disability (RMDQ) 2.22 (0.24) 1.97 (0.24) 4.84 (0.48) 4.76 (0.48) 
General Physical Health (SF-12 
PCS) 
-0.90 (0.24) -0.65 (0.24) 0.75 (0.48) 0.10 (0.48) 
Catastrophising (PCS) 1.71 (0.24) 1.48 (0.24) 3.23 (0.48) 3.76 (0.48) 
Fear avoidance (TSK) -0.34 (0.24) -0.32 (0.24) -0.25 (0.48) 0.08 (0.48) 
Anxiety (HADS A) 0.96 (0.24) 0.84 (0.24) 0.88 (0.48) 1.85 (0.48) 
Depression (HADS D) 1.23 (0.24) 0.76 (0.24) 0.50 (0.48) 0.72 (0.48) 
Pain 
Intensity 
Least 1.37 (0.24) 0.80 (0.24) 2.50 (0.48) 0.78 (0.48) 
Average 0.62 (0.24) 0.59 (0.24) -0.68 (0.48) -0.40 (0.48) 
Current 1.30 (0.24) 1.02 (0.24) 1.14 (0.48) 1.46 (0.48) 
 
Four-month follow-up scores: Treatment/Medium Risk 
Variable Skewness (SE) Kurtosis (SE) 
 
Four-month 
Score 
Residualised 
Score 
Original 
Score 
Residualised 
Score 
Disability (RMDQ) 1.01 (0.18) 0.41 (0.18) -0.17 (0.36) -0.41 (0.36) 
General Physical Health (SF-12 
PCS) 
-0.84 (0.18) -0.16 (0.18) 0.24 (0.36) -0.37 (0.36) 
Catastrophising (PCS) 1.30 (0.18) 0.88 (0.18) 1.08 (0.36) 0.67 (0.36) 
Fear avoidance (TSK) 0.27 (0.18) -0.05 (0.18) 2.39 (0.36) 1.19 (0.36) 
Anxiety (HADS A) 0.70 (0.18) 0.19 (0.18) -0.08 (0.36) 0.10 (0.36) 
Depression (HADS D) 1.32 (0.18) 0.71 (0.18) 1.84 (0.36) 1.88 (0.36) 
Pain Intensity Least 0.97 (0.18) 0.73 (0.18) 0.63 (0.36) 
Pain 
Intensity 
Average 0.43 (0.18) 0.32 (0.18) -0.87 (0.36) 0.52 (0.36) 
Current 0.83 (0.18) 0.63 (0.18) -0.40 (0.36) -0.94 (0.36) 
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Four-month follow-up scores: Treatment/High Risk 
Variable Skewness (SE) Kurtosis (SE) 
 
Original 
Score 
Residualised 
Score 
Original 
Score 
Residualised 
Score 
Disability (RMDQ) 0.59 (0.25) 0.27 (0.25) -1.03 (0.50) -0.87 (0.50) 
General Physical Health (SF-12 
PCS) 
-0.08 (0.25) 0.40 (0.25) -0.56 (0.50) 0.27 (0.50) 
Catastrophising (PCS) 0.88 (0.25) 0.56 (0.25) -0.23 (0.50) 0.30 (0.50) 
Fear avoidance (TSK) -0.04 (0.25) -0.31 (0.25) 0.99 (0.50) 1.46 (0.50) 
Anxiety (HADS A) 0.51 (0.25) 0.35 (0.25) -0.28 (0.50) 0.43 (0.50) 
Depression (HADS D) 0.93 (0.25) 0.59 (0.25) 0.18 (0.50) 0.85 (0.50) 
Pain 
Intensity 
Least 0.96 (0.25) 1.00 (0.25) 0.44 (0.50) 0.60 (0.50) 
Average 0.67 (0.25) 0.72 (0.25) -0.48 (0.50) 0.14 (0.50) 
Current 0.83 (0.25) 0.50 (0.25) -0.38 (0.50) -0.38 (0.50) 
 
Four-month follow-up scores: Control/Low Risk 
Variable Skewness (SE) Kurtosis (SE) 
 
Original 
Score 
Residualised 
Score 
Original 
Score 
Residualised 
Score 
Disability (RMDQ) 2.48 (0.34) 1.78 (0.34) 8.94 (0.66) 6.08 (0.66) 
General Physical Health (SF-12 
PCS) 
-0.96 (0.34) -1.46 (0.34) 1.06 (0.66) 3.39 (0.66) 
Catastrophising (PCS) 1.20 (0.34) 1.33 (0.34) 1.19 (0.66) 1.90 (0.66) 
Fear avoidance (TSK) -0.19 (0.34) -0.24 (0.34) 1.19 (0.66) 0.70 (0.66) 
Anxiety (HADS A) 0.50 (0.34) -0.24 (0.34) -0.69 (0.66) 0.35 (0.66) 
Depression (HADS D) 1.20 (0.34) 1.07 (0.34) 1.02 (0.66) 3.21 (0.66) 
Pain 
Intensity 
Least 0.54 (0.34) 0.59 (0.34) -1.15 (0.66) -0.78 (0.66) 
Average 0.20 (0.34) 0.28 (0.34) -1.11 (0.66) -0.70 (0.66) 
Current 0.88 (0.34) 0.94 (0.34) 0.18 (0.66) 0.55 (0.66) 
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Four-month follow-up scores: Control/Medium Risk 
Variable Skewness (SE) Kurtosis (SE) 
 
Original 
Score 
Residualised 
Score 
Original 
Score 
Residualised 
Score 
Disability (RMDQ) 0.79 (0.26) 0.50 (0.26) -0.76 (0.52) -0.69 (0.52) 
General Physical Health (SF-12 
PCS) 
-0.21 (0.26) 0.19 (0.26) -0.82 (0.52) -0.14 (0.52) 
Catastrophising (PCS) 1.21 (0.26) 0.94 (0.26) 1.77 (0.52) 1.82 (0.52) 
Fear avoidance (TSK) -0.44 (0.26) -0.16 (0.26) 0.23 (0.52) 0.18 (0.52) 
Anxiety (HADS A) 0.56 (0.26) -0.11 (0.26) -0.21 (0.52) 0.53 (0.52) 
Depression (HADS D) 1.45 (0.26) 0.95 (0.26) 2.45 (0.52) 1.43 (0.52) 
Pain 
Intensity 
Least 0.75 (0.26) 0.65 (0.26) -0.26 (0.52) 0.25 (0.52) 
Average 0.39 (0.26) 0.35 (0.26) -0.72 (0.52) -0.55 (0.52) 
Current 0.57 (0.26) 0.53 (0.26) -0.77 (0.52) -0.69 (0.52) 
 
Four-month follow-up scores: Control/High Risk 
Variable Skewness (SE) Kurtosis (SE) 
 
Original 
Score 
Residualised 
change score 
Original 
Score 
Residualised 
Score 
Disability (RMDQ) -0.06 (0.35) 0.04 (0.35) -1.11 (0.70) -0.98 (0.70) 
General Physical Health (SF-12 
PCS) 
0.48 (0.35) 0.68 (0.35) -0.85 (0.70) -0.08 (0.70) 
Catastrophising (PCS) 0.37 (0.35) 0.15 (0.35) -0.68 (0.70) -1.08 (0.70) 
Fear avoidance (TSK) 0.28 (0.35) -0.24 (0.35) 0.89 (0.70) 0.10 (0.79) 
Anxiety (HADS A) 0.61 (0.35) -0.13 (0.35) 0.47 (0.70) 0.11 (0.70) 
Depression (HADS D) 0.62 (0.35) -0.04 (0.35) 0.35 (0.70) -0.86 (0.70) 
Pain 
Intensity 
Least 0.56 (0.35) 0.53 (0.35) -0.55 (0.70) -0.15 (0.70) 
Average -0.24 (0.35) -0.22 (0.35) -0.97 (0.70) -0.82 (0.70) 
Current 0.00 (0.35) 0.35 (0.35) -1.21 (0.70) -0.34 (0.70) 
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High risk group: Baseline Scores: Histograms 
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Current Pain 
 
 
 
 
 
 
 
High Risk Group: Baseline Scores: P-Plots 
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High Risk: Four-month Follow-up Scores: Histograms 
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High Risk: 4m Follow-up scores: P-Plots 
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High Risk: Residualised Change Scores: Histograms 
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High Risk Group: Residualised Change Scores: P-Plots 
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Appendix 6.7 Analysis of Potential Non-Response Bias in STarT Back participants (baseline characteristics of responders 
and non-responders to follow-up questionnaires)  
All data 
Measure Baseline values (mean (SD)) 
(n=851) 
Baseline values (Mean (SD)) at four-month follow-up  
Resp (n=689) Non-resp (n=162) Difference 
Age 49.73 (14.76) 51.88 (14.19) 40.60 (13.65) 11.28 
Sex 500 (47%) f 410 (60%) f 90 (56%) f  
RMDQ 9.76 (5.67) 9.57 (5.63) 10.59 (5.78) 1.02 
SF-12 PCS 36.80 (10.47) 37.00 (10.49) 35.98 (10.39) 1.02 
TSK 40.42 (6.20) 40.31 (6.05) 40.88 (6.79) 0.57 
PCS 16.14 (10.86) 15.79 (10.70) 17.65 (11.42) 1.86 
HADS-A 7.47 (4.07) 7.43 (4.09) 7.64 (3.99) 0.21 
HADS-D 5.88 (4.08) 5.76 (3.98) 6.40 (4.44) 0.64 
Pain: least 4.39 (2.76) 4.34 (2.78) 4.58 (2.67) 0.24 
Pain: Average last two weeks 6.62 (2.37) 6.55 (2.41) 6.88 (2.18) 0.33 
Pain: Current 4.91 (2.63) 4.81 (2.62) 5.34 (2.64) 0.53 
 
Responders at four-month follow-up were older, less disabled (RMDQ and SF-12) and catastrophised less. Smaller differences between other measures 
but indication of responders being less fear-avoidant, less anxious, less depressed and reporting less pain. 
 
 
Appendix 6.7 Page 435 
 
High-risk Group only 
Measure Baseline values (mean (SD)) 
(n=851) 
Baseline values (Mean (SD)) at four-month follow-up  
Resp (n=188) Non-resp (n=48) Difference 
Age 49.73 (14.76) 53.95 (14.13) 43.33 (14.39) 10.62 
Sex 500 (47%) f 111 (59%) f 22 (46%) f  
RMDQ 9.76 (5.67) 14.28 (4.56) 15.40 (4.46) 1.12 
SF-12 PCS 36.80 (10.47) 31.12 (7.84) 27.61 (7.19) 3.51 
TSK 40.42 (6.20) 45.49 (5.19) 47.30 (5.25) 1.81 
PCS 16.14 (10.86) 20.04 (10.25) 28.67 (11.27) 8.63 
HADS-A 7.47 (4.07) 10.23 (3.96) 9.60 (4.25) 0.63 
HADS-D 5.88 (4.08) 8.73 (4.02) 9.56 (4.42) 0.83 
Pain: least 4.39 (2.76) 6.21 (2.73) 5.96 (2.75) 0.25 
Pain: Average last two weeks 6.62 (2.37) 7.86 (1.92) 8.44 (1.62) 0.58 
Pain: Current 4.91 (2.63) 6.56 (2.32) 7.00 (1.98) 0.44 
 
Much larger differences in the high-risk group – responders at four-month follow-up are older, less disabled (RMDQ and SF-12), catastrophised less and 
were less fear-avoidant. Smaller differences between other measures but responders were more anxious and less depressed.  
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High-risk Group only: Split by treatment and control 
Measure Baseline values (mean (SD)) 
(n=851) 
Baseline values (Mean (SD)) at four-month follow-up 
 
 
Treatment Control 
 
Resp (n=131) Non-resp 
(n=26) 
Resp 
(n=57) 
Non-resp (n=22) Difference 
Treatment Control 
Age 49.73 (14.76) 53.87 (13.85) 46.50 (16.42) 54.12 
(14.88) 
39.59 (10.74) 7.37 14.53 
Sex 500 (47%) f 76 (58%) f 12 (46%) f 35 (61%) f 10 (46%) f   
RMDQ 9.76 (5.67) 14.27 (4.54) 15.08 (5.15) 14.32 
(4.65) 
15.77 (3.56) 0.81 1.45 
SF-12 PCS 36.80 (10.47) 31.37 (7.67) 28.13 (6.72) 30.56 
(8.25) 
27.00 (7.83) 3.24 3.56 
TSK 40.42 (6.20) 45.57 (5.12) 47.05 (4.48) 45.32 
(5.38) 
47.60 (6.13) 1.48 2.28 
PCS 16.14 (10.86) 25.86 (10.32) 29.19 (11.89) 26.45 
(10.15) 
28.05 (10.73) 3.33 1.60 
HADS-A 7.47 (4.07) 10.17 (4.18) 9.81 (4.08) 10.37 
(3.44) 
9.36 (4.53) 0.36 1.01 
HADS-D 5.88 (4.08) 8.82 (4.20) 9.27 (4.94) 8.53 (3.60) 9.91 (3.80) 0.45 1.38 
Pain: least 4.39 (2.76) 6.32 (2.55) 6.38 (2.62) 5.98 (3.12) 5.45 (2.87) 0.06 0.53 
Pain: Average last two weeks 6.62 (2.37) 7.78 (1.97) 8.69 (5.12) 8.02 (1.79) 8.14 (1.73) 0.91 0.12 
Pain: Current 4.91 (2.63) 6.56 (2.27) 7.27 (1.76) 6.54 (2.49) 6.68 (2.21) 0.71 0.14 
 
In the treatment group, patients responding at four-month follow-up were older, less disabled (RMDQ and SF-12), catastrophised less and were less 
fear-avoidant than those who did not respond. They also reported less average and current pain. 
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In the control group, patients responding at four-month follow-up were older, less disabled (RMDQ and SF-12), less fear-avoidant and catastrophised 
less, and also reported more anxiety and less depression. No differences in pain between responders and non-responders. 
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1 
2 
1.2 
Appendix 7.1: Sensitivity analysis for Back In Action study: Complete Case 
analysis (based on responses to RMDQ and TSK) (n=172) 
 
LGM Model for Fear-avoidance beliefs (10-item TSK) 
 
 
 
 
 
 
 
 
 
 
Model Fit Statistics for Growth Curve Model of 10-item TSK 
Model Index Current Model Good Model Fit 
 
CMIN (Chi Square) 46.91 Non-significant result 
DF 14 
P 0.00 
CMIN/DF 3.35 Between 2-5 
CFI 0.95 >0.95 
RMSEA 0.12 <0.08 
SRMR 0.04 <0.08 
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1 2 1 2.5 
2.5 
LGM Model for Disability (23-item RMDQ) 
 
 
 
 
 
 
 
 
 
 
Model Fit Statistics for Growth Curve Model of RMDQ 
Model Index Current Model Good Model Fit 
 
CMIN (Chi Square) 26.27 Non-significant result 
DF 15 
P 0.04 
CMIN/DF 1.75 Between 2-5 
CFI 0.98 >0.95 
RMSEA 0.07 <0.08 
SRMR 0.03 <0.08 
 
 
 
 
 
 
 
 
Baseline  Two-month 
follow-up 
Six-month 
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24-month 
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RMDQ 
Slope 
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Within-domain Co-variance 
Between-
domain Co-
variance 
Simplified LGM Model to show Relationships between Mediator and Outcome Variables 
 
 
 
 
 
 
 
 
Model Fit Statistics for Parallel Process Model without Treatment Group Allocation as a Co-variate 
Model Index Original Model Modified Model Good Model Fit 
 
CMIN* (Chi Square) 152.62 135.74 Non-significant result 
DF 51 50 
P 0.00 0.00 
CMIN/DF 2.99 2.72 Between 2-5 
CFI 0.93 0.94 >0.95 
RMSEA 0.11 0.10 <0.08 
SRMR 0.04 0.04 <0.08 
 
 
 
 
 
 
 
 
 
 
TSK 
Intercept 
TSK 
Slope 
RMDQ 
Intercept 
RMDQ 
Slope 
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Table 7.7 Means, Co-variances, Correlations and Variances between Mediator and Outcome 
Variables 
 Variables 
 
Estimate Standard Error p-value 
Means TSK Intercept (baseline value) 40.42 0.64 <0.05 
TSK Slope  
(change over all time points) 
-2.84  0.32 <0.05 
RMDQ Intercept 11.55 0.42 <0.05 
RMDQ Slope -1.18  0.15 <0.05 
Co-variances TSK Intercept <-> TSK Slope 1.64  2.53 0.52 
TSK Intercept <-> RMDQ Intercept 22.50 3.76 <0.05 
TSK Slope <-> RMDQ Slope 2.98 0.62 <0.05 
RMDQ Intercept <-> RMDQ Slope 0.57 0.74 0.44 
Variances  TSK Intercept  52.41 7.56 <0.05 
TSK Slope 7.30 2.02 <0.05 
RMDQ Intercept 23.35 3.30 <0.05 
RMDQ Slope 1.52 0.41 <0.05 
β = Unstandardised estimate 
b = Standardised estimate 
 
 
Simplified LGM Model to show Relationships between Mediator and Outcome Variables, with 
Treatment Group Allocation as a Co-variate 
 
 
 
 
 
 
 
 
 
 
 
TSK 
Intercept 
TSK Slope 
RMDQ 
Intercept 
RMDQ 
Slope 
Intervention 
(Control=0; 
Intervention=1) 
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Model Fit Statistics for Parallel Process Model with Treatment Group Allocation Co-variate 
Model Index Original Model Modified Model Good Model Fit 
 
CMIN (Chi Square) 263.49 168.18 Non-significant result 
DF 61 59 
P 0.00 0.00 
CMIN/DF 4.31 2.85 Between 2-5 
CFI 0.86 0.93 >0.95 
RMSEA 0.14 (0.12 to .16, PCLOSE 
0.00) 
0.10 (0.09 to 0.12, 
PCLOSE 0.00) 
<0.08 
SRMR 0.27 0.04 <0.08 
 
Mean Values for Mediator and Outcome, Related to Treatment Group Allocation 
 Variables 
 
Estimate Standard Error p-value 
Regression 
Coefficients 
TSK Intercept β -0.94 
b 0.06 
1.30 0.47 
TSK Slope β -2.18 
b -0.40 
0.63 <0.05 
RMDQ Intercept β 0.94 
b 0.10 
0.86 0.27 
RMDQ Slope β -0.93 
-0.34 
0.30 0.00 
β = Unstandardised estimate 
b = Standardised estimate 
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1 1 1.5 1 2 
2.5 
1 1 1.5 
1.2 1.5 
β= 0.02 
b= 0.01 
β= -4.02 
b= -0.49 β=0.27 
b= 0.74 
β= -1.09 
b=-0.37 
Full Mediation Model: Change in Fear-avoidance beliefs (10-item TSK) as a Mediator between 
Intervention Allocation and Change in Disability Outcome (23-item RMDQ) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
β = Unstandardised estimate 
b = Standardised estimate 
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Mediating Effect of Change in Fear-avoidance beliefs (TSK) on the Relationship between 
Treatment Allocation and Change in Disability (RMDQ)  
 Effect Model 
Standardised Estimates (95% CI) Unstandardised Estimates (95% CI) 
RMDQ (23-item)
∆
 Total (ć)  -0.37 (-0.54 to -0.14)  -1.09 (-1.69 to -0.40) 
Direct (c) 0.01 (-0.27 to 0.27) 0.02 (-0.76 to 0.80) 
Indirect (ab) -0.37 (-0.54 to -0.22) -1.10 (-1.73 to -0.59) 
 
Model Fit Statistics for Full Mediation Model 
Model Index Full Mediation Model Modified Model Good Model Fit 
 
CMIN (Chi 
Square) 
811.92 295.98 Non-significant result 
DF 63 59 
P 0.00 0.00 
CMIN/DF 12.89 5.02 Between 2-5 
CFI 0.50 0.84 >0.95 
RMSEA 0.26 0.15 <0.08 
SRMR 0.36 0.25 (0.14 to 0.17, PCLOSE 
0.00) 
<0.08 
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Appendix 7.2: Assessing Trajectories of RMDQ and TSK – Model Fit 
 
RMDQ: Treatment Trajectory (Both groups) 
Factor Score Sequence 
 
CMIN (df) CFI RMSEA SRMR 
0, -0.2, -0.5, -1, -2  0.92 0.14 0.03 
0, -1, -1, -1.5, -3  0.91 0.15 0.05 
0, -1, -1.5, -2, -3  0.95 0.11 0.04 
0, -0.2, -0.4, -1, -2  0.91 0.15 0.03 
0, -1, -1.5, -2, -2.5  0.96 0.10 0.04 
 
RMDQ: Treatment Trajectory (Control group only) 
CFI = 0.93, RMSEA = 0.13, SRMR = 0.05 
 
RMDQ: Control Trajectory 
0, 0, -1, -2, -2: CFI = 0.97, RMSEA = 0.08, SRMR = 0.03 
 
TSK: Treatment Trajectory (Both groups) 
Factor Score Sequence 
 
CMIN (df) CFI RMSEA SRMR 
0, -0.2, -0.5, -1, -2  0.85 0.20 0.05 
0, -1.2, -1.5, -1, -2  0.90 0.17 0.04 
0, -1.2, -1.5, -1, -1.5  0.91 0.15 0.04 
0, -1.2, -1.5, -1.2, -2.5  0.89 0.17 0.04 
0, -1.2, -1.5, -1, -2.5  0.87 0.18 0.05 
0, -1.2, -1.5, -1.2, -1.5  0.94 0.13 0.04 
0, -1, -1.5, -1.2, -1.5  0.95 0.12 0.04 
0, -1, -1.4, -1, -1.7  0.92 0.15 0.04 
0, -1, -1.5, -1.2, -1.6  0.94 0.12 0.04 
 
TSK: Treatment Trajectory (Control group only) 
CFI = 0.91, RMSEA = 0.15, SRMR = 0.06 
TSK: Control Trajectory 
0, -0.5, -1, -2, -1: CFI = 0.94, RMSEA = 0.12, SRMR = 0.05 
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Appendix 8.1 Distribution of SIP Disability Score 
 
 Mean (SD) Skewness (SE) Kurtosis (SE) 
Post-treatment 
SIP Disability 
score 
0.16 (0.14) 1.02 (0.29) 1.27 (0.54) 
Residualised 
change in SIP 
Disability (pre-
post treatment) 
0.00 (1.00) 0.24 (0.29) 0.32 (0.57) 
 
 
 
 
 
 
